assays_doc_id,assays_assay_tax_id,assays_relationship_type,assays_tissue_id,assays_chembl_id,assays_assay_cell_type,assays_variant_id,assays_assay_category,assays_assay_tissue,assays_assay_id,assays_confidence_score,assays_description,assays_assay_strain,assays_curated_by,assays_tid,assays_cell_id,assays_bao_format,assays_assay_subcellular_fraction,assays_assay_test_type,assays_assay_organism,assays_src_id,assays_src_assay_id,assays_assay_type
9866,10116.0,N,2113.0,CHEMBL618647,,,,Kidney,7524,1,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL618648,,,,Kidney,7525,1,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL618649,,,,Kidney,7526,1,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL618650,,,,Liver,7527,1,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL618651,,,,Liver,7528,1,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL876497,,,,Liver,7529,1,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2048.0,CHEMBL618652,,,,Lung,7530,1,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2048.0,CHEMBL618653,,,,Lung,7531,1,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2048.0,CHEMBL618654,,,,Lung,7532,1,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6351,10116.0,N,,CHEMBL618655,,,,,7533,1,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1465,10116.0,N,,CHEMBL618656,,,,,7534,1,Compound was tested for solubility in water,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5182,,U,,CHEMBL618657,,,,,7535,0,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,Intermediate,22229,,BAO_0000100,,,,1,,P
17847,10116.0,N,,CHEMBL618658,,,,,7536,1,Solubility was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15339,10116.0,N,,CHEMBL618659,,,,,7537,1,solubility in water (ug/mL) at 37 degree C.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5202,10116.0,N,,CHEMBL618660,,,,,7538,1,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1088,10116.0,N,,CHEMBL618661,,,,,7539,1,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3169,10116.0,N,,CHEMBL873807,,,,,7540,1,Half life in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5353,10116.0,N,,CHEMBL618662,,,,,7541,1,Half life in Dawley rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2864,10116.0,N,,CHEMBL618663,,,,,7542,1,Half life period after 3 mg/kg iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2864,10116.0,N,,CHEMBL618664,,,,,7543,1,Half life period after 3 mg/kg iv administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2864,10116.0,N,,CHEMBL618665,,,,,7544,1,Half life period after 3 mg/kg iv administration in the rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6362,10116.0,N,,CHEMBL876498,,,,,7545,1,Half life period in female Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6249,10116.0,N,,CHEMBL618666,,,,,7546,1,Half life period in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3169,10116.0,N,,CHEMBL620440,,,,,7547,1,Half-life in rats was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3169,10116.0,N,,CHEMBL620441,,,,,7548,1,Half-life in rats with metabolic oxidation,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3169,10116.0,N,,CHEMBL620442,,,,,7549,1,Half-life in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17260,10116.0,N,,CHEMBL620443,,,,,7550,1,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17260,10116.0,N,,CHEMBL620444,,,,,7551,1,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17260,10116.0,N,,CHEMBL620445,,,,,7552,1,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17260,10116.0,N,,CHEMBL620446,,,,,7553,1,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2879,10116.0,N,1969.0,CHEMBL620447,,,,Plasma,7554,1,Biological half-life measured in plasma of rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2879,10116.0,N,1969.0,CHEMBL621129,,,,Plasma,7555,1,Biological half-life measured in plasma of rat; 22-25,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2879,10116.0,N,1969.0,CHEMBL621130,,,,Plasma,7556,1,Biological half-life measured in plasma of rat; 9-16,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3184,10116.0,N,,CHEMBL873808,,,,,7557,1,Compound was evaluated for its half life when administered intravenously in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4891,10116.0,N,,CHEMBL876598,,,,,7558,1,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
429,10116.0,N,,CHEMBL621131,,,,,7559,1,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5656,10116.0,N,,CHEMBL621132,,,,,7560,1,Half life (T1/2) after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4413,10116.0,N,,CHEMBL621133,,,,,7561,1,Half life of compound after iv administration of 20 mg/kg dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3598,10116.0,N,,CHEMBL621312,,,,,7562,1,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,Expert,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17267,10116.0,N,,CHEMBL621313,,,,,7563,1,Half life of compound was determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4727,10116.0,N,178.0,CHEMBL621314,,,,Blood,7564,1,Half life of compound was determined in rat blood,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17651,10116.0,N,,CHEMBL621315,,,,,7565,1,Half life at 1 mg/kg was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17651,10116.0,N,,CHEMBL621316,,,,,7566,1,Half life at 10 mg/kg was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
401,10116.0,N,,CHEMBL621317,,,,,7567,1,Half life in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4942,10116.0,N,,CHEMBL621318,,,,,7568,1,Half life in rats in hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17735,10116.0,N,,CHEMBL621319,,,,,7569,1,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6056,10116.0,N,,CHEMBL621377,,,,,7570,1,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5213,10116.0,N,,CHEMBL621378,,,,,7571,1,Half life was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6616,10116.0,N,,CHEMBL876599,,,,,7572,1,Half life after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5937,10116.0,N,,CHEMBL621379,,,,,7573,1,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5819,10116.0,N,1969.0,CHEMBL621380,,,,Plasma,7574,1,Half life in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5819,10116.0,N,1969.0,CHEMBL621381,,,,Plasma,7575,1,Half life in rat plasma; Not detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6803,10116.0,N,,CHEMBL618515,,,,,7576,1,Half life in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17804,10116.0,N,,CHEMBL618516,,,,,7577,1,Half life period of compound was determined after peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17804,10116.0,N,,CHEMBL618517,,,,,7578,1,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5948,10116.0,N,,CHEMBL618518,,,,,7579,1,Half life period in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1916,10116.0,N,,CHEMBL618519,,,,,7580,1,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1916,10116.0,N,,CHEMBL618698,,,,,7581,1,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1916,10116.0,N,,CHEMBL618862,,,,,7582,1,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4890,10116.0,N,,CHEMBL618863,,,,,7583,1,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17764,10116.0,N,,CHEMBL618864,,,,,7584,1,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4727,10116.0,N,,CHEMBL618865,,,,,7585,1,Half life time in rat the dose of 2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL618866,,,,,7586,1,Half-life 24 hr after 10 mg/kg iv administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL618867,,,,,7587,1,Half-life 24 hr after 2 mg/kg iv administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6597,10116.0,N,,CHEMBL875828,,,,,7588,1,Half-life consistent with the observed metabolic steady state in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17735,10116.0,N,,CHEMBL618868,,,,,7589,1,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6597,10116.0,N,,CHEMBL618869,,,,,7590,1,Half-life for oxidative metabolic stability was determined using male human,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17670,10116.0,N,,CHEMBL618870,,,,,7591,1,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1696,10116.0,N,1969.0,CHEMBL618871,,,,Plasma,7592,1,Half-life in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1742,10116.0,N,1969.0,CHEMBL618872,,,,Plasma,7593,1,Half-life in rat plasma was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17800,10116.0,N,,CHEMBL873816,,,,,7594,1,Half-life in rats was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12923,,U,,CHEMBL618873,,,,,7595,0,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,Autocuration,22224,,BAO_0000218,,,,1,,A
11954,,U,,CHEMBL621602,,,,,7596,0,Area under curve after oral dose of 0.1 mg//kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
11954,,U,,CHEMBL621603,,,,,7597,0,Area under curve after oral dose of 0.3 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
11954,,U,,CHEMBL621604,,,,,7598,0,Area under curve after oral dose of 1 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
11954,,U,,CHEMBL621605,,,,,7599,0,Area under curve after oral dose of 10 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
11954,,U,,CHEMBL621606,,,,,7600,0,Area under curve after oral dose of 23.4 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
11954,,U,,CHEMBL621607,,,,,7601,0,Area under curve after oral dose of 3 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
11954,,U,,CHEMBL621608,,,,,7602,0,Area under curve after oral dose of 3.87 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
5237,,U,,CHEMBL621609,,,,,7603,0,Area under curve was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
4026,,U,,CHEMBL621610,,,,,7604,0,Area under curve at a dose of 10 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
5237,10116.0,N,,CHEMBL621611,,,,,7605,1,Area under curve was determined; ND=No data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL621612,,,,,7606,1,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL622308,,,,,7607,1,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL622309,,,,,7608,1,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL622310,,,,,7609,1,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL622311,,,,,7610,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL622312,,,,,7611,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL622931,,,,,7612,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL622932,,,,,7613,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL622736,,,,Plasma,7614,1,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL622737,,,,Plasma,7615,1,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL622738,,,,Plasma,7616,1,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL622739,,,,Plasma,7617,1,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL622740,,,,Plasma,7618,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL622741,,,,Plasma,7619,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL622742,,,,Plasma,7620,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL622743,,,,Plasma,7621,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11637,10090.0,N,1969.0,CHEMBL622744,,,,Plasma,7622,1,AUC in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
11149,,U,,CHEMBL624134,,,,,7623,0,Area under curve was measured from the graph obtained from concentration Vs time,,Autocuration,22224,,BAO_0000019,,,,1,,A
10016,,U,,CHEMBL624135,,,,,7624,0,Area under curve value of compound per hour after oral administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
17796,10116.0,N,,CHEMBL624136,,,,,7625,1,Area under curve was determined after oral administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17796,10116.0,N,,CHEMBL624137,,,,,7626,1,Area under curve was determined after oral administration in rats; No data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17796,10116.0,N,,CHEMBL624320,,,,,7627,1,Area under curve was determined after oral administration in rats;No data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12923,9615.0,N,,CHEMBL624321,,,,,7628,1,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15372,10116.0,N,,CHEMBL624322,,,,,7629,1,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL624323,,,,,7630,1,Area under curve was determined for the compound after iv dose of 5.06 in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL624324,,,,,7631,1,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL624325,,,,,7632,1,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL624326,,,,,7633,1,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL624327,,,,,7634,1,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL624328,,,,,7635,1,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14169,9615.0,N,,CHEMBL627848,,,,,7636,1,Area under curve was determined in Dogs after peroral administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14169,10116.0,N,,CHEMBL627849,,,,,7637,1,Area under curve was determined in Rats after peroral administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14258,10116.0,N,,CHEMBL627850,,,,,7638,1,Area under curve was determined in carotid blood of rat when administered intradermally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14258,10116.0,N,,CHEMBL627851,,,,,7639,1,Area under curve was determined in portal blood of rat when administered intradermally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15011,10090.0,N,,CHEMBL627852,,,,,7640,1,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL627853,,,,,7641,1,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL627854,,,,,7642,1,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL627855,,,,,7643,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL627856,,,,,7644,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL875339,,,,,7645,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL627857,,,,,7646,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
11195,10116.0,N,2106.0,CHEMBL627858,,,,Spleen,7647,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10130,10116.0,N,178.0,CHEMBL627859,,,,Blood,7648,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,955.0,CHEMBL627860,,,,Brain,7649,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,948.0,CHEMBL627019,,,,Heart,7650,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2107.0,CHEMBL627020,,,,Liver,7651,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2048.0,CHEMBL627021,,,,Lung,7652,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2385.0,CHEMBL627022,,,,Muscle tissue,7653,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,,CHEMBL627023,,,,,7654,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2106.0,CHEMBL627024,,,,Spleen,7655,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2046.0,CHEMBL627025,,,,Thyroid gland,7656,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2113.0,CHEMBL627026,,,,Kidney,7657,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,178.0,CHEMBL627027,,,,Blood,7658,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,955.0,CHEMBL627028,,,,Brain,7659,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,948.0,CHEMBL627029,,,,Heart,7660,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2113.0,CHEMBL627030,,,,Kidney,7661,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2107.0,CHEMBL627031,,,,Liver,7662,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2048.0,CHEMBL627032,,,,Lung,7663,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2385.0,CHEMBL627033,,,,Muscle tissue,7664,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,,CHEMBL627034,,,,,7665,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2106.0,CHEMBL627035,,,,Spleen,7666,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2046.0,CHEMBL627036,,,,Thyroid gland,7667,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,178.0,CHEMBL875340,,,,Blood,7668,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,948.0,CHEMBL627037,,,,Heart,7669,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2113.0,CHEMBL627038,,,,Kidney,7670,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2107.0,CHEMBL627039,,,,Liver,7671,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2385.0,CHEMBL627040,,,,Muscle tissue,7672,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2106.0,CHEMBL624663,,,,Spleen,7673,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2046.0,CHEMBL625963,,,,Thyroid gland,7674,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,955.0,CHEMBL876799,,,,Brain,7675,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,2048.0,CHEMBL626133,,,,Lung,7676,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,,CHEMBL626134,,,,,7677,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6295,10116.0,N,,CHEMBL626135,,,,,7678,1,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6296,10116.0,N,,CHEMBL626136,,,,,7679,1,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6296,10116.0,N,,CHEMBL626137,,,,,7680,1,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6295,10116.0,N,,CHEMBL626138,,,,,7681,1,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6296,10116.0,N,,CHEMBL626139,,,,,7682,1,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17260,10116.0,N,,CHEMBL626140,,,,,7683,1,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17260,10116.0,N,,CHEMBL626141,,,,,7684,1,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17686,10116.0,N,,CHEMBL626142,,,,,7685,1,C24h in rat p.o. at 20 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL627930,,,,Muscle tissue,7686,1,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL627931,,,,Muscle tissue,7687,1,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL627932,,,,Muscle tissue,7688,1,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL627933,,,,Spleen,7689,1,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL627934,,,,Spleen,7690,1,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL627935,,,,Spleen,7691,1,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627936,,,,Blood,7692,1,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627937,,,,Blood,7693,1,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627938,,,,Blood,7694,1,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627939,,,,Blood,7695,1,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627940,,,,Blood,7696,1,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627941,,,,Blood,7697,1,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL876800,,,,Blood,7698,1,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627942,,,,Blood,7699,1,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627943,,,,Blood,7700,1,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627944,,,,Blood,7701,1,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627945,,,,Blood,7702,1,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL628584,,,,Blood,7703,1,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL628585,,,,Blood,7704,1,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL628586,,,,Blood,7705,1,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL628587,,,,Blood,7706,1,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL628588,,,,Blood,7707,1,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL628589,,,,Blood,7708,1,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL625304,,,,Blood,7709,1,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL625305,,,,Blood,7710,1,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL625306,,,,Blood,7711,1,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL625307,,,,Blood,7712,1,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL625308,,,,Blood,7713,1,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627740,,,,Blood,7714,1,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627741,,,,Blood,7715,1,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627742,,,,Blood,7716,1,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627743,,,,Blood,7717,1,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,178.0,CHEMBL627744,,,,Blood,7718,1,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL627745,,,,Bone,7719,1,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL627746,,,,Bone,7720,1,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL627747,,,,Bone,7721,1,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL876810,,,,Bone,7722,1,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL627748,,,,Bone,7723,1,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL627749,,,,Bone,7724,1,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL627750,,,,Bone,7725,1,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618728,,,,Bone,7726,1,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618729,,,,Bone,7727,1,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618730,,,,Bone,7728,1,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618731,,,,Bone,7729,1,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618732,,,,Bone,7730,1,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618733,,,,Bone,7731,1,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618734,,,,Bone,7732,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618735,,,,Bone,7733,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL876602,,,,Bone,7734,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618736,,,,Bone,7735,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618737,,,,Bone,7736,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618738,,,,Bone,7737,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618739,,,,Bone,7738,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618740,,,,Bone,7739,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618741,,,,Bone,7740,1,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618742,,,,Bone,7741,1,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,10000001.0,CHEMBL618743,,,,Bone,7742,1,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17752,10116.0,N,1969.0,CHEMBL618744,,,,Plasma,7743,1,Half-life from rat plasma at a single oral dose of 25 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5610,10116.0,N,,CHEMBL618745,,,,,7744,1,Half-life in male rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL620479,,,,,7745,1,Half-life in rat after peroral administration at 10 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL620480,,,,,7746,1,Half-life in rat after peroral administration at 5 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17771,10116.0,N,,CHEMBL620481,,,,,7747,1,Half-life in rat at a dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1974,10116.0,N,,CHEMBL620482,,,,,7748,1,Half-life was evaluated in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4239,10116.0,N,,CHEMBL876603,,,,,7749,1,Half-life was measured in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6681,10116.0,N,,CHEMBL620483,,,,,7750,1,Half-life period for the compound was determined in rats at 50 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17752,10116.0,N,,CHEMBL620484,,,,,7751,1,Half-life period in rats after intravenous administration at 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6046,10116.0,N,,CHEMBL620485,,,,,7752,1,Half-life period in rat at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL620486,,,,,7753,1,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL620487,,,,,7754,1,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL620488,,,,,7755,1,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4727,10116.0,N,,CHEMBL620489,,,,,7756,1,Half-life time in rat the dose of 2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1088,10116.0,N,,CHEMBL620490,,,,,7757,1,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5610,10116.0,N,,CHEMBL620491,,,,,7758,1,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3032,10116.0,N,1969.0,CHEMBL876604,,,,Plasma,7759,1,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5199,10116.0,N,,CHEMBL620492,,,,,7760,1,Oral half life was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14941,10116.0,N,,CHEMBL620493,,,,,7761,1,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4408,10116.0,N,,CHEMBL620494,,,,,7762,1,Pharmacokinetic property (t1/2) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2552,10116.0,N,1969.0,CHEMBL620495,,,,Plasma,7763,1,Plasma elimination half-life was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5199,10116.0,N,1969.0,CHEMBL620496,,,,Plasma,7764,1,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,1969.0,CHEMBL620497,,,,Plasma,7765,1,Plasma half life was observed after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1465,10116.0,N,1969.0,CHEMBL620498,,,,Plasma,7766,1,Plasma half-life was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1446,10116.0,N,1969.0,CHEMBL620499,,,,Plasma,7767,1,Plasma half-life following oral administration in Fisher rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6824,10116.0,N,1969.0,CHEMBL620500,,,,Plasma,7768,1,Plasma half-life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17533,10116.0,N,1969.0,CHEMBL873809,,,,Plasma,7769,1,Plasmatic Half-life after intravenous administration to rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5979,10116.0,N,,CHEMBL620501,,,,,7770,1,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4689,10116.0,N,,CHEMBL620502,,,,,7771,1,Terminal half life after intravenous administration (1 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4689,10116.0,N,,CHEMBL620503,,,,,7772,1,Terminal half life in Rat at a oral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2463,10116.0,N,,CHEMBL620504,,,,,7773,1,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4883,10116.0,N,,CHEMBL876605,,,,,7774,1,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4883,10116.0,N,,CHEMBL620505,,,,,7775,1,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,1969.0,CHEMBL873811,,,,Plasma,7776,1,plasma half life was observed after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3598,10116.0,N,,CHEMBL624016,,,,,7777,1,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,Expert,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4576,10116.0,N,,CHEMBL624017,,,,,7778,1,Half life of compound determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4576,10116.0,N,,CHEMBL624018,,,,,7779,1,Mean residence time determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4576,10116.0,N,,CHEMBL624019,,,,,7780,1,Plasma half life determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,955.0,CHEMBL624020,,,,Brain,7781,1,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4891,10116.0,N,,CHEMBL624201,,,,,7782,1,Compound was evaluated for pharmacokinetic parameter maximum time period,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
429,10116.0,N,,CHEMBL872528,,,,,7783,1,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL624202,,,,,7784,1,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL624203,,,,,7785,1,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL624350,,,,,7786,1,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL621320,,,,,7787,1,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL621321,,,,,7788,1,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4026,10116.0,N,,CHEMBL621322,,,,,7789,1,Maximum time (Tmax) required to reach Cmax in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4890,10116.0,N,,CHEMBL621323,,,,,7790,1,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6571,10116.0,N,,CHEMBL621324,,,,,7791,1,Maximum time of clearance of compound in rats after peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4727,10116.0,N,,CHEMBL621325,,,,,7792,1,Maximum time at the dose of 2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17651,10116.0,N,1969.0,CHEMBL875837,,,,Plasma,7793,1,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17651,10116.0,N,1969.0,CHEMBL621326,,,,Plasma,7794,1,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14465,10116.0,N,,CHEMBL621327,,,,,7795,1,Tmax in Guinea pig (PO dose),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14941,10116.0,N,,CHEMBL621328,,,,,7796,1,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5960,10116.0,N,,CHEMBL621329,,,,,7797,1,Pharmacokinetic parameter (Tmax) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5022,10116.0,N,,CHEMBL621330,,,,,7798,1,Pharmacokinetic parameter (Tmax) was estimated,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4408,10116.0,N,,CHEMBL621331,,,,,7799,1,Pharmacokinetic property (Tmax) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5983,10116.0,N,,CHEMBL621332,,,,,7800,1,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4689,10116.0,N,,CHEMBL621333,,,,,7801,1,T max in Rat at a oral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL621334,,,,,7802,1,T max was determined at 10 mg/kg po dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15011,10090.0,N,,CHEMBL621335,,,,,7803,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14180,9615.0,N,,CHEMBL621336,,,,,7804,1,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14180,10116.0,N,,CHEMBL621337,,,,,7805,1,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14599,9615.0,N,,CHEMBL621338,,,,,7806,1,Area under curve was measured after i.v. administration into Beagle dog.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14599,9615.0,N,,CHEMBL875838,,,,,7807,1,Area under curve was measured after iv administration into Beagle dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14599,9615.0,N,,CHEMBL621339,,,,,7808,1,Area under curve was measured after po administration into Beagle dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14599,9615.0,N,,CHEMBL621340,,,,,7809,1,Area under curve was measured after po administration into Beagle dog.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15675,,U,,CHEMBL621341,,,,,7810,0,Area under curve was measured at peroral dose of 3 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
12706,,U,,CHEMBL621342,,,,,7811,0,Area under curve was measured by using concentration Vs time,,Autocuration,22224,,BAO_0000019,,,,1,,A
12706,,U,,CHEMBL621343,,,,,7812,0,Area under curve was measured by using concentration Vs time; not tested,,Autocuration,22224,,BAO_0000019,,,,1,,A
9750,10090.0,N,,CHEMBL621344,,,,,7813,1,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
9750,10090.0,N,,CHEMBL621345,,,,,7814,1,Area under curve(AUC) was measured in mice after oral administration.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14691,,U,,CHEMBL621346,,,,,7815,0,Area under curve(AUC) value of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
14691,,U,,CHEMBL621347,,,,,7816,0,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,Autocuration,22224,,BAO_0000218,,,,1,,A
14691,9615.0,N,,CHEMBL621348,,,,,7817,1,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
2939,,U,178.0,CHEMBL621349,,,,Blood,7818,0,Area under curve(carotid artery) was determined by the availability in blood,,Autocuration,22224,,BAO_0000019,,,,1,,A
2939,,U,178.0,CHEMBL621350,,,,Blood,7819,0,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,Autocuration,22224,,BAO_0000019,,,,1,,A
2939,,U,178.0,CHEMBL875839,,,,Blood,7820,0,Area under curve(carotid artery) was determined by the availability in blood; No data,,Autocuration,22224,,BAO_0000019,,,,1,,A
2939,,U,178.0,CHEMBL620211,,,,Blood,7821,0,Area under curve(portal vein) was determined by the availability in blood,,Autocuration,22224,,BAO_0000019,,,,1,,A
2939,,U,178.0,CHEMBL620212,,,,Blood,7822,0,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,Autocuration,22224,,BAO_0000019,,,,1,,A
2939,,U,178.0,CHEMBL620213,,,,Blood,7823,0,Area under curve(portal vein) was determined by the availability in blood; No data,,Autocuration,22224,,BAO_0000019,,,,1,,A
9552,9544.0,N,1969.0,CHEMBL620214,,,,Plasma,7824,1,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,Intermediate,50797,,BAO_0000218,,,Macaca mulatta,1,,A
9552,9544.0,N,1969.0,CHEMBL620215,,,,Plasma,7825,1,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,Intermediate,50797,,BAO_0000218,,,Macaca mulatta,1,,A
9552,9544.0,N,1969.0,CHEMBL620216,,,,Plasma,7826,1,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,Intermediate,50797,,BAO_0000218,,,Macaca mulatta,1,,A
9552,9615.0,N,1969.0,CHEMBL620888,,,,Plasma,7827,1,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9552,9615.0,N,1969.0,CHEMBL620889,,,,Plasma,7828,1,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9552,,U,1969.0,CHEMBL620890,,,,Plasma,7829,0,Area under plasma concentration vs time curve observed in rats for 0-3 h,,Autocuration,22224,,BAO_0000019,,,,1,,A
11911,10116.0,N,1969.0,CHEMBL620891,,,,Plasma,7830,1,Area under plasma time curve determined in male rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16618,,U,,CHEMBL620892,,,,,7831,0,Area under the MAP curve measured over 5 min.,,Autocuration,22224,,BAO_0000019,,,,1,,A
14387,10090.0,N,,CHEMBL621079,,,,,7832,1,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14387,10090.0,N,,CHEMBL621080,,,,,7833,1,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12836,9615.0,N,,CHEMBL621081,,,,,7834,1,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12836,10026.0,N,,CHEMBL621082,,,,,7835,1,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,Intermediate,100712,,BAO_0000218,,,Cricetinae,1,,A
12836,10116.0,N,,CHEMBL621083,,,,,7836,1,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14339,9615.0,N,,CHEMBL621084,,,,,7837,1,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14339,9615.0,N,,CHEMBL621085,,,,,7838,1,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14339,9615.0,N,,CHEMBL621086,,,,,7839,1,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
10524,9615.0,N,,CHEMBL621087,,,,,7840,1,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9994,9615.0,N,,CHEMBL622607,,,,,7841,1,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
11325,9615.0,N,,CHEMBL622608,,,,,7842,1,Serum AUC in marmosets (IV dose),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12536,,U,,CHEMBL624481,,,,,7843,0,Area under the curve after intravenous administration at a dose of 10 umol/kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
12536,,U,,CHEMBL624482,,,,,7844,0,Area under the curve after intravenous administration at a dose of 2 umol/kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
12536,,U,,CHEMBL624483,,,,,7845,0,Area under the curve after intravenous administration at a dose of 4 umol/kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
12536,,U,,CHEMBL624484,,,,,7846,0,Area under the curve after intravenous administration at a dose of 40 umol/kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
12536,,U,,CHEMBL624485,,,,,7847,0,Area under the curve after intravenous administration at a dose of 5 umol/kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
15556,10116.0,N,,CHEMBL624486,,,,,7848,1,Area under the curve for fumarate salt was evaluated in F344 Rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2809,,U,,CHEMBL624487,,,,,7849,0,Area under the curve for the compound was calculated.,,Autocuration,22224,,BAO_0000019,,,,1,,A
9511,,U,,CHEMBL624488,,,,,7850,0,Area under the curve in concentration/ time,,Autocuration,22224,,BAO_0000019,,,,1,,A
12818,10116.0,N,,CHEMBL624489,,,,,7851,1,Area under the curve administered intraintestinal in rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12818,10116.0,N,,CHEMBL625184,,,,,7852,1,Area under the curve administered intravenously in rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15118,,U,,CHEMBL625185,,,,,7853,0,Area under the curve during intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
15118,,U,,CHEMBL875954,,,,,7854,0,Area under the curve during intravenous administration; Not determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
15118,,U,,CHEMBL625186,,,,,7855,0,Area under the curve during systemic administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
15118,,U,,CHEMBL625187,,,,,7856,0,Area under the curve during systemic administration; Not determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
2632,,U,,CHEMBL625188,,,,,7857,0,Area under the curve was calculated for the compound.,,Autocuration,22224,,BAO_0000019,,,,1,,A
14346,9615.0,N,,CHEMBL625189,,,,,7858,1,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14346,9615.0,N,,CHEMBL625190,,,,,7859,1,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14346,10116.0,N,,CHEMBL621733,,,,,7860,1,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14346,10116.0,N,,CHEMBL621734,,,,,7861,1,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11149,10116.0,N,,CHEMBL621735,,,,,7862,1,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17796,10116.0,N,1969.0,CHEMBL621736,,,,Plasma,7863,1,Clearance of the drug was measured in the plasma of rat; No data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5247,10116.0,N,1969.0,CHEMBL621737,,,,Plasma,7864,1,The pharmacokinetic parameter plasma clearance in vivo in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4727,10116.0,N,,CHEMBL621738,,,,,7865,1,Plasma clearance at the dose of 2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5654,10116.0,N,,CHEMBL622806,,,,,7866,1,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5654,10116.0,N,,CHEMBL623519,,,,,7867,1,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17260,10116.0,N,,CHEMBL623520,,,,,7868,1,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17065,10116.0,N,,CHEMBL623521,,,,,7869,1,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17671,10116.0,N,,CHEMBL623522,,,,,7870,1,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6672,10116.0,N,,CHEMBL623523,,,,,7871,1,Clearance rate in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6673,10116.0,N,,CHEMBL623690,,,,,7872,1,Clearance rate in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL623691,,,,,7873,1,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL623692,,,,,7874,1,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL623693,,,,,7875,1,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL623694,,,,,7876,1,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4413,10116.0,N,,CHEMBL623695,,,,,7877,1,Clearance of compound after iv administration of 20 mg/kg dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL623696,,,,,7878,1,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL623697,,,,,7879,1,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5005,9544.0,U,1969.0,CHEMBL623698,,,,Plasma,7880,0,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,Intermediate,22224,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
5005,10116.0,U,1969.0,CHEMBL623699,,,,Plasma,7881,0,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15765,10116.0,N,,CHEMBL623700,,,,,7882,1,Mean (%CV) PK parameters for CL(mL/min/kg).,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3747,10116.0,N,,CHEMBL623701,,,,,7883,1,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16366,10116.0,N,1969.0,CHEMBL623702,,,,Plasma,7884,1,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4199,10116.0,N,,CHEMBL623703,,,,,7885,1,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17267,10116.0,N,,CHEMBL623704,,,,,7886,1,Plasma clearance in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6535,10116.0,N,,CHEMBL623705,,,,,7887,1,Plasma clearance in rat after administration of 2 mg/kg iv,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6535,10116.0,N,,CHEMBL623706,,,,,7888,1,Plasma clearance in rat after administration of 2 mg/kg iv,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL623707,,,,,7889,1,Plasma clearance was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5960,10116.0,N,,CHEMBL623708,,,,,7890,1,Plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5937,10116.0,N,,CHEMBL623709,,,,,7891,1,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5871,10116.0,N,,CHEMBL623710,,,,,7892,1,Plasma clearance in rat by iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5874,10116.0,N,,CHEMBL623711,,,,,7893,1,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6504,10116.0,N,,CHEMBL623712,,,,,7894,1,Plasma clearance in rat p.o.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6803,10116.0,N,,CHEMBL623713,,,,,7895,1,Plasma clearance in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL623714,,,,,7896,1,Plasma clearance was determined; ND denotes no data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL623715,,,,,7897,1,Plasma clearance was determined; ND denotes not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1916,10116.0,N,,CHEMBL623716,,,,,7898,1,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5199,10116.0,N,,CHEMBL622980,,,,,7899,1,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16367,10116.0,N,,CHEMBL622981,,,,,7900,1,Plasma administration to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6362,10116.0,N,,CHEMBL622982,,,,,7901,1,Plasma clearance of the compound in female Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,,CHEMBL622983,,,,,7902,1,Plasma clearance was observed after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6215,10116.0,N,,CHEMBL622984,,,,,7903,1,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1466,10116.0,N,,CHEMBL622985,,,,,7904,1,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,1969.0,CHEMBL623631,,,,Plasma,7905,1,plasma clearance was observed after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL623632,,,,,7906,1,In vivo CL/F determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,1969.0,CHEMBL623633,,,,Plasma,7907,1,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,1969.0,CHEMBL623634,,,,Plasma,7908,1,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5213,10116.0,N,,CHEMBL623635,,,,,7909,1,Compound was tested for the lower blood clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4687,10116.0,N,,CHEMBL621195,,,,,7910,1,Evaluated for the low clearance in rat (in vivo),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3371,10116.0,N,,CHEMBL621196,,,,,7911,1,Pharmacokinetic property (CLb)of the compound was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4690,10116.0,N,,CHEMBL875287,,,,,7912,1,Rapid clearance after intravenous administration in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5702,10116.0,N,,CHEMBL621197,,,,,7913,1,Clearance measured in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
740,10116.0,N,1969.0,CHEMBL621198,,,,Plasma,7914,1,Compound was evaluated for plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4853,10116.0,N,1969.0,CHEMBL621199,,,,Plasma,7915,1,Low plasma clearance was calculated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5789,10116.0,N,,CHEMBL621200,,,,,7916,1,Pharmacokinetic property (Clp) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL621201,,,,,7917,1,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL621202,,,,,7918,1,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL621203,,,,,7919,1,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL621204,,,,,7920,1,Plasma clearance after IV dosing at 1 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621205,,,,Heart,7921,1,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621206,,,,Heart,7922,1,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621207,,,,Heart,7923,1,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621208,,,,Heart,7924,1,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621209,,,,Heart,7925,1,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL876484,,,,Heart,7926,1,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621210,,,,Heart,7927,1,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621211,,,,Heart,7928,1,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621212,,,,Heart,7929,1,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621213,,,,Heart,7930,1,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621214,,,,Heart,7931,1,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621215,,,,Heart,7932,1,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621216,,,,Heart,7933,1,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621217,,,,Heart,7934,1,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621218,,,,Heart,7935,1,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621219,,,,Heart,7936,1,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621220,,,,Heart,7937,1,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621221,,,,Heart,7938,1,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621222,,,,Heart,7939,1,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621223,,,,Heart,7940,1,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL876485,,,,Heart,7941,1,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621224,,,,Heart,7942,1,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621225,,,,Heart,7943,1,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,948.0,CHEMBL621226,,,,Heart,7944,1,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621227,,,,Kidney,7945,1,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621228,,,,Kidney,7946,1,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621229,,,,Kidney,7947,1,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621230,,,,Kidney,7948,1,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621231,,,,Kidney,7949,1,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621232,,,,Kidney,7950,1,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621233,,,,Kidney,7951,1,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621234,,,,Kidney,7952,1,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621235,,,,Kidney,7953,1,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621236,,,,Kidney,7954,1,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL621237,,,,Kidney,7955,1,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2113.0,CHEMBL876486,,,,Kidney,7956,1,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,160.0,CHEMBL622436,,,,Intestine,7957,1,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,160.0,CHEMBL622437,,,,Intestine,7958,1,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,160.0,CHEMBL622438,,,,Intestine,7959,1,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622439,,,,Liver,7960,1,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622440,,,,Liver,7961,1,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622441,,,,Liver,7962,1,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622442,,,,Liver,7963,1,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622443,,,,Liver,7964,1,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622444,,,,Liver,7965,1,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622445,,,,Liver,7966,1,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622446,,,,Liver,7967,1,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622447,,,,Liver,7968,1,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622448,,,,Liver,7969,1,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622449,,,,Liver,7970,1,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622450,,,,Liver,7971,1,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622451,,,,Liver,7972,1,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622452,,,,Liver,7973,1,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622453,,,,Liver,7974,1,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622454,,,,Liver,7975,1,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL622455,,,,Liver,7976,1,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL876024,,,,Liver,7977,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL622456,,,,,7978,1,T max was determined at 3 mg/kg po dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL622457,,,,,7979,1,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL622458,,,,,7980,1,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL622459,,,,,7981,1,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL873343,,,,,7982,1,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL622460,,,,,7983,1,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4576,10116.0,N,1969.0,CHEMBL622461,,,,Plasma,7984,1,Time for maximum plasma concentration determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6681,10116.0,N,1969.0,CHEMBL622462,,,,Plasma,7985,1,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL622463,,,,,7986,1,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL622464,,,,,7987,1,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL622465,,,,,7988,1,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL622466,,,,,7989,1,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL622467,,,,,7990,1,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6824,10116.0,N,1969.0,CHEMBL622468,,,,Plasma,7991,1,Time of maximum plasma concentration in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6685,10116.0,N,1969.0,CHEMBL876025,,,,Plasma,7992,1,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6685,10116.0,N,1969.0,CHEMBL622469,,,,Plasma,7993,1,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6685,10116.0,N,1969.0,CHEMBL622470,,,,Plasma,7994,1,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15662,10116.0,N,,CHEMBL622471,,,,,7995,1,Time required to reach maximum concentration (Cmax) after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1742,10116.0,N,1969.0,CHEMBL622472,,,,Plasma,7996,1,Time required to reach maximum concentration in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2774,10116.0,N,1969.0,CHEMBL622473,,,,Plasma,7997,1,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5199,10116.0,N,1969.0,CHEMBL624282,,,,Plasma,7998,1,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12873,10116.0,N,1969.0,CHEMBL624283,,,,Plasma,7999,1,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12873,10116.0,N,1969.0,CHEMBL624284,,,,Plasma,8000,1,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1916,10116.0,N,1969.0,CHEMBL624285,,,,Plasma,8001,1,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16367,10116.0,N,,CHEMBL624286,,,,,8002,1,Time to reach Cmax after oral administration to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16366,10116.0,N,,CHEMBL624287,,,,,8003,1,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
216,10116.0,N,,CHEMBL624288,,,,,8004,1,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6410,10116.0,N,1969.0,CHEMBL624289,,,,Plasma,8005,1,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6410,10116.0,N,1969.0,CHEMBL873344,,,,Plasma,8006,1,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6215,10116.0,N,,CHEMBL619623,,,,,8007,1,Tmax after peroral administration (10 mg/kg) was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3598,10116.0,N,,CHEMBL621399,,,,,8008,1,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,Expert,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL621400,,,,,8009,1,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17670,10116.0,N,,CHEMBL621401,,,,,8010,1,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1465,10116.0,N,,CHEMBL621402,,,,,8011,1,Tmax was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2552,10116.0,N,,CHEMBL621403,,,,,8012,1,Tmax was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5656,10116.0,N,,CHEMBL621121,,,,,8013,1,Tmax after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17764,10116.0,N,,CHEMBL872525,,,,,8014,1,Tmax after peroral administration in rats at 2.4 uM/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5610,10116.0,N,,CHEMBL621122,,,,,8015,1,Tmax in male rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6046,10116.0,N,,CHEMBL621123,,,,,8016,1,Tmax in rat at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5874,10116.0,N,,CHEMBL621124,,,,,8017,1,Tmax in rat by po administration at a dose of 40 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17596,10116.0,N,,CHEMBL621125,,,,,8018,1,Tmax in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17804,10116.0,N,,CHEMBL621126,,,,,8019,1,Tmax was measured in rats after peroral administration at 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1908,10116.0,N,,CHEMBL621127,,,,,8020,1,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2959,10116.0,N,,CHEMBL621128,,,,,8021,1,Tmax value after administration of 20 mg/Kg oral dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6757,10116.0,N,,CHEMBL618263,,,,,8022,1,Tmax value at a dose of 10 mg/kg in male SD rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6757,10116.0,N,,CHEMBL618264,,,,,8023,1,Tmax value at a dose of 100 mg/kg in male SD rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6757,10116.0,N,,CHEMBL618265,,,,,8024,1,Tmax value at a dose of 50 mg/kg in male SD rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4186,10116.0,N,1969.0,CHEMBL618266,,,,Plasma,8025,1,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,,CHEMBL618267,,,,,8026,1,time required to reach maximum concentration (Cmax) after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
429,10116.0,N,1088.0,CHEMBL618450,,,,Urine,8027,1,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
429,10116.0,N,1088.0,CHEMBL618451,,,,Urine,8028,1,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5546,10116.0,N,,CHEMBL618452,,,,,8029,1,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3173,10116.0,N,1088.0,CHEMBL618453,,,,Urine,8030,1,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3173,10116.0,N,1088.0,CHEMBL618454,,,,Urine,8031,1,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3173,10116.0,N,1088.0,CHEMBL618455,,,,Urine,8032,1,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4257,10116.0,N,,CHEMBL618456,,,,,8033,1,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6011,10116.0,N,,CHEMBL618457,,,,,8034,1,Compound distribution in rat tissues was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5472,10116.0,N,,CHEMBL618458,,,,,8035,1,Volume of distribution was evaluated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14346,10116.0,N,,CHEMBL618459,,,,,8036,1,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14346,10116.0,N,,CHEMBL876733,,,,,8037,1,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14346,9615.0,N,,CHEMBL618460,,,,,8038,1,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14346,10116.0,N,,CHEMBL618461,,,,,8039,1,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15469,,U,,CHEMBL618462,,,,,8040,0,Area under the curve was determined after oral administration (300 uM/Kg),,Autocuration,22224,,BAO_0000019,,,,1,,A
14346,10116.0,N,,CHEMBL618463,,,,,8041,1,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14346,10116.0,N,,CHEMBL618464,,,,,8042,1,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14346,10116.0,N,,CHEMBL618465,,,,,8043,1,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14346,10116.0,N,,CHEMBL618466,,,,,8044,1,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14346,10116.0,N,,CHEMBL618467,,,,,8045,1,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL618468,,,,,8046,1,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12935,9615.0,N,1969.0,CHEMBL618469,,,,Plasma,8047,1,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12935,9615.0,N,1969.0,CHEMBL618470,,,,Plasma,8048,1,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14813,,U,,CHEMBL618471,,,,,8049,0,Plasma drug AUC in rat (PO dose),,Autocuration,22224,,BAO_0000218,,,,1,,A
15792,10090.0,N,,CHEMBL618472,,,,,8050,1,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
3579,,U,,CHEMBL618473,,,,,8051,0,Area under was determined at a dose of 30 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
12487,9669.0,N,,CHEMBL621699,,,,,8052,1,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
12487,10116.0,N,,CHEMBL621700,,,,,8053,1,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12487,10116.0,N,,CHEMBL621701,,,,,8054,1,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12487,9669.0,N,,CHEMBL621702,,,,,8055,1,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
12487,9615.0,N,,CHEMBL621703,,,,,8056,1,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12487,9615.0,N,,CHEMBL621704,,,,,8057,1,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12902,10116.0,N,,CHEMBL624259,,,,,8058,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12902,10116.0,N,,CHEMBL624260,,,,,8059,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12902,10116.0,N,,CHEMBL624430,,,,,8060,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12902,10116.0,N,,CHEMBL624431,,,,,8061,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12902,10116.0,N,,CHEMBL624432,,,,,8062,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12902,10116.0,N,,CHEMBL624433,,,,,8063,1,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12902,10116.0,N,,CHEMBL624434,,,,,8064,1,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12902,10116.0,N,,CHEMBL624435,,,,,8065,1,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12745,10090.0,N,,CHEMBL618570,,,,,8066,1,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12745,10090.0,N,,CHEMBL618571,,,,,8067,1,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12745,10090.0,N,,CHEMBL618572,,,,,8068,1,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12745,10090.0,N,,CHEMBL618573,,,,,8069,1,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12745,10090.0,N,,CHEMBL619267,,,,,8070,1,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12745,10090.0,N,,CHEMBL619431,,,,,8071,1,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12745,10090.0,N,,CHEMBL619432,,,,,8072,1,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12745,10090.0,N,,CHEMBL619433,,,,,8073,1,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13298,,U,1969.0,CHEMBL619434,,,,Plasma,8074,0,AUC in mice after oral dose (50 mg/kg),,Autocuration,22224,,BAO_0000218,,,,1,,A
12226,10090.0,N,1977.0,CHEMBL619435,,,,Serum,8075,1,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12634,,U,1969.0,CHEMBL619436,,,,Plasma,8076,0,AUC (0-4 hr) ug/ml/h,,Autocuration,22224,,BAO_0000019,,,,1,,A
14810,10116.0,N,,CHEMBL619437,,,,,8077,1,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13889,,U,,CHEMBL619438,,,,,8078,0,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,Autocuration,22224,,BAO_0000218,,,,1,,A
10018,10090.0,N,,CHEMBL619439,,,,,8079,1,Compound was evaluated for Area under curve in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8758,10116.0,N,,CHEMBL619440,,,,,8080,1,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8758,,U,,CHEMBL619441,,,,,8081,0,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,Autocuration,22224,,BAO_0000218,,,,1,,F
8758,10116.0,N,,CHEMBL619442,,,,,8082,1,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2249,,U,,CHEMBL875156,,,,,8083,0,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,Autocuration,22224,,BAO_0000019,,,,1,,A
2249,,U,,CHEMBL619443,,,,,8084,0,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,Autocuration,22224,,BAO_0000019,,,,1,,A
2249,,U,,CHEMBL619444,,,,,8085,0,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,Autocuration,22224,,BAO_0000019,,,,1,,A
2249,,U,,CHEMBL623464,,,,,8086,0,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,Autocuration,22224,,BAO_0000019,,,,1,,A
15115,10090.0,N,,CHEMBL623465,,,,,8087,1,Compound was evaluated for area under curve when administered through oral route in mouse,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
6518,10116.0,N,,CHEMBL623466,,,,,8088,1,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL623467,,,,,8089,1,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6249,10116.0,N,,CHEMBL623468,,,,,8090,1,Plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2463,10116.0,N,,CHEMBL622660,,,,,8091,1,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4969,10116.0,N,,CHEMBL622661,,,,,8092,1,Plasma clearance rate in Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17720,10116.0,N,,CHEMBL622662,,,,,8093,1,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,F
3457,10116.0,N,,CHEMBL622663,,,,,8094,1,Pharmacokinetic property (total body clearance) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5983,10116.0,N,,CHEMBL622664,,,,,8095,1,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6295,10116.0,N,,CHEMBL622665,,,,,8096,1,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6296,10116.0,N,,CHEMBL622666,,,,,8097,1,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17686,10116.0,N,,CHEMBL621615,,,,,8098,1,Cl in rat i.v. at 2 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17764,10116.0,N,,CHEMBL621616,,,,,8099,1,Clearance of compound after intravenous administration in rats at 24 uM/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5503,10116.0,N,,CHEMBL621617,,,,,8100,1,Clearance was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4368,10116.0,N,,CHEMBL621618,,,,,8101,1,Clearance by intravenous administration of 3.4 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6005,10116.0,N,,CHEMBL621619,,,,,8102,1,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5031,10116.0,N,,CHEMBL621620,,,,,8103,1,Clearance rate after i.v. administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4890,10116.0,N,,CHEMBL621786,,,,,8104,1,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5182,10116.0,N,,CHEMBL621787,,,,,8105,1,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5979,10116.0,N,,CHEMBL621788,,,,,8106,1,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5656,10116.0,N,,CHEMBL621789,,,,,8107,1,Clearance (Cl) after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17804,10116.0,N,,CHEMBL621790,,,,,8108,1,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4839,10116.0,N,1969.0,CHEMBL621791,,,,Plasma,8109,1,Compound was tested for plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL621792,,,,,8110,1,In vitro microsome metabolism clearance in rat was determined,,Intermediate,50597,,BAO_0000218,Microsomes,In vitro,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL621793,,,,,8111,1,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,Intermediate,50597,,BAO_0000218,Microsomes,In vitro,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL621794,,,,,8112,1,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5496,10116.0,N,1969.0,CHEMBL621795,,,,Plasma,8113,1,In vivo plasma clearance was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5739,10116.0,N,,CHEMBL621796,,,,,8114,1,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5676,10116.0,N,2107.0,CHEMBL621797,Hepatocyte,,,Liver,8115,1,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,Intermediate,50597,401.0,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4239,10116.0,N,,CHEMBL621798,,,,,8116,1,Pharmacokinetic property (Plasma clearance) was measured in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5676,10116.0,N,,CHEMBL621799,,,,,8117,1,Pharmacokinetic property (clearance) in rat i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1918,10116.0,N,,CHEMBL621800,,,,,8118,1,"Plasma Clearance was evaluated in rats, iv",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17800,10116.0,N,,CHEMBL621801,,,,,8119,1,Plasma clearance (in vivo) in rats was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6056,10116.0,N,,CHEMBL621802,,,,,8120,1,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5496,10116.0,N,,CHEMBL618596,,,,,8121,1,Plasma clearance was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL618597,,,,,8122,1,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL618598,,,,,8123,1,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17752,10116.0,N,,CHEMBL618599,,,,,8124,1,Plasma clearance in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4576,10116.0,N,,CHEMBL618600,,,,,8125,1,Plasma clearance rate determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6011,10116.0,N,,CHEMBL618601,,,,,8126,1,Plasma clearance was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL618602,,,,,8127,1,Plasma clearance was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5948,10116.0,N,,CHEMBL618603,,,,,8128,1,Plasma clearance value in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6125,10116.0,N,2107.0,CHEMBL618604,,,,Liver,8129,1,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,Intermediate,50597,,BAO_0000218,,Ex vivo,Rattus norvegicus,1,,A
4839,10116.0,N,,CHEMBL618605,,,,,8130,1,Clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17686,10116.0,N,,CHEMBL618606,,,,,8131,1,Total body clearance in rat i.v. at 2 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6571,10116.0,N,,CHEMBL618607,,,,,8132,1,Clearance of compound in rats after intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3364,10116.0,N,,CHEMBL618608,,,,,8133,1,Clearance after iv administration to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618609,,,,,8134,1,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618610,,,,,8135,1,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618611,,,,,8136,1,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618612,,,,,8137,1,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618613,,,,,8138,1,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL621076,,,,,8139,1,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL621077,,,,,8140,1,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17670,10116.0,N,,CHEMBL621078,,,,,8141,1,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5970,10116.0,N,,CHEMBL621251,,,,,8142,1,Clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6495,10116.0,N,,CHEMBL621252,,,,,8143,1,Clearance in rat after oral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4590,10116.0,N,,CHEMBL621253,,,,,8144,1,Clearance in rat.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6193,10116.0,N,,CHEMBL621254,,,,,8145,1,Clearance rate following an oral dose of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2832,10116.0,N,,CHEMBL621255,,,,,8146,1,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1052,10116.0,N,1969.0,CHEMBL621256,,,,Plasma,8147,1,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL621257,,,,Liver,8148,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL621258,,,,Liver,8149,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL621259,,,,Liver,8150,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL621260,,,,Liver,8151,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL876494,,,,Liver,8152,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL621261,,,,Liver,8153,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL621262,,,,Liver,8154,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL621263,,,,Liver,8155,1,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2107.0,CHEMBL621264,,,,Liver,8156,1,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621265,,,,Muscle tissue,8157,1,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621266,,,,Muscle tissue,8158,1,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621267,,,,Muscle tissue,8159,1,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621268,,,,Muscle tissue,8160,1,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621269,,,,Muscle tissue,8161,1,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621270,,,,Muscle tissue,8162,1,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621271,,,,Muscle tissue,8163,1,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621272,,,,Muscle tissue,8164,1,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621273,,,,Muscle tissue,8165,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621274,,,,Muscle tissue,8166,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL876495,,,,Muscle tissue,8167,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621275,,,,Muscle tissue,8168,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621276,,,,Muscle tissue,8169,1,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2385.0,CHEMBL621277,,,,Muscle tissue,8170,1,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,160.0,CHEMBL621278,,,,Intestine,8171,1,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,160.0,CHEMBL621279,,,,Intestine,8172,1,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,160.0,CHEMBL621280,,,,Intestine,8173,1,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL621281,,,,Spleen,8174,1,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL621282,,,,Spleen,8175,1,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL621283,,,,Spleen,8176,1,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL621284,,,,Spleen,8177,1,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL621285,,,,Spleen,8178,1,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL621286,,,,Spleen,8179,1,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL623220,,,,Spleen,8180,1,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL623221,,,,Spleen,8181,1,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,2106.0,CHEMBL876029,,,,Spleen,8182,1,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,945.0,CHEMBL623222,,,,Stomach,8183,1,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,945.0,CHEMBL623223,,,,Stomach,8184,1,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9866,10116.0,N,945.0,CHEMBL621445,,,,Stomach,8185,1,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,178.0,CHEMBL621446,,,,Blood,8186,1,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,178.0,CHEMBL621447,,,,Blood,8187,1,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,178.0,CHEMBL619681,,,,Blood,8188,1,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,178.0,CHEMBL619682,,,,Blood,8189,1,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,178.0,CHEMBL619683,,,,Blood,8190,1,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,955.0,CHEMBL619684,,,,Brain,8191,1,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,955.0,CHEMBL619685,,,,Brain,8192,1,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,955.0,CHEMBL619686,,,,Brain,8193,1,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,955.0,CHEMBL619687,,,,Brain,8194,1,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,955.0,CHEMBL619688,,,,Brain,8195,1,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,948.0,CHEMBL619689,,,,Heart,8196,1,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,948.0,CHEMBL619690,,,,Heart,8197,1,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,948.0,CHEMBL619691,,,,Heart,8198,1,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6062,10116.0,N,,CHEMBL619692,,,,,8199,1,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3598,10116.0,N,,CHEMBL619693,,,,,8200,1,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,Expert,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1908,10116.0,N,,CHEMBL619694,,,,,8201,1,Vc value after IV dose at a dose of 5 mg/kg in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17596,10116.0,N,,CHEMBL619695,,,,,8202,1,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4891,10116.0,N,,CHEMBL619696,,,,,8203,1,Compound was evaluated for pharmacokinetic parameter volume of distribution,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
740,10116.0,N,,CHEMBL619697,,,,,8204,1,Compound was evaluated for volume of distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16366,10116.0,N,,CHEMBL619698,,,,,8205,1,Steady state volume distribution was determined; steady state(ss),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3364,10116.0,N,,CHEMBL619699,,,,,8206,1,Steady state volume of distribution after iv administration to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2552,10116.0,N,,CHEMBL619700,,,,,8207,1,Steady state volume of distribution dosing at 3 mg/kg iv,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
406,10116.0,N,,CHEMBL619701,,,,,8208,1,The compound was evaluated for volume of distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12500,10116.0,N,,CHEMBL619702,,,,,8209,1,The compound was tested for volume of distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12500,10116.0,N,,CHEMBL620335,,,,,8210,1,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5656,10116.0,N,,CHEMBL620336,,,,,8211,1,Volume distribution (VD) after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17671,10116.0,N,,CHEMBL620337,,,,,8212,1,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1094,10116.0,N,,CHEMBL620520,,,,,8213,1,Volume distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5833,10116.0,N,,CHEMBL620521,,,,,8214,1,Volume distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL875825,,,,,8215,1,Volume distribution in rat after peroral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL620522,,,,,8216,1,Volume distribution in rat after peroral administration at 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6005,10116.0,N,,CHEMBL620523,,,,,8217,1,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1696,10116.0,N,,CHEMBL620524,,,,,8218,1,Volume of distribution in rat.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6672,10116.0,N,,CHEMBL620525,,,,,8219,1,Volume of distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6673,10116.0,N,,CHEMBL620526,,,,,8220,1,Volume of distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5871,10116.0,N,,CHEMBL620527,,,,,8221,1,Volume of distribution in rat by iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6803,10116.0,N,,CHEMBL620528,,,,,8222,1,Volume of distribution in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5199,10116.0,N,,CHEMBL620529,,,,,8223,1,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4727,10116.0,N,,CHEMBL620530,,,,,8224,1,Volume distribution at the dose of 2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16367,10116.0,N,,CHEMBL620531,,,,,8225,1,Steady state volume of distribution was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5005,9544.0,U,,CHEMBL620532,,,,,8226,0,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,Intermediate,22224,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
5005,10116.0,U,,CHEMBL620533,,,,,8227,0,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5005,10116.0,U,,CHEMBL620534,,,,,8228,0,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15765,10116.0,N,,CHEMBL620535,,,,,8229,1,Mean (%CV) PK parameters for Vdss(mL/kg).,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL875826,,,,,8230,1,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL620536,,,,,8231,1,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL620537,,,,,8232,1,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL618526,,,,,8233,1,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5739,10116.0,N,,CHEMBL618527,,,,,8234,1,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5789,10116.0,N,,CHEMBL618528,,,,,8235,1,Pharmacokinetic property (Vdss) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4239,10116.0,N,,CHEMBL618529,,,,,8236,1,Pharmacokinetic property (vdss) was measured in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4709,10116.0,N,,CHEMBL618530,,,,,8237,1,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6642,10116.0,N,,CHEMBL618531,,,,,8238,1,Volume of distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5247,10116.0,N,,CHEMBL618532,,,,,8239,1,The pharmacokinetic parameter volume of distribution in vivo in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17720,10116.0,N,,CHEMBL618533,,,,,8240,1,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,F
17686,10116.0,N,,CHEMBL618534,,,,,8241,1,Vdss in rat i.v. at 2 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4689,10116.0,N,,CHEMBL618535,,,,,8242,1,Volume distribution after intravenous administration (1 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5654,10116.0,N,,CHEMBL618536,,,,,8243,1,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5654,10116.0,N,,CHEMBL618537,,,,,8244,1,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL618538,,,,,8245,1,Volume distribution at a dose of 10 uM/kg in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4521,10116.0,N,,CHEMBL618539,,,,,8246,1,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL618540,,,,,8247,1,Volume distribution was calculated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL618541,,,,,8248,1,Volume distribution was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2938,10116.0,N,,CHEMBL618542,,,,,8249,1,Volume of distribution after intravenous administration was evaluated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6679,10116.0,N,,CHEMBL622544,,,,,8250,1,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL622545,,,,,8251,1,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL622546,,,,,8252,1,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL622547,,,,,8253,1,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5145,10116.0,N,,CHEMBL622548,,,,,8254,1,Volume of distribution in steady state was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6467,10116.0,N,,CHEMBL622549,,,,,8255,1,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6467,10116.0,N,,CHEMBL622550,,,,,8256,1,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15115,10090.0,N,,CHEMBL622551,,,,,8257,1,Compound was evaluated for area under curve when administered through oral route to mouse,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8758,10116.0,N,,CHEMBL622552,,,,,8258,1,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8758,10116.0,N,,CHEMBL622553,,,,,8259,1,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8267,,U,,CHEMBL622554,,,,,8260,0,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,F
8267,9615.0,N,,CHEMBL622555,,,,,8261,1,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14239,10090.0,N,,CHEMBL622556,,,,,8262,1,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14239,10090.0,N,,CHEMBL622557,,,,,8263,1,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10754,10090.0,N,178.0,CHEMBL622558,,,,Blood,8264,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10754,10090.0,N,178.0,CHEMBL622559,,,,Blood,8265,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10754,9615.0,N,,CHEMBL622560,,,,,8266,1,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14681,10116.0,N,,CHEMBL622561,,,,,8267,1,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14681,10116.0,N,,CHEMBL622562,,,,,8268,1,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14681,10116.0,N,,CHEMBL622563,,,,,8269,1,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13118,,U,,CHEMBL622564,,,,,8270,0,Concentration of compound in Central nervous system,,Autocuration,22224,,BAO_0000019,,,,1,,A
13118,,U,,CHEMBL622565,,,,,8271,0,Concentration of compound in Central nervous system; Not detectable,,Autocuration,22224,,BAO_0000019,,,,1,,A
13318,10090.0,N,,CHEMBL622566,,,,,8272,1,"Concentration of diester in the blood, following oral administration in mice",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13318,10090.0,N,,CHEMBL624515,,,,,8273,1,"Concentration of monoester in the blood, following oral administration in mice",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13318,10090.0,N,,CHEMBL624516,,,,,8274,1,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15692,,U,,CHEMBL624517,,,,,8275,0,Evaluated for Pharmacokinetic property: Area under the curve,,Autocuration,22224,,BAO_0000019,,,,1,,A
14839,10090.0,N,,CHEMBL624518,,,,,8276,1,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,9541.0,N,,CHEMBL624519,,,,,8277,1,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL624520,,,,,8278,1,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL624521,,,,,8279,1,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL624522,,,,,8280,1,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL624523,,,,,8281,1,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL624409,,,,,8282,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL624410,,,,,8283,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL624411,,,,,8284,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL623531,,,,,8285,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL623532,,,,,8286,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL623533,,,,,8287,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL623534,,,,,8288,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14839,10090.0,N,,CHEMBL623535,,,,,8289,1,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623536,,,,,8290,1,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623537,,,,,8291,1,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623538,,,,,8292,1,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623539,,,,,8293,1,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623540,,,,,8294,1,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623541,,,,,8295,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623542,,,,,8296,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623543,,,,,8297,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623544,,,,,8298,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623545,,,,,8299,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623546,,,,,8300,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
5408,10116.0,N,1969.0,CHEMBL623547,,,,Plasma,8301,1,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6827,10116.0,N,,CHEMBL623548,,,,,8302,1,High i.v. clearance in Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17538,10116.0,N,2107.0,CHEMBL623549,,,,Liver,8303,1,In vitro clearance in rat liver microsomes,,Intermediate,50597,,BAO_0000218,Microsomes,In vitro,Rattus norvegicus,1,,A
6331,10116.0,N,2107.0,CHEMBL623550,,,,Liver,8304,1,Intrinsic clearance in rat liver microsomes was determined,,Intermediate,50597,,BAO_0000218,Microsomes,In vitro,Rattus norvegicus,1,,A
5948,10116.0,N,2107.0,CHEMBL875276,Hepatocyte,,,Liver,8305,1,Intrinsic clearance in rat hepatocytes was determined,,Intermediate,50597,401.0,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
4026,10116.0,N,,CHEMBL621872,,,,,8306,1,Plasma Clearance was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6647,10116.0,N,,CHEMBL621873,,,,,8307,1,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1696,10116.0,N,,CHEMBL621874,,,,,8308,1,Plasma clearance in rat.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6597,10116.0,N,,CHEMBL621875,,,,,8309,1,Plasma clearance in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
347,10116.0,N,,CHEMBL621876,,,,,8310,1,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16423,10116.0,N,,CHEMBL621877,,,,,8311,1,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2879,10116.0,N,,CHEMBL621878,,,,,8312,1,Plasma clearance was measured in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4883,10116.0,N,,CHEMBL621879,,,,,8313,1,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5328,10116.0,N,1969.0,CHEMBL621880,,,,Plasma,8314,1,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5160,10116.0,N,,CHEMBL621881,,,,,8315,1,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL621882,,,,,8316,1,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17651,10116.0,N,,CHEMBL875283,,,,,8317,1,Total clearance at 1 mg/kg was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17651,10116.0,N,,CHEMBL621883,,,,,8318,1,Total clearance at 10 mg/kg was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6596,10116.0,N,,CHEMBL621884,,,,,8319,1,Clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4796,10116.0,N,,CHEMBL621885,,,,,8320,1,Plasma clearance rate determined in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6850,10116.0,N,,CHEMBL621886,,,,,8321,1,Clearance of compound in rat was evaluated,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5932,10116.0,N,1969.0,CHEMBL621887,,,,Plasma,8322,1,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3371,10116.0,N,,CHEMBL621888,,,,,8323,1,Pharmacokinetic property (blood clearance) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2083,10116.0,N,,CHEMBL621889,,,,,8324,1,Plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4942,10116.0,N,,CHEMBL621890,,,,,8325,1,Plasma clearance in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6838,10116.0,N,2107.0,CHEMBL621891,,,,Liver,8326,1,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,Intermediate,50597,,BAO_0000218,Microsomes,In vitro,Rattus norvegicus,1,,A
5353,10116.0,N,,CHEMBL621892,,,,,8327,1,Clearance in Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL621893,,,,,8328,1,Clearance rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL621894,,,,,8329,1,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL621895,,,,,8330,1,Clearance rat; Not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6444,10116.0,N,,CHEMBL875284,,,,,8331,1,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6444,10116.0,N,,CHEMBL618699,,,,,8332,1,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6444,10116.0,N,,CHEMBL618700,,,,,8333,1,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6211,10116.0,N,,CHEMBL618701,,,,,8334,1,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12873,10116.0,N,1969.0,CHEMBL876600,,,,Plasma,8335,1,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL618702,,,,,8336,1,Clearance of compound in rat after 1 mg/kg i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3341,10116.0,N,,CHEMBL618703,,,,,8337,1,Compound was evaluated for Hepatic clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4891,10116.0,N,,CHEMBL618704,,,,,8338,1,In vivo clearance after 5 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1094,10116.0,N,1969.0,CHEMBL618705,,,,Plasma,8339,1,Compound was tested for plasma clearance in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2938,10116.0,N,,CHEMBL618706,,,,,8340,1,Hepatic clearance after intravenous administration was evaluated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17853,10116.0,N,,CHEMBL618707,,,,,8341,1,Lower clearance in rat (i.v.) at 0.5 mpk,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6049,10116.0,N,1969.0,CHEMBL618708,,,,Plasma,8342,1,Pharmacokinetic parameter expressed as plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5789,10116.0,N,,CHEMBL618709,,,,,8343,1,Pharmacokinetic property (Clp) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4514,10116.0,N,,CHEMBL618710,,,,,8344,1,Plasma clearance in Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6448,10116.0,N,,CHEMBL618711,,,,,8345,1,Plasma clearance (Clp) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6062,10116.0,N,,CHEMBL618712,,,,,8346,1,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5710,10116.0,N,,CHEMBL618713,,,,,8347,1,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4709,10116.0,N,,CHEMBL618714,,,,,8348,1,Plasma clearance after intravenous administration of 1 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4521,10116.0,N,,CHEMBL618715,,,,,8349,1,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1742,10116.0,N,,CHEMBL618716,,,,,8350,1,Plasma clearance in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL876601,,,,,8351,1,Plasma clearance measured in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL618717,,,,,8352,1,Plasma clearance was calculated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5145,10116.0,N,,CHEMBL618718,,,,,8353,1,Plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5833,10116.0,N,,CHEMBL618719,,,,,8354,1,Plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6453,10116.0,N,,CHEMBL618720,,,,,8355,1,Plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6640,10116.0,N,,CHEMBL618721,,,,,8356,1,Plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6305,10116.0,N,,CHEMBL621477,,,,,8357,1,Plasma clearance in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6642,10116.0,N,,CHEMBL621478,,,,,8358,1,Plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5472,10116.0,N,,CHEMBL621479,,,,,8359,1,Plasma clearance was evaluated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5472,10116.0,N,,CHEMBL621480,,,,,8360,1,Plasma clearance was evaluated in rat; Not tested,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5144,10116.0,N,,CHEMBL621481,,,,,8361,1,Plasma clearance rate was determined for the compound in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL621482,,,,,8362,1,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL621483,,,,,8363,1,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL621484,,,,,8364,1,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,948.0,CHEMBL621485,,,,Heart,8365,1,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,948.0,CHEMBL621486,,,,Heart,8366,1,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,160.0,CHEMBL621487,,,,Intestine,8367,1,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,160.0,CHEMBL621488,,,,Intestine,8368,1,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,160.0,CHEMBL621489,,,,Intestine,8369,1,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,160.0,CHEMBL621490,,,,Intestine,8370,1,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,160.0,CHEMBL621491,,,,Intestine,8371,1,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2113.0,CHEMBL621492,,,,Kidney,8372,1,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2113.0,CHEMBL621493,,,,Kidney,8373,1,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2113.0,CHEMBL621494,,,,Kidney,8374,1,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2113.0,CHEMBL621495,,,,Kidney,8375,1,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2113.0,CHEMBL621496,,,,Kidney,8376,1,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2107.0,CHEMBL621497,,,,Liver,8377,1,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2107.0,CHEMBL621498,,,,Liver,8378,1,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2107.0,CHEMBL621499,,,,Liver,8379,1,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2107.0,CHEMBL618634,,,,Liver,8380,1,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2107.0,CHEMBL618635,,,,Liver,8381,1,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2048.0,CHEMBL618636,,,,Lung,8382,1,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2048.0,CHEMBL619737,,,,Lung,8383,1,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2048.0,CHEMBL619738,,,,Lung,8384,1,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2048.0,CHEMBL624329,,,,Lung,8385,1,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2048.0,CHEMBL624330,,,,Lung,8386,1,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2385.0,CHEMBL624331,,,,Muscle tissue,8387,1,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2385.0,CHEMBL624332,,,,Muscle tissue,8388,1,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2385.0,CHEMBL624333,,,,Muscle tissue,8389,1,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2385.0,CHEMBL624334,,,,Muscle tissue,8390,1,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2385.0,CHEMBL624335,,,,Muscle tissue,8391,1,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2106.0,CHEMBL620016,,,,Spleen,8392,1,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2106.0,CHEMBL620169,,,,Spleen,8393,1,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2106.0,CHEMBL620170,,,,Spleen,8394,1,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2106.0,CHEMBL620171,,,,Spleen,8395,1,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2106.0,CHEMBL620172,,,,Spleen,8396,1,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,945.0,CHEMBL620173,,,,Stomach,8397,1,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,945.0,CHEMBL620174,,,,Stomach,8398,1,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,945.0,CHEMBL620175,,,,Stomach,8399,1,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,945.0,CHEMBL620176,,,,Stomach,8400,1,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,945.0,CHEMBL620177,,,,Stomach,8401,1,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,2037.0,CHEMBL620178,,,,Cerebellum,8402,1,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,2037.0,CHEMBL620179,,,,Cerebellum,8403,1,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,,CHEMBL620180,,,,,8404,1,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL620181,,,,,8405,1,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6571,10116.0,N,,CHEMBL620182,,,,,8406,1,Volume of distribution of compound in rats after intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6453,10116.0,N,,CHEMBL620183,,,,,8407,1,Volume of distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6444,10116.0,N,,CHEMBL620184,,,,,8408,1,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6444,10116.0,N,,CHEMBL620185,,,,,8409,1,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6444,10116.0,N,,CHEMBL620186,,,,,8410,1,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5353,10116.0,N,,CHEMBL620187,,,,,8411,1,Volume of distribution was determined in Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL620188,,,,,8412,1,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL620189,,,,,8413,1,Volume of distribution was reported in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL620190,,,,,8414,1,Volumes of distribution in rat after peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL620191,,,,,8415,1,Volumes of distribution in rat after po administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL620192,,,,,8416,1,Volumes of distribution in rat after po administration; Not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5676,10116.0,N,,CHEMBL620193,,,,,8417,1,Pharmacokinetic property (Volume) in rat i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6410,10116.0,N,,CHEMBL620194,,,,,8418,1,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17670,10116.0,N,,CHEMBL876730,,,,,8419,1,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6495,10116.0,N,,CHEMBL620195,,,,,8420,1,Volume distribution in rat after oral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5408,10116.0,N,,CHEMBL620196,,,,,8421,1,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4883,10116.0,N,,CHEMBL620197,,,,,8422,1,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6647,10116.0,N,,CHEMBL620198,,,,,8423,1,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6495,10116.0,N,,CHEMBL620199,,,,,8424,1,Volume of distribution in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL620200,,,,,8425,1,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL620201,,,,,8426,1,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL620202,,,,,8427,1,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL620203,,,,,8428,1,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL620204,,,,,8429,1,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL620205,,,,,8430,1,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5960,10116.0,N,,CHEMBL624664,,,,,8431,1,Pharmacokinetic parameter (Vss) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5676,10116.0,N,,CHEMBL624665,,,,,8432,1,Pharmacokinetic property (Volume) in rat i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5948,10116.0,N,,CHEMBL624666,,,,,8433,1,Pharmacokinetic property (Vss) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5979,10116.0,N,,CHEMBL624667,,,,,8434,1,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL624668,,,,,8435,1,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL624669,,,,,8436,1,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL624670,,,,,8437,1,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL624671,,,,,8438,1,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6448,10116.0,N,,CHEMBL624672,,,,,8439,1,Steady state volume distribution in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12873,10116.0,N,1969.0,CHEMBL624673,,,,Plasma,8440,1,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4576,10116.0,N,,CHEMBL624674,,,,,8441,1,Steady state volume of distribution determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL624675,,,,,8442,1,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1466,10116.0,N,,CHEMBL621728,,,,,8443,1,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5182,10116.0,N,,CHEMBL621729,,,,,8444,1,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5182,10116.0,N,,CHEMBL621730,,,,,8445,1,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6535,10116.0,N,,CHEMBL621731,,,,,8446,1,Volume distribution in rat after administration of 2 mg/kg iv,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6535,10116.0,N,,CHEMBL621732,,,,,8447,1,Volume distribution in rat after administration of 2 mg/kg iv,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL621908,,,,,8448,1,Volume in steady state distribution value was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL875347,,,,,8449,1,Volume in steady state distribution value was determined; ND denotes no data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL621909,,,,,8450,1,Volume in steady state distribution value was determined; ND denotes not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17065,10116.0,N,,CHEMBL621910,,,,,8451,1,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6597,10116.0,N,,CHEMBL621911,,,,,8452,1,Volume of distribution at steady state was evaluated in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,,CHEMBL621912,,,,,8453,1,Volume of distribution at steady state was observed after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6485,10116.0,N,,CHEMBL621913,,,,,8454,1,Volume of distribution in steady state was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17655,10116.0,N,,CHEMBL621914,,,,,8455,1,Volume of distribution in steady state was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6616,10116.0,N,,CHEMBL621915,,,,,8456,1,Volume of distribution after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1916,10116.0,N,,CHEMBL621916,,,,,8457,1,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16438,10090.0,N,2107.0,CHEMBL621917,,,,Liver,8458,1,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2107.0,CHEMBL621918,,,,Liver,8459,1,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2106.0,CHEMBL621919,,,,Spleen,8460,1,Biodistribution of compound (oxidized form) in spleen tissue,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2106.0,CHEMBL621920,,,,Spleen,8461,1,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2106.0,CHEMBL621921,,,,Spleen,8462,1,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2106.0,CHEMBL622401,,,,Spleen,8463,1,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2106.0,CHEMBL875348,,,,Spleen,8464,1,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2106.0,CHEMBL622402,,,,Spleen,8465,1,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,178.0,CHEMBL622403,,,,Blood,8466,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,178.0,CHEMBL622404,,,,Blood,8467,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,955.0,CHEMBL622405,,,,Brain,8468,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,955.0,CHEMBL622406,,,,Brain,8469,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,955.0,CHEMBL622407,,,,Brain,8470,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,948.0,CHEMBL622408,,,,Heart,8471,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,948.0,CHEMBL622409,,,,Heart,8472,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,948.0,CHEMBL622410,,,,Heart,8473,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2113.0,CHEMBL622411,,,,Kidney,8474,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2113.0,CHEMBL627864,,,,Kidney,8475,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2113.0,CHEMBL627865,,,,Kidney,8476,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2107.0,CHEMBL627866,,,,Liver,8477,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2107.0,CHEMBL627751,,,,Liver,8478,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2106.0,CHEMBL627752,,,,Spleen,8479,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2106.0,CHEMBL627753,,,,Spleen,8480,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
16438,10090.0,N,2106.0,CHEMBL627754,,,,Spleen,8481,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
12467,10090.0,N,,CHEMBL627755,,,,,8482,1,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
17208,10090.0,N,955.0,CHEMBL627756,,,,Brain,8483,1,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,955.0,CHEMBL627757,,,,Brain,8484,1,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,955.0,CHEMBL627758,,,,Brain,8485,1,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,955.0,CHEMBL627759,,,,Brain,8486,1,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,955.0,CHEMBL627760,,,,Brain,8487,1,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,955.0,CHEMBL627761,,,,Brain,8488,1,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,948.0,CHEMBL876811,,,,Heart,8489,1,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,948.0,CHEMBL627762,,,,Heart,8490,1,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,948.0,CHEMBL627763,,,,Heart,8491,1,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,948.0,CHEMBL627764,,,,Heart,8492,1,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,948.0,CHEMBL627765,,,,Heart,8493,1,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,948.0,CHEMBL627766,,,,Heart,8494,1,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2113.0,CHEMBL627767,,,,Kidney,8495,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2113.0,CHEMBL627768,,,,Kidney,8496,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2113.0,CHEMBL628422,,,,Kidney,8497,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2113.0,CHEMBL628423,,,,Kidney,8498,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
5089,10116.0,N,,CHEMBL628424,,,,,8499,1,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5089,10116.0,N,,CHEMBL628425,,,,,8500,1,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4257,10116.0,N,,CHEMBL628426,,,,,8501,1,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6679,10116.0,N,,CHEMBL628427,,,,,8502,1,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5546,10116.0,N,,CHEMBL626938,,,,,8503,1,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6141,10116.0,N,,CHEMBL626939,,,,,8504,1,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL626940,,,,,8505,1,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL626941,,,,,8506,1,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL626942,,,,,8507,1,Plasma clearance was reported in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4689,10116.0,N,,CHEMBL876812,,,,,8508,1,Plasma clearance after intravenous administration (1 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6848,10116.0,N,,CHEMBL626943,,,,,8509,1,Plasma clearance of compound in rats was evaluated,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6848,10116.0,N,,CHEMBL626944,,,,,8510,1,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6467,10116.0,N,,CHEMBL626945,,,,,8511,1,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6467,10116.0,N,,CHEMBL626946,,,,,8512,1,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4956,10116.0,N,,CHEMBL626856,,,,,8513,1,Plasma clearance rate in Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5529,10116.0,N,,CHEMBL626857,,,,,8514,1,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
406,10116.0,N,1969.0,CHEMBL626858,,,,Plasma,8515,1,The compound was evaluated for plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17655,10116.0,N,1969.0,CHEMBL627018,,,,Plasma,8516,1,Total plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3293,10116.0,N,178.0,CHEMBL625331,,,,Blood,8517,1,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4075,10116.0,N,178.0,CHEMBL625332,,,,Blood,8518,1,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL877590,,,,,8519,1,C max was determined at 10 mg/kg po dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL625333,,,,,8520,1,C max was determined at 3 mg/kg po dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17594,10116.0,N,,CHEMBL625334,,,,,8521,1,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17594,10116.0,N,,CHEMBL625335,,,,,8522,1,Cmax after single intravenous bolus of 1 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4762,10116.0,N,,CHEMBL625336,,,,,8523,1,Cmax of compound at 5 mg/kg after po administration was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL625337,,,,,8524,1,Cmax 24 hr after 10 mg/kg oral administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL625338,,,,,8525,1,Cmax 24 hr after 2 mg/kg oral administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1466,10116.0,N,1969.0,CHEMBL625339,,,,Plasma,8526,1,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6535,10116.0,N,,CHEMBL625340,,,,,8527,1,Cmax in rat after administration of 2 mg/kg iv,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6535,10116.0,N,,CHEMBL625341,,,,,8528,1,Cmax in rat after administration of 2 mg/kg iv,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3169,10116.0,N,,CHEMBL622687,,,,,8529,1,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6515,10116.0,N,1969.0,CHEMBL622688,,,,Plasma,8530,1,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11149,10116.0,N,178.0,CHEMBL622689,,,,Blood,8531,1,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11149,10116.0,N,178.0,CHEMBL620295,,,,Blood,8532,1,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17858,10116.0,N,,CHEMBL620296,,,,,8533,1,Cmax after 10 mg/kg oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL620297,,,,,8534,1,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL620298,,,,,8535,1,Cmax after IV dosing at 1 mg/kg in rat; no data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4426,10116.0,N,,CHEMBL620299,,,,,8536,1,Cmax after oral administration at 20 mpk in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4426,10116.0,N,,CHEMBL620300,,,,,8537,1,Cmax after oral administration at 20 mpk in rats; Not performed.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4426,10116.0,N,,CHEMBL620301,,,,,8538,1,Cmax after oral administration at 20 mpk in rats d; Not performed.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5656,10116.0,N,,CHEMBL620302,,,,,8539,1,Cmax after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL620303,,,,,8540,1,Cmax after oral administration at a dose of 2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL620304,,,,,8541,1,Cmax after oral administration at a dose of 4 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6113,10116.0,N,,CHEMBL620305,,,,,8542,1,Cmax in rats after 20 mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17764,10116.0,N,,CHEMBL620306,,,,,8543,1,Cmax after peroral administration in rats at 2.4 uM/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4756,10116.0,N,,CHEMBL620307,,,,,8544,1,Cmax at the dose of 2 mg/Kg administered perorally in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4756,10116.0,N,,CHEMBL620308,,,,,8545,1,Cmax at the dose of 5 mg/Kg administered perorally in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6402,10116.0,N,,CHEMBL620309,,,,,8546,1,Cmax by administering at 20 mg/kg p.o. in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5610,10116.0,N,,CHEMBL620310,,,,,8547,1,Cmax in male rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5207,10116.0,N,,CHEMBL620311,,,,,8548,1,Cmax in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6011,10116.0,N,,CHEMBL620312,,,,,8549,1,Cmax in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6504,10116.0,N,,CHEMBL620313,,,,,8550,1,Cmax in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6046,10116.0,N,,CHEMBL620314,,,,,8551,1,Cmax in rat at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6504,10116.0,N,,CHEMBL620315,,,,,8552,1,Cmax in rat at the dose of 1 mg/kg i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5874,10116.0,N,,CHEMBL620316,,,,,8553,1,Cmax in rat by po administration at a dose of 40 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17686,10116.0,N,,CHEMBL620317,,,,,8554,1,Cmax in rat p.o. at 20 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5836,10116.0,N,,CHEMBL620318,,,,,8555,1,Cmax in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17596,10116.0,N,,CHEMBL620319,,,,,8556,1,Cmax in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16423,10116.0,N,,CHEMBL620320,,,,,8557,1,Cmax was evaluated after 20 uM/kg of peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17804,10116.0,N,,CHEMBL620321,,,,,8558,1,Cmax was measured in rats after peroral administration at 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1908,10116.0,N,,CHEMBL620322,,,,,8559,1,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13950,10116.0,N,,CHEMBL620323,,,,,8560,1,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,1870.0,CHEMBL620324,,,,Frontal cortex,8561,1,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,1870.0,CHEMBL620325,,,,Frontal cortex,8562,1,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,10000000.0,CHEMBL620326,,,,Hippocampus,8563,1,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,10000000.0,CHEMBL620327,,,,Hippocampus,8564,1,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,,CHEMBL620328,,,,,8565,1,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,,CHEMBL620329,,,,,8566,1,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,1891.0,CHEMBL620330,,,,Midbrain,8567,1,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,1891.0,CHEMBL875286,,,,Midbrain,8568,1,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,,CHEMBL620331,,,,,8569,1,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,,CHEMBL620332,,,,,8570,1,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,2435.0,CHEMBL620333,,,,Striatum,8571,1,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13950,10116.0,N,2435.0,CHEMBL620334,,,,Striatum,8572,1,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL621015,,,,Blood,8573,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL621016,,,,Blood,8574,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL621191,,,,Blood,8575,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL621192,,,,Blood,8576,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL621193,,,,Blood,8577,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL621194,,,,Blood,8578,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL624204,,,,Blood,8579,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL624205,,,,Blood,8580,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624206,,,,Blood,8581,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624207,,,,Blood,8582,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624208,,,,Blood,8583,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624209,,,,Blood,8584,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624210,,,,Blood,8585,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624211,,,,Blood,8586,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624212,,,,Blood,8587,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624213,,,,Blood,8588,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL876611,,,,Blood,8589,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL624214,,,,Blood,8590,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,178.0,CHEMBL624215,,,,Blood,8591,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624216,,,,Blood,8592,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624217,,,,Blood,8593,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624218,,,,Blood,8594,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624219,,,,Blood,8595,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624220,,,,Blood,8596,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,178.0,CHEMBL624221,,,,Blood,8597,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL624222,,,,,8598,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL624223,,,,,8599,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL624224,,,,,8600,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL624225,,,,,8601,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17764,10116.0,N,,CHEMBL622420,,,,,8602,1,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5031,10116.0,N,,CHEMBL622421,,,,,8603,1,Volume of steady state distribution after i.v. administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6215,10116.0,N,,CHEMBL622422,,,,,8604,1,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17671,10116.0,N,,CHEMBL622423,,,,,8605,1,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17752,10116.0,N,,CHEMBL622424,,,,,8606,1,Vss was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6596,10116.0,N,,CHEMBL622425,,,,,8607,1,Vss in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16423,10116.0,N,,CHEMBL876612,,,,,8608,1,Vss was evaluated after 10 uM/kg of intra arterial administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,,CHEMBL622426,,,,,8609,1,volume of distribution at steady state was observed after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6062,10116.0,N,,CHEMBL622427,,,,,8610,1,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5874,10116.0,N,,CHEMBL622428,,,,,8611,1,Pharmacokinetic (PK) parameter Vz in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4942,10116.0,N,,CHEMBL622429,,,,,8612,1,Volume distribution in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17796,10116.0,N,,CHEMBL622430,,,,,8613,1,Volume of distribution in rat; No data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4890,10116.0,N,,CHEMBL622431,,,,,8614,1,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15765,10116.0,N,2116.0,CHEMBL622432,,,,Ileum,8615,1,% absorption predicted from in vitro rat ileum transport studies,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL622433,,,,,8616,1,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL622434,,,,,8617,1,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL622435,,,,,8618,1,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618748,,,,,8619,1,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618749,,,,,8620,1,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618750,,,,,8621,1,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618751,,,,,8622,1,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,10116.0,N,,CHEMBL618752,,,,,8623,1,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4576,10116.0,N,,CHEMBL618753,,,,,8624,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
750,10116.0,N,1969.0,CHEMBL618754,,,,Plasma,8625,1,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
750,10116.0,N,,CHEMBL618755,,,,,8626,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4590,10116.0,N,,CHEMBL618756,,,,,8627,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1716,10116.0,N,,CHEMBL618757,,,,,8628,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1974,10116.0,N,,CHEMBL618758,,,,,8629,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4502,10116.0,N,,CHEMBL621088,,,,,8630,1,Oral bioavailability in rat (dose 30 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3371,10116.0,N,,CHEMBL621089,,,,,8631,1,Pharmacokinetic property (cLogP) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9099,10116.0,N,178.0,CHEMBL621090,,,,Blood,8632,1,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
9099,10116.0,N,178.0,CHEMBL621091,,,,Blood,8633,1,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
4590,10116.0,N,,CHEMBL876731,,,,,8634,1,Clearance in rat.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3184,10116.0,N,,CHEMBL621092,,,,,8635,1,Compound was evaluated for its clearance when administered intravenously in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16456,10116.0,N,,CHEMBL621093,,,,,8636,1,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4199,10116.0,N,,CHEMBL621094,,,,,8637,1,Blood: Brain distribution ratio is determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4199,10116.0,N,,CHEMBL621095,,,,,8638,1,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4199,10116.0,N,,CHEMBL621096,,,,,8639,1,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8677,10116.0,N,2113.0,CHEMBL621097,,,,Kidney,8640,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
7449,10116.0,N,,CHEMBL621098,,,,,8641,1,Percent dose excreted in 0-48 hours administered ip to male rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
11977,10116.0,N,2037.0,CHEMBL621099,,,,Cerebellum,8642,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2037.0,CHEMBL621100,,,,Cerebellum,8643,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2037.0,CHEMBL621101,,,,Cerebellum,8644,1,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2037.0,CHEMBL621102,,,,Cerebellum,8645,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2037.0,CHEMBL876732,,,,Cerebellum,8646,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL621103,,,,,8647,1,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL621104,,,,,8648,1,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL621105,,,,,8649,1,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL621106,,,,,8650,1,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL621107,,,,,8651,1,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL621108,,,,,8652,1,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL621109,,,,,8653,1,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17208,10090.0,N,2113.0,CHEMBL621110,,,,Kidney,8654,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2113.0,CHEMBL621111,,,,Kidney,8655,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2107.0,CHEMBL622541,,,,Liver,8656,1,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2107.0,CHEMBL622542,,,,Liver,8657,1,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2107.0,CHEMBL622543,,,,Liver,8658,1,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2107.0,CHEMBL624412,,,,Liver,8659,1,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2107.0,CHEMBL624413,,,,Liver,8660,1,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2107.0,CHEMBL624414,,,,Liver,8661,1,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2048.0,CHEMBL624415,,,,Lung,8662,1,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2048.0,CHEMBL624416,,,,Lung,8663,1,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2048.0,CHEMBL624417,,,,Lung,8664,1,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2048.0,CHEMBL624418,,,,Lung,8665,1,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2048.0,CHEMBL624419,,,,Lung,8666,1,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2048.0,CHEMBL624420,,,,Lung,8667,1,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2385.0,CHEMBL624421,,,,Muscle tissue,8668,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2385.0,CHEMBL624422,,,,Muscle tissue,8669,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2385.0,CHEMBL624423,,,,Muscle tissue,8670,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2385.0,CHEMBL625123,,,,Muscle tissue,8671,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2385.0,CHEMBL625124,,,,Muscle tissue,8672,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2385.0,CHEMBL625125,,,,Muscle tissue,8673,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,14.0,CHEMBL625126,,,,Zone of skin,8674,1,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,14.0,CHEMBL626947,,,,Zone of skin,8675,1,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,14.0,CHEMBL626948,,,,Zone of skin,8676,1,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,14.0,CHEMBL626949,,,,Zone of skin,8677,1,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,14.0,CHEMBL626950,,,,Zone of skin,8678,1,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,14.0,CHEMBL626951,,,,Zone of skin,8679,1,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2106.0,CHEMBL626952,,,,Spleen,8680,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2106.0,CHEMBL626953,,,,Spleen,8681,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2106.0,CHEMBL626954,,,,Spleen,8682,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2106.0,CHEMBL626955,,,,Spleen,8683,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2106.0,CHEMBL626956,,,,Spleen,8684,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,2106.0,CHEMBL626957,,,,Spleen,8685,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,178.0,CHEMBL626958,,,,Blood,8686,1,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,178.0,CHEMBL626959,,,,Blood,8687,1,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,178.0,CHEMBL626960,,,,Blood,8688,1,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,178.0,CHEMBL626961,,,,Blood,8689,1,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,178.0,CHEMBL627589,,,,Blood,8690,1,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17208,10090.0,N,178.0,CHEMBL627590,,,,Blood,8691,1,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
3132,10090.0,N,,CHEMBL627591,,,,,8692,1,Time taken for EC90 was determined when tested in mouse,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
3132,10090.0,N,,CHEMBL627592,,,,,8693,1,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
16597,10090.0,N,,CHEMBL627593,,,,,8694,1,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
5727,10090.0,N,,CHEMBL627594,,,,,8695,1,Half life in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
5302,10090.0,N,,CHEMBL876813,,,,,8696,1,Half life period in mouse after 10 mg/Kg dose,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
5302,10090.0,N,,CHEMBL627595,,,,,8697,1,Half life period in mouse after 10 mg/kg dose,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
6348,10090.0,N,,CHEMBL627596,,,,,8698,1,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
5964,10116.0,N,,CHEMBL627597,,,,,8699,1,Cmax value at 5 mg/kg po was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6078,10116.0,N,,CHEMBL627598,,,,,8700,1,Cmax value evaluated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5206,10116.0,N,955.0,CHEMBL627599,,,,Brain,8701,1,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2959,10116.0,N,,CHEMBL627600,,,,,8702,1,Cmax value after administration of 20 mg/Kg oral dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5964,10116.0,N,,CHEMBL627601,,,,,8703,1,Cmax value at 1 mg/kg po in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5964,10116.0,N,,CHEMBL627776,,,,,8704,1,Cmax value at 5 mg/kg po in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6757,10116.0,N,,CHEMBL627777,,,,,8705,1,Cmax value at a dose of 10 mg/kg in male SD rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6757,10116.0,N,,CHEMBL627778,,,,,8706,1,Cmax value at a dose of 100 mg/kg in male SD rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6757,10116.0,N,,CHEMBL627779,,,,,8707,1,Cmax value at a dose of 50 mg/kg in male SD rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17617,10116.0,N,,CHEMBL876814,,,,,8708,1,Cmax value in rats at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1445,10116.0,N,,CHEMBL627780,,,,,8709,1,Cmax value was evaluated in rats at a dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6082,10116.0,N,,CHEMBL627781,,,,,8710,1,Cmax value was determined after peroral administration of 20 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1446,10116.0,N,,CHEMBL627782,,,,,8711,1,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5407,10116.0,N,1969.0,CHEMBL627783,,,,Plasma,8712,1,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2690,10116.0,N,1969.0,CHEMBL627784,,,,Plasma,8713,1,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL627785,,,,,8714,1,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL627786,,,,,8715,1,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4891,10116.0,N,1969.0,CHEMBL627787,,,,Plasma,8716,1,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2807,10116.0,N,1969.0,CHEMBL627788,,,,Plasma,8717,1,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2807,10116.0,N,1969.0,CHEMBL626579,,,,Plasma,8718,1,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2807,10116.0,N,1969.0,CHEMBL626580,,,,Plasma,8719,1,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3634,10116.0,N,,CHEMBL876815,,,,,8720,1,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1881,10116.0,N,1969.0,CHEMBL626581,,,,Plasma,8721,1,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1881,10116.0,N,1969.0,CHEMBL626582,,,,Plasma,8722,1,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
429,10116.0,N,,CHEMBL626583,,,,,8723,1,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL626205,,,,,8724,1,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL626206,,,,,8725,1,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL626207,,,,,8726,1,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL623882,,,,,8727,1,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL623883,,,,,8728,1,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL623884,,,,,8729,1,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3032,10116.0,N,1969.0,CHEMBL623885,,,,Plasma,8730,1,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6295,10116.0,N,1969.0,CHEMBL623886,,,,Plasma,8731,1,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6619,10116.0,N,,CHEMBL623887,,,,,8732,1,Maximal concentration in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6616,10116.0,N,,CHEMBL623888,,,,,8733,1,Maximal concentration after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3249,10116.0,N,1969.0,CHEMBL623889,,,,Plasma,8734,1,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17791,10116.0,N,1969.0,CHEMBL623890,,,,Plasma,8735,1,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17791,10116.0,N,1969.0,CHEMBL623891,,,,Plasma,8736,1,Cmax in rat plasma after oral dose (50 mg/Kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1360,10116.0,N,1969.0,CHEMBL623892,,,,Plasma,8737,1,Maximal plasma concentration was determined.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2552,10116.0,N,1969.0,CHEMBL623893,,,,Plasma,8738,1,Maximal plasma drug concentration was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6571,10116.0,N,,CHEMBL877616,,,,,8739,1,Maximal concentration in rats after peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL623894,,,,,8740,1,Maximum concentration in rat after 2 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6567,10116.0,N,1969.0,CHEMBL623895,,,,Plasma,8741,1,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3031,10116.0,N,,CHEMBL623896,,,,,8742,1,Maximum concentration of compound in rat was evaluated.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3436,10116.0,N,,CHEMBL623897,,,,,8743,1,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3436,10116.0,N,,CHEMBL623898,,,,,8744,1,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2083,10116.0,N,,CHEMBL623899,,,,,8745,1,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3436,10116.0,N,,CHEMBL623900,,,,,8746,1,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL623901,,,,,8747,1,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1974,10116.0,N,,CHEMBL623902,,,,,8748,1,Maximum concentration was evaluated in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3307,10116.0,N,1359.0,CHEMBL623903,,,,Cerebrospinal fluid,8749,1,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3307,10116.0,N,1969.0,CHEMBL623904,,,,Plasma,8750,1,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1916,10116.0,N,1969.0,CHEMBL877617,,,,Plasma,8751,1,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1500,10116.0,N,,CHEMBL623905,,,,,8752,1,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1500,10116.0,N,,CHEMBL623906,,,,,8753,1,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4186,10116.0,N,1969.0,CHEMBL623907,,,,Plasma,8754,1,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL623908,,,,,8755,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL623909,,,,,8756,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL623910,,,,,8757,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL623911,,,,,8758,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623912,,,,,8759,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL624616,,,,,8760,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL624617,,,,,8761,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL624618,,,,,8762,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL624619,,,,,8763,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL624794,,,,,8764,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL624795,,,,,8765,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623921,,,,,8766,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL623922,,,,,8767,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL623923,,,,,8768,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL623924,,,,,8769,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623925,,,,,8770,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623926,,,,,8771,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623927,,,,,8772,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623928,,,,,8773,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623929,,,,,8774,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623930,,,,,8775,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL623931,,,,Brain,8776,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL622165,,,,Brain,8777,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL621249,,,,Brain,8778,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL621250,,,,Brain,8779,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL621448,,,,Brain,8780,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL621449,,,,Brain,8781,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL621450,,,,Brain,8782,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL621451,,,,Brain,8783,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL621452,,,,Brain,8784,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL621453,,,,Brain,8785,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL621454,,,,Brain,8786,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL621455,,,,Brain,8787,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL621456,,,,Brain,8788,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL625145,,,,Brain,8789,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL875847,,,,Brain,8790,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL625146,,,,Brain,8791,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL625147,,,,Brain,8792,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL625148,,,,Brain,8793,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,955.0,CHEMBL625149,,,,Brain,8794,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL625150,,,,Brain,8795,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL625151,,,,Brain,8796,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL625152,,,,Brain,8797,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL625153,,,,Brain,8798,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL625154,,,,Brain,8799,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,955.0,CHEMBL625155,,,,Brain,8800,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL625156,,,,,8801,1,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL624354,,,,,8802,1,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,10000000.0,CHEMBL624355,,,,Hippocampus,8803,1,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,10000000.0,CHEMBL624356,,,,Hippocampus,8804,1,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,10000000.0,CHEMBL624357,,,,Hippocampus,8805,1,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,10000000.0,CHEMBL624358,,,,Hippocampus,8806,1,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2435.0,CHEMBL624359,,,,Striatum,8807,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2435.0,CHEMBL624360,,,,Striatum,8808,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2435.0,CHEMBL624361,,,,Striatum,8809,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2435.0,CHEMBL624362,,,,Striatum,8810,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2435.0,CHEMBL624363,,,,Striatum,8811,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,178.0,CHEMBL624364,,,,Blood,8812,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,178.0,CHEMBL624365,,,,Blood,8813,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,178.0,CHEMBL624366,,,,Blood,8814,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,178.0,CHEMBL624367,,,,Blood,8815,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,955.0,CHEMBL624368,,,,Brain,8816,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,955.0,CHEMBL624369,,,,Brain,8817,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,955.0,CHEMBL624370,,,,Brain,8818,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,955.0,CHEMBL625069,,,,Brain,8819,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,955.0,CHEMBL625070,,,,Brain,8820,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,948.0,CHEMBL626051,,,,Heart,8821,1,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,948.0,CHEMBL626052,,,,Heart,8822,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,948.0,CHEMBL626053,,,,Heart,8823,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,948.0,CHEMBL626054,,,,Heart,8824,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,948.0,CHEMBL626055,,,,Heart,8825,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2113.0,CHEMBL626056,,,,Kidney,8826,1,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2113.0,CHEMBL626057,,,,Kidney,8827,1,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2113.0,CHEMBL625193,,,,Kidney,8828,1,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2113.0,CHEMBL625194,,,,Kidney,8829,1,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2107.0,CHEMBL625195,,,,Liver,8830,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2107.0,CHEMBL625196,,,,Liver,8831,1,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2107.0,CHEMBL625197,,,,Liver,8832,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2107.0,CHEMBL625198,,,,Liver,8833,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2107.0,CHEMBL627929,,,,Liver,8834,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2048.0,CHEMBL627074,,,,Lung,8835,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2048.0,CHEMBL627075,,,,Lung,8836,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2048.0,CHEMBL627076,,,,Lung,8837,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2048.0,CHEMBL627077,,,,Lung,8838,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2048.0,CHEMBL627078,,,,Lung,8839,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2385.0,CHEMBL627079,,,,Muscle tissue,8840,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4573,10090.0,N,,CHEMBL873824,,,,,8841,1,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
3132,10090.0,N,1969.0,CHEMBL627080,,,,Plasma,8842,1,Half life in mouse plasma was determined at dose 25 mg/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17718,10090.0,N,,CHEMBL627081,,,,,8843,1,Half life was determined,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
17728,10090.0,N,,CHEMBL627082,,,,,8844,1,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
5961,10090.0,N,,CHEMBL627083,,,,,8845,1,Half-life in male mice after 1 mg/kg intravenous dose,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17731,10090.0,N,1969.0,CHEMBL627085,,,,Plasma,8847,1,Half life in mice plasma,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
17592,10090.0,N,,CHEMBL627086,,,,,8848,1,Half life in mouse,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
3132,10090.0,N,1969.0,CHEMBL627087,,,,Plasma,8849,1,Half life in mouse plasma at dose 25 mg/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17729,10090.0,N,,CHEMBL627088,,,,,8850,1,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17729,10090.0,N,,CHEMBL627089,,,,,8851,1,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17729,10090.0,N,,CHEMBL627090,,,,,8852,1,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
3277,10090.0,N,,CHEMBL627091,,,,,8853,1,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
3760,10090.0,N,,CHEMBL627092,,,,,8854,1,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
3760,10090.0,N,,CHEMBL876785,,,,,8855,1,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
2862,10090.0,N,,CHEMBL627093,,,,,8856,1,Half-life by iv administration in mouse,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
2862,10090.0,N,,CHEMBL627094,,,,,8857,1,Half-life by oral administration in mouse,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
5980,10090.0,N,,CHEMBL627095,,,,,8858,1,Half-life in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
6159,10090.0,N,955.0,CHEMBL627096,,,,Brain,8859,1,Half-life using mouse brain homogenate,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
6254,10090.0,N,,CHEMBL627097,,,,,8860,1,Half-life was measured in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
6062,10090.0,N,,CHEMBL627098,,,,,8861,1,Half-life was measured in mouse after an iv dose of 1 mg/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
1574,10090.0,N,178.0,CHEMBL627099,,,,Blood,8862,1,Half-life period was determined in mouse blood,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
56,10090.0,N,955.0,CHEMBL627100,,,,Brain,8863,1,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
993,10090.0,N,1969.0,CHEMBL627101,,,,Plasma,8864,1,Plasma half life in mouse,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
6652,10090.0,N,,CHEMBL627102,,,,,8865,1,Stability of the peptide in the presence of mouse serum,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
17852,10090.0,N,,CHEMBL627103,,,,,8866,1,Terminal half life of compound was determined in mouse,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
2675,10090.0,N,,CHEMBL627104,,,,,8867,1,Terminal half life was evaluated in mice after intravenous administration,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
2675,10090.0,N,,CHEMBL627105,,,,,8868,1,Terminal half life was evaluated in mice after oral administration,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
499,10090.0,N,,CHEMBL876786,,,,,8869,1,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
499,10090.0,N,,CHEMBL873825,,,,,8870,1,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
499,10090.0,N,,CHEMBL627106,,,,,8871,1,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14239,10090.0,N,,CHEMBL626336,,,,,8872,1,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
5506,10090.0,N,,CHEMBL877462,,,,,8873,1,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
5506,10090.0,N,,CHEMBL626337,,,,,8874,1,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17734,10090.0,N,,CHEMBL626338,,,,,8875,1,Half life after intraperitoneal administration of 100 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
17728,10090.0,N,,CHEMBL626339,,,,,8876,1,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17728,10090.0,N,,CHEMBL626340,,,,,8877,1,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17728,10090.0,N,,CHEMBL625377,,,,,8878,1,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17728,10090.0,N,,CHEMBL625378,,,,,8879,1,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17728,10090.0,N,,CHEMBL625379,,,,,8880,1,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14294,9823.0,U,,CHEMBL625380,,,,,8881,0,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,Autocuration,22224,,BAO_0000251,Microsomes,,Sus scrofa,1,,A
14294,9823.0,U,,CHEMBL625381,,,,,8882,0,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,Autocuration,22224,,BAO_0000251,Microsomes,,Sus scrofa,1,,A
6056,9823.0,U,,CHEMBL625382,,,,,8883,0,Stability to porcine renal DHP-I,,Autocuration,22224,,BAO_0000019,,,Sus scrofa,1,,A
1317,9823.0,U,,CHEMBL873828,,,,,8884,0,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Sus scrofa,1,,A
1317,9823.0,U,,CHEMBL625383,,,,,8885,0,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Sus scrofa,1,,A
5229,9823.0,U,,CHEMBL625384,,,,,8886,0,Half-life of the parent prodrug in porcine esterase solution,,Autocuration,22224,,BAO_0000019,,,Sus scrofa,1,,A
4231,9823.0,U,,CHEMBL625385,,,,,8887,0,"First order rate constant, k was determined in in pig liver Esterase",,Autocuration,22224,,BAO_0000019,,,Sus scrofa,1,,A
4231,9823.0,U,2107.0,CHEMBL625386,,,,Liver,8888,0,Half life of the in pig liver Esterase,,Autocuration,22224,,BAO_0000221,,,Sus scrofa,1,,A
5318,9823.0,U,2107.0,CHEMBL623571,,,,Liver,8889,0,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,Autocuration,22224,,BAO_0000221,,,Sus scrofa,1,,A
5318,9823.0,U,2107.0,CHEMBL623572,,,,Liver,8890,0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,Autocuration,22224,,BAO_0000221,,,Sus scrofa,1,,A
5318,9823.0,U,2107.0,CHEMBL623573,,,,Liver,8891,0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,Autocuration,22224,,BAO_0000221,,,Sus scrofa,1,,A
3305,9823.0,U,2107.0,CHEMBL623574,,,,Liver,8892,0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,Autocuration,22224,,BAO_0000221,,,Sus scrofa,1,,A
3305,9823.0,U,2107.0,CHEMBL623575,,,,Liver,8893,0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,Autocuration,22224,,BAO_0000221,,,Sus scrofa,1,,A
2842,9823.0,U,2107.0,CHEMBL623749,,,,Liver,8894,0,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,Autocuration,22224,,BAO_0000221,,,Sus scrofa,1,,A
2842,9823.0,U,2107.0,CHEMBL623750,,,,Liver,8895,0,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,Autocuration,22224,,BAO_0000221,,,Sus scrofa,1,,A
889,9823.0,U,2107.0,CHEMBL623751,,,,Liver,8896,0,Half-life in vitro in pig liver,,Autocuration,22224,,BAO_0000221,,In vitro,Sus scrofa,1,,A
1904,9823.0,U,2107.0,CHEMBL623752,,,,Liver,8897,0,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,Autocuration,22224,,BAO_0000221,,,Sus scrofa,1,,A
4186,10116.0,N,1969.0,CHEMBL623753,,,,Plasma,8898,1,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2774,10116.0,N,1969.0,CHEMBL623754,,,,Plasma,8899,1,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1742,10116.0,N,1969.0,CHEMBL623755,,,,Plasma,8900,1,Maximum concentration in rat plasma was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3169,10116.0,N,,CHEMBL623756,,,,,8901,1,Maximum concentration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3169,10116.0,N,,CHEMBL623757,,,,,8902,1,Maximum concentration in rats at 1-2 hours,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2081,10116.0,N,,CHEMBL623758,,,,,8903,1,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3307,10116.0,N,955.0,CHEMBL623759,,,,Brain,8904,1,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4727,10116.0,N,,CHEMBL623760,,,,,8905,1,Maximum concentration at the dose of 2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6597,10116.0,N,,CHEMBL623761,,,,,8906,1,Maximum concentration was evaluated in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,1969.0,CHEMBL623762,,,,Plasma,8907,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,1969.0,CHEMBL877594,,,,Plasma,8908,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,1969.0,CHEMBL623763,,,,Plasma,8909,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,1969.0,CHEMBL623764,,,,Plasma,8910,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,1969.0,CHEMBL623765,,,,Plasma,8911,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2591,10116.0,N,178.0,CHEMBL623766,,,,Blood,8912,1,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2591,10116.0,N,178.0,CHEMBL623767,,,,Blood,8913,1,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2591,10116.0,N,178.0,CHEMBL623768,,,,Blood,8914,1,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,1969.0,CHEMBL623769,,,,Plasma,8915,1,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,1969.0,CHEMBL623770,,,,Plasma,8916,1,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,1969.0,CHEMBL623771,,,,Plasma,8917,1,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,1969.0,CHEMBL623772,,,,Plasma,8918,1,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,1969.0,CHEMBL623773,,,,Plasma,8919,1,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,1969.0,CHEMBL623774,,,,Plasma,8920,1,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,1969.0,CHEMBL623775,,,,Plasma,8921,1,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14465,10116.0,N,,CHEMBL623776,,,,,8922,1,Cmax in rat (PO dose),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4723,10116.0,N,1969.0,CHEMBL622191,,,,Plasma,8923,1,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4723,10116.0,N,1969.0,CHEMBL622192,,,,Plasma,8924,1,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4576,10116.0,N,1969.0,CHEMBL622193,,,,Plasma,8925,1,Maximum plasma concentration determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12873,10116.0,N,1969.0,CHEMBL622194,,,,Plasma,8926,1,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12873,10116.0,N,1969.0,CHEMBL622195,,,,Plasma,8927,1,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6824,10116.0,N,1969.0,CHEMBL622196,,,,Plasma,8928,1,Maximum plasma concentration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17065,10116.0,N,1969.0,CHEMBL622197,,,,Plasma,8929,1,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2932,10116.0,N,1969.0,CHEMBL622198,,,,Plasma,8930,1,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2932,10116.0,N,1969.0,CHEMBL622199,,,,Plasma,8931,1,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2879,10116.0,N,1969.0,CHEMBL622200,,,,Plasma,8932,1,Maximum plasma concentration of compound was measured in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2864,10116.0,N,1969.0,CHEMBL622201,,,,Plasma,8933,1,Maximum plasma concentration after 20 mg/kg oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16367,10116.0,N,1969.0,CHEMBL623990,,,,Plasma,8934,1,Maximum plasma concentration after oral administration to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,1969.0,CHEMBL623991,,,,Plasma,8935,1,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,1969.0,CHEMBL623992,,,,Plasma,8936,1,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,1969.0,CHEMBL623993,,,,Plasma,8937,1,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,1969.0,CHEMBL623994,,,,Plasma,8938,1,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17720,10116.0,N,1969.0,CHEMBL623995,,,,Plasma,8939,1,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,F
17720,10116.0,N,1969.0,CHEMBL623996,,,,Plasma,8940,1,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,F
17720,10116.0,N,1969.0,CHEMBL623997,,,,Plasma,8941,1,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,F
4516,10116.0,N,1969.0,CHEMBL623998,,,,Plasma,8942,1,Maximum plasma concentration dosed orally in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4516,10116.0,N,1969.0,CHEMBL623999,,,,Plasma,8943,1,Maximum plasma concentration dosed orally in rats after 6 hours,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4516,10116.0,N,1969.0,CHEMBL624000,,,,Plasma,8944,1,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5199,10116.0,N,1969.0,CHEMBL624001,,,,Plasma,8945,1,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17538,10116.0,N,1969.0,CHEMBL624002,,,,Plasma,8946,1,Maximum plasma concentration in rat after po administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,1969.0,CHEMBL624003,,,,Plasma,8947,1,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,1969.0,CHEMBL624004,,,,Plasma,8948,1,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624005,,,,Heart,8949,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624006,,,,Heart,8950,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624007,,,,Heart,8951,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624008,,,,Heart,8952,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624009,,,,Heart,8953,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL874387,,,,Heart,8954,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624010,,,,Heart,8955,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624011,,,,Heart,8956,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624012,,,,Heart,8957,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624013,,,,Heart,8958,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624736,,,,Heart,8959,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624737,,,,Heart,8960,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624738,,,,Heart,8961,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624739,,,,Heart,8962,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,948.0,CHEMBL624740,,,,Heart,8963,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624896,,,,Heart,8964,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624897,,,,Heart,8965,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624108,,,,Heart,8966,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624109,,,,Heart,8967,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624110,,,,Heart,8968,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624111,,,,Heart,8969,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624112,,,,Heart,8970,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL624113,,,,Heart,8971,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL619709,,,,Heart,8972,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,948.0,CHEMBL619710,,,,Heart,8973,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619711,,,,Kidney,8974,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619712,,,,Kidney,8975,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619713,,,,Kidney,8976,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619714,,,,Kidney,8977,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619715,,,,Kidney,8978,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619716,,,,Kidney,8979,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619717,,,,Kidney,8980,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619718,,,,Kidney,8981,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL619719,,,,Kidney,8982,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL875329,,,,Kidney,8983,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL619720,,,,Kidney,8984,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL619721,,,,Kidney,8985,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL619722,,,,Kidney,8986,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL619723,,,,Kidney,8987,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL619724,,,,Kidney,8988,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL619725,,,,Kidney,8989,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619726,,,,Kidney,8990,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619727,,,,Kidney,8991,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2113.0,CHEMBL619728,,,,Kidney,8992,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL619729,,,,Kidney,8993,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,2385.0,CHEMBL619730,,,,Muscle tissue,8994,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2385.0,CHEMBL619731,,,,Muscle tissue,8995,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2385.0,CHEMBL619732,,,,Muscle tissue,8996,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2385.0,CHEMBL619733,,,,Muscle tissue,8997,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2385.0,CHEMBL619734,,,,Muscle tissue,8998,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,14.0,CHEMBL619735,,,,Zone of skin,8999,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,14.0,CHEMBL875330,,,,Zone of skin,9000,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,14.0,CHEMBL628465,,,,Zone of skin,9001,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,14.0,CHEMBL628466,,,,Zone of skin,9002,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,14.0,CHEMBL628467,,,,Zone of skin,9003,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2106.0,CHEMBL628468,,,,Spleen,9004,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2106.0,CHEMBL628469,,,,Spleen,9005,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2106.0,CHEMBL628470,,,,Spleen,9006,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2106.0,CHEMBL628471,,,,Spleen,9007,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2106.0,CHEMBL628472,,,,Spleen,9008,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2046.0,CHEMBL625191,,,,Thyroid gland,9009,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2046.0,CHEMBL625192,,,,Thyroid gland,9010,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2046.0,CHEMBL875337,,,,Thyroid gland,9011,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2046.0,CHEMBL626341,,,,Thyroid gland,9012,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2046.0,CHEMBL626342,,,,Thyroid gland,9013,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11977,10116.0,N,2107.0,CHEMBL621943,,,,Liver,9014,1,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3748,10116.0,N,,CHEMBL621944,,,,,9015,1,Half life in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15765,10116.0,N,,CHEMBL621945,,,,,9016,1,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4871,10116.0,N,,CHEMBL621946,,,,,9017,1,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4871,10116.0,N,,CHEMBL621947,,,,,9018,1,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4872,10116.0,N,,CHEMBL621948,,,,,9019,1,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4872,10116.0,N,,CHEMBL621949,,,,,9020,1,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5413,10116.0,N,,CHEMBL621950,,,,,9021,1,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5413,10116.0,N,,CHEMBL621951,,,,,9022,1,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15272,10116.0,N,178.0,CHEMBL621952,,,,Blood,9023,1,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4689,10116.0,N,2107.0,CHEMBL621953,,,,Liver,9024,1,Stability (%) in rat liver microsomes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL621954,,,,,9025,1,Area under curve was calculated after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL621955,,,,,9026,1,Area under the curve was calculated after iv administration in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL621956,,,,,9027,1,Area under the curve was calculated in rat after peroral administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6211,10116.0,N,,CHEMBL621957,,,,,9028,1,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5710,10116.0,N,,CHEMBL621958,,,,,9029,1,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5710,10116.0,N,,CHEMBL621959,,,,,9030,1,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17853,10116.0,N,,CHEMBL621960,,,,,9031,1,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17853,10116.0,N,,CHEMBL621961,,,,,9032,1,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15765,10116.0,N,,CHEMBL621962,,,,,9033,1,p value of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15765,10116.0,N,,CHEMBL876787,,,,,9034,1,p value of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
15765,10116.0,N,,CHEMBL621963,,,,,9035,1,p value of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6175,10116.0,N,945.0,CHEMBL622637,,,,Stomach,9036,1,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6175,10116.0,N,945.0,CHEMBL622638,,,,Stomach,9037,1,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6175,10116.0,N,945.0,CHEMBL626561,,,,Stomach,9038,1,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7991,9986.0,U,,CHEMBL626562,,,,,9039,0,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,Autocuration,22224,,BAO_0000019,,,Oryctolagus cuniculus,1,,F
429,9986.0,U,,CHEMBL626563,,,,,9040,0,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,Autocuration,22224,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
429,9986.0,U,,CHEMBL626564,,,,,9041,0,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,Autocuration,22224,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
6253,9986.0,U,,CHEMBL626565,,,,,9042,0,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
6253,9986.0,U,,CHEMBL626566,,,,,9043,0,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
3615,9986.0,U,,CHEMBL626567,,,,,9044,0,Clearance rate in rabbits,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
4059,9986.0,U,,CHEMBL626568,,,,,9045,0,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
5124,9986.0,U,,CHEMBL626569,,,,,9046,0,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
5124,9986.0,U,,CHEMBL626570,,,,,9047,0,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
5124,9986.0,U,,CHEMBL626571,,,,,9048,0,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
429,9986.0,U,,CHEMBL626572,,,,,9049,0,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
4059,9986.0,U,1969.0,CHEMBL626573,,,,Plasma,9050,0,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
9659,9986.0,U,2107.0,CHEMBL626574,,,,Liver,9051,0,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,Autocuration,22224,,BAO_0000251,Microsomes,,Oryctolagus cuniculus,1,,A
9659,9986.0,U,2107.0,CHEMBL626575,,,,Liver,9052,0,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,Autocuration,22224,,BAO_0000251,Microsomes,,Oryctolagus cuniculus,1,,A
3639,9986.0,U,,CHEMBL626576,,,,,9053,0,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,Autocuration,22224,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
3639,9986.0,U,,CHEMBL626577,,,,,9054,0,Dose at which bioavailability of perorally administered compound was tested in rabbit,,Autocuration,22224,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
3639,9986.0,U,,CHEMBL626578,,,,,9055,0,The compound was tested for its bioavailability in rabbit (by oral dosage).,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
5124,9986.0,U,,CHEMBL625263,,,,,9056,0,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
5124,9986.0,U,,CHEMBL625264,,,,,9057,0,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
5124,9986.0,U,,CHEMBL625265,,,,,9058,0,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
14294,9986.0,U,,CHEMBL625266,,,,,9059,0,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,Autocuration,22224,,BAO_0000251,Microsomes,,Oryctolagus cuniculus,1,,A
14294,9986.0,U,,CHEMBL876796,,,,,9060,0,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,Autocuration,22224,,BAO_0000251,Microsomes,,Oryctolagus cuniculus,1,,A
429,9986.0,U,,CHEMBL625267,,,,,9061,0,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
5124,9986.0,U,1969.0,CHEMBL625268,,,,Plasma,9062,0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
5124,9986.0,U,1969.0,CHEMBL625269,,,,Plasma,9063,0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
5124,9986.0,U,1969.0,CHEMBL624689,,,,Plasma,9064,0,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
429,9986.0,U,,CHEMBL624690,,,,,9065,0,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
429,9986.0,U,1088.0,CHEMBL624691,,,,Urine,9066,0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,Autocuration,22224,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
429,9986.0,U,1088.0,CHEMBL624692,,,,Urine,9067,0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,Autocuration,22224,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
4059,9986.0,U,,CHEMBL624693,,,,,9068,0,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
4137,9986.0,U,,CHEMBL624694,,,,,9069,0,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
11672,9986.0,U,,CHEMBL877596,,,,,9070,0,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,Autocuration,22224,,BAO_0000221,,In vitro,Oryctolagus cuniculus,1,,A
12886,9986.0,U,,CHEMBL624695,,,,,9071,0,Time within which only 10% of the drug was degraded,,Autocuration,22224,,BAO_0000019,,,Oryctolagus cuniculus,1,,A
3853,9986.0,U,2107.0,CHEMBL624696,,,,Liver,9072,0,Half life period in rabbit liver homogenate,,Autocuration,22224,,BAO_0000221,,,Oryctolagus cuniculus,1,,A
3615,9986.0,U,,CHEMBL624697,,,,,9073,0,Half life value in rabbits,,Autocuration,22224,,BAO_0000019,,,Oryctolagus cuniculus,1,,A
6253,9986.0,U,178.0,CHEMBL624698,,,,Blood,9074,0,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
6253,9986.0,U,178.0,CHEMBL624699,,,,Blood,9075,0,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
6077,9986.0,U,,CHEMBL624700,,,,,9076,0,Half-life period in rabbits following intravenous administration at 2 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
17617,10116.0,N,1969.0,CHEMBL622903,,,,Plasma,9077,1,AUC 0-8 hr value in rats at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17594,10116.0,N,1969.0,CHEMBL622904,,,,Plasma,9078,1,AUC after administration at 2000 mg/kg/day in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6149,10116.0,N,1969.0,CHEMBL622905,,,,Plasma,9079,1,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17260,10116.0,N,1969.0,CHEMBL622906,,,,Plasma,9080,1,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17260,10116.0,N,1969.0,CHEMBL622907,,,,Plasma,9081,1,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6644,10116.0,N,1969.0,CHEMBL622908,,,,Plasma,9082,1,AUC in rat after oral administration at 10.5 mg/kg dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6644,10116.0,N,1969.0,CHEMBL622909,,,,Plasma,9083,1,AUC in rat after oral administration at 11.2 mg/kg dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6644,10116.0,N,1969.0,CHEMBL622910,,,,Plasma,9084,1,AUC in rat after oral administration at 9.7 mg/kg dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6495,10116.0,N,955.0,CHEMBL622911,,,,Brain,9085,1,AUC in rat brain after oral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6504,10116.0,N,1969.0,CHEMBL622912,,,,Plasma,9086,1,AUC in rat p.o.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17686,10116.0,N,1969.0,CHEMBL622913,,,,Plasma,9087,1,AUC in rat p.o. at 20 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6495,10116.0,N,1969.0,CHEMBL622914,,,,Plasma,9088,1,AUC in rat plasma after oral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
216,10116.0,N,1969.0,CHEMBL622915,,,,Plasma,9089,1,AUC in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1908,10116.0,N,1969.0,CHEMBL622916,,,,Plasma,9090,1,AUC value after IV dose at a dose of 5 mg/kg in rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1908,10116.0,N,1969.0,CHEMBL622917,,,,Plasma,9091,1,AUC value after oral dose at a dose of 10 mg/kg in rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6685,10116.0,N,1969.0,CHEMBL622918,,,,Plasma,9092,1,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
216,10116.0,N,1969.0,CHEMBL622919,,,,Plasma,9093,1,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6049,10116.0,N,1969.0,CHEMBL622920,,,,Plasma,9094,1,Maximum plasma concentration was evaluated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2463,10116.0,N,1969.0,CHEMBL622921,,,,Plasma,9095,1,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6679,10116.0,N,1969.0,CHEMBL622922,,,,Plasma,9096,1,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6681,10116.0,N,1969.0,CHEMBL622923,,,,Plasma,9097,1,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4890,10116.0,N,1969.0,CHEMBL877604,,,,Plasma,9098,1,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6410,10116.0,N,1969.0,CHEMBL622924,,,,Plasma,9099,1,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6410,10116.0,N,1969.0,CHEMBL622925,,,,Plasma,9100,1,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16366,10116.0,N,1969.0,CHEMBL622926,,,,Plasma,9101,1,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6227,10116.0,N,1969.0,CHEMBL623625,,,,Plasma,9102,1,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3598,10116.0,N,1969.0,CHEMBL623626,,,,Plasma,9103,1,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,Expert,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1465,10116.0,N,1969.0,CHEMBL623627,,,,Plasma,9104,1,Maximum plasma drug concentration was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4368,10116.0,N,,CHEMBL623628,,,,,9105,1,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,1969.0,CHEMBL623629,,,,Plasma,9106,1,Mean peak plasma concentration was observed after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,1969.0,CHEMBL623630,,,,Plasma,9107,1,Mean peak plasma concentration was observed after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5355,10116.0,N,,CHEMBL623804,,,,,9108,1,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5355,10116.0,N,,CHEMBL623805,,,,,9109,1,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1567,10116.0,N,1969.0,CHEMBL623806,,,,Plasma,9110,1,Peak oral plasma concentration was determined in rats by oral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4026,10116.0,N,1969.0,CHEMBL623807,,,,Plasma,9111,1,Peak plasma concentration (Cmax) was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6193,10116.0,N,1969.0,CHEMBL623808,,,,Plasma,9112,1,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4026,10116.0,N,1969.0,CHEMBL623809,,,,Plasma,9113,1,Peak plasma concentration (Cmax) in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6485,10116.0,N,1969.0,CHEMBL623810,,,,Plasma,9114,1,Peak plasma concentration at 1 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17655,10116.0,N,1969.0,CHEMBL623811,,,,Plasma,9115,1,Peak plasma concentration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14941,10116.0,N,1969.0,CHEMBL623812,,,,Plasma,9116,1,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5394,10116.0,N,,CHEMBL877605,,,,,9117,1,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4408,10116.0,N,,CHEMBL623813,,,,,9118,1,Pharmacokinetic property (Cmax) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5983,10116.0,N,,CHEMBL623814,,,,,9119,1,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4878,10116.0,N,,CHEMBL623815,,,,,9120,1,Cmax in rat after 3mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5862,10116.0,N,,CHEMBL623816,,,,,9121,1,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Sprague-Dawley,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4517,10116.0,N,,CHEMBL623145,,,,,9122,1,Cmax in rats after 20 mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5932,10116.0,N,1969.0,CHEMBL623146,,,,Plasma,9123,1,Cmax in rat plasma after 30mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5436,10116.0,N,1969.0,CHEMBL623147,,,,Plasma,9124,1,Plasma concentration after oral administration of 100 mg/kg to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4910,10116.0,N,955.0,CHEMBL623042,,,,Brain,9125,1,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4950,10116.0,N,,CHEMBL623043,,,,,9126,1,Tested for the Cmax in rat at 10 mg/kg per orally,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL623044,,,,,9127,1,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL623045,,,,,9128,1,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3360,10116.0,N,,CHEMBL623046,,,,,9129,1,Bioavailability as oral Cmax in rats at 30 mins,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3360,10116.0,N,,CHEMBL623226,,,,,9130,1,Bioavailability as oral Cmax in rats at 6hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL623227,,,,,9131,1,The maximum concentration of compound was measured at the dose of 100 umol/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL623228,,,,,9132,1,The maximum concentration of compound was measured at the dose of 300 umol/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL623229,,,,,9133,1,The maximum concentration of compound was measured at the dose of 30 umol/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5160,10116.0,N,1969.0,CHEMBL623230,,,,Plasma,9134,1,The maximum plasma levels for the compounds were determined by LC-MS.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,1969.0,CHEMBL623231,,,,Plasma,9135,1,mean peak plasma concentration was observed after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,1969.0,CHEMBL623232,,,,Plasma,9136,1,mean peak plasma concentration was observed after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4709,10116.0,N,,CHEMBL623233,,,,,9137,1,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3535,10116.0,N,,CHEMBL623234,,,,,9138,1,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3535,10116.0,N,,CHEMBL623235,,,,,9139,1,Concentration in plasma (portal) following oral dose in rats at 1 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3535,10116.0,N,,CHEMBL623236,,,,,9140,1,Concentration in plasma (portal) following oral dose in rats at 2 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3535,10116.0,N,,CHEMBL623237,,,,,9141,1,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3535,10116.0,N,,CHEMBL623238,,,,,9142,1,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3535,10116.0,N,,CHEMBL623239,,,,,9143,1,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5005,10116.0,U,1969.0,CHEMBL623240,,,,Plasma,9144,0,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6326,10116.0,N,1898.0,CHEMBL623241,,,,Hypothalamus,9145,1,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6326,10116.0,N,1898.0,CHEMBL623242,,,,Hypothalamus,9146,1,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6326,10116.0,N,,CHEMBL874394,,,,,9147,1,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6326,10116.0,N,,CHEMBL623243,,,,,9148,1,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17411,10116.0,N,,CHEMBL623244,,,,,9149,1,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL623245,,,,Kidney,9150,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL623246,,,,Kidney,9151,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL623247,,,,Kidney,9152,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL623248,,,,Kidney,9153,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2113.0,CHEMBL623249,,,,Kidney,9154,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL625072,,,,Liver,9155,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL625073,,,,Liver,9156,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL625074,,,,Liver,9157,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL625075,,,,Liver,9158,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL625076,,,,Liver,9159,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL625077,,,,Liver,9160,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL625078,,,,Liver,9161,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL874395,,,,Liver,9162,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL625079,,,,Liver,9163,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL625080,,,,Liver,9164,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL625081,,,,Liver,9165,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL625082,,,,Liver,9166,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL625083,,,,Liver,9167,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL625084,,,,Liver,9168,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL625085,,,,Liver,9169,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL625086,,,,Liver,9170,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL625087,,,,Liver,9171,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL625088,,,,Liver,9172,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2107.0,CHEMBL622205,,,,Liver,9173,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL622206,,,,Liver,9174,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL622207,,,,Liver,9175,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL622366,,,,Liver,9176,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL622367,,,,Liver,9177,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL875331,,,,Liver,9178,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2107.0,CHEMBL622368,,,,Liver,9179,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL622369,,,,Lung,9180,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL622370,,,,Lung,9181,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL622371,,,,Lung,9182,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL622372,,,,Lung,9183,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL622373,,,,Lung,9184,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL622374,,,,Lung,9185,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL622375,,,,Lung,9186,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL622376,,,,Lung,9187,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622377,,,,Lung,9188,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622378,,,,Lung,9189,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622379,,,,Lung,9190,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622380,,,,Lung,9191,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622381,,,,Lung,9192,1,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622382,,,,Lung,9193,1,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL622383,,,,Lung,9194,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6175,10116.0,N,945.0,CHEMBL875332,,,,Stomach,9195,1,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6175,10116.0,N,945.0,CHEMBL622384,,,,Stomach,9196,1,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6175,10116.0,N,945.0,CHEMBL622385,,,,Stomach,9197,1,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6175,10116.0,N,945.0,CHEMBL622386,,,,Stomach,9198,1,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10839,10116.0,N,,CHEMBL622387,,,,,9199,1,The compound was tested for the plasma binding in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16459,10116.0,N,,CHEMBL622388,,,,,9200,1,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16459,10116.0,N,,CHEMBL622389,,,,,9201,1,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16459,10116.0,N,,CHEMBL622390,,,,,9202,1,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16459,10116.0,N,,CHEMBL622391,,,,,9203,1,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16459,10116.0,N,,CHEMBL622392,,,,,9204,1,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16459,10116.0,N,,CHEMBL622393,,,,,9205,1,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3278,10116.0,N,,CHEMBL622394,,,,,9206,1,Plasma level at 2 hr after administration of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3278,10116.0,N,,CHEMBL622395,,,,,9207,1,plasma level at 2 hr after administration of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4684,10116.0,N,1977.0,CHEMBL622396,,,,Serum,9208,1,Stability in rat serum measured as % recovery at 1 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4684,10116.0,N,1977.0,CHEMBL624894,,,,Serum,9209,1,Stability in rat serum measured as % recovery at 10 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4684,10116.0,N,1977.0,CHEMBL624895,,,,Serum,9210,1,Stability in rat serum measured as % recovery at 10 mins,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4684,10116.0,N,1977.0,CHEMBL624058,,,,Serum,9211,1,Stability in rat serum measured as % recovery at 2 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4684,10116.0,N,1977.0,CHEMBL624059,,,,Serum,9212,1,Stability in rat serum measured as % recovery at 3 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4684,10116.0,N,1977.0,CHEMBL624060,,,,Serum,9213,1,Stability in rat serum measured as % recovery at 3 mins,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4684,10116.0,N,1977.0,CHEMBL624061,,,,Serum,9214,1,Stability in rat serum measured as % recovery at 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4684,10116.0,N,1977.0,CHEMBL624062,,,,Serum,9215,1,Stability in rat serum measured as % recovery at 5 mins,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16456,10116.0,N,,CHEMBL624063,,,,,9216,1,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16456,10116.0,N,,CHEMBL624064,,,,,9217,1,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
723,10116.0,N,1969.0,CHEMBL624065,,,,Plasma,9218,1,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
723,10116.0,N,1969.0,CHEMBL624066,,,,Plasma,9219,1,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5160,10116.0,N,,CHEMBL877490,,,,,9220,1,Half life tested in mature male rat at a dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4709,10116.0,N,,CHEMBL874442,,,,,9221,1,Half life after intravenous administration of 1 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5633,10116.0,N,,CHEMBL626890,,,,,9222,1,Half life period after administration (30 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5302,10116.0,N,,CHEMBL626891,,,,,9223,1,Half life period in rat after 5 mg/Kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5302,10116.0,N,,CHEMBL626892,,,,,9224,1,Half life period in rat after 5 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL626893,,,,,9225,1,Half life period was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL626894,,,,,9226,1,Half life period was evaluated in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL626895,,,,,9227,1,Half life period was evaluated in rat; 0.5-1.0,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL626896,,,,,9228,1,Half life period was evaluated in rat; 5.9-7.5,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14512,10116.0,N,1969.0,CHEMBL626897,,,,Plasma,9229,1,Half-life in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6230,10116.0,N,,CHEMBL626898,,,,,9230,1,Half-life time in rat was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3364,10116.0,N,,CHEMBL626899,,,,,9231,1,Terminal half-life after iv administration to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6874,10116.0,N,,CHEMBL626900,,,,,9232,1,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
857,10116.0,N,,CHEMBL626901,,,,,9233,1,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
858,10116.0,N,,CHEMBL626902,,,,,9234,1,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
858,10116.0,N,,CHEMBL626903,,,,,9235,1,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5355,10116.0,N,,CHEMBL874443,,,,,9236,1,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5355,10116.0,N,,CHEMBL626904,,,,,9237,1,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6305,10116.0,N,,CHEMBL626905,,,,,9238,1,Half life in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13501,10116.0,N,1969.0,CHEMBL873830,,,,Plasma,9239,1,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17594,10116.0,N,,CHEMBL626906,,,,,9240,1,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4186,10116.0,N,1969.0,CHEMBL631076,,,,Plasma,9241,1,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2932,10116.0,N,1969.0,CHEMBL631077,,,,Plasma,9242,1,Biological half-life was measured in plasma of rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17065,10116.0,N,,CHEMBL631078,,,,,9243,1,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15765,10116.0,N,,CHEMBL631079,,,,,9244,1,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2713,10116.0,N,,CHEMBL631080,,,,,9245,1,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL631081,,,,,9246,1,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL631239,,,,,9247,1,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
740,10116.0,N,1969.0,CHEMBL631240,,,,Plasma,9248,1,Compound was evaluated for plasma half life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6597,10116.0,N,1969.0,CHEMBL631241,,,,Plasma,9249,1,AUC value at a dose of 5 mg/kg (p.o.) in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2959,10116.0,N,1969.0,CHEMBL631242,,,,Plasma,9250,1,AUC value after administration of 20 mg/Kg oral dose in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17594,10116.0,N,1969.0,CHEMBL631243,,,,Plasma,9251,1,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17596,10116.0,N,1969.0,CHEMBL874444,,,,Plasma,9252,1,AUC0-96 after administration at 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17594,10116.0,N,1969.0,CHEMBL631244,,,,Plasma,9253,1,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3293,10116.0,N,,CHEMBL631245,,,,,9254,1,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6757,10116.0,N,,CHEMBL627162,,,,,9255,1,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6757,10116.0,N,,CHEMBL627163,,,,,9256,1,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6757,10116.0,N,,CHEMBL627164,,,,,9257,1,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5979,10116.0,N,2113.0,CHEMBL627165,,,,Kidney,9258,1,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5979,10116.0,N,,CHEMBL627166,,,,,9259,1,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5979,10116.0,N,,CHEMBL627167,,,,,9260,1,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4026,10116.0,N,,CHEMBL627822,,,,,9261,1,Area under curve (AUC) at a dose of 30 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5355,10116.0,N,,CHEMBL627823,,,,,9262,1,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5355,10116.0,N,,CHEMBL627824,,,,,9263,1,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5355,10116.0,N,,CHEMBL627825,,,,,9264,1,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5633,10116.0,N,,CHEMBL627826,,,,,9265,1,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1716,10116.0,N,,CHEMBL627827,,,,,9266,1,Area under curve (Pharmacokinetic property) was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1716,10116.0,N,,CHEMBL627828,,,,,9267,1,Area under curve (Pharmacokinetic property) of the compound; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4689,10116.0,N,,CHEMBL627829,,,,,9268,1,Area under curve after intravenous administration (1 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL627830,,,,,9269,1,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL627831,,,,,9270,1,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15662,10116.0,N,,CHEMBL627832,,,,,9271,1,Area under curve in male SD rats was observed after oral administration in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4413,10116.0,N,,CHEMBL627833,,,,,9272,1,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3598,10116.0,N,,CHEMBL627834,,,,,9273,1,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,Expert,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3598,10116.0,N,,CHEMBL628004,,,,,9274,1,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,Expert,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5964,10116.0,N,,CHEMBL628005,,,,,9275,1,Area under curve at 5 mg/kg po was determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4689,10116.0,N,,CHEMBL628006,,,,,9276,1,Area under curve in Rat at a oral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4186,10116.0,N,,CHEMBL628007,,,,,9277,1,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL625676,,,,,9278,1,Area under curve was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17858,10116.0,N,,CHEMBL631309,,,,,9279,1,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17804,10116.0,N,,CHEMBL631310,,,,,9280,1,Area under curve after intravenous administration at 3 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6106,10116.0,N,,CHEMBL631311,,,,,9281,1,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5964,10116.0,N,,CHEMBL631312,,,,,9282,1,Area under curve at 4 hr in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4026,10116.0,N,,CHEMBL631313,,,,,9283,1,Area under curve at a dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4756,10116.0,N,,CHEMBL631314,,,,,9284,1,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4756,10116.0,N,,CHEMBL631315,,,,,9285,1,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5862,10116.0,N,,CHEMBL631316,,,,,9286,1,Area under curve for a 2-mpk po dose in SD rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5862,10116.0,N,,CHEMBL631317,,,,,9287,1,Area under curve in SD rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6644,10116.0,N,,CHEMBL874471,,,,,9288,1,Area under curve in rat after oral administration at 13 mg/kg dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5871,10116.0,N,,CHEMBL631318,,,,,9289,1,Area under curve in rat by po administration at 0-24 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5919,10116.0,N,1969.0,CHEMBL631319,,,,Plasma,9290,1,Area under curve in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL631320,,,,,9291,1,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL631321,,,,,9292,1,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10,10116.0,N,,CHEMBL631322,,,,,9293,1,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11149,10116.0,N,,CHEMBL631323,,,,,9294,1,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5302,10116.0,N,,CHEMBL631324,,,,,9295,1,Area under curve value in rat at a dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17796,10116.0,N,,CHEMBL631325,,,,,9296,1,Area under curve was determined after oral administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4890,10116.0,N,,CHEMBL631326,,,,,9297,1,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6011,10116.0,N,,CHEMBL631327,,,,,9298,1,Area under curve was determined after peroral administration in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5375,10116.0,N,,CHEMBL631328,,,,,9299,1,Area under curve was determined at a dose 30 mpk administered orally.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17764,10116.0,N,,CHEMBL631329,,,,,9300,1,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4368,10116.0,N,,CHEMBL627217,,,,,9301,1,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5610,10116.0,N,,CHEMBL626352,,,,,9302,1,Area under curve was determined in male rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5833,10116.0,N,,CHEMBL626353,,,,,9303,1,Area under curve was determined in rat after PO administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4257,10116.0,N,,CHEMBL626354,,,,,9304,1,Area under curve was determined in rat after a 3 mg/kg of oral dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5937,10116.0,N,,CHEMBL626355,,,,,9305,1,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5932,10116.0,N,,CHEMBL626356,,,,,9306,1,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5932,10116.0,N,,CHEMBL626357,,,,,9307,1,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17411,10116.0,N,,CHEMBL626358,,,,,9308,1,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17411,10116.0,N,,CHEMBL626359,,,,,9309,1,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17771,10116.0,N,1969.0,CHEMBL626360,,,,Plasma,9310,1,Peak plasma concentration in rat at a dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1628,10116.0,N,,CHEMBL626361,,,,,9311,1,Plasma concentration at 2 hr in rats was evaluated.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1628,10116.0,N,,CHEMBL626362,,,,,9312,1,Plasma concentration at 2 hr in rats was evaluated; Not available,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17411,10116.0,N,,CHEMBL626363,,,,,9313,1,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL626970,,,,,9314,1,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL626971,,,,,9315,1,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,1969.0,CHEMBL626972,,,,Plasma,9316,1,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,1969.0,CHEMBL626973,,,,Plasma,9317,1,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,1969.0,CHEMBL626974,,,,Plasma,9318,1,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,1969.0,CHEMBL874592,,,,Plasma,9319,1,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL626975,,,,,9320,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL626976,,,,,9321,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL626977,,,,,9322,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL626978,,,,,9323,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16427,10116.0,N,,CHEMBL626979,,,,,9324,1,PK study was carried to determine the relative absorption ranking in rat.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4689,10116.0,N,1969.0,CHEMBL626980,,,,Plasma,9325,1,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11450,10116.0,N,178.0,CHEMBL626981,,,,Blood,9326,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,178.0,CHEMBL626982,,,,Blood,9327,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,178.0,CHEMBL626983,,,,Blood,9328,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,178.0,CHEMBL622522,,,,Blood,9329,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,178.0,CHEMBL622523,,,,Blood,9330,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,178.0,CHEMBL622524,,,,Blood,9331,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,955.0,CHEMBL622525,,,,Brain,9332,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,955.0,CHEMBL622526,,,,Brain,9333,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,955.0,CHEMBL619849,,,,Brain,9334,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,955.0,CHEMBL619850,,,,Brain,9335,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,955.0,CHEMBL623864,,,,Brain,9336,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,955.0,CHEMBL623865,,,,Brain,9337,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,948.0,CHEMBL623866,,,,Heart,9338,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,948.0,CHEMBL623867,,,,Heart,9339,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,948.0,CHEMBL877615,,,,Heart,9340,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,948.0,CHEMBL623868,,,,Heart,9341,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,948.0,CHEMBL623869,,,,Heart,9342,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,948.0,CHEMBL623870,,,,Heart,9343,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL623871,,,,Lung,9344,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2048.0,CHEMBL623872,,,,Lung,9345,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622129,,,,Lung,9346,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622130,,,,Lung,9347,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622131,,,,Lung,9348,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622132,,,,Lung,9349,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622133,,,,Lung,9350,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622134,,,,Lung,9351,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622135,,,,Lung,9352,1,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2048.0,CHEMBL622136,,,,Lung,9353,1,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL622137,,,,Muscle tissue,9354,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL622138,,,,Muscle tissue,9355,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL623017,,,,Muscle tissue,9356,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL623018,,,,Muscle tissue,9357,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL623019,,,,Muscle tissue,9358,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL623020,,,,Muscle tissue,9359,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL623021,,,,Muscle tissue,9360,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL623022,,,,Muscle tissue,9361,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL623023,,,,Muscle tissue,9362,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL623024,,,,Muscle tissue,9363,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL623025,,,,Muscle tissue,9364,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620545,,,,Muscle tissue,9365,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620546,,,,Muscle tissue,9366,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620547,,,,Muscle tissue,9367,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620548,,,,Muscle tissue,9368,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620549,,,,Muscle tissue,9369,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL620550,,,,Muscle tissue,9370,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL620551,,,,Muscle tissue,9371,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2385.0,CHEMBL620552,,,,Muscle tissue,9372,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620553,,,,Muscle tissue,9373,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620554,,,,Muscle tissue,9374,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL875845,,,,Muscle tissue,9375,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620555,,,,Muscle tissue,9376,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620556,,,,Muscle tissue,9377,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2385.0,CHEMBL620557,,,,Muscle tissue,9378,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL620558,,,,,9379,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL620559,,,,,9380,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622939,,,,,9381,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622940,,,,,9382,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622941,,,,,9383,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622942,,,,,9384,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622943,,,,,9385,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622944,,,,,9386,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622945,,,,,9387,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622946,,,,,9388,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3341,10116.0,N,,CHEMBL622947,,,,,9389,1,Compound was evaluated for terminal half life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3634,10116.0,N,1969.0,CHEMBL622948,,,,Plasma,9390,1,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3634,10116.0,N,1969.0,CHEMBL622949,,,,Plasma,9391,1,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4839,10116.0,N,,CHEMBL622950,,,,,9392,1,Compound was tested for its half life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5005,9544.0,U,1969.0,CHEMBL622951,,,,Plasma,9393,0,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,Intermediate,22224,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
5005,10116.0,U,1969.0,CHEMBL622952,,,,Plasma,9394,0,Compound was tested for its plasma half life in Sprague Dawley rats,,Intermediate,22224,,BAO_0000366,,,Rattus norvegicus,1,,A
5005,10116.0,U,1969.0,CHEMBL622953,,,,Plasma,9395,0,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,Intermediate,22224,,BAO_0000366,,,Rattus norvegicus,1,,A
1094,10116.0,N,1969.0,CHEMBL873818,,,,Plasma,9396,1,Compound was tested for plasma half-life period in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5031,10116.0,N,,CHEMBL622954,,,,,9397,1,Elimination half life after i.v. administration of compound in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL622955,,,,,9398,1,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL875229,,,,,9399,1,Elimination half-life after IV dosing at 1 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL622956,,,,,9400,1,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL622957,,,,,9401,1,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5408,10116.0,N,955.0,CHEMBL622958,,,,Brain,9402,1,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5408,10116.0,N,1969.0,CHEMBL622959,,,,Plasma,9403,1,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5408,10116.0,N,955.0,CHEMBL622960,,,,Brain,9404,1,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5408,10116.0,N,1969.0,CHEMBL622961,,,,Plasma,9405,1,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4687,10116.0,N,,CHEMBL622962,,,,,9406,1,Evaluated for the half life in rat (in vivo),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6640,10116.0,N,,CHEMBL622963,,,,,9407,1,Hafl life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6640,10116.0,N,,CHEMBL622964,,,,,9408,1,Hafl life rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL622965,,,,,9409,1,Hafl life rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6640,10116.0,N,,CHEMBL622966,,,,,9410,1,Hafl life rat; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL622967,,,,,9411,1,Hafl life rat; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17411,10116.0,N,2113.0,CHEMBL622968,,,,Kidney,9412,1,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17411,10116.0,N,2107.0,CHEMBL622969,,,,Liver,9413,1,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17411,10116.0,N,2048.0,CHEMBL875327,,,,Lung,9414,1,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL628638,,,,,9415,1,Half life in rat after 1 mg/kg i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL628639,,,,,9416,1,Half life in rat after 2 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17411,10116.0,N,,CHEMBL625840,,,,,9417,1,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4722,10116.0,N,,CHEMBL625841,,,,,9418,1,Half life of 10 mg/kg oral dose determined in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL625842,,,,,9419,1,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL625843,,,,,9420,1,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL625844,,,,,9421,1,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL873822,,,,,9422,1,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL625845,,,,,9423,1,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL627059,,,,,9424,1,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL627060,,,,,9425,1,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL627061,,,,,9426,1,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4762,10116.0,N,,CHEMBL627709,,,,,9427,1,Half life of compound at 5 mg/kg after po administration was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5327,10116.0,N,,CHEMBL627710,,,,,9428,1,Half life of compound determined after intravenous administration to rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4847,10116.0,N,,CHEMBL627711,,,,,9429,1,Half life of compound was determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17720,10116.0,N,1969.0,CHEMBL627712,,,,Plasma,9430,1,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL627713,,,,,9431,1,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL627714,,,,,9432,1,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4256,9541.0,U,,CHEMBL627889,,,,,9433,0,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,Intermediate,22224,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
4256,10116.0,U,,CHEMBL627890,,,,,9434,0,Half life determined in rat by intravenous administration,,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4722,10116.0,N,,CHEMBL627891,,,,,9435,1,Half life determined in rats after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6535,10116.0,N,1969.0,CHEMBL627892,,,,Plasma,9436,1,Half life in rat plasma after administration of 2 mg/kg iv,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6535,10116.0,N,1969.0,CHEMBL627893,,,,Plasma,9437,1,Half life in rat plasma after administration of 2 mg/kg iv,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1435,10116.0,N,1969.0,CHEMBL627894,,,,Plasma,9438,1,Half life in rat plasma was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1435,10116.0,N,1969.0,CHEMBL627895,,,,Plasma,9439,1,Half life in rat plasma was determined; NA means not applicable,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5206,10116.0,N,,CHEMBL627896,,,,,9440,1,Half life in rat was tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6080,10116.0,N,1969.0,CHEMBL627897,,,,Plasma,9441,1,Half life measured in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4449,10116.0,N,,CHEMBL627898,,,,,9442,1,Half life recorded in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL627899,,,,,9443,1,Half life was calculated,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL873823,,,,,9444,1,Half life was calculated in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3747,10116.0,N,,CHEMBL627900,,,,,9445,1,Half life was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17858,10116.0,N,,CHEMBL627901,,,,,9446,1,Half life after 10 mg/kg oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL627902,,,,,9447,1,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL627903,,,,,9448,1,Half life after administering orally a dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5031,10116.0,N,,CHEMBL627904,,,,,9449,1,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4722,10116.0,N,,CHEMBL627905,,,,,9450,1,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6078,10116.0,N,,CHEMBL627906,,,,,9451,1,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6078,10116.0,N,,CHEMBL627907,,,,,9452,1,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6078,10116.0,N,,CHEMBL876783,,,,,9453,1,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6078,10116.0,N,,CHEMBL627908,,,,,9454,1,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17065,10116.0,N,,CHEMBL627909,,,,,9455,1,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1353,10116.0,N,,CHEMBL627910,,,,,9456,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1353,10116.0,N,,CHEMBL627911,,,,,9457,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1353,10116.0,N,,CHEMBL627912,,,,,9458,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1353,10116.0,N,,CHEMBL627913,,,,,9459,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1353,10116.0,N,,CHEMBL627914,,,,,9460,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16423,10116.0,N,,CHEMBL627915,,,,,9461,1,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16423,10116.0,N,,CHEMBL627916,,,,,9462,1,Area under the curve was evaluated after 20 uM/kg of peroral administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6062,10116.0,N,,CHEMBL627917,,,,,9463,1,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6056,10116.0,N,,CHEMBL627918,,,,,9464,1,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5182,10116.0,N,,CHEMBL627919,,,,,9465,1,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6410,10116.0,N,,CHEMBL627920,,,,,9466,1,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6410,10116.0,N,,CHEMBL627921,,,,,9467,1,Area under the curve was evaluated at an oral dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL627922,,,,,9468,1,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL876784,,,,,9469,1,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL627923,,,,,9470,1,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL626208,,,,,9471,1,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL626209,,,,,9472,1,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL626210,,,,,9473,1,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2463,10116.0,N,1969.0,CHEMBL627994,,,,Plasma,9474,1,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4709,10116.0,N,,CHEMBL627995,,,,,9475,1,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4075,10116.0,N,,CHEMBL627996,,,,,9476,1,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5394,10116.0,N,,CHEMBL627997,,,,,9477,1,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL627998,,,,,9478,1,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL628640,,,,,9479,1,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL628641,,,,,9480,1,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL628642,,,,,9481,1,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL628643,,,,,9482,1,Compound was evaluated for area under the curve expressed as (h*ug/ml),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2591,10116.0,N,,CHEMBL628644,,,,,9483,1,Compound was tested for area under curve in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6567,10116.0,N,,CHEMBL628645,,,,,9484,1,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6211,10116.0,N,,CHEMBL628646,,,,,9485,1,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5529,10116.0,N,,CHEMBL628647,,,,,9486,1,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5408,10116.0,N,,CHEMBL628648,,,,,9487,1,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5408,10116.0,N,,CHEMBL625358,,,,,9488,1,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5408,10116.0,N,,CHEMBL625359,,,,,9489,1,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5408,10116.0,N,,CHEMBL625360,,,,,9490,1,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
429,10116.0,N,,CHEMBL625361,,,,,9491,1,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
429,10116.0,N,,CHEMBL625362,,,,,9492,1,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
429,10116.0,N,,CHEMBL625363,,,,,9493,1,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4796,10116.0,N,,CHEMBL625364,,,,,9494,1,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL625365,,,,,9495,1,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL625366,,,,,9496,1,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL625367,,,,,9497,1,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2113.0,CHEMBL625368,,,,Kidney,9498,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2113.0,CHEMBL625369,,,,Kidney,9499,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2113.0,CHEMBL625370,,,,Kidney,9500,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2113.0,CHEMBL625371,,,,Kidney,9501,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2113.0,CHEMBL625372,,,,Kidney,9502,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2113.0,CHEMBL625373,,,,Kidney,9503,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2107.0,CHEMBL625374,,,,Liver,9504,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2107.0,CHEMBL877593,,,,Liver,9505,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2107.0,CHEMBL625375,,,,Liver,9506,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2107.0,CHEMBL625376,,,,Liver,9507,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2107.0,CHEMBL621973,,,,Liver,9508,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2107.0,CHEMBL621974,,,,Liver,9509,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2048.0,CHEMBL621975,,,,Lung,9510,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2048.0,CHEMBL622166,,,,Lung,9511,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2048.0,CHEMBL622167,,,,Lung,9512,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2048.0,CHEMBL622168,,,,Lung,9513,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2048.0,CHEMBL622169,,,,Lung,9514,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2048.0,CHEMBL622170,,,,Lung,9515,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622171,,,,Thyroid gland,9516,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622172,,,,Thyroid gland,9517,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622173,,,,Thyroid gland,9518,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622174,,,,Thyroid gland,9519,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622175,,,,Thyroid gland,9520,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622176,,,,Thyroid gland,9521,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622177,,,,Thyroid gland,9522,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622178,,,,Thyroid gland,9523,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622179,,,,Thyroid gland,9524,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622180,,,,Thyroid gland,9525,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622181,,,,,9526,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622182,,,,,9527,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622183,,,,,9528,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622184,,,,,9529,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622185,,,,,9530,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622186,,,,,9531,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622187,,,,,9532,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL625002,,,,,9533,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622090,,,,,9534,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622091,,,,,9535,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622092,,,,,9536,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622093,,,,,9537,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622094,,,,,9538,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622095,,,,,9539,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622264,,,,,9540,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL622265,,,,Spleen,9541,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL622266,,,,Spleen,9542,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL622267,,,,Spleen,9543,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL622268,,,,Spleen,9544,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL622269,,,,Spleen,9545,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL625071,,,,Spleen,9546,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL621621,,,,Spleen,9547,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL621622,,,,Spleen,9548,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621623,,,,Spleen,9549,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621624,,,,Spleen,9550,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621625,,,,Spleen,9551,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621626,,,,Spleen,9552,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621627,,,,Spleen,9553,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621628,,,,Spleen,9554,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL875328,,,,Spleen,9555,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621629,,,,Spleen,9556,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL621630,,,,Spleen,9557,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL621631,,,,Spleen,9558,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,2106.0,CHEMBL621632,,,,Spleen,9559,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621633,,,,Spleen,9560,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621634,,,,Spleen,9561,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621635,,,,Spleen,9562,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621636,,,,Spleen,9563,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621637,,,,Spleen,9564,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,2106.0,CHEMBL621638,,,,Spleen,9565,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL618883,,,,,9566,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL618884,,,,,9567,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL628627,,,,,9568,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL628628,,,,,9569,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL628629,,,,,9570,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL628630,,,,,9571,1,Half life after administering orally a dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL628631,,,,,9572,1,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL628632,,,,,9573,1,Half life after administering intravenously a dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
526,10116.0,N,,CHEMBL628633,,,,,9574,1,Half life after oral dosing in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL628634,,,,,9575,1,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4368,10116.0,N,,CHEMBL627789,,,,,9576,1,Half life by intravenous administration of 3.4 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3371,10116.0,N,,CHEMBL627790,,,,,9577,1,Half life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6448,10116.0,N,,CHEMBL627791,,,,,9578,1,Half life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6453,10116.0,N,,CHEMBL627792,,,,,9579,1,Half life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4353,10116.0,N,,CHEMBL627793,,,,,9580,1,Half life in rat after intravenous administration of the compound,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4353,10116.0,N,1969.0,CHEMBL627794,,,,Plasma,9581,1,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4353,10116.0,N,,CHEMBL627795,,,,,9582,1,Half life in rat after po administration of the compound,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4353,10116.0,N,,CHEMBL627796,,,,,9583,1,Half life in rat after po administration of the compound; ND means Not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4353,10116.0,N,1969.0,CHEMBL875335,,,,Plasma,9584,1,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4353,10116.0,N,1969.0,CHEMBL627797,,,,Plasma,9585,1,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5789,10116.0,N,,CHEMBL627798,,,,,9586,1,Half life in rat i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17686,10116.0,N,,CHEMBL627799,,,,,9587,1,Half life in rat i.v. at 2 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6495,10116.0,N,,CHEMBL627800,,,,,9588,1,Half life in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
484,10116.0,N,,CHEMBL627801,,,,,9589,1,Half life in rats after intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6467,10116.0,N,,CHEMBL627802,,,,,9590,1,Half life in rats at the dose of 1.0 mpk by i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6642,10116.0,N,,CHEMBL627803,,,,,9591,1,Half life in rat,,Expert,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16367,10116.0,N,,CHEMBL873820,,,,,9592,1,Half life was evaluated after intravenous administration to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1369,10116.0,N,,CHEMBL627804,,,,,9593,1,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5472,10116.0,N,,CHEMBL627805,,,,,9594,1,Half life was evaluated in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6049,10116.0,N,,CHEMBL627806,,,,,9595,1,Half life was evaluated in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5472,10116.0,N,,CHEMBL627107,,,,,9596,1,Half life was evaluated in rat; Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16366,10116.0,N,,CHEMBL627108,,,,,9597,1,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11149,10116.0,N,,CHEMBL627109,,,,,9598,1,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11149,10116.0,N,178.0,CHEMBL627110,,,,Blood,9599,1,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2891,9443.0,U,,CHEMBL627111,,,,,9600,0,Half life was measured in monkey at dose of 10 mg/kg by po administration,,Intermediate,22224,,BAO_0000218,,In vivo,Primates,1,,A
2891,9443.0,U,,CHEMBL627112,,,,,9601,0,Half life was measured in monkey at dose of 10 mg/kg by po administration,,Intermediate,22224,,BAO_0000218,,In vivo,Primates,1,,A
2891,10116.0,U,,CHEMBL627113,,,,,9602,0,Half life was measured in rat at dose of 30 mg/kg by iv administration,,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2891,10116.0,U,,CHEMBL627114,,,,,9603,0,Half life was measured in rat at dose of 30 mg/kg by po administration,,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4026,10116.0,N,,CHEMBL627115,,,,,9604,1,Half life (t1/2) was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL627116,,,,,9605,1,Half life period at a dose of 10 uM/kg in rat was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL627117,,,,,9606,1,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5503,10116.0,N,,CHEMBL627118,,,,,9607,1,Half life period was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4426,10116.0,N,,CHEMBL627119,,,,,9608,1,Half life period after intravenous administration at 20 mpk in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4426,10116.0,N,,CHEMBL627120,,,,,9609,1,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6109,10116.0,N,,CHEMBL626922,,,,,9610,1,Half life period after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5654,10116.0,N,,CHEMBL626923,,,,,9611,1,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5654,10116.0,N,,CHEMBL626924,,,,,9612,1,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4755,10116.0,N,1969.0,CHEMBL626925,,,,Plasma,9613,1,Half life period in 80% rat plasma at 37 degree Centigrade,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5862,10116.0,N,,CHEMBL626926,,,,,9614,1,Half life period in SD rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1515,10116.0,N,1969.0,CHEMBL626927,,,,Plasma,9615,1,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1515,10116.0,N,1969.0,CHEMBL626928,,,,Plasma,9616,1,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1515,10116.0,N,1969.0,CHEMBL626929,,,,Plasma,9617,1,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1515,10116.0,N,1969.0,CHEMBL626930,,,,Plasma,9618,1,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5960,10116.0,N,,CHEMBL626931,,,,,9619,1,Half life period in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6103,10116.0,N,,CHEMBL626932,,,,,9620,1,Half life period in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6317,10116.0,N,,CHEMBL626933,,,,,9621,1,Half life period in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6644,10116.0,N,,CHEMBL873826,,,,,9622,1,Half life period in rat after oral administration at 10.5 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6644,10116.0,N,,CHEMBL626934,,,,,9623,1,Half life period in rat after oral administration at 11.2 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6644,10116.0,N,,CHEMBL626935,,,,,9624,1,Half life period in rat after oral administration at 13 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6644,10116.0,N,,CHEMBL626936,,,,,9625,1,Half life period in rat after oral administration at 9.7 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL626937,,,,,9626,1,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6295,10116.0,N,,CHEMBL625906,,,,,9627,1,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6296,10116.0,N,,CHEMBL625907,,,,,9628,1,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16427,10116.0,N,,CHEMBL625908,,,,,9629,1,PK study was carried to determine AUC (area under curve) value in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16367,10116.0,N,,CHEMBL625909,,,,,9630,1,Pharmacokinetic parameter AUC after intravenous administration to rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16367,10116.0,N,,CHEMBL625910,,,,,9631,1,Pharmacokinetic parameter AUC after oral administration to rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL625911,,,,,9632,1,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL625912,,,,,9633,1,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL626538,,,,,9634,1,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL876794,,,,,9635,1,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL626539,,,,,9636,1,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL626540,,,,,9637,1,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5394,10116.0,N,,CHEMBL626541,,,,,9638,1,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5394,10116.0,N,,CHEMBL626542,,,,,9639,1,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL626543,,,,,9640,1,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL626544,,,,,9641,1,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL626545,,,,,9642,1,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL626546,,,,,9643,1,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL626547,,,,,9644,1,Pharmacokinetic parameter area under curve was reported,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4408,10116.0,N,,CHEMBL626548,,,,,9645,1,Pharmacokinetic property (AUC) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5983,10116.0,N,,CHEMBL626549,,,,,9646,1,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4397,10116.0,N,,CHEMBL626550,,,,,9647,1,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4397,10116.0,N,,CHEMBL626551,,,,,9648,1,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5491,10116.0,N,,CHEMBL623777,,,,,9649,1,Pharmacokinetic property was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5491,10116.0,N,,CHEMBL623778,,,,,9650,1,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5491,10116.0,N,,CHEMBL623779,,,,,9651,1,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4199,10116.0,N,1969.0,CHEMBL623780,,,,Plasma,9652,1,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4199,10116.0,N,1969.0,CHEMBL622015,,,,Plasma,9653,1,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4199,10116.0,N,1969.0,CHEMBL622016,,,,Plasma,9654,1,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5173,10116.0,N,,CHEMBL622017,,,,,9655,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5173,10116.0,N,,CHEMBL622018,,,,,9656,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5173,10116.0,N,,CHEMBL622019,,,,,9657,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5173,10116.0,N,,CHEMBL622020,,,,,9658,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16366,10116.0,N,,CHEMBL622021,,,,,9659,1,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16366,10116.0,N,,CHEMBL622022,,,,,9660,1,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5327,10116.0,N,,CHEMBL622023,,,,,9661,1,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6681,10116.0,N,,CHEMBL622024,,,,,9662,1,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12873,10116.0,N,,CHEMBL622693,,,,,9663,1,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12873,10116.0,N,,CHEMBL622694,,,,,9664,1,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL622695,,,,,9665,1,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL622696,,,,,9666,1,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL622697,,,,,9667,1,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6619,10116.0,N,,CHEMBL622874,,,,,9668,1,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6619,10116.0,N,,CHEMBL622875,,,,,9669,1,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10363,10116.0,N,,CHEMBL622876,,,,,9670,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4796,10116.0,N,,CHEMBL622877,,,,,9671,1,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL622878,,,,,9672,1,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,1969.0,CHEMBL622879,,,,Plasma,9673,1,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4839,10116.0,N,,CHEMBL877602,,,,,9674,1,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL622880,,,,,9675,1,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL622881,,,,,9676,1,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL622882,,,,,9677,1,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL622883,,,,,9678,1,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622884,,,,Thyroid gland,9679,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11450,10116.0,N,2046.0,CHEMBL622885,,,,Thyroid gland,9680,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8151,10116.0,N,,CHEMBL622886,,,,,9681,1,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8151,10116.0,N,,CHEMBL622887,,,,,9682,1,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8151,10116.0,N,1088.0,CHEMBL622888,,,,Urine,9683,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8677,10116.0,N,178.0,CHEMBL622889,,,,Blood,9684,1,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,178.0,CHEMBL622890,,,,Blood,9685,1,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,178.0,CHEMBL622891,,,,Blood,9686,1,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,178.0,CHEMBL877603,,,,Blood,9687,1,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,955.0,CHEMBL622892,,,,Brain,9688,1,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,955.0,CHEMBL622893,,,,Brain,9689,1,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,955.0,CHEMBL622894,,,,Brain,9690,1,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,955.0,CHEMBL622895,,,,Brain,9691,1,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,955.0,CHEMBL622896,,,,Brain,9692,1,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,948.0,CHEMBL622897,,,,Heart,9693,1,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,948.0,CHEMBL622898,,,,Heart,9694,1,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,948.0,CHEMBL622899,,,,Heart,9695,1,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2113.0,CHEMBL622900,,,,Kidney,9696,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2113.0,CHEMBL624114,,,,Kidney,9697,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2113.0,CHEMBL624115,,,,Kidney,9698,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2113.0,CHEMBL624116,,,,Kidney,9699,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2107.0,CHEMBL624117,,,,Liver,9700,1,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2107.0,CHEMBL624118,,,,Liver,9701,1,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2107.0,CHEMBL624119,,,,Liver,9702,1,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2107.0,CHEMBL624120,,,,Liver,9703,1,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2048.0,CHEMBL624121,,,,Lung,9704,1,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2048.0,CHEMBL624122,,,,Lung,9705,1,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2048.0,CHEMBL624123,,,,Lung,9706,1,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2048.0,CHEMBL624124,,,,Lung,9707,1,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2385.0,CHEMBL624125,,,,Muscle tissue,9708,1,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2385.0,CHEMBL624126,,,,Muscle tissue,9709,1,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2385.0,CHEMBL624127,,,,Muscle tissue,9710,1,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2385.0,CHEMBL624128,,,,Muscle tissue,9711,1,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,14.0,CHEMBL624129,,,,Zone of skin,9712,1,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,14.0,CHEMBL624130,,,,Zone of skin,9713,1,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,14.0,CHEMBL622340,,,,Zone of skin,9714,1,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,14.0,CHEMBL622341,,,,Zone of skin,9715,1,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,160.0,CHEMBL622342,,,,Intestine,9716,1,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,160.0,CHEMBL622343,,,,Intestine,9717,1,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,160.0,CHEMBL622344,,,,Intestine,9718,1,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,160.0,CHEMBL622345,,,,Intestine,9719,1,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2106.0,CHEMBL622346,,,,Spleen,9720,1,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2106.0,CHEMBL622347,,,,Spleen,9721,1,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2106.0,CHEMBL622348,,,,Spleen,9722,1,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2106.0,CHEMBL622349,,,,Spleen,9723,1,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622350,,,,,9724,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622351,,,,,9725,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622352,,,,,9726,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622353,,,,,9727,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622354,,,,,9728,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622355,,,,,9729,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622356,,,,,9730,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622357,,,,,9731,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622358,,,,,9732,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL622359,,,,,9733,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL874393,,,,,9734,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622872,,,,,9735,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL622873,,,,,9736,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL623047,,,,,9737,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623048,,,,,9738,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623049,,,,,9739,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623050,,,,,9740,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623051,,,,,9741,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL623052,,,,,9742,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL626343,,,,,9743,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL626344,,,,,9744,1,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL626345,,,,,9745,1,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL626346,,,,,9746,1,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL626347,,,,,9747,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL626348,,,,,9748,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16434,10116.0,N,,CHEMBL626349,,,,,9749,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL626350,,,,,9750,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
16435,10116.0,N,,CHEMBL626351,,,,,9751,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL627650,,,,,9752,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL627651,,,,,9753,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
16435,10116.0,N,,CHEMBL627652,,,,,9754,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16435,10116.0,N,,CHEMBL627653,,,,,9755,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627654,,,,,9756,1,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627835,,,,,9757,1,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627836,,,,,9758,1,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627837,,,,,9759,1,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627838,,,,,9760,1,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL875338,,,,,9761,1,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627839,,,,,9762,1,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627840,,,,,9763,1,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627841,,,,,9764,1,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627842,,,,,9765,1,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627843,,,,,9766,1,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627844,,,,,9767,1,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL627845,,,,,9768,1,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5874,10116.0,N,,CHEMBL627846,,,,,9769,1,Half life period in rat by iv administration at a dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1515,10116.0,N,1969.0,CHEMBL627847,,,,Plasma,9770,1,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1515,10116.0,N,1969.0,CHEMBL873821,,,,Plasma,9771,1,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1515,10116.0,N,1969.0,CHEMBL626079,,,,Plasma,9772,1,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1515,10116.0,N,1969.0,CHEMBL626080,,,,Plasma,9773,1,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5491,10116.0,N,1969.0,CHEMBL626081,,,,Plasma,9774,1,Half life period was evaluated in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5491,10116.0,N,1969.0,CHEMBL875344,,,,Plasma,9775,1,Half life period was evaluated in rat plasma; Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1918,10116.0,N,,CHEMBL626082,,,,,9776,1,Half life period was evaluated in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1918,10116.0,N,,CHEMBL626250,,,,,9777,1,"Half life period was evaluated in rats, iv",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6113,10116.0,N,,CHEMBL626251,,,,,9778,1,Half life period after intravenous administration at 5 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5546,10116.0,N,,CHEMBL626252,,,,,9779,1,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5553,10116.0,N,,CHEMBL626253,,,,,9780,1,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4188,10116.0,N,1969.0,CHEMBL626254,,,,Plasma,9781,1,Half life stability of compound was evaluated in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6215,10116.0,N,,CHEMBL626255,,,,,9782,1,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6141,10116.0,N,,CHEMBL626256,,,,,9783,1,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5182,10116.0,N,,CHEMBL626257,,,,,9784,1,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5182,10116.0,N,,CHEMBL626258,,,,,9785,1,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5710,10116.0,N,,CHEMBL626259,,,,,9786,1,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5789,10116.0,N,,CHEMBL626260,,,,,9787,1,Half in rat i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6011,10116.0,N,,CHEMBL875345,,,,,9788,1,Half period in rat after intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17594,10116.0,N,,CHEMBL626261,,,,,9789,1,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12357,10116.0,N,2107.0,CHEMBL626262,,,,Liver,9790,1,Half-life measured in in vitro Cathepsin B assay in rat liver,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
5210,10116.0,N,,CHEMBL626263,,,,,9791,1,Half-life of compound was determined in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17596,10116.0,N,,CHEMBL625270,,,,,9792,1,Half-life at 10 mg/kg in rat upon intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6672,10116.0,N,,CHEMBL625271,,,,,9793,1,Half-life determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6673,10116.0,N,,CHEMBL625272,,,,,9794,1,Half-life determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,955.0,CHEMBL625273,,,,Brain,9795,1,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3741,10116.0,N,1969.0,CHEMBL625274,,,,Plasma,9796,1,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17671,10116.0,N,,CHEMBL625275,,,,,9797,1,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4910,10116.0,N,1969.0,CHEMBL625276,,,,Plasma,9798,1,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17537,10116.0,N,1969.0,CHEMBL625277,,,,Plasma,9799,1,Half-life in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4965,10116.0,N,1969.0,CHEMBL625278,,,,Plasma,9800,1,Half-life in rat plasma was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17537,10116.0,N,1969.0,CHEMBL625279,,,,Plasma,9801,1,Half-life in rat plasma; Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6124,10116.0,N,1977.0,CHEMBL625280,,,,Serum,9802,1,Half-life in rat serum,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6124,10116.0,N,1977.0,CHEMBL876797,,,,Serum,9803,1,Half-life in rat serum; na is not available,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6078,10116.0,N,,CHEMBL625281,,,,,9804,1,Half-life was calculated in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17668,10116.0,N,1969.0,CHEMBL873827,,,,Plasma,9805,1,Half-life was calculated in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3185,10116.0,N,,CHEMBL625282,,,,,9806,1,Half-life was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4883,10116.0,N,,CHEMBL625283,,,,,9807,1,Half-life was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2959,10116.0,N,,CHEMBL625284,,,,,9808,1,Half-life after administration of 20 mg/Kg oral dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4029,10116.0,N,,CHEMBL625285,,,,,9809,1,Half-life after administration of 3.2 mg/kg intravenously in male rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4029,10116.0,N,,CHEMBL625286,,,,,9810,1,Half-life after intravenous administration in female rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4029,10116.0,N,,CHEMBL625287,,,,,9811,1,Half-life after intravenous administration in male rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6180,10116.0,N,,CHEMBL625288,,,,,9812,1,Half-life after intravenous dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1557,10116.0,N,2107.0,CHEMBL625289,,,,Liver,9813,1,Half-life in a rat liver homogenate preparation,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12500,10116.0,N,1969.0,CHEMBL625290,,,,Plasma,9814,1,Half-life in plasma of rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12500,10116.0,N,1969.0,CHEMBL876798,,,,Plasma,9815,1,Half-life in plasma of rat at dose of 3-10 mgkg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5064,10116.0,N,,CHEMBL625291,,,,,9816,1,Half-life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5145,10116.0,N,,CHEMBL625292,,,,,9817,1,Half-life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5147,10116.0,N,,CHEMBL625293,,,,,9818,1,Half-life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5833,10116.0,N,,CHEMBL622832,,,,,9819,1,Half-life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6596,10116.0,N,,CHEMBL622833,,,,,9820,1,Half-life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17655,10116.0,N,,CHEMBL622834,,,,,9821,1,Half-life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6495,10116.0,N,,CHEMBL622835,,,,,9822,1,Half-life in rat after oral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17538,10116.0,N,,CHEMBL622836,,,,,9823,1,Half-life in rat after po administration at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17538,10116.0,N,,CHEMBL622837,,,,,9824,1,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10,10116.0,N,,CHEMBL622838,,,,,9825,1,Half-life in rat at 3 mg/kg dose administered intravenously,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17669,10116.0,N,955.0,CHEMBL622839,,,,Brain,9826,1,Half-life in rat brain homogenate,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17065,10116.0,N,1969.0,CHEMBL622840,,,,Plasma,9827,1,Half-life in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4333,10116.0,N,,CHEMBL622841,,,,,9828,1,Half-life in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6827,10116.0,N,,CHEMBL622842,,,,,9829,1,Half-life in Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
889,10116.0,N,1969.0,CHEMBL622843,,,,Plasma,9830,1,Half-life in vitro in rat plasma,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
889,10116.0,N,1969.0,CHEMBL622844,,,,Plasma,9831,1,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
3747,10116.0,N,,CHEMBL622845,,,,,9832,1,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL622846,,,,,9833,1,The area under the curve of compound was measured at the dose of 100 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL622847,,,,,9834,1,The area under the curve of compound was measured at the dose of 300 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL622848,,,,,9835,1,The area under the curve of compound was measured at the dose of 30 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3360,10116.0,N,,CHEMBL622849,,,,,9836,1,Bioavailability as oral AUC in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,1969.0,CHEMBL622850,,,,Plasma,9837,1,The plasma concentration versus time curve (AUC) was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17411,10116.0,N,,CHEMBL876807,,,,,9838,1,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17411,10116.0,N,,CHEMBL622851,,,,,9839,1,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17411,10116.0,N,,CHEMBL622852,,,,,9840,1,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL622853,,,,,9841,1,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL622854,,,,,9842,1,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17411,10116.0,N,,CHEMBL622855,,,,,9843,1,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14941,10116.0,N,1969.0,CHEMBL622856,,,,Plasma,9844,1,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14941,10116.0,N,1969.0,CHEMBL622857,,,,Plasma,9845,1,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17538,10116.0,N,1969.0,CHEMBL622858,,,,Plasma,9846,1,AUC in rat after po administration at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17752,10116.0,N,1969.0,CHEMBL622859,,,,Plasma,9847,1,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL622860,,,,,9848,1,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL622861,,,,,9849,1,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL622862,,,,,9850,1,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL622863,,,,,9851,1,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL623817,,,,,9852,1,Area under curve value 6 hr after po administration in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL623818,,,,,9853,1,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL623819,,,,,9854,1,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL623820,,,,,9855,1,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL623821,,,,,9856,1,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6642,10116.0,N,1969.0,CHEMBL623822,,,,Plasma,9857,1,AUC normalized for dose (AUCN) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6640,10116.0,N,,CHEMBL623823,,,,,9858,1,Area under curve in rat after p.o. administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL623824,,,,,9859,1,Area under curve in rat after p.o. administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL623825,,,,,9860,1,Area under curve in rat after p.o. administration; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL622070,,,,,9861,1,Area under curve in rat after peroral administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3603,10116.0,N,,CHEMBL622071,,,,,9862,1,Area under curve (carotid artery) value of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3550,10116.0,N,,CHEMBL622072,,,,,9863,1,Bioavailability expressed as the area under curve of rat carotid artery,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15662,10116.0,N,,CHEMBL622073,,,,,9864,1,Area under curve in male SD rats was observed after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17720,10116.0,N,,CHEMBL622074,,,,,9865,1,Area under curve of the compound was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5407,10116.0,N,,CHEMBL622075,,,,,9866,1,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17752,10116.0,N,1969.0,CHEMBL622076,,,,Plasma,9867,1,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17752,10116.0,N,1969.0,CHEMBL622077,,,,Plasma,9868,1,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3603,10116.0,N,,CHEMBL622078,,,,,9869,1,Area under curve (portal vein) value of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3550,10116.0,N,,CHEMBL622079,,,,,9870,1,Bioavailability expressed as the area under curve of rat portal vein,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17655,10116.0,N,1969.0,CHEMBL622080,,,,Plasma,9871,1,Area Under plasma concentration time curve in rat upon peroral administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL877612,,,,,9872,1,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL622081,,,,,9873,1,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL622082,,,,,9874,1,Compound was evaluated for oral bioavailability in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL622083,,,,,9875,1,Compound was evaluated for oral bioavailability in rats after iv administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL622084,,,,,9876,1,Compound was evaluated for oral bioavailability in rats; 30-80,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL622085,,,,,9877,1,Compound was evaluated for oral bioavailability in rats; 50-60,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL622086,,,,,9878,1,Compound was evaluated for oral bioavailability in rats; no data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17791,10116.0,N,,CHEMBL622087,,,,,9879,1,Compound was evaluated for oral bioavailability in rats; peptide,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,178.0,CHEMBL622088,,,,Blood,9880,1,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,178.0,CHEMBL622089,,,,Blood,9881,1,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,178.0,CHEMBL623685,,,,Blood,9882,1,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,178.0,CHEMBL623686,,,,Blood,9883,1,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8677,10116.0,N,945.0,CHEMBL623687,,,,Stomach,9884,1,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,945.0,CHEMBL623688,,,,Stomach,9885,1,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,945.0,CHEMBL623689,,,,Stomach,9886,1,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,945.0,CHEMBL622485,,,,Stomach,9887,1,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2046.0,CHEMBL622486,,,,Thyroid gland,9888,1,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2046.0,CHEMBL877613,,,,Thyroid gland,9889,1,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2046.0,CHEMBL622487,,,,Thyroid gland,9890,1,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,2046.0,CHEMBL622488,,,,Thyroid gland,9891,1,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8677,10116.0,N,948.0,CHEMBL622489,,,,Heart,9892,1,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6899,10116.0,N,1088.0,CHEMBL622490,,,,Urine,9893,1,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6899,10116.0,N,1088.0,CHEMBL622491,,,,Urine,9894,1,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6899,10116.0,N,2107.0,CHEMBL622492,,,,Liver,9895,1,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6899,10116.0,N,1088.0,CHEMBL622493,,,,Urine,9896,1,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6899,10116.0,N,1088.0,CHEMBL622494,,,,Urine,9897,1,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8677,10116.0,N,2385.0,CHEMBL622495,,,,Muscle tissue,9898,1,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6899,10116.0,N,,CHEMBL622496,,,,,9899,1,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6899,10116.0,N,1088.0,CHEMBL622497,,,,Urine,9900,1,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2189,10116.0,N,,CHEMBL622498,,,,,9901,1,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2189,10116.0,N,1088.0,CHEMBL624918,,,,Urine,9902,1,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2189,10116.0,N,1088.0,CHEMBL624919,,,,Urine,9903,1,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10839,10116.0,N,178.0,CHEMBL624920,,,,Blood,9904,1,Biodistribution of compound in rat blood after 5 min of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,178.0,CHEMBL624921,,,,Blood,9905,1,Biodistribution of compound in rat blood after 5 min of administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,955.0,CHEMBL624922,,,,Brain,9906,1,Biodistribution of compound in rat brain after 5 min of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,948.0,CHEMBL624923,,,,Heart,9907,1,Biodistribution of compound in rat heart after 5 min of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,948.0,CHEMBL624924,,,,Heart,9908,1,Biodistribution of compound in rat heart after 5 min of administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,2113.0,CHEMBL624925,,,,Kidney,9909,1,Biodistribution of compound in rat kidney after 5 min of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,2113.0,CHEMBL624926,,,,Kidney,9910,1,Biodistribution of compound in rat kidney after 5 min of administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,2107.0,CHEMBL624927,,,,Liver,9911,1,Biodistribution of compound in rat liver after 5 min of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,2107.0,CHEMBL874402,,,,Liver,9912,1,Biodistribution of compound in rat liver after 5 min of administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,2048.0,CHEMBL624928,,,,Lung,9913,1,Biodistribution of compound in rat lung after 5 min of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,2048.0,CHEMBL624929,,,,Lung,9914,1,Biodistribution of compound in rat lung after 5 min of administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,2385.0,CHEMBL624930,,,,Muscle tissue,9915,1,Biodistribution of compound in rat muscle after 5 min of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,10116.0,N,2385.0,CHEMBL624931,,,,Muscle tissue,9916,1,Biodistribution of compound in rat muscle after 5 min of administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4043,10116.0,N,948.0,CHEMBL624932,,,,Heart,9917,1,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4043,10116.0,N,948.0,CHEMBL624933,,,,Heart,9918,1,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4043,10116.0,N,2107.0,CHEMBL624934,,,,Liver,9919,1,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4043,10116.0,N,2107.0,CHEMBL624935,,,,Liver,9920,1,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4043,10116.0,N,,CHEMBL624936,,,,,9921,1,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4043,10116.0,N,,CHEMBL624937,,,,,9922,1,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4043,10116.0,N,2106.0,CHEMBL624938,,,,Spleen,9923,1,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4043,10116.0,N,2106.0,CHEMBL624939,,,,Spleen,9924,1,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4043,10116.0,N,,CHEMBL624940,,,,,9925,1,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4043,10116.0,N,,CHEMBL874403,,,,,9926,1,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1446,10116.0,N,,CHEMBL624941,,,,,9927,1,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9971,10116.0,N,1088.0,CHEMBL624942,,,,Urine,9928,1,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9971,10116.0,N,1088.0,CHEMBL624943,,,,Urine,9929,1,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5765,10116.0,N,,CHEMBL624944,,,,,9930,1,% Bioavailability after 1 day of the drug administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5765,10116.0,N,,CHEMBL624945,,,,,9931,1,% Bioavailability after 4 day of the drug administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4257,10116.0,N,,CHEMBL624946,,,,,9932,1,Absolute bioavailability was evaluated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL624947,,,,,9933,1,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL624948,,,,,9934,1,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL624949,,,,,9935,1,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2113.0,CHEMBL622025,,,,Kidney,9936,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2113.0,CHEMBL622026,,,,Kidney,9937,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2113.0,CHEMBL622027,,,,Kidney,9938,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2113.0,CHEMBL622028,,,,Kidney,9939,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2107.0,CHEMBL622029,,,,Liver,9940,1,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2107.0,CHEMBL622208,,,,Liver,9941,1,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2107.0,CHEMBL622209,,,,Liver,9942,1,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2107.0,CHEMBL622210,,,,Liver,9943,1,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL622211,,,,,9944,1,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL622212,,,,,9945,1,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL622213,,,,,9946,1,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL874404,,,,,9947,1,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2385.0,CHEMBL620452,,,,Muscle tissue,9948,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2385.0,CHEMBL620453,,,,Muscle tissue,9949,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2385.0,CHEMBL620454,,,,Muscle tissue,9950,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2385.0,CHEMBL624067,,,,Muscle tissue,9951,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL624068,,,,,9952,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,992.0,CHEMBL624069,,,,Female gonad,9953,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,992.0,CHEMBL624070,,,,Female gonad,9954,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,992.0,CHEMBL624071,,,,Female gonad,9955,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,995.0,CHEMBL624072,,,,Uterus,9956,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,995.0,CHEMBL624073,,,,Uterus,9957,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,995.0,CHEMBL624788,,,,Uterus,9958,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,995.0,CHEMBL624789,,,,Uterus,9959,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL624790,,,,,9960,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL624791,,,,,9961,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL624792,,,,,9962,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,,CHEMBL624793,,,,,9963,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2385.0,CHEMBL877491,,,,Muscle tissue,9964,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2385.0,CHEMBL624957,,,,Muscle tissue,9965,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2385.0,CHEMBL624958,,,,Muscle tissue,9966,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13091,10116.0,N,2385.0,CHEMBL624959,,,,Muscle tissue,9967,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11977,10116.0,N,,CHEMBL624960,,,,,9968,1,Dissociation constant was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14941,10116.0,N,,CHEMBL624961,,,,,9969,1,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL624962,,,,,9970,1,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL624963,,,,,9971,1,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4755,10116.0,N,,CHEMBL624964,,,,,9972,1,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
589,10116.0,N,,CHEMBL624965,,,,,9973,1,LogP value was evaluated in the in situ rat gut perfusion assay,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL624966,,,,,9974,1,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5031,10116.0,N,,CHEMBL624967,,,,,9975,1,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17764,10116.0,N,,CHEMBL624968,,,,,9976,1,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17720,10116.0,N,,CHEMBL624969,,,,,9977,1,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2862,10116.0,N,,CHEMBL624970,,,,,9978,1,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,Expert,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
16423,10116.0,N,,CHEMBL624971,,,,,9979,1,Half-life was evaluated after 10 uM/kg of intra arterial administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16423,10116.0,N,,CHEMBL624972,,,,,9980,1,Half-life was evaluated after 20 uM/kg of peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6005,10116.0,N,,CHEMBL624973,,,,,9981,1,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2938,10116.0,N,1969.0,CHEMBL624974,,,,Plasma,9982,1,Half-life was evaluated in plasma of rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6410,10116.0,N,,CHEMBL624975,,,,,9983,1,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6410,10116.0,N,,CHEMBL877492,,,,,9984,1,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6062,10116.0,N,,CHEMBL624976,,,,,9985,1,Half-life was measured in rat after an iv dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6571,10116.0,N,,CHEMBL624977,,,,,9986,1,Half-life period of compound in rats after peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3136,10116.0,N,1969.0,CHEMBL626848,,,,Plasma,9987,1,Half-life period of compound was measured in rat plasma.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3136,10116.0,N,1969.0,CHEMBL626849,,,,Plasma,9988,1,Half-life period of compound was measured in rat plasma; ND is not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3136,10116.0,N,1969.0,CHEMBL626850,,,,Plasma,9989,1,Half-life period of compound was measured in rat plasma; not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4521,10116.0,N,,CHEMBL626851,,,,,9990,1,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5871,10116.0,N,,CHEMBL626852,,,,,9991,1,Half-life period in rat by iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6077,10116.0,N,,CHEMBL626853,,,,,9992,1,Half-life period in rats following intravenous administration at 2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6679,10116.0,N,,CHEMBL626854,,,,,9993,1,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5144,10116.0,N,,CHEMBL627486,,,,,9994,1,Half-life period was determined for the compound in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4498,10116.0,N,,CHEMBL627487,,,,,9995,1,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4498,10116.0,N,,CHEMBL627488,,,,,9996,1,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1908,10116.0,N,,CHEMBL627489,,,,,9997,1,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6211,10116.0,N,,CHEMBL627490,,,,,9998,1,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5529,10116.0,N,,CHEMBL873829,,,,,9999,1,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6444,10116.0,N,,CHEMBL627655,,,,,10000,1,Half-life was determined in rat at a dose of 1 mpk i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6444,10116.0,N,,CHEMBL625994,,,,,10001,1,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6444,10116.0,N,,CHEMBL625995,,,,,10002,1,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5207,10116.0,N,,CHEMBL625996,,,,,10003,1,Half-life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
530,10116.0,N,1969.0,CHEMBL625850,,,,Plasma,10004,1,In vitro half life in rat plasma,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
1116,10116.0,N,1969.0,CHEMBL625851,,,,Plasma,10005,1,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
3219,10116.0,N,,CHEMBL625852,,,,,10006,1,In vitro half life in rat,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
6109,10116.0,N,,CHEMBL625853,,,,,10007,1,In vivo half life period after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL625854,,,,,10008,1,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL874450,,,,,10009,1,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL625855,,,,,10010,1,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL625856,,,,,10011,1,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL625857,,,,,10012,1,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL873831,,,,,10013,1,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17853,10116.0,N,,CHEMBL625858,,,,,10014,1,Longer half-life in rat (i.v.) at 0.5 mpk,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17853,10116.0,N,,CHEMBL625859,,,,,10015,1,Longer half-life in rat (p.o.) at 2.0 mpk,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3457,10116.0,N,,CHEMBL625860,,,,,10016,1,Pharmacokinetic property (half life) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL625861,,,,,10017,1,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL625862,,,,,10018,1,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL625863,,,,,10019,1,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL625864,,,,,10020,1,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5739,10116.0,N,,CHEMBL625865,,,,,10021,1,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15765,10116.0,N,,CHEMBL625866,,,,,10022,1,Pharmacokinetic half time was determined intravenously in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6567,10116.0,N,1969.0,CHEMBL625867,,,,Plasma,10023,1,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2448,10116.0,N,1969.0,CHEMBL625868,,,,Plasma,10024,1,Plasma half life of hydrolysis of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5423,10116.0,N,1969.0,CHEMBL625869,,,,Plasma,10025,1,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4853,10116.0,N,1969.0,CHEMBL874451,,,,Plasma,10026,1,Plasma half life period was calculated in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4514,10116.0,N,1969.0,CHEMBL625870,,,,Plasma,10027,1,Plasma half-life in Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4514,10116.0,N,1969.0,CHEMBL625871,,,,Plasma,10028,1,Plasma half-life in Sprague-Dawley rats; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1500,10116.0,N,1969.0,CHEMBL625872,,,,Plasma,10029,1,Plasma half-life in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1500,10116.0,N,1969.0,CHEMBL625873,,,,Plasma,10030,1,Plasma half-life in rats; <MQL,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5334,10116.0,N,1969.0,CHEMBL625874,,,,Plasma,10031,1,Plasma half-life period (0-8 h) was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5334,10116.0,N,1969.0,CHEMBL625875,,,,Plasma,10032,1,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5334,10116.0,N,1969.0,CHEMBL625876,,,,Plasma,10033,1,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,1969.0,CHEMBL631258,,,,Plasma,10034,1,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4956,10116.0,N,1969.0,CHEMBL631259,,,,Plasma,10035,1,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4956,10116.0,N,1969.0,CHEMBL631260,,,,Plasma,10036,1,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,178.0,CHEMBL631261,,,,Blood,10037,1,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,178.0,CHEMBL631262,,,,Blood,10038,1,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,178.0,CHEMBL631263,,,,Blood,10039,1,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,,CHEMBL631264,,,,,10040,1,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,,CHEMBL631265,,,,,10041,1,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,,CHEMBL631266,,,,,10042,1,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,,CHEMBL631267,,,,,10043,1,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,,CHEMBL631268,,,,,10044,1,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,,CHEMBL631269,,,,,10045,1,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,,CHEMBL631270,,,,,10046,1,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,948.0,CHEMBL631271,,,,Heart,10047,1,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,948.0,CHEMBL631272,,,,Heart,10048,1,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,948.0,CHEMBL631273,,,,Heart,10049,1,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,948.0,CHEMBL631274,,,,Heart,10050,1,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,948.0,CHEMBL631275,,,,Heart,10051,1,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,948.0,CHEMBL626984,,,,Heart,10052,1,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,948.0,CHEMBL626985,,,,Heart,10053,1,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2107.0,CHEMBL626986,,,,Liver,10054,1,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2107.0,CHEMBL626987,,,,Liver,10055,1,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2107.0,CHEMBL626988,,,,Liver,10056,1,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2107.0,CHEMBL626989,,,,Liver,10057,1,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2107.0,CHEMBL626990,,,,Liver,10058,1,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2107.0,CHEMBL626991,,,,Liver,10059,1,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2107.0,CHEMBL626992,,,,Liver,10060,1,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2048.0,CHEMBL626993,,,,Lung,10061,1,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2048.0,CHEMBL874593,,,,Lung,10062,1,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2048.0,CHEMBL626994,,,,Lung,10063,1,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2048.0,CHEMBL626995,,,,Lung,10064,1,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2048.0,CHEMBL626190,,,,Lung,10065,1,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2048.0,CHEMBL626191,,,,Lung,10066,1,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2048.0,CHEMBL626364,,,,Lung,10067,1,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2046.0,CHEMBL626365,,,,Thyroid gland,10068,1,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2046.0,CHEMBL626366,,,,Thyroid gland,10069,1,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2046.0,CHEMBL626367,,,,Thyroid gland,10070,1,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2046.0,CHEMBL626368,,,,Thyroid gland,10071,1,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2046.0,CHEMBL626369,,,,Thyroid gland,10072,1,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7768,10116.0,N,2046.0,CHEMBL626370,,,,Thyroid gland,10073,1,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4498,10116.0,N,,CHEMBL626371,,,,,10074,1,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4498,10116.0,N,,CHEMBL626372,,,,,10075,1,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3603,10116.0,N,,CHEMBL626373,,,,,10076,1,Bioavailability after a dose of 10 mg/kg p.o.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6215,10116.0,N,,CHEMBL626374,,,,,10077,1,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5710,10116.0,N,,CHEMBL626375,,,,,10078,1,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5710,10116.0,N,,CHEMBL626376,,,,,10079,1,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5676,10116.0,N,,CHEMBL626377,,,,,10080,1,Bioavailability in rat po was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17667,10116.0,N,,CHEMBL626378,,,,,10081,1,Bioavailability of compound at 10 mg/kg in rat after oral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17667,10116.0,N,,CHEMBL626379,,,,,10082,1,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6848,10116.0,N,,CHEMBL626380,,,,,10083,1,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6848,10116.0,N,,CHEMBL626381,,,,,10084,1,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17267,10116.0,N,,CHEMBL626382,,,,,10085,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6362,10116.0,N,,CHEMBL626383,,,,,10086,1,Bioavailability in rat (Sprague-Dawley) (female),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17671,10116.0,N,,CHEMBL874652,,,,,10087,1,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17671,10116.0,N,,CHEMBL626384,,,,,10088,1,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4333,10116.0,N,,CHEMBL626385,,,,,10089,1,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6077,10116.0,N,,CHEMBL626386,,,,,10090,1,Bioavailability in rat at an oral dose of 2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3278,10116.0,N,,CHEMBL626387,,,,,10091,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5964,10116.0,N,,CHEMBL626388,,,,,10092,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4884,10116.0,N,,CHEMBL626389,,,,,10093,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4905,10116.0,N,,CHEMBL626390,,,,,10094,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4884,10116.0,N,,CHEMBL626391,,,,,10095,1,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6850,10116.0,N,,CHEMBL626392,,,,,10096,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2864,10116.0,N,,CHEMBL626393,,,,,10097,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5780,10116.0,N,,CHEMBL623026,,,,,10098,1,Bioavailability was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1465,10116.0,N,,CHEMBL623027,,,,,10099,1,Bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5199,10116.0,N,,CHEMBL623028,,,,,10100,1,Bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5765,10116.0,N,,CHEMBL623029,,,,,10101,1,Bioavailability in rat after 1 day dosing,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5765,10116.0,N,,CHEMBL623030,,,,,10102,1,Bioavailability in rat after 4 day dosing,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL623031,,,,,10103,1,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL623032,,,,,10104,1,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL623033,,,,,10105,1,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6518,10116.0,N,,CHEMBL623034,,,,,10106,1,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2083,10116.0,N,,CHEMBL623035,,,,,10107,1,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17260,10116.0,N,,CHEMBL623036,,,,,10108,1,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4956,10116.0,N,,CHEMBL623037,,,,,10109,1,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4368,10116.0,N,,CHEMBL623038,,,,,10110,1,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17752,10116.0,N,1969.0,CHEMBL874385,,,,Plasma,10111,1,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1446,10116.0,N,,CHEMBL623039,,,,,10112,1,Bioavailability in rat (Fisher) (fasted),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2891,9443.0,U,,CHEMBL623040,,,,,10113,0,Bioavailability in monkey after po administration of 10 mg/kg dose,,Intermediate,22224,,BAO_0000218,,In vivo,Primates,1,,A
2891,9443.0,U,,CHEMBL623041,,,,,10114,0,Oral bioavailability in monkey (dose 10 mg/kg),,Intermediate,22224,,BAO_0000218,,In vivo,Primates,1,,A
6672,10116.0,N,,CHEMBL623741,,,,,10115,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6673,10116.0,N,,CHEMBL623742,,,,,10116,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17655,10116.0,N,,CHEMBL623743,,,,,10117,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17796,10116.0,N,,CHEMBL623744,,,,,10118,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17853,10116.0,N,,CHEMBL623745,,,,,10119,1,Bioavailability in rat (dose 2.0 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4521,10116.0,N,,CHEMBL623746,,,,,10120,1,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4940,10116.0,N,,CHEMBL623747,,,,,10121,1,Oral bioavailability in rat (dose 5 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2891,10116.0,U,,CHEMBL623748,,,,,10122,0,Bioavailability in rat after po administration of 30 mg/kg dose,,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2891,10116.0,U,,CHEMBL623916,,,,,10123,0,Bioavailability in rat after po administration of 30 mg/kg dose,,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4521,10116.0,N,,CHEMBL623917,,,,,10124,1,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17686,10116.0,N,,CHEMBL623918,,,,,10125,1,Bioavailability in rat (dose 2 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17796,10116.0,N,,CHEMBL874386,,,,,10126,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17796,10116.0,N,1969.0,CHEMBL623919,,,,Plasma,10127,1,Bioavailability in rat; Only traces detected in rat plasma,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5064,10116.0,N,,CHEMBL623920,,,,,10128,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5147,10116.0,N,,CHEMBL623148,,,,,10129,1,Bioavailability upon oral administration of compound,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1916,10116.0,N,,CHEMBL623149,,,,,10130,1,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6049,10116.0,N,,CHEMBL623150,,,,,10131,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1445,10116.0,N,,CHEMBL623151,,,,,10132,1,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1445,10116.0,N,,CHEMBL623152,,,,,10133,1,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2862,10116.0,N,,CHEMBL623153,,,,,10134,1,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,Expert,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
2862,10116.0,N,,CHEMBL623154,,,,,10135,1,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,Expert,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
4194,10116.0,N,,CHEMBL623155,,,,,10136,1,In vitro and metabolic stability was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4194,10116.0,N,,CHEMBL623156,,,,,10137,1,In vitro metabolic stability in rat hepatocytes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5486,10116.0,N,,CHEMBL623157,,,,,10138,1,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17582,10116.0,N,2107.0,CHEMBL623158,Hepatocyte,,,Liver,10139,1,Metabolic rate for compound was observed in rat hepatocytes,,Intermediate,50597,401.0,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
5600,10116.0,N,,CHEMBL623159,,,,,10140,1,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14294,10116.0,N,,CHEMBL874390,,,,,10141,1,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14294,10116.0,N,,CHEMBL623160,,,,,10142,1,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14294,10116.0,N,,CHEMBL623161,,,,,10143,1,Metabolism of compound in rat S9 microsomes; Trace,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17847,10116.0,N,,CHEMBL623162,,,,,10144,1,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623163,,,,,10145,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623164,,,,,10146,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623165,,,,,10147,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623166,,,,,10148,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL624983,,,,,10149,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL624984,,,,,10150,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL624985,,,,,10151,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622970,,,,,10152,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622971,,,,,10153,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622972,,,,,10154,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622973,,,,,10155,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622974,,,,,10156,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622975,,,,,10157,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622976,,,,,10158,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622977,,,,,10159,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL624351,,,,,10160,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL624352,,,,,10161,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL624353,,,,,10162,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622397,,,,,10163,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622398,,,,,10164,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622399,,,,,10165,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL622400,,,,,10166,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL628428,,,,,10167,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL628590,,,,,10168,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL628591,,,,,10169,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL628592,,,,,10170,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL628593,,,,,10171,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL875333,,,,,10172,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL628594,,,,,10173,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4969,10116.0,N,1969.0,CHEMBL628595,,,,Plasma,10174,1,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6737,10116.0,N,1969.0,CHEMBL628596,,,,Plasma,10175,1,Stability in rat plasma was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6737,10116.0,N,1969.0,CHEMBL628597,,,,Plasma,10176,1,Stability in rat plasma was determined; ND= no data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5089,10116.0,N,1969.0,CHEMBL628598,,,,Plasma,10177,1,Tested for plasma half life period in rat (0-8 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5089,10116.0,N,1969.0,CHEMBL628599,,,,Plasma,10178,1,Tested for plasma half life period in rat (0-8 hr); Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1466,10116.0,N,,CHEMBL628600,,,,,10179,1,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1466,10116.0,N,,CHEMBL628601,,,,,10180,1,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4950,10116.0,N,,CHEMBL628602,,,,,10181,1,Tested for the half life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2412,10116.0,N,,CHEMBL628603,,,,,10182,1,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
2412,10116.0,N,,CHEMBL628604,,,,,10183,1,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
2412,10116.0,N,,CHEMBL628605,,,,,10184,1,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
2412,10116.0,N,,CHEMBL628606,,,,,10185,1,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
2412,10116.0,N,,CHEMBL628607,,,,,10186,1,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL628608,,,,,10187,1,The biological half life the compound was measured at the dose of 100 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15022,10116.0,N,,CHEMBL628609,,,,,10188,1,The biological half life the compound was measured at the dose of 30 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
406,10116.0,N,1969.0,CHEMBL628610,,,,Plasma,10189,1,The compound was evaluated for plasma half life period in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL873819,,,,,10190,1,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL628611,,,,,10191,1,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5247,10116.0,N,,CHEMBL628612,,,,,10192,1,The pharmacokinetic parameter half-life period in vivo in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL628613,,,,,10193,1,"The pharmacokinetic property, Half-life was determined",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL628614,,,,,10194,1,"The pharmacokinetic property, Half-life in rat in vivo",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL628615,,,,,10195,1,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL628616,,,,,10196,1,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3918,10116.0,N,1969.0,CHEMBL627924,,,,Plasma,10197,1,The plasma half life period in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2906,10116.0,N,2107.0,CHEMBL627925,,,,Liver,10198,1,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6467,10116.0,N,,CHEMBL627926,,,,,10199,1,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL627927,,,,,10200,1,t1/2 (apparent elimination)of the compound was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3788,10116.0,N,,CHEMBL627928,,,,,10201,1,t1/2 value in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17796,10116.0,N,,CHEMBL627539,,,,,10202,1,Half life in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12873,10116.0,N,1969.0,CHEMBL876790,,,,Plasma,10203,1,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5983,10116.0,N,,CHEMBL858186,,,,,10204,1,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15765,10116.0,N,,CHEMBL627540,,,,,10205,1,Half-life period in fasted rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL627541,,,,,10206,1,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL627715,,,,,10207,1,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
429,10116.0,N,,CHEMBL627716,,,,,10208,1,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17655,10116.0,N,,CHEMBL627717,,,,,10209,1,Maximum time required to achieve Cmax was determined in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL627718,,,,,10210,1,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL627719,,,,,10211,1,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL627720,,,,,10212,1,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL627721,,,,,10213,1,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL627722,,,,,10214,1,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL627723,,,,,10215,1,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL626058,,,,,10216,1,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL626059,,,,,10217,1,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL626060,,,,,10218,1,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17720,10116.0,N,1969.0,CHEMBL626061,,,,Plasma,10219,1,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL876791,,,,,10220,1,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4723,10116.0,N,,CHEMBL626062,,,,,10221,1,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4756,10116.0,N,,CHEMBL626063,,,,,10222,1,Tmax at the dose of 2 mg/Kg administered perorally in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4756,10116.0,N,,CHEMBL626064,,,,,10223,1,Tmax at the dose of 5 mg/Kg administered perorally in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17720,10116.0,N,1969.0,CHEMBL626065,,,,Plasma,10224,1,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17720,10116.0,N,1969.0,CHEMBL626066,,,,Plasma,10225,1,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1466,10116.0,N,,CHEMBL626067,,,,,10226,1,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
7449,10116.0,N,,CHEMBL626068,,,,,10227,1,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
7449,10116.0,N,,CHEMBL626069,,,,,10228,1,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
7449,10116.0,N,,CHEMBL626070,,,,,10229,1,Percent total excretion of 3-methoxyacetaminophen glucuronide,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
7449,10116.0,N,,CHEMBL626071,,,,,10230,1,Percent total excretion of N-methoxyacetaminophen glucuronide,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
7449,10116.0,N,,CHEMBL626072,,,,,10231,1,Percent total excretion of N-methoxyacetaminophen sulfate,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
7449,10116.0,N,,CHEMBL626073,,,,,10232,1,Percent total excretion of acetaminophen,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
7768,10116.0,N,2046.0,CHEMBL626741,,,,Thyroid gland,10233,1,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17655,10116.0,N,,CHEMBL626742,,,,,10234,1,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17735,10116.0,N,,CHEMBL626743,,,,,10235,1,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5960,10116.0,N,,CHEMBL876792,,,,,10236,1,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17735,10116.0,N,,CHEMBL626744,,,,,10237,1,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7116,10116.0,N,,CHEMBL626745,,,,,10238,1,Compound was tested for antidiuretic activity in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4878,10116.0,N,1969.0,CHEMBL626746,,,,Plasma,10239,1,AUC in rat after 3mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL626747,,,,,10240,1,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL626748,,,,,10241,1,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16367,10116.0,N,,CHEMBL626749,,,,,10242,1,Bioavailability administered orally at a dose of 10 mg/kg to rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16366,10116.0,N,,CHEMBL626750,,,,,10243,1,Oral Bioavailability was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4426,10116.0,N,,CHEMBL626751,,,,,10244,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4426,10116.0,N,,CHEMBL626913,,,,,10245,1,Oral bioavailability in rat; Not performed.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL626914,,,,,10246,1,Bioavailability,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5041,10116.0,N,,CHEMBL626915,,,,,10247,1,Bioavailability was determined; ND denotes no data,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1500,10116.0,N,,CHEMBL626916,,,,,10248,1,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1500,10116.0,N,,CHEMBL626917,,,,,10249,1,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17409,10116.0,N,,CHEMBL626918,,,,,10250,1,Binding towards rat plasma protein at 10 uM,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17409,10116.0,N,,CHEMBL626919,,,,,10251,1,Binding towards rat plasma protein at 100 uM,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2959,10116.0,N,,CHEMBL626920,,,,,10252,1,Bioavailability in rat (dose 20 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13501,10116.0,N,,CHEMBL621976,,,,,10253,1,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6567,10116.0,N,,CHEMBL877599,,,,,10254,1,Bioavailability in rat after 5 mg/kg oral gavage,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6571,10116.0,N,,CHEMBL621977,,,,,10255,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6715,10116.0,N,,CHEMBL621978,,,,,10256,1,Bioavailability in rat (dose 1 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6715,10116.0,N,,CHEMBL621979,,,,,10257,1,Bioavailability in rat (dose 3 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2932,10116.0,N,,CHEMBL621980,,,,,10258,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4171,10116.0,N,,CHEMBL621981,,,,,10259,1,Bioavailability of the compound in rats after administration of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL621982,,,,,10260,1,Bioavailability after administration of 10 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17509,10116.0,N,,CHEMBL882953,,,,,10261,1,Bioavailability after administration of 2 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4527,10116.0,N,,CHEMBL621983,,,,,10262,1,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4026,10116.0,N,,CHEMBL621984,,,,,10263,1,Bioavailability in dogs was determined; high,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6659,10116.0,N,,CHEMBL621985,,,,,10264,1,Bioavailability in monkey after intravenous administration at 1 mpk,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6659,10116.0,N,,CHEMBL621986,,,,,10265,1,Bioavailability in monkey after peroral administration at 10 mpk,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6659,10116.0,N,,CHEMBL621987,,,,,10266,1,Bioavailability in rat after intravenous administration at 1 mpk,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6659,10116.0,N,,CHEMBL877600,,,,,10267,1,Bioavailability in rat after intravenous administration at 2 mpk,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,F
6659,10116.0,N,,CHEMBL621988,,,,,10268,1,Bioavailability in rat after peroral administration at 30 mpk,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6659,10116.0,N,,CHEMBL621989,,,,,10269,1,Bioavailability in rat after peroral administration at at 100 mpk,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,F
6597,10116.0,N,,CHEMBL621990,,,,,10270,1,Bioavailability in rats was evaluated,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1202,10116.0,N,,CHEMBL621991,,,,,10271,1,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1202,10116.0,N,,CHEMBL621992,,,,,10272,1,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1202,10116.0,N,,CHEMBL621993,,,,,10273,1,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1202,10116.0,N,,CHEMBL621994,,,,,10274,1,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5207,10116.0,N,,CHEMBL621995,,,,,10275,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5970,10116.0,N,,CHEMBL621996,,,,,10276,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17538,10116.0,N,,CHEMBL621997,,,,,10277,1,Oral bioavailability in rat (dose 10 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17538,10116.0,N,,CHEMBL621998,,,,,10278,1,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1466,10116.0,N,,CHEMBL621999,,,,,10279,1,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2879,10116.0,N,,CHEMBL622000,,,,,10280,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2879,10116.0,N,,CHEMBL622001,,,,,10281,1,Bioavailability was measured in rat after oral administration; 2-4,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2879,10116.0,N,,CHEMBL622002,,,,,10282,1,Bioavailability was measured in rat after oral administration; 3-7,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3777,10116.0,N,,CHEMBL622003,,,,,10283,1,Bioavailability in rat (intraduodenal administration),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3777,10116.0,N,,CHEMBL877601,,,,,10284,1,Bioavailability in rat (intraduodenal administration),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3777,10116.0,N,,CHEMBL624871,,,,,10285,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3777,10116.0,N,,CHEMBL622004,,,,,10286,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5423,10116.0,N,,CHEMBL882954,,,,,10287,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL622005,,,,,10288,1,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16365,10116.0,N,,CHEMBL622006,,,,,10289,1,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4239,10116.0,N,,CHEMBL622007,,,,,10290,1,Bioavailability was measured in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5438,10116.0,N,,CHEMBL622008,,,,,10291,1,Bioavailability was reported,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL622009,,,,,10292,1,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL622010,,,,,10293,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4199,10116.0,N,,CHEMBL622011,,,,,10294,1,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4199,10116.0,N,,CHEMBL622012,,,,,10295,1,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4199,10116.0,N,,CHEMBL622013,,,,,10296,1,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4890,10116.0,N,,CHEMBL622014,,,,,10297,1,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2792,10116.0,N,,CHEMBL624749,,,,,10298,1,Bioavailability was determined at 3 mg/kg po dose in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5529,10116.0,N,,CHEMBL624750,,,,,10299,1,Oral bioavailability in rat (dose 2 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL624751,,,,,10300,1,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL624752,,,,,10301,1,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6685,10116.0,N,,CHEMBL624753,,,,,10302,1,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6005,10116.0,N,,CHEMBL624754,,,,,10303,1,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6410,10116.0,N,,CHEMBL624755,,,,,10304,1,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6410,10116.0,N,,CHEMBL624756,,,,,10305,1,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6103,10116.0,N,,CHEMBL624757,,,,,10306,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6410,10116.0,N,,CHEMBL624758,,,,,10307,1,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6410,10116.0,N,,CHEMBL622270,,,,,10308,1,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5353,10116.0,N,,CHEMBL622271,,,,,10309,1,Bioavailability in rat (Sprague-Dawley),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4727,10116.0,N,,CHEMBL622272,,,,,10310,1,Bioavailability in rat at the dose of 2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17804,10116.0,N,,CHEMBL622273,,,,,10311,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5809,10116.0,N,,CHEMBL622274,,,,,10312,1,Bioavailability in rat (cannulated) (dose 2 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17804,10116.0,N,,CHEMBL622275,,,,,10313,1,Bioavailability value of compound in rats was determined after peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3634,10116.0,N,,CHEMBL622276,,,,,10314,1,Oral bioavailability in rat (dose 20 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3341,10116.0,N,,CHEMBL622277,,,,,10315,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2690,10116.0,N,,CHEMBL622278,,,,,10316,1,Oral bioavailability in rat (dose 5 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3184,10116.0,N,,CHEMBL622279,,,,,10317,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
740,10116.0,N,,CHEMBL622280,,,,,10318,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1806,10116.0,N,,CHEMBL624083,,,,,10319,1,Compound was evaluated for oral bioavailability in rats; 15-27 %,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4891,10116.0,N,,CHEMBL624084,,,,,10320,1,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3634,10116.0,N,,CHEMBL624085,,,,,10321,1,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
64,10116.0,N,,CHEMBL624086,,,,,10322,1,Compound was tested for bioavailability in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4839,10116.0,N,,CHEMBL624087,,,,,10323,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1094,10116.0,N,,CHEMBL624088,,,,,10324,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5005,9544.0,U,,CHEMBL624089,,,,,10325,0,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,Intermediate,22224,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
5005,10116.0,U,,CHEMBL624090,,,,,10326,0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,Intermediate,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4687,10116.0,N,,CHEMBL624091,,,,,10327,1,Evaluated for the bioavailability in rat (in vivo),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17804,10116.0,N,,CHEMBL624092,,,,,10328,1,F value of compound in rats was determined after peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL624093,,,,,10329,1,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL624094,,,,,10330,1,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL624095,,,,,10331,1,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5974,10116.0,N,,CHEMBL624096,,,,,10332,1,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1088,10116.0,N,,CHEMBL624097,,,,,10333,1,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1742,10116.0,N,,CHEMBL624098,,,,,10334,1,Maximum fall in carotid flow in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4689,10116.0,N,,CHEMBL874392,,,,,10335,1,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2463,10116.0,N,,CHEMBL624099,,,,,10336,1,Oral bioavailability in rat (dose 5 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5654,10116.0,N,,CHEMBL624100,,,,,10337,1,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5654,10116.0,N,,CHEMBL624101,,,,,10338,1,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6874,10116.0,N,,CHEMBL624102,,,,,10339,1,Oral bioavailability in rat (male Wistar),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5633,10116.0,N,,CHEMBL624103,,,,,10340,1,Oral bioavailability after administration (30 mg/kg) in rat; good,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5496,10116.0,N,,CHEMBL624104,,,,,10341,1,Oral bioavailability at the dose of 2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2358,10116.0,N,,CHEMBL624105,,,,,10342,1,Oral bioavailability determined in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16456,10116.0,N,,CHEMBL624106,,,,,10343,1,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5302,10116.0,N,,CHEMBL624107,,,,,10344,1,Oral bioavailability in rat (dose single 10 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5302,10116.0,N,,CHEMBL623943,,,,,10345,1,Oral bioavailability in rat (dose single 10 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5302,10116.0,N,,CHEMBL623944,,,,,10346,1,Oral bioavailability in rat (dose 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623945,,,,,10347,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623946,,,,,10348,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623947,,,,,10349,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623948,,,,,10350,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623949,,,,,10351,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623950,,,,,10352,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL874398,,,,,10353,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623951,,,,,10354,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623952,,,,,10355,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623953,,,,,10356,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623954,,,,,10357,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623955,,,,,10358,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL623956,,,,,10359,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627807,,,,,10360,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627808,,,,,10361,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627809,,,,,10362,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627810,,,,,10363,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627811,,,,,10364,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627812,,,,,10365,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627813,,,,,10366,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627814,,,,,10367,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL875336,,,,,10368,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627815,,,,,10369,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627816,,,,,10370,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627817,,,,,10371,1,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627818,,,,,10372,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627819,,,,,10373,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627820,,,,,10374,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL627821,,,,,10375,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL628464,,,,,10376,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626239,,,,,10377,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626240,,,,,10378,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626241,,,,,10379,1,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626242,,,,,10380,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626243,,,,,10381,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626244,,,,,10382,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626907,,,,,10383,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626908,,,,,10384,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626909,,,,,10385,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL626910,,,,,10386,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7449,10116.0,N,,CHEMBL875342,,,,,10387,1,Percent total excretion of acetaminophen cysteine conjugate,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
7449,10116.0,N,,CHEMBL626911,,,,,10388,1,Percent total excretion of acetaminophen glucuronide,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
7449,10116.0,N,,CHEMBL626912,,,,,10389,1,Percent total excretion of acetaminophen sulfate,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
7449,10116.0,N,,CHEMBL627065,,,,,10390,1,Percent total excretion of acetaminophen-mercapturic acid,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
3172,10116.0,N,1088.0,CHEMBL627066,,,,Urine,10391,1,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16456,10116.0,N,,CHEMBL627067,,,,,10392,1,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10839,8656.0,U,2385.0,CHEMBL627068,,,,Muscle tissue,10393,0,Biodistribution of compound in rat muscle after 5 min of administration,,Autocuration,22224,,BAO_0000218,,In vivo,ratrat,1,,A
10839,8656.0,U,2385.0,CHEMBL627069,,,,Muscle tissue,10394,0,Biodistribution of compound in rat muscle after 5 min of administration.,,Autocuration,22224,,BAO_0000218,,In vivo,ratrat,1,,A
5334,9940.0,U,,CHEMBL627070,,,,,10395,0,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,Autocuration,22224,,BAO_0000218,,In vivo,Ovis aries,1,,A
5334,9940.0,U,,CHEMBL627071,,,,,10396,0,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,Autocuration,22224,,BAO_0000218,,In vivo,Ovis aries,1,,A
5334,9940.0,U,,CHEMBL627072,,,,,10397,0,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,Autocuration,22224,,BAO_0000218,,In vivo,Ovis aries,1,,A
5334,9940.0,U,,CHEMBL627073,,,,,10398,0,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,Autocuration,22224,,BAO_0000218,,In vivo,Ovis aries,1,,A
5334,9940.0,U,,CHEMBL625387,,,,,10399,0,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,Autocuration,22224,,BAO_0000218,,In vivo,Ovis aries,1,,A
5334,9940.0,U,,CHEMBL625388,,,,,10400,0,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,Autocuration,22224,,BAO_0000218,,In vivo,Ovis aries,1,,A
5334,9940.0,U,1969.0,CHEMBL625389,,,,Plasma,10401,0,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,Autocuration,22224,,BAO_0000218,,In vivo,Ovis aries,1,,A
5334,9940.0,U,1969.0,CHEMBL875343,,,,Plasma,10402,0,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,Autocuration,22224,,BAO_0000218,,In vivo,Ovis aries,1,,A
1735,8570.0,N,,CHEMBL876795,,,,,10403,1,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,Intermediate,50497,,BAO_0000218,,,Serpentes,1,,A
1469,8570.0,N,,CHEMBL626552,,,,,10404,1,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,Intermediate,50497,,BAO_0000218,,,Serpentes,1,,A
1336,8570.0,N,,CHEMBL626553,,,,,10405,1,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,Intermediate,50497,,BAO_0000218,,,Serpentes,1,,A
12403,9606.0,U,1969.0,CHEMBL626554,,,,Plasma,10406,0,The human biological plasma half life of the compound,,Autocuration,22224,,BAO_0000366,,,Homo sapiens,1,,A
8151,10116.0,N,1088.0,CHEMBL626555,,,,Urine,10407,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL626556,,,,,10408,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL626557,,,,,10409,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL626558,,,,,10410,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL626559,,,,,10411,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL626560,,,,,10412,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL876803,,,,,10413,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL627964,,,,,10414,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL627965,,,,,10415,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL627966,,,,,10416,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL627967,,,,,10417,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL627968,,,,,10418,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL627969,,,,,10419,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,,CHEMBL627970,,,,,10420,1,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,178.0,CHEMBL627971,,,,Blood,10421,1,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8004,10116.0,N,178.0,CHEMBL627972,,,,Blood,10422,1,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15917,9606.0,D,,CHEMBL856029,,,,,10423,9,Dissociation constant against binding to human cyclophilin A,,Expert,180,,BAO_0000357,,,Homo sapiens,1,,B
12396,9913.0,H,,CHEMBL627973,,,,,10424,8,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,Expert,11591,,BAO_0000019,,,Bos taurus,1,,B
7065,,U,,CHEMBL627974,,,,,10425,0,-Log C was determined by performing the electroshock minimum test,,Autocuration,22224,,BAO_0000019,,,,1,,A
7065,,U,,CHEMBL627975,,,,,10426,0,-Log C was determined by performing the foot shock test,,Autocuration,22224,,BAO_0000019,,,,1,,A
7065,,U,,CHEMBL627976,,,,,10427,0,-Log C was determined by performing the incl screen test,,Autocuration,22224,,BAO_0000019,,,,1,,A
7065,,U,,CHEMBL627977,,,,,10428,0,-Log C was determined by performing the maximum electroshock test,,Autocuration,22224,,BAO_0000019,,,,1,,A
7065,,U,,CHEMBL627978,,,,,10429,0,-Log C was determined by performing the pentylenetetrazole test,,Autocuration,22224,,BAO_0000019,,,,1,,A
12415,,U,,CHEMBL627979,,,,,10430,0,Tested for experimental arotinoid inhibitory dose,,Autocuration,22224,,BAO_0000019,,,,1,,A
10256,,U,,CHEMBL876804,,,,,10431,0,Negative log transformed activity,,Autocuration,22224,,BAO_0000019,,,,1,,A
7991,,U,,CHEMBL627980,,,,,10432,0,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,Autocuration,22224,,BAO_0000019,,,,1,,A
14342,10141.0,N,,CHEMBL627981,,,,,10433,1,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
14342,10141.0,N,,CHEMBL627982,,,,,10434,1,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
14342,10141.0,N,,CHEMBL627983,,,,,10435,1,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
14342,10141.0,N,2116.0,CHEMBL627984,,,,Ileum,10436,1,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
6047,,U,,CHEMBL627985,,,,,10437,0,Solubility in water was determined; values expressed as -log,,Autocuration,22229,,BAO_0000100,,,,1,,P
17269,,U,,CHEMBL627986,,,,,10438,0,Ratio of Kcat to that of Km was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
10026,,U,,CHEMBL627987,,,,,10439,0,Observed first order rate constant,,Autocuration,22224,,BAO_0000019,,,,1,,A
14583,,U,,CHEMBL627988,,,,,10440,0,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,Autocuration,22224,,BAO_0000019,,,,1,,A
2661,10116.0,N,,CHEMBL627989,,,,,10441,1,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2661,10116.0,N,,CHEMBL627990,,,,,10442,1,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4029,10116.0,N,,CHEMBL876805,,,,,10443,1,Oral Bioavailability after administration of 10 mg/kg in male rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17735,10116.0,N,,CHEMBL627991,,,,,10444,1,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4576,10116.0,N,,CHEMBL627992,,,,,10445,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17582,10116.0,N,,CHEMBL627993,,,,,10446,1,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17651,10116.0,N,,CHEMBL622817,,,,,10447,1,Oral bioavailability at 1 mg/kg was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17651,10116.0,N,,CHEMBL622818,,,,,10448,1,Oral bioavailability at 10 mg/kg was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17670,10116.0,N,,CHEMBL622819,,,,,10449,1,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5045,10116.0,N,,CHEMBL872267,,,,,10450,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1696,10116.0,N,,CHEMBL622820,,,,,10451,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17764,10116.0,N,,CHEMBL622821,,,,,10452,1,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6448,10116.0,N,,CHEMBL622822,,,,,10453,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6596,10116.0,N,,CHEMBL622823,,,,,10454,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17547,10116.0,N,,CHEMBL622824,,,,,10455,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17771,10116.0,N,,CHEMBL622825,,,,,10456,1,Oral bioavailability in rat at a dose of 3 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6495,10116.0,N,,CHEMBL622901,,,,,10457,1,Oral bioavailability in rat after oral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4558,10116.0,N,,CHEMBL622902,,,,,10458,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17596,10116.0,N,,CHEMBL621844,,,,,10459,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6827,10116.0,N,,CHEMBL621845,,,,,10460,1,Oral bioavailability in Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4026,10116.0,N,,CHEMBL621846,,,,,10461,1,Oral bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10,10116.0,N,,CHEMBL621847,,,,,10462,1,Oral bioavailability in rat (dose 30 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL877609,,,,,10463,1,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL621848,,,,,10464,1,Bioavailability in rat (dose 3 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL621849,,,,,10465,1,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL622030,,,,,10466,1,Oral bioavailability in rat (dose 60 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4796,10116.0,N,,CHEMBL622031,,,,,10467,1,Percent oral bioavailability determined in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4883,10116.0,N,,CHEMBL622032,,,,,10468,1,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2137,10116.0,N,,CHEMBL622033,,,,,10469,1,The compound was evaluated for bioavailability in rats; 32-51,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2959,10116.0,N,,CHEMBL622034,,,,,10470,1,Bioavailability in rat (dose 20 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1361,10116.0,N,,CHEMBL622035,,,,,10471,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4727,10116.0,N,,CHEMBL882966,,,,,10472,1,Bioavailability percent in rat at the dose of 2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16423,10116.0,N,,CHEMBL622036,,,,,10473,1,Bioavailability was evaluated after 20 uM/kg of peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5206,10116.0,N,,CHEMBL622037,,,,,10474,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6448,10116.0,N,,CHEMBL622038,,,,,10475,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17723,10116.0,N,,CHEMBL622039,,,,,10476,1,Bioavailability in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,178.0,CHEMBL622040,,,,Blood,10477,1,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,178.0,CHEMBL622041,,,,Blood,10478,1,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,178.0,CHEMBL622042,,,,Blood,10479,1,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,178.0,CHEMBL622043,,,,Blood,10480,1,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,178.0,CHEMBL622044,,,,Blood,10481,1,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,10000001.0,CHEMBL622045,,,,Bone,10482,1,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,10000001.0,CHEMBL622046,,,,Bone,10483,1,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,10000001.0,CHEMBL622047,,,,Bone,10484,1,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,10000001.0,CHEMBL877610,,,,Bone,10485,1,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,955.0,CHEMBL622048,,,,Brain,10486,1,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,955.0,CHEMBL622049,,,,Brain,10487,1,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,955.0,CHEMBL622050,,,,Brain,10488,1,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,955.0,CHEMBL622051,,,,Brain,10489,1,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,,CHEMBL622052,,,,,10490,1,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,,CHEMBL622053,,,,,10491,1,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,,CHEMBL622054,,,,,10492,1,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,,CHEMBL622055,,,,,10493,1,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5237,10116.0,N,,CHEMBL622056,,,,,10494,1,Oral bioavailability in rats was determined; High,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5503,10116.0,N,,CHEMBL622057,,,,,10495,1,Oral bioavailability in the rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15765,10116.0,N,,CHEMBL628008,,,,,10496,1,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15660,10116.0,N,,CHEMBL622058,,,,,10497,1,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL622059,,,,,10498,1,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL622060,,,,,10499,1,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL622061,,,,,10500,1,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5978,10116.0,N,,CHEMBL622062,,,,,10501,1,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5656,10116.0,N,,CHEMBL622063,,,,,10502,1,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3598,10116.0,N,,CHEMBL877611,,,,,10503,1,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,Expert,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4216,10116.0,N,,CHEMBL622064,,,,,10504,1,Oral bioavailability of compound in Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17839,10116.0,N,,CHEMBL622065,,,,,10505,1,Oral bioavailability of compound in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6570,10116.0,N,,CHEMBL622066,,,,,10506,1,Oral bioavailability in rat (dose 2 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5334,10116.0,N,,CHEMBL622067,,,,,10507,1,Oral bioavailability of compound in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6886,10116.0,N,,CHEMBL622068,,,,,10508,1,Oral bioavailability of compound in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5210,10116.0,N,,CHEMBL622069,,,,,10509,1,Oral bioavailability of compound was determined in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4170,10116.0,N,,CHEMBL624796,,,,,10510,1,Oral bioavailability at a dose of 30 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6028,10116.0,N,,CHEMBL624797,,,,,10511,1,Oral bioavailability in rat (dose 10 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6028,10116.0,N,,CHEMBL623053,,,,,10512,1,Oral bioavailability in rat (dose 10 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6078,10116.0,N,,CHEMBL623054,,,,,10513,1,Oral bioavailability evaluated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6168,10116.0,N,,CHEMBL623055,,,,,10514,1,Oral bioavailability in fasted rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6168,10116.0,N,,CHEMBL623056,,,,,10515,1,Oral bioavailability in fed rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5160,10116.0,N,,CHEMBL623057,,,,,10516,1,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL623058,,,,,10517,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6535,10116.0,N,,CHEMBL623059,,,,,10518,1,Oral bioavailability in rat (dose 10 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6535,10116.0,N,,CHEMBL623060,,,,,10519,1,Oral bioavailability in rat after administration of 10 mg/kg po,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4194,10116.0,N,,CHEMBL623061,,,,,10520,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6230,10116.0,N,,CHEMBL623062,,,,,10521,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6619,10116.0,N,,CHEMBL623063,,,,,10522,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17607,10116.0,N,,CHEMBL623064,,,,,10523,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4942,10116.0,N,,CHEMBL623065,,,,,10524,1,Oral bioavailability in ratrs,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4942,10116.0,N,,CHEMBL623066,,,,,10525,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6646,10116.0,N,,CHEMBL623067,,,,,10526,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5237,10116.0,N,,CHEMBL623068,,,,,10527,1,Oral bioavailability in rats was determined; High,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6646,10116.0,N,,CHEMBL623069,,,,,10528,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4449,10116.0,N,,CHEMBL623070,,,,,10529,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6057,10116.0,N,,CHEMBL623071,,,,,10530,1,Oral bioavailability was calculated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2552,10116.0,N,,CHEMBL623072,,,,,10531,1,Oral bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5496,10116.0,N,,CHEMBL623073,,,,,10532,1,Oral bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6484,10116.0,N,,CHEMBL623074,,,,,10533,1,Oral bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6485,10116.0,N,,CHEMBL623075,,,,,10534,1,Oral bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6616,10116.0,N,,CHEMBL623076,,,,,10535,1,Oral bioavailability after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4969,10116.0,N,,CHEMBL623077,,,,,10536,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5862,10116.0,N,,CHEMBL623078,,,,,10537,1,Oral bioavailability in rat (Sprague-Dawley),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4514,10116.0,N,,CHEMBL623079,,,,,10538,1,Oral bioavailability in Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4514,10116.0,N,,CHEMBL623080,,,,,10539,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4514,10116.0,N,,CHEMBL623081,,,,,10540,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5546,10116.0,N,,CHEMBL623082,,,,,10541,1,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6168,10116.0,N,,CHEMBL874400,,,,,10542,1,Oral bioavailability in fasted rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6168,10116.0,N,,CHEMBL623083,,,,,10543,1,Oral bioavailability in fed rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3624,10116.0,N,,CHEMBL623084,,,,,10544,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5213,10116.0,N,,CHEMBL623085,,,,,10545,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5496,10116.0,N,,CHEMBL623086,,,,,10546,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5553,10116.0,N,,CHEMBL623087,,,,,10547,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5833,10116.0,N,,CHEMBL623088,,,,,10548,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5836,10116.0,N,,CHEMBL623089,,,,,10549,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5865,10116.0,N,,CHEMBL623090,,,,,10550,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5960,10116.0,N,,CHEMBL623091,,,,,10551,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6249,10116.0,N,,CHEMBL623092,,,,,10552,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6448,10116.0,N,,CHEMBL623093,,,,,10553,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6453,10116.0,N,,CHEMBL874401,,,,,10554,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6640,10116.0,N,,CHEMBL623094,,,,,10555,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17607,10116.0,N,,CHEMBL623095,,,,,10556,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL623096,,,,,10557,1,Oral bioavailability in rat after peroral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5939,10116.0,N,,CHEMBL624913,,,,,10558,1,Oral bioavailability in rat after peroral administration at 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6281,10116.0,N,,CHEMBL624914,,,,,10559,1,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5874,10116.0,N,,CHEMBL624915,,,,,10560,1,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5213,10116.0,N,,CHEMBL624916,,,,,10561,1,Oral bioavailability in rat; Not measured,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4964,10116.0,N,,CHEMBL624917,,,,,10562,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11020,10116.0,N,,CHEMBL625157,,,,,10563,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6251,10116.0,N,2107.0,CHEMBL625158,,,,Liver,10564,1,In vitro metabolic potential in rat liver microsomes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1568,10116.0,N,,CHEMBL625159,,,,,10565,1,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3032,10116.0,N,,CHEMBL625160,,,,,10566,1,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3748,10116.0,N,,CHEMBL625161,,,,,10567,1,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
401,10116.0,N,,CHEMBL625162,,,,,10568,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6512,10116.0,N,,CHEMBL625163,,,,,10569,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17617,10116.0,N,,CHEMBL625164,,,,,10570,1,Oral bioavailability in rats at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6679,10116.0,N,,CHEMBL625165,,,,,10571,1,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6742,10116.0,N,,CHEMBL625166,,,,,10572,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
589,10116.0,N,,CHEMBL625167,,,,,10573,1,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
589,10116.0,N,,CHEMBL625168,,,,,10574,1,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
3185,10116.0,N,,CHEMBL625169,,,,,10575,1,Plasma clearance of the compound,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17596,10116.0,N,,CHEMBL626264,,,,,10576,1,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2713,10116.0,N,,CHEMBL626265,,,,,10577,1,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12500,10116.0,N,1969.0,CHEMBL626266,,,,Plasma,10578,1,The compound was tested for plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12500,10116.0,N,1969.0,CHEMBL626267,,,,Plasma,10579,1,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2713,10116.0,N,,CHEMBL626268,,,,,10580,1,Plasma concentration upon oral administration of 1 mg/Kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1446,10116.0,N,,CHEMBL626269,,,,,10581,1,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6227,10116.0,N,,CHEMBL626270,,,,,10582,1,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4709,10116.0,N,,CHEMBL626271,,,,,10583,1,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL626272,,,,,10584,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL626273,,,,,10585,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL875346,,,,,10586,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5510,10116.0,N,,CHEMBL626274,,,,,10587,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4514,10116.0,N,,CHEMBL626275,,,,,10588,1,Compound was tested for protein binding in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2713,10116.0,N,,CHEMBL624646,,,,,10589,1,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2713,10116.0,N,,CHEMBL624647,,,,,10590,1,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5340,10116.0,N,2107.0,CHEMBL624648,,,,Liver,10591,1,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12058,10116.0,N,,CHEMBL624649,,,,,10592,1,Area under curve ratio was determined (po/iv) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11195,10116.0,N,,CHEMBL624650,,,,,10593,1,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11195,10116.0,N,,CHEMBL624651,,,,,10594,1,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11195,10116.0,N,,CHEMBL624652,,,,,10595,1,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6495,10116.0,N,,CHEMBL624653,,,,,10596,1,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6078,10116.0,N,,CHEMBL624654,,,,,10597,1,Ratio of AUCbrain to AUCplasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5656,10116.0,N,,CHEMBL624655,,,,,10598,1,Ratio of brain to plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL624656,,,,,10599,1,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL624657,,,,,10600,1,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL624658,,,,,10601,1,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,,CHEMBL624659,,,,,10602,1,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,,CHEMBL624660,,,,,10603,1,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10130,10116.0,N,,CHEMBL624661,,,,,10604,1,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5213,10116.0,N,,CHEMBL624662,,,,,10605,1,Steady state brain :blood ratio was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL625199,,,,,10606,1,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL625200,,,,,10607,1,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL625201,,,,,10608,1,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4910,10116.0,N,,CHEMBL625202,,,,,10609,1,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2083,10116.0,N,,CHEMBL625203,,,,,10610,1,Percentage recovery after 3h incubation with rat hapatocytes was determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2082,10116.0,N,,CHEMBL625204,,,,,10611,1,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
2082,10116.0,N,,CHEMBL625205,,,,,10612,1,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6351,10116.0,N,,CHEMBL625206,,,,,10613,1,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14583,,U,,CHEMBL625207,,,,,10614,0,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,Autocuration,22224,,BAO_0000019,,,,1,,A
14583,,U,,CHEMBL625208,,,,,10615,0,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,Autocuration,22224,,BAO_0000019,,,,1,,A
4608,9606.0,N,,CHEMBL625209,Caco-2,,,,10616,1,In vivo absorption in Caco-2 cell line monolayers was determined,,Intermediate,50587,495.0,BAO_0000218,,,Homo sapiens,1,,A
13668,,U,,CHEMBL625210,,,,,10617,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
5669,10116.0,N,,CHEMBL625211,,,,,10618,1,Area under curve was determine after peroral administration at 10 mpk in Rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5669,9544.0,N,,CHEMBL625212,,,,,10619,1,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,Intermediate,50797,,BAO_0000218,,,Macaca mulatta,1,,A
5669,10116.0,N,,CHEMBL625213,,,,,10620,1,Area under curve was determine after peroral administration at 160 mpk in Rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5669,10116.0,N,,CHEMBL625214,,,,,10621,1,Area under curve was determine after peroral administration at 20 mpk in Rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5669,10116.0,N,,CHEMBL874542,,,,,10622,1,Area under curve was determine after peroral administration at 50 mpk in Rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6472,,U,,CHEMBL625215,,,,,10623,0,Calculated partition coefficient (clogP) (AlogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
15106,,U,,CHEMBL625216,,,,,10624,0,Activated partial thromboplastin time measured,,Autocuration,22224,,BAO_0000019,,,,1,,A
15207,,U,,CHEMBL625217,,,,,10625,0,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,Autocuration,22224,,BAO_0000100,,,,1,,P
15207,,U,,CHEMBL625218,,,,,10626,0,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,Autocuration,22224,,BAO_0000100,,,,1,,P
13941,9615.0,N,1969.0,CHEMBL622864,,,,Plasma,10627,1,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
13941,10116.0,N,1969.0,CHEMBL622865,,,,Plasma,10628,1,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13941,10116.0,N,1969.0,CHEMBL622866,,,,Plasma,10629,1,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13941,9615.0,N,1969.0,CHEMBL622867,,,,Plasma,10630,1,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15240,10141.0,N,1969.0,CHEMBL876808,,,,Plasma,10631,1,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
10655,,U,955.0,CHEMBL627725,,,,Brain,10632,0,AUC in brain,,Autocuration,22224,,BAO_0000019,,,,1,,A
10655,,U,1977.0,CHEMBL627726,,,,Serum,10633,0,AUC in serum,,Autocuration,22224,,BAO_0000019,,,,1,,A
6504,,U,1969.0,CHEMBL627727,,,,Plasma,10634,0,AUC was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
10615,,U,1969.0,CHEMBL627728,,,,Plasma,10635,0,AUC of the compound.,,Autocuration,22224,,BAO_0000019,,,,1,,A
10353,,U,1969.0,CHEMBL627729,,,,Plasma,10636,0,AUC value (0-4 hr),,Autocuration,22224,,BAO_0000019,,,,1,,A
14907,,U,1969.0,CHEMBL627730,,,,Plasma,10637,0,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,Autocuration,22224,,BAO_0000019,,,,1,,A
14907,,U,1969.0,CHEMBL627731,,,,Plasma,10638,0,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
14907,,U,1969.0,CHEMBL627732,,,,Plasma,10639,0,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,Autocuration,22224,,BAO_0000019,,,,1,,A
14907,,U,1969.0,CHEMBL627733,,,,Plasma,10640,0,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,Autocuration,22224,,BAO_0000019,,,,1,,A
16359,10116.0,N,1969.0,CHEMBL627734,,,,Plasma,10641,1,AUC(area under curve) was determined after intravenous administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16359,10116.0,N,1969.0,CHEMBL627735,,,,Plasma,10642,1,AUC(area under curve) was determined after oral administration in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15240,10141.0,N,1969.0,CHEMBL627736,,,,Plasma,10643,1,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
15240,10116.0,N,1969.0,CHEMBL876809,,,,Plasma,10644,1,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15469,,U,,CHEMBL627737,,,,,10645,0,Area Under Curve after oral dosing of 100 uM/Kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
15469,,U,,CHEMBL627738,,,,,10646,0,Area Under Curve after oral dosing of 30 uM/Kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
13520,,U,,CHEMBL627739,,,,,10647,0,Area Under Curve was measured by ploting the graph between concentration verses time,,Autocuration,22224,,BAO_0000019,,,,1,,A
17025,9615.0,N,,CHEMBL626143,,,,,10648,1,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
17025,314293.0,U,,CHEMBL626144,,,,,10649,0,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
17025,9986.0,N,,CHEMBL626145,,,,,10650,1,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
17025,10116.0,N,,CHEMBL626146,,,,,10651,1,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12032,10116.0,N,178.0,CHEMBL626147,,,,Blood,10652,1,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10291,,U,,CHEMBL626148,,,,,10653,0,Area under curve (AUC) was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
5767,,U,,CHEMBL626149,,,,,10654,0,Area under curve (AUC) following ip administration at 1 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
1434,,U,,CHEMBL626150,,,,,10655,0,Area under curve (AUC) was determined; ND is Not determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
14925,9615.0,N,,CHEMBL626151,,,,,10656,1,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14925,9615.0,N,,CHEMBL626152,,,,,10657,1,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14925,9615.0,N,,CHEMBL626153,,,,,10658,1,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
1434,,U,,CHEMBL626154,,,,,10659,0,Area under curve (AUR) was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
11883,,U,,CHEMBL626155,,,,,10660,0,Area under curve at 1 uM/dg administered intravenously,,Autocuration,22224,,BAO_0000019,,,,1,,A
11883,,U,,CHEMBL626156,,,,,10661,0,Area under curve at 10 uM/dg administered perorally,,Autocuration,22224,,BAO_0000019,,,,1,,A
11883,,U,,CHEMBL626157,,,,,10662,0,Area under curve at 2 uM/dg administered intravenously,,Autocuration,22224,,BAO_0000019,,,,1,,A
11883,,U,,CHEMBL626158,,,,,10663,0,Area under curve at 20 uM/dg administered perorally,,Autocuration,22224,,BAO_0000019,,,,1,,A
15233,9615.0,N,,CHEMBL626159,,,,,10664,1,Area under curve at a peroral dose of 3 mg/kg in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15233,10116.0,N,,CHEMBL626160,,,,,10665,1,Area under curve at a peroral dose of 3 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15233,9615.0,N,,CHEMBL626161,,,,,10666,1,Area under curve at an iv dose of 1 mg/kg in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15233,10116.0,N,,CHEMBL626162,,,,,10667,1,Area under curve at an iv dose of 1 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12978,,U,,CHEMBL626163,,,,,10668,0,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,Autocuration,22224,,BAO_0000019,,,,1,,A
12978,,U,,CHEMBL626164,,,,,10669,0,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,Autocuration,22224,,BAO_0000019,,,,1,,A
11355,10090.0,N,,CHEMBL626165,,,,,10670,1,Area under curve measured as conc vs time after intravenous administration to mice.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
11355,10090.0,N,,CHEMBL626166,,,,,10671,1,Area under curve measured as conc vs time after peroral administration to mice.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12923,9615.0,N,,CHEMBL626167,,,,,10672,1,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12923,9615.0,N,,CHEMBL626168,,,,,10673,1,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12923,9615.0,N,,CHEMBL877463,,,,,10674,1,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12923,9615.0,N,,CHEMBL626169,,,,,10675,1,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
17738,10116.0,N,948.0,CHEMBL626170,,,,Heart,10676,1,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,948.0,CHEMBL626171,,,,Heart,10677,1,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,948.0,CHEMBL626172,,,,Heart,10678,1,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,948.0,CHEMBL626173,,,,Heart,10679,1,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2113.0,CHEMBL626174,,,,Kidney,10680,1,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2113.0,CHEMBL626175,,,,Kidney,10681,1,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2113.0,CHEMBL626176,,,,Kidney,10682,1,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2113.0,CHEMBL626177,,,,Kidney,10683,1,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2113.0,CHEMBL622499,,,,Kidney,10684,1,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2107.0,CHEMBL622500,,,,Liver,10685,1,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2107.0,CHEMBL622501,,,,Liver,10686,1,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2107.0,CHEMBL622502,,,,Liver,10687,1,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2107.0,CHEMBL622503,,,,Liver,10688,1,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2107.0,CHEMBL877614,,,,Liver,10689,1,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2048.0,CHEMBL624839,,,,Lung,10690,1,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2048.0,CHEMBL624840,,,,Lung,10691,1,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2048.0,CHEMBL624841,,,,Lung,10692,1,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2048.0,CHEMBL624842,,,,Lung,10693,1,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2385.0,CHEMBL624843,,,,Muscle tissue,10694,1,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2385.0,CHEMBL624844,,,,Muscle tissue,10695,1,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2385.0,CHEMBL624845,,,,Muscle tissue,10696,1,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17738,10116.0,N,2385.0,CHEMBL621904,,,,Muscle tissue,10697,1,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,178.0,CHEMBL621905,,,,Blood,10698,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,178.0,CHEMBL874382,,,,Blood,10699,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,178.0,CHEMBL621906,,,,Blood,10700,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,955.0,CHEMBL621907,,,,Brain,10701,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,955.0,CHEMBL622096,,,,Brain,10702,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,955.0,CHEMBL622097,,,,Brain,10703,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,948.0,CHEMBL622098,,,,Heart,10704,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,948.0,CHEMBL622099,,,,Heart,10705,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,948.0,CHEMBL622100,,,,Heart,10706,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2113.0,CHEMBL622101,,,,Kidney,10707,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2113.0,CHEMBL622102,,,,Kidney,10708,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2113.0,CHEMBL622103,,,,Kidney,10709,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2107.0,CHEMBL622104,,,,Liver,10710,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2107.0,CHEMBL622105,,,,Liver,10711,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2107.0,CHEMBL622106,,,,Liver,10712,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2048.0,CHEMBL622107,,,,Lung,10713,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2048.0,CHEMBL622108,,,,Lung,10714,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2048.0,CHEMBL622109,,,,Lung,10715,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2385.0,CHEMBL622110,,,,Muscle tissue,10716,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2385.0,CHEMBL622111,,,,Muscle tissue,10717,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2385.0,CHEMBL874383,,,,Muscle tissue,10718,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,14.0,CHEMBL622112,,,,Zone of skin,10719,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,14.0,CHEMBL622113,,,,Zone of skin,10720,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,14.0,CHEMBL622114,,,,Zone of skin,10721,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2106.0,CHEMBL622115,,,,Spleen,10722,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11195,10116.0,N,2106.0,CHEMBL622116,,,,Spleen,10723,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6193,10116.0,N,,CHEMBL622117,,,,,10724,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6803,10116.0,N,,CHEMBL622118,,,,,10725,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6647,10116.0,N,,CHEMBL622119,,,,,10726,1,Oral bioavailability in rats at 6 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6647,10116.0,N,,CHEMBL622120,,,,,10727,1,Oral bioavailability in rat (dose 6 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6647,10116.0,N,,CHEMBL622121,,,,,10728,1,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6640,10116.0,N,,CHEMBL622122,,,,,10729,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL622123,,,,,10730,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6641,10116.0,N,,CHEMBL622124,,,,,10731,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6642,10116.0,N,,CHEMBL622125,,,,,10732,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5472,10116.0,N,,CHEMBL622126,,,,,10733,1,Oral bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6141,10116.0,N,,CHEMBL620455,,,,,10734,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4390,10116.0,N,,CHEMBL620456,,,,,10735,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5472,10116.0,N,,CHEMBL620457,,,,,10736,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5472,10116.0,N,,CHEMBL620458,,,,,10737,1,Oral bioavailability was evaluated; Not tested,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5438,10116.0,N,,CHEMBL620459,,,,,10738,1,Oral bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4883,10116.0,N,,CHEMBL620460,,,,,10739,1,Oral bioavailability in rat by oral dosing,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1908,10116.0,N,,CHEMBL620461,,,,,10740,1,Oral bioavailability in rat (dose 10 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4853,10116.0,N,,CHEMBL620462,,,,,10741,1,Oral bioavailability in rat (Sprague-Dawley),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4853,10116.0,N,,CHEMBL620463,,,,,10742,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4853,10116.0,N,,CHEMBL620464,,,,,10743,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4853,10116.0,N,,CHEMBL620465,,,,,10744,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4853,10116.0,N,,CHEMBL620466,,,,,10745,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4853,10116.0,N,,CHEMBL620467,,,,,10746,1,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4853,10116.0,N,,CHEMBL620468,,,,,10747,1,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12873,10116.0,N,,CHEMBL620469,,,,,10748,1,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12873,10116.0,N,,CHEMBL620470,,,,,10749,1,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3169,10116.0,N,,CHEMBL620471,,,,,10750,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6305,10116.0,N,,CHEMBL620472,,,,,10751,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4762,10116.0,N,,CHEMBL620473,,,,,10752,1,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17847,10116.0,N,,CHEMBL620474,,,,,10753,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6211,10116.0,N,,CHEMBL620475,,,,,10754,1,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6011,10116.0,N,,CHEMBL620476,,,,,10755,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6317,10116.0,N,,CHEMBL620477,,,,,10756,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6644,10116.0,N,,CHEMBL620478,,,,,10757,1,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6644,10116.0,N,,CHEMBL618768,,,,,10758,1,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6644,10116.0,N,,CHEMBL618769,,,,,10759,1,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6644,10116.0,N,,CHEMBL618770,,,,,10760,1,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6113,10116.0,N,,CHEMBL618771,,,,,10761,1,Oral bioavailability (dose 20 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5937,10116.0,N,,CHEMBL618772,,,,,10762,1,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5711,10116.0,N,,CHEMBL618773,,,,,10763,1,Oral bioavailability in rat at 10 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL875842,,,,,10764,1,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL618774,,,,,10765,1,Bioavailability in rat (dose 3 mg/kg i.v.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL618775,,,,,10766,1,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17717,10116.0,N,,CHEMBL618776,,,,,10767,1,Oral bioavailability in rat (dose 60 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4722,10116.0,N,,CHEMBL618777,,,,,10768,1,Percent bioavailability (F) in rats after iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4722,10116.0,N,,CHEMBL618778,,,,,10769,1,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4353,10116.0,N,,CHEMBL618779,,,,,10770,1,Bioavailability in rat (dose 5 uM/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15662,10116.0,N,,CHEMBL618780,,,,,10771,1,Oral bioavailability,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4756,10116.0,N,,CHEMBL618781,,,,,10772,1,Bioavailability in rat (dose 2 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4756,10116.0,N,,CHEMBL618782,,,,,10773,1,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3436,10116.0,N,,CHEMBL618783,,,,,10774,1,Oral bioavailability in rat (dose 20 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17800,10116.0,N,,CHEMBL618784,,,,,10775,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15762,10116.0,N,,CHEMBL618785,,,,,10776,1,Percent oral bioavailability evaluated in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5089,10116.0,N,,CHEMBL618786,,,,,10777,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5089,10116.0,N,,CHEMBL618787,,,,,10778,1,Percent oral bioavailability in rat; Not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3185,10116.0,N,,CHEMBL618788,,,,,10779,1,Oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5145,10116.0,N,,CHEMBL618789,,,,,10780,1,Bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3457,10116.0,N,,CHEMBL618790,,,,,10781,1,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3457,10116.0,N,,CHEMBL618791,,,,,10782,1,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5983,10116.0,N,,CHEMBL875843,,,,,10783,1,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5739,10116.0,N,,CHEMBL618792,,,,,10784,1,Oral bioavailability in rat (dose 20 mg/kg p.o.),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3579,10116.0,N,,CHEMBL623395,,,,,10785,1,Cmax at a dose of 30 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17788,314293.0,U,,CHEMBL623396,,,,,10786,0,Cmax in monkeys at a dose of 1 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
14956,10116.0,N,,CHEMBL623397,,,,,10787,1,Cmax in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17788,10116.0,N,,CHEMBL623398,,,,,10788,1,Cmax in rats at a dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9750,10090.0,N,,CHEMBL623399,,,,,10789,1,Cmax was measured in mice after an oral dose of 50 mg/kg.,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
12767,,U,,CHEMBL623400,,,,,10790,0,"Cmax value at a dose of 12.7 uM/kg, po",,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12767,,U,,CHEMBL623401,,,,,10791,0,"Cmax value at a dose of 6.3 uM/kg, iv",,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12767,,U,,CHEMBL623402,,,,,10792,0,"Cmax value at a dose of 7.1 uM/kg, iv",,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12703,,U,,CHEMBL623403,,,,,10793,0,Cmax value of compound was determined after 1 hr,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15778,,U,,CHEMBL623404,,,,,10794,0,Cmax value of the compound,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12818,10116.0,N,,CHEMBL625997,,,,,10795,1,Cmax value administered intraintestinal in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14964,10116.0,N,,CHEMBL625998,,,,,10796,1,Cmax value administered perorally was determined in rat; Not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15808,,U,,CHEMBL625999,,,,,10797,0,Cmax value at the dose of 2.3 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15808,,U,,CHEMBL626000,,,,,10798,0,Cmax value at the dose of 5 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15778,,U,,CHEMBL626001,,,,,10799,0,Cmax value in the period of 8 hr after dosing. ,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
3715,,U,,CHEMBL626002,,,,,10800,0,Cmax value at a oral dose of 20 mg/kg; Not tested,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
3715,,U,,CHEMBL626003,,,,,10801,0,Cmax value at a oral dose of 20 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
1446,10116.0,N,,CHEMBL626004,,,,,10802,1,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15240,10141.0,N,,CHEMBL626005,,,,,10803,1,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,Intermediate,50512,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
15240,10116.0,N,,CHEMBL626006,,,,,10804,1,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14810,10116.0,N,1969.0,CHEMBL626007,,,,Plasma,10805,1,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14239,10090.0,N,1969.0,CHEMBL626008,,,,Plasma,10806,1,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
12555,9615.0,N,2107.0,CHEMBL626009,,,,Liver,10807,1,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
10754,9615.0,N,,CHEMBL626010,,,,,10808,1,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
10754,10090.0,N,178.0,CHEMBL626011,,,,Blood,10809,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
10754,10090.0,N,178.0,CHEMBL626012,,,,Blood,10810,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
10754,10090.0,N,178.0,CHEMBL626013,,,,Blood,10811,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
10754,10090.0,N,178.0,CHEMBL626014,,,,Blood,10812,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
10754,10090.0,N,178.0,CHEMBL877496,,,,Blood,10813,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14600,9615.0,N,,CHEMBL626015,,,,,10814,1,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,F
14600,9615.0,N,,CHEMBL626016,,,,,10815,1,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,F
14600,9615.0,N,,CHEMBL626017,,,,,10816,1,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,F
13543,9615.0,N,1969.0,CHEMBL626018,,,,Plasma,10817,1,Bioavailability as maximal plasma concentration in dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13543,9615.0,N,1969.0,CHEMBL626692,,,,Plasma,10818,1,Bioavailability as maximal plasma concentration in dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13543,10116.0,N,1969.0,CHEMBL626693,,,,Plasma,10819,1,Bioavailability as maximal plasma concentration in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13543,10116.0,U,1969.0,CHEMBL626694,,,,Plasma,10820,0,Bioavailability as maximal plasma concentration in rats,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14600,9615.0,N,178.0,CHEMBL626695,,,,Blood,10821,1,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14600,9615.0,N,178.0,CHEMBL626696,,,,Blood,10822,1,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14600,9615.0,N,178.0,CHEMBL626697,,,,Blood,10823,1,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14600,9615.0,N,178.0,CHEMBL626859,,,,Blood,10824,1,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14600,9615.0,N,178.0,CHEMBL626860,,,,Blood,10825,1,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14600,9615.0,N,178.0,CHEMBL626861,,,,Blood,10826,1,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14681,10116.0,N,,CHEMBL626296,,,,,10827,1,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15905,,U,,CHEMBL626297,,,,,10828,0,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15905,,U,1969.0,CHEMBL626298,,,,Plasma,10829,0,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13304,10116.0,N,1969.0,CHEMBL626299,,,,Plasma,10830,1,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15137,10116.0,N,1969.0,CHEMBL626300,,,,Plasma,10831,1,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15137,10116.0,N,1969.0,CHEMBL626301,,,,Plasma,10832,1,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15137,10116.0,N,1969.0,CHEMBL626962,,,,Plasma,10833,1,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15137,10116.0,N,1969.0,CHEMBL626963,,,,Plasma,10834,1,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15137,10116.0,N,1969.0,CHEMBL626964,,,,Plasma,10835,1,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14839,9541.0,N,1969.0,CHEMBL626965,,,,Plasma,10836,1,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14839,10090.0,N,1969.0,CHEMBL626966,,,,Plasma,10837,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14839,10090.0,N,1969.0,CHEMBL626967,,,,Plasma,10838,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14839,9541.0,N,1969.0,CHEMBL626968,,,,Plasma,10839,1,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
8418,10116.0,N,948.0,CHEMBL626969,,,,Heart,10840,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL627126,,,,Heart,10841,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631276,,,,Heart,10842,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631277,,,,Heart,10843,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631278,,,,Heart,10844,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL874457,,,,Heart,10845,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631279,,,,Heart,10846,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631280,,,,Heart,10847,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631281,,,,Heart,10848,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631968,,,,Heart,10849,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631969,,,,Heart,10850,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631970,,,,Heart,10851,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631971,,,,Heart,10852,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL631972,,,,Heart,10853,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL630435,,,,Heart,10854,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL630436,,,,Heart,10855,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL630437,,,,Heart,10856,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL630438,,,,Heart,10857,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,948.0,CHEMBL630439,,,,Heart,10858,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL630440,,,,Kidney,10859,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL630441,,,,Kidney,10860,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL630442,,,,Kidney,10861,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL625234,,,,Kidney,10862,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL625235,,,,Kidney,10863,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL625236,,,,Kidney,10864,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL625237,,,,Kidney,10865,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626125,,,,Kidney,10866,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626126,,,,Kidney,10867,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626127,,,,Kidney,10868,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626128,,,,Kidney,10869,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626129,,,,Kidney,10870,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626130,,,,Kidney,10871,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626131,,,,Kidney,10872,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626132,,,,Kidney,10873,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626752,,,,Kidney,10874,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626753,,,,Kidney,10875,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626754,,,,Kidney,10876,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2113.0,CHEMBL626755,,,,Kidney,10877,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL626756,,,,Liver,10878,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL626757,,,,Liver,10879,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL626758,,,,Liver,10880,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL626759,,,,Liver,10881,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL626760,,,,Liver,10882,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,9615.0,N,,CHEMBL626394,,,,,10883,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL626395,,,,,10884,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL626396,,,,,10885,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL626397,,,,,10886,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL626398,,,,,10887,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL626399,,,,,10888,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,10116.0,N,,CHEMBL874653,,,,,10889,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL626400,,,,,10890,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL626401,,,,,10891,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL626402,,,,,10892,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL626403,,,,,10893,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL626404,,,,,10894,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL626405,,,,,10895,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625529,,,,,10896,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625530,,,,,10897,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625531,,,,,10898,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625532,,,,,10899,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625533,,,,,10900,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL875474,,,,,10901,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625534,,,,,10902,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625535,,,,,10903,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625536,,,,,10904,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625537,,,,,10905,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625538,,,,,10906,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625539,,,,,10907,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625540,,,,,10908,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625541,,,,,10909,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625542,,,,,10910,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625543,,,,,10911,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625544,,,,,10912,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,9615.0,N,,CHEMBL625545,,,,,10913,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625546,,,,,10914,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625547,,,,,10915,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625548,,,,,10916,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625549,,,,,10917,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625550,,,,,10918,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625551,,,,,10919,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL875475,,,,,10920,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625552,,,,,10921,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625553,,,,,10922,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625554,,,,,10923,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625555,,,,,10924,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL625556,,,,,10925,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624986,,,,,10926,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624987,,,,,10927,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624988,,,,,10928,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624989,,,,Artery,10929,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624990,,,,Artery,10930,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL874391,,,,Artery,10931,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624991,,,,Artery,10932,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624992,,,,Artery,10933,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624993,,,,Artery,10934,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624994,,,,Artery,10935,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624995,,,,Artery,10936,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624996,,,,Artery,10937,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624997,,,,Artery,10938,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624998,,,,Artery,10939,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL624999,,,,Artery,10940,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL882955,,,,Artery,10941,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL625000,,,,Artery,10942,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL625001,,,,Artery,10943,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL625089,,,,Artery,10944,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL625090,,,,Artery,10945,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL625091,,,,Artery,10946,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL625092,,,,Artery,10947,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL625093,,,,Artery,10948,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL625094,,,,Artery,10949,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,1637.0,CHEMBL625095,,,,Artery,10950,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
2249,9615.0,N,,CHEMBL625096,,,,,10951,1,Compound was evaluated for its bioavailability in the dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
2249,10116.0,N,,CHEMBL625097,,,,,10952,1,Compound was evaluated for its bioavailability in the rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17515,,U,,CHEMBL882956,,,,,10953,0,Compound was evaluated for oral bioavailability,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14541,10116.0,N,,CHEMBL625098,,,,,10954,1,Compound was evaluated for percentage of Oral bioavailability in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12797,10141.0,U,,CHEMBL625099,,,,,10955,0,Bioavailability in guinea pig,,Autocuration,22224,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
12797,10116.0,N,,CHEMBL625100,,,,,10956,1,Compound was evaluated for the oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12797,9615.0,N,,CHEMBL625101,,,,,10957,1,Compound was evaluated for the oral bioavailability in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12797,10116.0,N,,CHEMBL874396,,,,,10958,1,Compound was evaluated for the oral bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11727,9615.0,U,,CHEMBL625102,,,,,10959,0,Bioavailability in dog (dosed i.v.),,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,F
13249,9615.0,N,,CHEMBL625103,,,,,10960,1,Compound was tested for in vivo bioavailability in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13249,10026.0,N,,CHEMBL625104,,,,,10961,1,Compound was tested for in vivo bioavailability in hamsters,,Intermediate,100712,,BAO_0000218,,In vivo,Cricetinae,1,,A
13249,314293.0,U,,CHEMBL625105,,,,,10962,0,Compound was tested for in vivo bioavailability in monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
13249,10116.0,N,,CHEMBL625106,,,,,10963,1,Compound was tested for in vivo bioavailability in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9552,10090.0,U,,CHEMBL625107,,,,,10964,0,Oral bioavailability in mouse,,Autocuration,22224,,BAO_0000218,,In vivo,Mus musculus,1,,A
9552,10090.0,N,,CHEMBL625108,,,,,10965,1,Compound was tested for percent of oral bioavailability in mice; 56-74,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14839,10090.0,U,,CHEMBL625109,,,,,10966,0,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,Autocuration,22224,,BAO_0000218,,In vivo,Mus musculus,1,,A
14839,9541.0,U,,CHEMBL625110,,,,,10967,0,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,Autocuration,22224,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14839,9541.0,U,,CHEMBL625111,,,,,10968,0,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,Autocuration,22224,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14839,10090.0,N,,CHEMBL625112,,,,,10969,1,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL875334,,,,,10970,1,Oral bioavailability in nude mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
11219,9443.0,U,,CHEMBL628617,,,,,10971,0,Bioavailability in monkey (i.d. dosing),,Autocuration,22224,,BAO_0000218,,In vivo,Primates,1,,A
9552,10116.0,U,,CHEMBL628618,,,,,10972,0,Bioavailability in rat,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11732,,U,,CHEMBL628619,,,,,10973,0,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11732,,U,,CHEMBL628620,,,,,10974,0,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14839,9541.0,N,,CHEMBL628621,,,,,10975,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL628622,,,,,10976,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14839,9541.0,N,,CHEMBL628623,,,,,10977,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14839,9541.0,N,1969.0,CHEMBL628624,,,,Plasma,10978,1,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14839,10090.0,N,1969.0,CHEMBL628625,,,,Plasma,10979,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14839,9541.0,N,1969.0,CHEMBL628626,,,,Plasma,10980,1,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14839,10090.0,N,1969.0,CHEMBL627041,,,,Plasma,10981,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14839,10090.0,N,1969.0,CHEMBL627042,,,,Plasma,10982,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14839,10090.0,N,1969.0,CHEMBL627043,,,,Plasma,10983,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13932,,U,1969.0,CHEMBL627044,,,,Plasma,10984,0,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11637,10090.0,N,1969.0,CHEMBL627045,,,,Plasma,10985,1,Cmax in mouse plasma,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
11637,,U,1969.0,CHEMBL627046,,,,Plasma,10986,0,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13960,10116.0,N,1969.0,CHEMBL627047,,,,Plasma,10987,1,Maximal plasma concentration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15905,10116.0,N,1969.0,CHEMBL627048,,,,Plasma,10988,1,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL627049,,,,,10989,1,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL627050,,,,,10990,1,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL627051,,,,,10991,1,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL627052,,,,,10992,1,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL627053,,,,,10993,1,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL627054,,,,,10994,1,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15011,10090.0,N,,CHEMBL627055,,,,,10995,1,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL627056,,,,,10996,1,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL627057,,,,,10997,1,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL627058,,,,,10998,1,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15011,10090.0,N,,CHEMBL626211,,,,,10999,1,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
10291,,U,,CHEMBL626212,,,,,11000,0,Maximum Concentration of the compound.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14599,9615.0,N,,CHEMBL626213,,,,,11001,1,Maximum Concentration was measured after iv administration into Beagle dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14599,9615.0,N,,CHEMBL626214,,,,,11002,1,Maximum Concentration was measured after iv administration into Beagle dog.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14599,9615.0,N,,CHEMBL626215,,,,,11003,1,Maximum Concentration was measured after po administration into Beagle dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14599,9615.0,N,,CHEMBL626216,,,,,11004,1,Maximum Concentration was measured after po administration into Beagle dog.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12767,,U,178.0,CHEMBL626217,,,,Blood,11005,0,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12767,,U,178.0,CHEMBL626218,,,,Blood,11006,0,Maximum blood level reached after an iv dose of 12.2 uM/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12767,,U,178.0,CHEMBL626219,,,,Blood,11007,0,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12767,,U,178.0,CHEMBL626220,,,,Blood,11008,0,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12767,,U,178.0,CHEMBL626221,,,,Blood,11009,0,Maximum blood level reached after an oral dose of 5.0 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12767,,U,178.0,CHEMBL626222,,,,Blood,11010,0,Maximum blood level reached at dose of 10.6 uM/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14706,10141.0,N,,CHEMBL626223,,,,,11011,1,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,Intermediate,50512,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
14706,10141.0,N,,CHEMBL626224,,,,,11012,1,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,Intermediate,50512,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
14793,10116.0,N,955.0,CHEMBL626225,,,,Brain,11013,1,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,955.0,CHEMBL626226,,,,Brain,11014,1,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,955.0,CHEMBL626227,,,,Brain,11015,1,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,955.0,CHEMBL626228,,,,Brain,11016,1,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL626229,,,,,11017,1,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL626921,,,,,11018,1,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL876793,,,,,11019,1,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,,CHEMBL625309,,,,,11020,1,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10524,1423.0,N,,CHEMBL625310,,,,,11021,1,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,Intermediate,50278,,BAO_0000218,,In vivo,Bacillus subtilis,1,,A
11871,314293.0,U,,CHEMBL625311,,,,,11022,0,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
11871,10116.0,N,,CHEMBL625312,,,,,11023,1,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3437,,U,,CHEMBL625313,,,,,11024,0,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12038,10090.0,N,,CHEMBL625314,,,,,11025,1,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
12038,10116.0,N,,CHEMBL625315,,,,,11026,1,Maximum concentration in male rats after iv administration of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625316,,,,Liver,11027,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625317,,,,Liver,11028,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625318,,,,Liver,11029,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625319,,,,Liver,11030,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625320,,,,Liver,11031,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625321,,,,Liver,11032,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625322,,,,Liver,11033,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL876801,,,,Liver,11034,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625323,,,,Liver,11035,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625324,,,,Liver,11036,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625325,,,,Liver,11037,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625326,,,,Liver,11038,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625327,,,,Liver,11039,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2107.0,CHEMBL625328,,,,Liver,11040,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL625329,,,,Lung,11041,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL625330,,,,Lung,11042,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627774,,,,Lung,11043,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627775,,,,Lung,11044,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627949,,,,Lung,11045,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627950,,,,Lung,11046,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627951,,,,Lung,11047,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627952,,,,Lung,11048,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627953,,,,Lung,11049,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627954,,,,Lung,11050,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627955,,,,Lung,11051,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627956,,,,Lung,11052,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL876802,,,,Lung,11053,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627957,,,,Lung,11054,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627958,,,,Lung,11055,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627959,,,,Lung,11056,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627960,,,,Lung,11057,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627961,,,,Lung,11058,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,2048.0,CHEMBL627962,,,,Lung,11059,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,,CHEMBL627963,,,,,11060,1,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,,CHEMBL624759,,,,,11061,1,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,,CHEMBL624760,,,,,11062,1,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,,CHEMBL624761,,,,,11063,1,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,,CHEMBL877607,,,,,11064,1,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,2107.0,CHEMBL624762,,,,Liver,11065,1,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,2107.0,CHEMBL624763,,,,Liver,11066,1,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,2107.0,CHEMBL624764,,,,Liver,11067,1,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,2107.0,CHEMBL624765,,,,Liver,11068,1,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,2107.0,CHEMBL624766,,,,Liver,11069,1,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,9615.0,N,,CHEMBL624767,,,,,11070,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624768,,,,,11071,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624769,,,,,11072,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624770,,,,,11073,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624771,,,,,11074,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624772,,,,,11075,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,10116.0,N,,CHEMBL624773,,,,,11076,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624774,,,,,11077,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624775,,,,,11078,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624776,,,,,11079,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624777,,,,,11080,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624778,,,,,11081,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624779,,,,,11082,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624780,,,,,11083,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624781,,,,,11084,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL877608,,,,,11085,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624782,,,,,11086,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624783,,,,,11087,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624784,,,,,11088,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624785,,,,,11089,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624786,,,,,11090,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL624787,,,,,11091,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL628676,,,,,11092,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL621842,,,,,11093,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL621843,,,,,11094,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL623873,,,,,11095,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL623874,,,,,11096,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL623875,,,,,11097,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL623876,,,,,11098,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,9615.0,N,,CHEMBL623877,,,,,11099,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623878,,,,,11100,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623879,,,,,11101,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623880,,,,,11102,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623881,,,,,11103,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623957,,,,,11104,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623958,,,,,11105,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623959,,,,,11106,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623960,,,,,11107,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623961,,,,,11108,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL623962,,,,,11109,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624676,,,,,11110,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624677,,,,,11111,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624678,,,,,11112,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624679,,,,,11113,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624680,,,,,11114,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
11732,,U,,CHEMBL624849,,,,,11115,0,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11732,,U,,CHEMBL624850,,,,,11116,0,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11732,,U,,CHEMBL874399,,,,,11117,0,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11732,,U,,CHEMBL624851,,,,,11118,0,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11732,,U,,CHEMBL624852,,,,,11119,0,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13359,10116.0,U,,CHEMBL624853,,,,,11120,0,Oral bioavailability in rat (dose 10 mg/kg),,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16618,10116.0,U,,CHEMBL624854,,,,,11121,0,Oral bioavailability in rat (Sprague-Dawley),,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13960,10116.0,U,,CHEMBL624855,,,,,11122,0,Oral bioavailability in rat,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13917,10116.0,U,,CHEMBL624856,,,,,11123,0,Oral bioavailability in rats was determined in vivo,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14266,9615.0,U,,CHEMBL882957,,,,,11124,0,Oral bioavailability in dog,,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12359,314293.0,U,,CHEMBL624857,,,,,11125,0,Oral bioavailability of compound in monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
12359,10116.0,N,,CHEMBL622202,,,,,11126,1,Oral bioavailability of compound in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12359,10116.0,U,,CHEMBL622203,,,,,11127,0,Bioavailability in rat of PMEA prodrug,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12359,10116.0,N,,CHEMBL625522,,,,,11128,1,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10791,9544.0,U,,CHEMBL622868,,,,,11129,0,Serum conc at 3 hours following 25 mg/kg dose,,Autocuration,22224,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
10791,9544.0,U,1088.0,CHEMBL622869,,,,Urine,11130,0,Urine conc 0-5 hours following 25 mg/kg dose,,Autocuration,22224,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
10791,9544.0,U,1088.0,CHEMBL622870,,,,Urine,11131,0,Urine conc 0-24 hours following 25 mg/kg dose,,Autocuration,22224,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
138,9534.0,U,,CHEMBL622871,,,,,11132,0,Oral bioavailability in African green monkeys; 20-25,,Autocuration,22224,,BAO_0000218,,In vivo,Chlorocebus aethiops,1,,A
14521,9541.0,N,,CHEMBL620560,,,,,11133,1,Oral bioavailability in cynomolgus monkey.,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
13953,9615.0,U,,CHEMBL620561,,,,,11134,0,Oral bioavailability in dog,,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12836,9615.0,N,,CHEMBL620562,,,,,11135,1,Oral bioavailability in dog at 10 mg/kg oral dose,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12836,10026.0,N,,CHEMBL620563,,,,,11136,1,Oral bioavailability in hamster at 10 mg/kg oral dose,,Intermediate,100712,,BAO_0000218,,In vivo,Cricetinae,1,,A
12836,10116.0,N,,CHEMBL620564,,,,,11137,1,Oral bioavailability in rat at 10 mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14521,10116.0,U,,CHEMBL872265,,,,,11138,0,Oral bioavailability in rat,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13953,10116.0,U,,CHEMBL620565,,,,,11139,0,Oral bioavailability in rat,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6799,9347.0,U,,CHEMBL620566,,,,,11140,0,Oral bioavailability,,Autocuration,22224,,BAO_0000218,,In vivo,Eutheria,1,,A
11311,,U,,CHEMBL620567,,,,,11141,0,Oral bioavailability was determined; range 49-102%,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
4013,9615.0,N,,CHEMBL620568,,,,,11142,1,Oral bioavailability was determined in dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
4013,10116.0,U,,CHEMBL620569,,,,,11143,0,Oral bioavailability in rat,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17591,9347.0,U,,CHEMBL620570,,,,,11144,0,Oral bioavailability,,Autocuration,22224,,BAO_0000218,,In vivo,Eutheria,1,,A
17591,,U,,CHEMBL620571,,,,,11145,0,Oral bioavailability was determined; Not orally available,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15011,10090.0,N,,CHEMBL620572,,,,,11146,1,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15011,10090.0,U,,CHEMBL620573,,,,,11147,0,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,Autocuration,22224,,BAO_0000218,,In vivo,Mus musculus,1,,A
15011,10090.0,U,,CHEMBL620574,,,,,11148,0,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Mus musculus,1,,A
9552,9544.0,U,,CHEMBL620575,,,,,11149,0,Oral bioavailability in Rhesus monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
9552,9615.0,U,,CHEMBL620576,,,,,11150,0,Oral bioavailability in dog (female mongrel),,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
3639,,U,,CHEMBL875846,,,,,11151,0,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13397,9615.0,U,,CHEMBL620577,,,,,11152,0,Oral bioavailability in dog,,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
3031,,U,,CHEMBL620578,,,,,11153,0,Percentage Bioavailability was evaluated.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12818,10116.0,U,,CHEMBL620579,,,,,11154,0,Bioavailability in rat administered i.d.,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4847,9347.0,U,,CHEMBL621248,,,,,11155,0,Bioavailability,,Autocuration,22224,,BAO_0000218,,In vivo,Eutheria,1,,A
12421,9615.0,U,,CHEMBL625390,,,,,11156,0,Bioavailability in dog (male Beagle) i.v. administration,,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
11966,10116.0,U,,CHEMBL625391,,,,,11157,0,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11218,9443.0,U,,CHEMBL872266,,,,,11158,0,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,Autocuration,22224,,BAO_0000218,,In vivo,Primates,1,,A
13129,10116.0,U,,CHEMBL625392,,,,,11159,0,Oral bioavailability in rat (Sprague-Dawley) (male),,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12350,10116.0,N,,CHEMBL625393,,,,,11160,1,The oral bioavailability was measured on rats after oral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2231,10116.0,N,,CHEMBL625394,,,,,11161,1,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2231,9544.0,N,,CHEMBL625395,,,,,11162,1,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,Intermediate,50797,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
12187,10116.0,U,,CHEMBL625396,,,,,11163,0,Bioavailability in rat (dose 10 mg/kg i.d.),,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12421,9615.0,U,,CHEMBL625397,,,,,11164,0,Bioavailability in dog (male Beagle) i.v. administration,,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13256,10090.0,N,,CHEMBL625398,,,,,11165,1,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,178.0,CHEMBL625399,,,,Blood,11166,1,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,2037.0,CHEMBL626074,,,,Cerebellum,11167,1,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL626075,,,,,11168,1,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
2231,10116.0,N,1969.0,CHEMBL626076,,,,Plasma,11169,1,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2231,9544.0,N,1969.0,CHEMBL626077,,,,Plasma,11170,1,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,Intermediate,50797,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
12178,10116.0,N,178.0,CHEMBL626078,,,,Blood,11171,1,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12178,,U,178.0,CHEMBL625846,,,,Blood,11172,0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12178,,U,178.0,CHEMBL625847,,,,Blood,11173,0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15633,10116.0,N,,CHEMBL625848,,,,,11174,1,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,Expert,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14258,10116.0,N,1969.0,CHEMBL625849,,,,Plasma,11175,1,Maximum concentration of compound in plasma administered orally to rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14224,9615.0,N,1969.0,CHEMBL626023,,,,Plasma,11176,1,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14224,9615.0,N,1969.0,CHEMBL626024,,,,Plasma,11177,1,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14224,9615.0,N,1969.0,CHEMBL626025,,,,Plasma,11178,1,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
5566,,U,,CHEMBL626026,,,,,11179,0,Maximum concentration after 10 mg/kg by oral administration,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
16935,,U,,CHEMBL626027,,,,,11180,0,Maximum concentration at a dose of 1.5 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
16935,,U,,CHEMBL626028,,,,,11181,0,Maximum concentration at a dose of 2.0 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14224,9615.0,N,1969.0,CHEMBL626029,,,,Plasma,11182,1,Maximum concentration in dog plasma,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12536,,U,1969.0,CHEMBL626030,,,,Plasma,11183,0,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12536,,U,1969.0,CHEMBL626031,,,,Plasma,11184,0,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12536,,U,1969.0,CHEMBL626032,,,,Plasma,11185,0,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12536,,U,1969.0,CHEMBL626033,,,,Plasma,11186,0,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12536,,U,1969.0,CHEMBL626034,,,,Plasma,11187,0,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
9994,9615.0,N,1969.0,CHEMBL626035,,,,Plasma,11188,1,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
1434,,U,1969.0,CHEMBL626036,,,,Plasma,11189,0,Maximum concentration in plasma at Tmax,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12836,9615.0,N,1969.0,CHEMBL626037,,,,Plasma,11190,1,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,Expert,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12836,10026.0,N,1969.0,CHEMBL626038,,,,Plasma,11191,1,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,Intermediate,100712,,BAO_0000218,,In vivo,Cricetinae,1,,A
12836,10116.0,N,1969.0,CHEMBL626039,,,,Plasma,11192,1,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12545,10116.0,N,1969.0,CHEMBL626040,,,,Plasma,11193,1,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13856,9986.0,N,1969.0,CHEMBL626041,,,,Plasma,11194,1,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,Intermediate,50592,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
3550,,U,,CHEMBL626042,,,,,11195,0,Maximum concentration was calculated,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
2632,,U,,CHEMBL626043,,,,,11196,0,Maximum concentration was calculated.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
5566,,U,,CHEMBL626044,,,,,11197,0,Maximum concentration at a peroral dose of 10 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11883,,U,,CHEMBL626045,,,,,11198,0,Maximum concentration of the drug at 10 uM/dg administered perorally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11883,,U,,CHEMBL626046,,,,,11199,0,Maximum concentration of the drug at 2 uM/dg administered intravenously,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14122,9615.0,N,1969.0,CHEMBL626047,,,,Plasma,11200,1,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14122,10026.0,N,1969.0,CHEMBL626048,,,,Plasma,11201,1,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,Intermediate,100712,,BAO_0000218,,In vivo,Cricetinae,1,,A
14122,10116.0,N,1969.0,CHEMBL626049,,,,Plasma,11202,1,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12542,10116.0,N,1969.0,CHEMBL626050,,,,Plasma,11203,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12542,9615.0,N,1969.0,CHEMBL874541,,,,Plasma,11204,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12542,10026.0,N,1969.0,CHEMBL622826,,,,Plasma,11205,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,Intermediate,100712,,BAO_0000218,,In vivo,Cricetinae,1,,A
12542,10026.0,N,1969.0,CHEMBL622827,,,,Plasma,11206,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,Intermediate,100712,,BAO_0000218,,In vivo,Cricetinae,1,,A
12542,10116.0,N,1969.0,CHEMBL622828,,,,Plasma,11207,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14080,10116.0,N,1969.0,CHEMBL622829,,,,Plasma,11208,1,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11911,10116.0,N,,CHEMBL876806,,,,,11209,1,Maximum concentration reached following intravenous administration in male rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13204,9615.0,N,,CHEMBL622830,,,,,11210,1,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13204,10116.0,N,,CHEMBL622831,,,,,11211,1,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14346,9615.0,N,,CHEMBL626794,,,,,11212,1,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14346,10116.0,N,,CHEMBL626795,,,,,11213,1,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14346,10116.0,N,,CHEMBL626796,,,,,11214,1,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14346,10116.0,N,,CHEMBL626797,,,,,11215,1,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14127,10116.0,N,,CHEMBL626798,,,,,11216,1,Maximum drug concentration is determined after oral dosing in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14339,9615.0,N,,CHEMBL626799,,,,,11217,1,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14339,9615.0,N,,CHEMBL626800,,,,,11218,1,Maximum observed concentration in oral (5 mg/kg) fed dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13494,,U,1969.0,CHEMBL626801,,,,Plasma,11219,0,Maximum plasma concentration,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14925,10116.0,N,1969.0,CHEMBL876816,,,,Plasma,11220,1,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14474,10116.0,N,1969.0,CHEMBL626802,,,,Plasma,11221,1,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14474,9615.0,N,1969.0,CHEMBL626803,,,,Plasma,11222,1,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13917,,U,1969.0,CHEMBL626804,,,,Plasma,11223,0,Maximum plasma concentration following oral administration of 30 umol/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
9796,10116.0,N,1969.0,CHEMBL626805,,,,Plasma,11224,1,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,1969.0,CHEMBL626309,,,,Plasma,11225,1,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,1969.0,CHEMBL626310,,,,Plasma,11226,1,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,1969.0,CHEMBL626311,,,,Plasma,11227,1,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,1969.0,CHEMBL626312,,,,Plasma,11228,1,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,995.0,CHEMBL626313,,,,Uterus,11229,1,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,995.0,CHEMBL626314,,,,Uterus,11230,1,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,995.0,CHEMBL626315,,,,Uterus,11231,1,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,995.0,CHEMBL626316,,,,Uterus,11232,1,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9796,10116.0,N,995.0,CHEMBL626317,,,,Uterus,11233,1,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626318,,,,,11234,1,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626319,,,,,11235,1,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626320,,,,,11236,1,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL875053,,,,,11237,1,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626321,,,,,11238,1,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626322,,,,,11239,1,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626323,,,,,11240,1,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626324,,,,,11241,1,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626325,,,,,11242,1,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626326,,,,,11243,1,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626327,,,,,11244,1,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8363,10116.0,N,,CHEMBL626328,,,,,11245,1,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,178.0,CHEMBL626329,,,,Blood,11246,1,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,178.0,CHEMBL626330,,,,Blood,11247,1,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,178.0,CHEMBL626331,,,,Blood,11248,1,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,178.0,CHEMBL626332,,,,Blood,11249,1,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,178.0,CHEMBL626333,,,,Blood,11250,1,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,178.0,CHEMBL626334,,,,Blood,11251,1,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,178.0,CHEMBL626335,,,,Blood,11252,1,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,178.0,CHEMBL624798,,,,Blood,11253,1,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,955.0,CHEMBL624799,,,,Brain,11254,1,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,955.0,CHEMBL624800,,,,Brain,11255,1,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,955.0,CHEMBL624801,,,,Brain,11256,1,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,955.0,CHEMBL624802,,,,Brain,11257,1,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,955.0,CHEMBL624803,,,,Brain,11258,1,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,955.0,CHEMBL624804,,,,Brain,11259,1,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,955.0,CHEMBL624805,,,,Brain,11260,1,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,955.0,CHEMBL624806,,,,Brain,11261,1,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624807,,,,,11262,1,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624808,,,,,11263,1,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624809,,,,,11264,1,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624810,,,,,11265,1,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL877618,,,,,11266,1,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624811,,,,,11267,1,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624812,,,,,11268,1,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624813,,,,,11269,1,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624814,,,,,11270,1,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624815,,,,,11271,1,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624816,,,,,11272,1,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624817,,,,,11273,1,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,9615.0,N,,CHEMBL624818,,,,,11274,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624819,,,,,11275,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624820,,,,,11276,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624821,,,,,11277,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624822,,,,,11278,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624823,,,,,11279,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15599,562.0,N,,CHEMBL624824,,,,,11280,1,Observed diffusion coefficient in organic solvent for Escherichia coli,,Intermediate,50212,,BAO_0000218,,,Escherichia coli,1,,A
9614,10116.0,N,178.0,CHEMBL624825,,,,Blood,11281,1,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,178.0,CHEMBL624826,,,,Blood,11282,1,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,2081.0,CHEMBL876817,,,,Cardiac atrium,11283,1,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,2081.0,CHEMBL624827,,,,Cardiac atrium,11284,1,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,,CHEMBL624828,,,,,11285,1,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,,CHEMBL624829,,,,,11286,1,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,2107.0,CHEMBL624830,,,,Liver,11287,1,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,2107.0,CHEMBL624831,,,,Liver,11288,1,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,2081.0,CHEMBL624832,,,,Cardiac atrium,11289,1,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,2081.0,CHEMBL624833,,,,Cardiac atrium,11290,1,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,,CHEMBL624834,,,,,11291,1,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,,CHEMBL624835,,,,,11292,1,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,2106.0,CHEMBL624836,,,,Spleen,11293,1,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,10116.0,N,2106.0,CHEMBL624837,,,,Spleen,11294,1,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,178.0,CHEMBL624838,,,,Blood,11295,1,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,178.0,CHEMBL622188,,,,Blood,11296,1,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,948.0,CHEMBL622189,,,,Heart,11297,1,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,948.0,CHEMBL622190,,,,Heart,11298,1,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,948.0,CHEMBL625170,,,,Heart,11299,1,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2113.0,CHEMBL625171,,,,Kidney,11300,1,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2113.0,CHEMBL625172,,,,Kidney,11301,1,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2113.0,CHEMBL625173,,,,Kidney,11302,1,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2107.0,CHEMBL625174,,,,Liver,11303,1,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2107.0,CHEMBL625175,,,,Liver,11304,1,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2107.0,CHEMBL625176,,,,Liver,11305,1,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2048.0,CHEMBL625177,,,,Lung,11306,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2048.0,CHEMBL625178,,,,Lung,11307,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2048.0,CHEMBL625179,,,,Lung,11308,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9071,10116.0,N,2048.0,CHEMBL625180,,,,Lung,11309,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10677,,U,,CHEMBL625181,,,,,11310,0,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,Autocuration,22224,,BAO_0000218,,,,1,,A
9750,10090.0,N,1088.0,CHEMBL625182,,,,Urine,11311,1,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8319,10116.0,N,,CHEMBL625183,,,,,11312,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL875848,,,,,11313,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL622260,,,,,11314,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL622261,,,,,11315,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL622262,,,,,11316,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2113.0,CHEMBL622263,,,,Kidney,11317,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2113.0,CHEMBL622418,,,,Kidney,11318,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2107.0,CHEMBL622419,,,,Liver,11319,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13256,10090.0,N,,CHEMBL623388,,,,,11320,1,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,2107.0,CHEMBL623389,,,,Liver,11321,1,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL623390,,,,,11322,1,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL623391,,,,,11323,1,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,178.0,CHEMBL623392,,,,Blood,11324,1,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,2037.0,CHEMBL623393,,,,Cerebellum,11325,1,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL623394,,,,,11326,1,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL618885,,,,,11327,1,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,2107.0,CHEMBL618886,,,,Liver,11328,1,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL618887,,,,,11329,1,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL619535,,,,,11330,1,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,178.0,CHEMBL619536,,,,Blood,11331,1,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,2037.0,CHEMBL619537,,,,Cerebellum,11332,1,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL619705,,,,,11333,1,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL619706,,,,,11334,1,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,2107.0,CHEMBL619707,,,,Liver,11335,1,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL619708,,,,,11336,1,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL625219,,,,,11337,1,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,178.0,CHEMBL625220,,,,Blood,11338,1,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,2037.0,CHEMBL625221,,,,Cerebellum,11339,1,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL625222,,,,,11340,1,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL625223,,,,,11341,1,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,2107.0,CHEMBL625224,,,,Liver,11342,1,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13256,10090.0,N,,CHEMBL625225,,,,,11343,1,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
8829,10116.0,N,178.0,CHEMBL625226,,,,Blood,11344,1,Biodistribution in Rat blood after 24 hours of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,178.0,CHEMBL625227,,,,Blood,11345,1,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,178.0,CHEMBL625228,,,,Blood,11346,1,Biodistribution in Rat blood after 30 minutes of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,178.0,CHEMBL875354,,,,Blood,11347,1,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,178.0,CHEMBL625229,,,,Blood,11348,1,Biodistribution in Rat blood after 5 minutes of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,178.0,CHEMBL625230,,,,Blood,11349,1,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,948.0,CHEMBL625231,,,,Heart,11350,1,Biodistribution in Rat heart after 24 hours of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,948.0,CHEMBL625900,,,,Heart,11351,1,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,948.0,CHEMBL625901,,,,Heart,11352,1,Biodistribution in Rat heart after 30 minutes of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,948.0,CHEMBL625902,,,,Heart,11353,1,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,948.0,CHEMBL625903,,,,Heart,11354,1,Biodistribution in Rat heart after 5 minutes of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,948.0,CHEMBL625904,,,,Heart,11355,1,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2107.0,CHEMBL625905,,,,Liver,11356,1,Biodistribution in Rat liver after 24 hours of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2107.0,CHEMBL627861,,,,Liver,11357,1,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2107.0,CHEMBL627862,,,,Liver,11358,1,Biodistribution in Rat liver after 30 minutes of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2107.0,CHEMBL627863,,,,Liver,11359,1,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2107.0,CHEMBL627769,,,,Liver,11360,1,Biodistribution in Rat liver after 30 minutes of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13249,9615.0,N,1969.0,CHEMBL627770,,,,Plasma,11361,1,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13622,9541.0,N,,CHEMBL627771,,,,,11362,1,Cmax in cynomolgus monkey (PO dose),,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
13622,10116.0,N,,CHEMBL627772,,,,,11363,1,Cmax in rat (PO dose),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13622,10116.0,N,,CHEMBL627773,,,,,11364,1,Cmax in rat (PO dose),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13494,10116.0,N,1969.0,CHEMBL621922,,,,Plasma,11365,1,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12170,10116.0,N,1969.0,CHEMBL621923,,,,Plasma,11366,1,Cmax in rat plasma after oral dose (10 mg/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12170,,U,1969.0,CHEMBL621924,,,,Plasma,11367,0,Cmax in plasma after oral dose (10 mg/kg),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
17025,9615.0,N,1969.0,CHEMBL621925,,,,Plasma,11368,1,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
17025,314293.0,U,1969.0,CHEMBL621926,,,,Plasma,11369,0,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
17025,9986.0,N,1969.0,CHEMBL621927,,,,Plasma,11370,1,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,Intermediate,50592,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
17025,10116.0,N,1969.0,CHEMBL621928,,,,Plasma,11371,1,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14187,10116.0,N,1969.0,CHEMBL621929,,,,Plasma,11372,1,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14816,10090.0,N,1969.0,CHEMBL621930,,,,Plasma,11373,1,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
17820,10116.0,N,1969.0,CHEMBL621931,,,,Plasma,11374,1,Maximum plasma concentration after oral dosing in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14380,,U,1969.0,CHEMBL621932,,,,Plasma,11375,0,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14380,,U,1969.0,CHEMBL621933,,,,Plasma,11376,0,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14691,9615.0,N,1969.0,CHEMBL621934,,,,Plasma,11377,1,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14691,9615.0,N,1969.0,CHEMBL621935,,,,Plasma,11378,1,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13375,10116.0,N,1969.0,CHEMBL621936,,,,Plasma,11379,1,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6236,,U,1969.0,CHEMBL621937,,,,Plasma,11380,0,Maximum plasma concentration was determined,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14380,,U,1969.0,CHEMBL621938,,,,Plasma,11381,0,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14380,,U,1969.0,CHEMBL621939,,,,Plasma,11382,0,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14380,,U,1969.0,CHEMBL621940,,,,Plasma,11383,0,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14380,,U,1969.0,CHEMBL621941,,,,Plasma,11384,0,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14380,,U,1969.0,CHEMBL621942,,,,Plasma,11385,0,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14380,,U,1969.0,CHEMBL626178,,,,Plasma,11386,0,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14380,,U,1969.0,CHEMBL626179,,,,Plasma,11387,0,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14380,,U,1969.0,CHEMBL626180,,,,Plasma,11388,0,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13622,10116.0,N,1969.0,CHEMBL626181,,,,Plasma,11389,1,Plasma Cmax in rat (PO dose),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL626182,,,,,11390,1,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL626183,,,,,11391,1,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL626184,,,,,11392,1,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15372,10116.0,N,,CHEMBL626185,,,,,11393,1,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14925,9615.0,N,1969.0,CHEMBL626186,,,,Plasma,11394,1,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14925,9615.0,N,1969.0,CHEMBL877589,,,,Plasma,11395,1,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
11883,,U,,CHEMBL626187,,,,,11396,0,Maximum concentration of the drug at 1 uM/dg administered intravenously,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11883,,U,,CHEMBL626188,,,,,11397,0,Maximum concentration of the drug at 20 uM/dg administered perorally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13391,,U,,CHEMBL626189,,,,,11398,0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13391,,U,178.0,CHEMBL626855,,,,Blood,11399,0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13391,,U,178.0,CHEMBL623781,,,,Blood,11400,0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13391,,U,178.0,CHEMBL623782,,,,Blood,11401,0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
16360,10116.0,N,1969.0,CHEMBL623783,,,,Plasma,11402,1,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3673,9615.0,N,1969.0,CHEMBL623784,,,,Plasma,11403,1,Cmax in dog plasma after 1mg/kg oral dose,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14431,9615.0,N,1969.0,CHEMBL623785,,,,Plasma,11404,1,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14431,10116.0,N,1969.0,CHEMBL623786,,,,Plasma,11405,1,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14964,10116.0,N,,CHEMBL623787,,,,,11406,1,Oral maximum concentration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14964,10116.0,N,,CHEMBL623788,,,,,11407,1,Oral maximum concentration in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14209,10090.0,N,1969.0,CHEMBL623789,,,,Plasma,11408,1,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
11355,10090.0,N,178.0,CHEMBL623790,,,,Blood,11409,1,Peak concentration in blood after intravenous administration to mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
11355,10090.0,N,178.0,CHEMBL623791,,,,Blood,11410,1,Peak concentration in blood after peroral administration to mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
11966,10116.0,N,1969.0,CHEMBL623792,,,,Plasma,11411,1,Peak concentration in rat plasma was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8918,314293.0,U,1969.0,CHEMBL623793,,,,Plasma,11412,0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
8918,10090.0,N,1969.0,CHEMBL623794,,,,Plasma,11413,1,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
8918,10116.0,N,1969.0,CHEMBL623795,,,,Plasma,11414,1,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623796,,,,,11415,1,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623797,,,,,11416,1,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623798,,,,,11417,1,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623799,,,,,11418,1,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,160.0,CHEMBL624490,,,,Intestine,11419,1,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,160.0,CHEMBL624491,,,,Intestine,11420,1,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,160.0,CHEMBL624492,,,,Intestine,11421,1,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,160.0,CHEMBL624493,,,,Intestine,11422,1,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,160.0,CHEMBL877595,,,,Intestine,11423,1,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,160.0,CHEMBL624494,,,,Intestine,11424,1,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,160.0,CHEMBL624495,,,,Intestine,11425,1,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,160.0,CHEMBL624681,,,,Intestine,11426,1,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624682,,,,,11427,1,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624683,,,,,11428,1,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624684,,,,,11429,1,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624685,,,,,11430,1,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624686,,,,,11431,1,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624687,,,,,11432,1,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624688,,,,,11433,1,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL627161,,,,,11434,1,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL622127,,,,,11435,1,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL622128,,,,,11436,1,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL874384,,,,,11437,1,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624898,,,,,11438,1,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624899,,,,,11439,1,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624900,,,,,11440,1,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624901,,,,,11441,1,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624902,,,,,11442,1,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624903,,,,,11443,1,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624904,,,,,11444,1,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624905,,,,,11445,1,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624906,,,,,11446,1,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624907,,,,,11447,1,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624908,,,,,11448,1,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624909,,,,,11449,1,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL624910,,,,,11450,1,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2385.0,CHEMBL624911,,,,Muscle tissue,11451,1,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2385.0,CHEMBL874388,,,,Muscle tissue,11452,1,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2385.0,CHEMBL624912,,,,Muscle tissue,11453,1,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2385.0,CHEMBL622930,,,,Muscle tissue,11454,1,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2385.0,CHEMBL623121,,,,Muscle tissue,11455,1,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2385.0,CHEMBL623122,,,,Muscle tissue,11456,1,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2385.0,CHEMBL623123,,,,Muscle tissue,11457,1,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2385.0,CHEMBL623124,,,,Muscle tissue,11458,1,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623125,,,,,11459,1,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623126,,,,,11460,1,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623127,,,,,11461,1,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623128,,,,,11462,1,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623129,,,,,11463,1,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623130,,,,,11464,1,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623131,,,,,11465,1,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL623132,,,,,11466,1,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2107.0,CHEMBL623133,,,,Liver,11467,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL623134,,,,,11468,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL874389,,,,,11469,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL623135,,,,,11470,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL623136,,,,,11471,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL623137,,,,,11472,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL623138,,,,,11473,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2113.0,CHEMBL623139,,,,Kidney,11474,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2113.0,CHEMBL623140,,,,Kidney,11475,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2107.0,CHEMBL623141,,,,Liver,11476,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2107.0,CHEMBL623142,,,,Liver,11477,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL623143,,,,,11478,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14571,10090.0,N,1088.0,CHEMBL623144,,,,Urine,11479,1,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14571,10116.0,N,1088.0,CHEMBL623405,,,,Urine,11480,1,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624074,,,,,11481,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624075,,,,,11482,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624076,,,,,11483,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624077,,,,,11484,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624078,,,,,11485,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2113.0,CHEMBL624079,,,,Kidney,11486,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2113.0,CHEMBL624261,,,,Kidney,11487,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624262,,,,,11488,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624263,,,,,11489,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624264,,,,,11490,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624265,,,,,11491,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624266,,,,,11492,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624267,,,,,11493,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624268,,,,,11494,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL875227,,,,,11495,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2113.0,CHEMBL624269,,,,Kidney,11496,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,2113.0,CHEMBL624270,,,,Kidney,11497,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624271,,,,,11498,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624272,,,,,11499,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8319,10116.0,N,,CHEMBL624273,,,,,11500,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12064,10116.0,N,1088.0,CHEMBL624274,,,,Urine,11501,1,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12064,10116.0,N,1088.0,CHEMBL624275,,,,Urine,11502,1,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12064,10116.0,N,1088.0,CHEMBL624276,,,,Urine,11503,1,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12038,10116.0,N,1088.0,CHEMBL624277,,,,Urine,11504,1,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14314,,U,,CHEMBL624278,,,,,11505,0,% dose converted to 2-amino-5-chlorophenyl sulfate,,Autocuration,22224,,BAO_0000019,,,,1,,A
14314,,U,,CHEMBL624279,,,,,11506,0,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,Autocuration,22224,,BAO_0000019,,,,1,,A
11488,10116.0,N,1988.0,CHEMBL624280,,,,Feces,11507,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,1988.0,CHEMBL624281,,,,Feces,11508,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,1988.0,CHEMBL622933,,,,Feces,11509,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,1988.0,CHEMBL622934,,,,Feces,11510,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8829,10116.0,N,2107.0,CHEMBL622935,,,,Liver,11511,1,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2107.0,CHEMBL622936,,,,Liver,11512,1,Biodistribution in Rat liver after 5 minutes of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2107.0,CHEMBL875228,,,,Liver,11513,1,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2048.0,CHEMBL622937,,,,Lung,11514,1,Biodistribution in Rat lung after 24 hours of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2048.0,CHEMBL622938,,,,Lung,11515,1,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2048.0,CHEMBL619736,,,,Lung,11516,1,Biodistribution in Rat lung after 30 minutes of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2048.0,CHEMBL625117,,,,Lung,11517,1,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2048.0,CHEMBL625118,,,,Lung,11518,1,Biodistribution in Rat lung after 5 minutes of iv administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8829,10116.0,N,2048.0,CHEMBL625119,,,,Lung,11519,1,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14972,10116.0,N,2037.0,CHEMBL625120,,,,Cerebellum,11520,1,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14972,10116.0,N,,CHEMBL625121,,,,,11521,1,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14972,10116.0,N,10000006.0,CHEMBL625122,,,,Thalamus,11522,1,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,178.0,CHEMBL622204,,,,Blood,11523,1,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,178.0,CHEMBL877503,,,,Blood,11524,1,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,178.0,CHEMBL627127,,,,Blood,11525,1,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,,U,10000000.0,CHEMBL627128,,,,Hippocampus,11526,0,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14608,,U,10000000.0,CHEMBL627129,,,,Hippocampus,11527,0,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14608,,U,10000000.0,CHEMBL627130,,,,Hippocampus,11528,0,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14608,10116.0,N,955.0,CHEMBL627131,,,,Brain,11529,1,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,955.0,CHEMBL627132,,,,Brain,11530,1,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,955.0,CHEMBL627133,,,,Brain,11531,1,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2037.0,CHEMBL627134,,,,Cerebellum,11532,1,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2037.0,CHEMBL627135,,,,Cerebellum,11533,1,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2037.0,CHEMBL627136,,,,Cerebellum,11534,1,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,,CHEMBL628435,,,,,11535,1,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,,CHEMBL628436,,,,,11536,1,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,,CHEMBL628437,,,,,11537,1,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,948.0,CHEMBL628438,,,,Heart,11538,1,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,948.0,CHEMBL628439,,,,Heart,11539,1,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,948.0,CHEMBL628440,,,,Heart,11540,1,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,10000000.0,CHEMBL628441,,,,Hippocampus,11541,1,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,10000000.0,CHEMBL628442,,,,Hippocampus,11542,1,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,10000000.0,CHEMBL628443,,,,Hippocampus,11543,1,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2113.0,CHEMBL628444,,,,Kidney,11544,1,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2113.0,CHEMBL628445,,,,Kidney,11545,1,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2113.0,CHEMBL877504,,,,Kidney,11546,1,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2107.0,CHEMBL628446,,,,Liver,11547,1,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2107.0,CHEMBL626874,,,,Liver,11548,1,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2107.0,CHEMBL626875,,,,Liver,11549,1,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2048.0,CHEMBL626876,,,,Lung,11550,1,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2048.0,CHEMBL626877,,,,Lung,11551,1,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2048.0,CHEMBL626878,,,,Lung,11552,1,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2385.0,CHEMBL626879,,,,Muscle tissue,11553,1,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8918,314293.0,U,1969.0,CHEMBL626880,,,,Plasma,11554,0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
8918,10090.0,N,1969.0,CHEMBL626881,,,,Plasma,11555,1,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
8918,10116.0,N,1969.0,CHEMBL626882,,,,Plasma,11556,1,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14470,9615.0,N,1969.0,CHEMBL626883,,,,Plasma,11557,1,Peak plasma concentration was measured in dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14393,10116.0,N,,CHEMBL626884,,,,,11558,1,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14886,10116.0,N,,CHEMBL626885,,,,,11559,1,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14886,10116.0,N,,CHEMBL626886,,,,,11560,1,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14886,10116.0,N,,CHEMBL626887,,,,,11561,1,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14393,10116.0,N,,CHEMBL626888,,,,,11562,1,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13465,9615.0,N,,CHEMBL626889,,,,,11563,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13465,314293.0,U,,CHEMBL626761,,,,,11564,0,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
13465,9615.0,N,,CHEMBL626762,,,,,11565,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13465,9615.0,N,,CHEMBL626763,,,,,11566,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13465,10116.0,N,,CHEMBL626764,,,,,11567,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13465,10116.0,N,,CHEMBL626765,,,,,11568,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13465,9615.0,N,,CHEMBL626766,,,,,11569,1,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13465,10116.0,N,,CHEMBL626767,,,,,11570,1,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13465,10116.0,N,,CHEMBL626768,,,,,11571,1,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13465,9615.0,N,,CHEMBL626769,,,,,11572,1,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13465,9615.0,N,,CHEMBL874463,,,,,11573,1,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13465,314293.0,U,,CHEMBL626770,,,,,11574,0,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
13465,314293.0,U,,CHEMBL626771,,,,,11575,0,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
13465,10116.0,N,,CHEMBL626772,,,,,11576,1,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14731,9541.0,N,,CHEMBL626773,,,,,11577,1,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14731,10090.0,N,,CHEMBL626774,,,,,11578,1,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13376,9615.0,N,,CHEMBL626775,,,,,11579,1,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13376,9615.0,N,,CHEMBL626776,,,,,11580,1,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14443,10116.0,N,,CHEMBL626777,,,,,11581,1,Maximum concentration (Cmax) in rat when administered orally,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13465,314293.0,U,1969.0,CHEMBL626778,,,,Plasma,11582,0,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
16359,10116.0,U,,CHEMBL626779,,,,,11583,0,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16359,10116.0,U,,CHEMBL626780,,,,,11584,0,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15618,,U,1969.0,CHEMBL626781,,,,Plasma,11585,0,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14554,10116.0,N,,CHEMBL632164,,,,,11586,1,Pharmacokinetic profile Cmax was evaluated in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11537,9615.0,N,,CHEMBL632165,,,,,11587,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
11537,10090.0,N,,CHEMBL632166,,,,,11588,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
11537,9615.0,N,,CHEMBL632167,,,,,11589,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
11537,10090.0,N,,CHEMBL632168,,,,,11590,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
2021,10116.0,U,1969.0,CHEMBL632169,,,,Plasma,11591,0,Cmax in rat plasma,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5932,9615.0,N,1969.0,CHEMBL632170,,,,Plasma,11592,1,Cmax in dog plasma after 30mg/kg oral dose,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
5932,10116.0,N,1969.0,CHEMBL632171,,,,Plasma,11593,1,Cmax in rat plasma after 30mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17320,10116.0,N,1969.0,CHEMBL632172,,,,Plasma,11594,1,Plasma level in rats at 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15831,10090.0,N,1969.0,CHEMBL632173,,,,Plasma,11595,1,Tested for maximum plasma concentration in mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15078,10116.0,N,,CHEMBL632174,,,,,11596,1,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14941,10116.0,N,,CHEMBL632175,,,,,11597,1,The Cmax values in female wistar rats.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15343,9615.0,N,1969.0,CHEMBL632176,,,,Plasma,11598,1,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
15343,10116.0,N,1969.0,CHEMBL632177,,,,Plasma,11599,1,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14856,10116.0,N,1969.0,CHEMBL632178,,,,Plasma,11600,1,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13129,10116.0,N,,CHEMBL632179,,,,,11601,1,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13098,10116.0,N,178.0,CHEMBL632180,,,,Blood,11602,1,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13098,10116.0,N,178.0,CHEMBL632181,,,,Blood,11603,1,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13098,10116.0,N,178.0,CHEMBL632182,,,,Blood,11604,1,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15478,10090.0,U,178.0,CHEMBL632183,,,,Blood,11605,0,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,Autocuration,22224,,BAO_0000218,,In vivo,Mus musculus,1,,A
15341,9615.0,N,,CHEMBL632184,,,,,11606,1,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
15341,10116.0,N,,CHEMBL874470,,,,,11607,1,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL631302,,,,,11608,1,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL631303,,,,,11609,1,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL631304,,,,,11610,1,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL631305,,,,,11611,1,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL631306,,,,,11612,1,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL631307,,,,,11613,1,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL631308,,,,,11614,1,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,,CHEMBL625557,,,,,11615,1,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2106.0,CHEMBL625558,,,,Spleen,11616,1,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2106.0,CHEMBL625559,,,,Spleen,11617,1,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2106.0,CHEMBL625560,,,,Spleen,11618,1,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2106.0,CHEMBL625561,,,,Spleen,11619,1,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2106.0,CHEMBL625562,,,,Spleen,11620,1,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2106.0,CHEMBL875320,,,,Spleen,11621,1,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2106.0,CHEMBL625563,,,,Spleen,11622,1,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,2106.0,CHEMBL625564,,,,Spleen,11623,1,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,995.0,CHEMBL625565,,,,Uterus,11624,1,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,995.0,CHEMBL625566,,,,Uterus,11625,1,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,995.0,CHEMBL625567,,,,Uterus,11626,1,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,995.0,CHEMBL625568,,,,Uterus,11627,1,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,995.0,CHEMBL628217,,,,Uterus,11628,1,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,995.0,CHEMBL628218,,,,Uterus,11629,1,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,995.0,CHEMBL628219,,,,Uterus,11630,1,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8684,10116.0,N,995.0,CHEMBL628220,,,,Uterus,11631,1,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8926,,U,,CHEMBL628221,,,,,11632,0,Distribution in the blood after 120 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628222,,,,,11633,0,Distribution in the blood after 15 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628223,,,,,11634,0,Distribution in the blood after 30 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628224,,,,,11635,0,Distribution in the blood after 5 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628225,,,,,11636,0,Distribution in the blood after 60 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628226,,,,,11637,0,Distribution in the blood after 90 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628227,,,,,11638,0,Distribution in the bone after 120 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL875481,,,,,11639,0,Distribution in the bone after 15 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628228,,,,,11640,0,Distribution in the bone after 30 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628229,,,,,11641,0,Distribution in the bone after 5 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628230,,,,,11642,0,Distribution in the bone after 60 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628231,,,,,11643,0,Distribution in the bone after 90 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628232,,,,,11644,0,Distribution in the heart after 120 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628233,,,,,11645,0,Distribution in the heart after 15 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628234,,,,,11646,0,Distribution in the heart after 30 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628235,,,,,11647,0,Distribution in the heart after 5 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628236,,,,,11648,0,Distribution in the heart after 60 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628237,,,,,11649,0,Distribution in the heart after 90 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628238,,,,,11650,0,Distribution in the kidneys after 120 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628239,,,,,11651,0,Distribution in the kidneys after 15 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628240,,,,,11652,0,Distribution in the kidneys after 30 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628241,,,,,11653,0,Distribution in the kidneys after 5 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628242,,,,,11654,0,Distribution in the kidneys after 60 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL875482,,,,,11655,0,Distribution in the kidneys after 90 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628243,,,,,11656,0,Distribution in the liver after 120 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628244,,,,,11657,0,Distribution in the liver after 15 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628245,,,,,11658,0,Distribution in the liver after 30 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628246,,,,,11659,0,Distribution in the liver after 5 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628247,,,,,11660,0,Distribution in the liver after 60 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628248,,,,,11661,0,Distribution in the liver after 90 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628249,,,,,11662,0,Distribution in the lung after 120 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
14839,10090.0,N,,CHEMBL625452,,,,,11663,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL625453,,,,,11664,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL625454,,,,,11665,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14839,10090.0,N,,CHEMBL623844,,,,,11666,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12178,10116.0,N,,CHEMBL623845,,,,,11667,1,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12178,10116.0,N,,CHEMBL623846,,,,,11668,1,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12178,,U,,CHEMBL623847,,,,,11669,0,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,Autocuration,22224,,BAO_0000218,,,,1,,A
12186,9541.0,N,,CHEMBL623848,,,,,11670,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
12186,9541.0,N,,CHEMBL623849,,,,,11671,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
12186,9541.0,N,,CHEMBL623850,,,,,11672,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
12186,9541.0,N,,CHEMBL623851,,,,,11673,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
12187,314293.0,U,,CHEMBL623852,,,,,11674,0,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
12187,9669.0,N,,CHEMBL624551,,,,,11675,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
12187,9669.0,N,,CHEMBL624552,,,,,11676,1,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
12187,314293.0,U,,CHEMBL624553,,,,,11677,0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
12187,314293.0,U,,CHEMBL624554,,,,,11678,0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
12187,10116.0,N,,CHEMBL624555,,,,,11679,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12187,10116.0,N,,CHEMBL624741,,,,,11680,1,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14122,9615.0,N,,CHEMBL624742,,,,,11681,1,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14122,10026.0,N,,CHEMBL624743,,,,,11682,1,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,Intermediate,100712,,BAO_0000218,,,Cricetinae,1,,A
14122,10116.0,N,,CHEMBL877606,,,,,11683,1,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13391,,U,,CHEMBL624744,,,,,11684,0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
13391,,U,178.0,CHEMBL624745,,,,Blood,11685,0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,22224,,BAO_0000218,,,,1,,A
13391,,U,178.0,CHEMBL624746,,,,Blood,11686,0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,22224,,BAO_0000218,,,,1,,A
13391,,U,178.0,CHEMBL624747,,,,Blood,11687,0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,22224,,BAO_0000218,,,,1,,A
16360,,U,,CHEMBL624748,,,,,11688,0,Oral absorption expressed as Area under curve was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
3673,9615.0,N,,CHEMBL622504,,,,,11689,1,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14122,9615.0,N,,CHEMBL622505,,,,,11690,1,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14122,10026.0,N,,CHEMBL622506,,,,,11691,1,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,Intermediate,100712,,BAO_0000218,,,Cricetinae,1,,A
14122,10026.0,N,,CHEMBL622507,,,,,11692,1,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,Intermediate,100712,,BAO_0000218,,,Cricetinae,1,,A
14122,10116.0,N,,CHEMBL622508,,,,,11693,1,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13889,,U,,CHEMBL622509,,,,,11694,0,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
14393,10116.0,N,,CHEMBL622510,,,,,11695,1,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17279,10116.0,N,,CHEMBL622511,,,,,11696,1,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14548,9541.0,N,,CHEMBL622512,,,,,11697,1,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14548,9541.0,N,,CHEMBL622513,,,,,11698,1,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14548,9541.0,N,,CHEMBL622514,,,,,11699,1,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14548,9615.0,N,,CHEMBL622515,,,,,11700,1,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14548,9615.0,N,,CHEMBL622516,,,,,11701,1,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14548,10116.0,N,,CHEMBL622517,,,,,11702,1,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14548,10116.0,N,,CHEMBL622518,,,,,11703,1,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14548,10116.0,N,,CHEMBL622519,,,,,11704,1,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14608,10116.0,N,2385.0,CHEMBL622520,,,,Muscle tissue,11705,1,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2385.0,CHEMBL622521,,,,Muscle tissue,11706,1,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10090.0,N,14.0,CHEMBL625113,,,,Zone of skin,11707,1,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14608,10116.0,N,14.0,CHEMBL625114,,,,Zone of skin,11708,1,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,14.0,CHEMBL874397,,,,Zone of skin,11709,1,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2106.0,CHEMBL625115,,,,Spleen,11710,1,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2106.0,CHEMBL625116,,,,Spleen,11711,1,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2106.0,CHEMBL623932,,,,Spleen,11712,1,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2435.0,CHEMBL623933,,,,Striatum,11713,1,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2435.0,CHEMBL623934,,,,Striatum,11714,1,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2435.0,CHEMBL623935,,,,Striatum,11715,1,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2046.0,CHEMBL623936,,,,Thyroid gland,11716,1,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2046.0,CHEMBL623937,,,,Thyroid gland,11717,1,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14608,10116.0,N,2046.0,CHEMBL623938,,,,Thyroid gland,11718,1,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15383,10090.0,N,,CHEMBL623939,,,,,11719,1,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL623940,,,,,11720,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL623941,,,,,11721,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL627216,,,,,11722,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL623942,,,,,11723,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,955.0,CHEMBL618793,,,,Brain,11724,1,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,955.0,CHEMBL618794,,,,Brain,11725,1,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,955.0,CHEMBL618795,,,,Brain,11726,1,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL618796,,,,,11727,1,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL618797,,,,,11728,1,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2113.0,CHEMBL618798,,,,Kidney,11729,1,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2113.0,CHEMBL618799,,,,Kidney,11730,1,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2113.0,CHEMBL618800,,,,Kidney,11731,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2113.0,CHEMBL618801,,,,Kidney,11732,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2113.0,CHEMBL618802,,,,Kidney,11733,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2113.0,CHEMBL618803,,,,Kidney,11734,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2107.0,CHEMBL618804,,,,Liver,11735,1,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2107.0,CHEMBL618805,,,,Liver,11736,1,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2107.0,CHEMBL618806,,,,Liver,11737,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2107.0,CHEMBL618807,,,,Liver,11738,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2107.0,CHEMBL618808,,,,Liver,11739,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2107.0,CHEMBL618809,,,,Liver,11740,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2385.0,CHEMBL618810,,,,Muscle tissue,11741,1,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2385.0,CHEMBL618811,,,,Muscle tissue,11742,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2385.0,CHEMBL875844,,,,Muscle tissue,11743,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2385.0,CHEMBL618812,,,,Muscle tissue,11744,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2385.0,CHEMBL618813,,,,Muscle tissue,11745,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL618814,,,,,11746,1,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL618815,,,,,11747,1,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL618816,,,,,11748,1,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL618817,,,,,11749,1,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL620544,,,,,11750,1,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15341,10116.0,N,,CHEMBL626230,,,,,11751,1,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15341,10116.0,N,,CHEMBL626231,,,,,11752,1,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15341,10116.0,N,,CHEMBL626232,,,,,11753,1,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14906,9615.0,N,1969.0,CHEMBL626233,,,,Plasma,11754,1,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14906,10116.0,N,1969.0,CHEMBL626234,,,,Plasma,11755,1,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14906,10116.0,N,1969.0,CHEMBL875341,,,,Plasma,11756,1,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14215,9606.0,N,1969.0,CHEMBL626235,,,,Plasma,11757,1,The maximum plasma concentration (100 mg/kg) administered orally in human,,Intermediate,50587,,BAO_0000218,,In vivo,Homo sapiens,1,,A
14215,9481.0,U,1969.0,CHEMBL626236,,,,Plasma,11758,0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,Autocuration,22224,,BAO_0000218,,In vivo,Callithrix,1,,A
14215,314293.0,U,1969.0,CHEMBL626237,,,,Plasma,11759,0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
14215,9615.0,N,1969.0,CHEMBL626238,,,,Plasma,11760,1,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14215,9606.0,N,1969.0,CHEMBL622412,,,,Plasma,11761,1,The maximum plasma concentration (200 mg/kg) administered orally in human,,Intermediate,50587,,BAO_0000218,,In vivo,Homo sapiens,1,,A
14215,10116.0,N,1969.0,CHEMBL623114,,,,Plasma,11762,1,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14215,9481.0,U,1969.0,CHEMBL623115,,,,Plasma,11763,0,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,Autocuration,22224,,BAO_0000218,,In vivo,Callithrix,1,,A
14215,314293.0,U,1969.0,CHEMBL623116,,,,Plasma,11764,0,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
14215,9615.0,U,1969.0,CHEMBL623117,,,,Plasma,11765,0,The maximum plasma concentration (30 mg/kg) administered orally in dog,,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14215,9606.0,N,1969.0,CHEMBL623118,,,,Plasma,11766,1,The maximum plasma concentration (400 mg/kg) administered orally in human,,Intermediate,50587,,BAO_0000218,,In vivo,Homo sapiens,1,,A
14215,10116.0,N,1969.0,CHEMBL623119,,,,Plasma,11767,1,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14215,10116.0,N,1969.0,CHEMBL623120,,,,Plasma,11768,1,The maximum plasma concentration (50 mg/kg) administered orally in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14215,9606.0,N,1969.0,CHEMBL623286,,,,Plasma,11769,1,The maximum plasma concentration (800 mg/kg) administered orally in human,,Intermediate,50587,,BAO_0000218,,In vivo,Homo sapiens,1,,A
14067,10116.0,N,1969.0,CHEMBL623287,,,,Plasma,11770,1,The maximum plasma concentration was measured on rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12350,10116.0,N,1969.0,CHEMBL623288,,,,Plasma,11771,1,The maximum plasma concentration was measured on rats after oral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14813,10116.0,N,1969.0,CHEMBL623289,,,,Plasma,11772,1,Plasma drug Cmax in rat (PO dose),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12536,,U,,CHEMBL623290,,,,,11773,0,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14169,9615.0,N,1969.0,CHEMBL623291,,,,Plasma,11774,1,maximum Plasma concentration in Dog was determined after Peroral administration,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14169,10116.0,N,1969.0,CHEMBL623292,,,,Plasma,11775,1,maximum Plasma concentration in Rats was determined after Peroral administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15604,9615.0,N,1969.0,CHEMBL623293,,,,Plasma,11776,1,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
15604,314293.0,U,1969.0,CHEMBL623294,,,,Plasma,11777,0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
15604,10116.0,N,1969.0,CHEMBL623295,,,,Plasma,11778,1,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14387,10090.0,N,,CHEMBL623296,,,,,11779,1,maximum concentration was measured when administered through oral route in mice,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15115,10090.0,N,,CHEMBL875349,,,,,11780,1,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15115,314293.0,U,,CHEMBL623297,,,,,11781,0,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,Autocuration,22224,,BAO_0000019,,,Simiiformes,1,,A
15115,314293.0,U,,CHEMBL623298,,,,,11782,0,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,Autocuration,22224,,BAO_0000019,,,Simiiformes,1,,A
15115,314293.0,U,,CHEMBL623299,,,,,11783,0,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,Autocuration,22224,,BAO_0000019,,,Simiiformes,1,,A
16359,10116.0,N,,CHEMBL623300,,,,,11784,1,Pharmacokinetic parameter was evaluated in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12829,10090.0,N,,CHEMBL623301,,,,,11785,1,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12829,10090.0,N,,CHEMBL623302,,,,,11786,1,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12829,10090.0,N,,CHEMBL623303,,,,,11787,1,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12829,10090.0,N,,CHEMBL623304,,,,,11788,1,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12829,10090.0,N,,CHEMBL623305,,,,,11789,1,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15137,10116.0,N,1969.0,CHEMBL623306,,,,Plasma,11790,1,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15137,10116.0,N,1969.0,CHEMBL623307,,,,Plasma,11791,1,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15137,10116.0,N,1969.0,CHEMBL623308,,,,Plasma,11792,1,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15137,10090.0,N,1969.0,CHEMBL623309,,,,Plasma,11793,1,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13509,10090.0,N,,CHEMBL623310,,,,,11794,1,Plasma Concentration after 120 min of oral administration to mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13509,10090.0,N,,CHEMBL623311,,,,,11795,1,Plasma Concentration after 30 min of oral administration to mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13509,9541.0,N,,CHEMBL623312,,,,,11796,1,Plasma Concentration after 60 min of oral administration to mice,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
13509,10090.0,N,,CHEMBL875350,,,,,11797,1,Plasma Concentration after 60 min of oral administration to mice; Not determined,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13509,10090.0,N,,CHEMBL628635,,,,,11798,1,Plasma Concentration after 90 min of oral administration to mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12064,10116.0,N,,CHEMBL628636,,,,,11799,1,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12064,10116.0,N,,CHEMBL628637,,,,,11800,1,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12064,10116.0,N,,CHEMBL628058,,,,,11801,1,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10677,10116.0,N,,CHEMBL628059,,,,,11802,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10677,10116.0,N,,CHEMBL628060,,,,,11803,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8926,,U,,CHEMBL628061,,,,,11804,0,Distribution in the lung after 15 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628062,,,,,11805,0,Distribution in the lung after 30 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628063,,,,,11806,0,Distribution in the lung after 5 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628064,,,,,11807,0,Distribution in the lung after 60 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,,CHEMBL628065,,,,,11808,0,Distribution in the lung after 90 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2385.0,CHEMBL628066,,,,Muscle tissue,11809,0,Distribution in the muscle after 120 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2385.0,CHEMBL628067,,,,Muscle tissue,11810,0,Distribution in the muscle after 15 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,10090.0,N,2385.0,CHEMBL874646,,,,Muscle tissue,11811,1,Distribution in the muscle after 30 min of intravenous administration,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8926,,U,2385.0,CHEMBL628068,,,,Muscle tissue,11812,0,Distribution in the muscle after 5 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2385.0,CHEMBL628069,,,,Muscle tissue,11813,0,Distribution in the muscle after 60 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2385.0,CHEMBL628070,,,,Muscle tissue,11814,0,Distribution in the muscle after 90 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2106.0,CHEMBL628071,,,,Spleen,11815,0,Distribution in the spleen after 120 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2106.0,CHEMBL628072,,,,Spleen,11816,0,Distribution in the spleen after 15 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2106.0,CHEMBL628073,,,,Spleen,11817,0,Distribution in the spleen after 30 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2106.0,CHEMBL628074,,,,Spleen,11818,0,Distribution in the spleen after 5 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2106.0,CHEMBL628075,,,,Spleen,11819,0,Distribution in the spleen after 60 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
8926,,U,2106.0,CHEMBL628076,,,,Spleen,11820,0,Distribution in the spleen after 90 min of intravenous administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,10116.0,N,1235.0,CHEMBL628077,,,,Adrenal cortex,11821,1,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7570,10116.0,N,178.0,CHEMBL628078,,,,Blood,11822,1,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7570,10116.0,N,2107.0,CHEMBL628079,,,,Liver,11823,1,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7570,10116.0,N,992.0,CHEMBL628080,,,,Female gonad,11824,1,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7570,10116.0,N,2046.0,CHEMBL628081,,,,Thyroid gland,11825,1,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7570,10116.0,N,1235.0,CHEMBL628082,,,,Adrenal cortex,11826,1,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7570,10116.0,N,178.0,CHEMBL874647,,,,Blood,11827,1,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7570,10116.0,N,2107.0,CHEMBL626406,,,,Liver,11828,1,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7570,10116.0,N,992.0,CHEMBL626407,,,,Female gonad,11829,1,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7570,10116.0,N,2046.0,CHEMBL626408,,,,Thyroid gland,11830,1,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL626409,,,,Blood,11831,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL626410,,,,Blood,11832,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL626411,,,,Blood,11833,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL626412,,,,Blood,11834,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL626413,,,,Blood,11835,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL626414,,,,Blood,11836,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL626415,,,,Blood,11837,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL626416,,,,Blood,11838,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL627062,,,,Blood,11839,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL627063,,,,Blood,11840,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL627064,,,,Blood,11841,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL627227,,,,Blood,11842,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL627228,,,,Blood,11843,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL627229,,,,Blood,11844,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL625792,,,,Blood,11845,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL625793,,,,Blood,11846,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL625794,,,,Blood,11847,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,178.0,CHEMBL625795,,,,Blood,11848,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13792,10090.0,N,,CHEMBL625796,,,,,11849,1,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13376,9615.0,N,,CHEMBL625797,,,,,11850,1,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
13376,9615.0,N,,CHEMBL625798,,,,,11851,1,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14380,,U,,CHEMBL875613,,,,,11852,0,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14380,,U,,CHEMBL625799,,,,,11853,0,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14380,,U,,CHEMBL625800,,,,,11854,0,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14380,,U,,CHEMBL625801,,,,,11855,0,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14380,,U,,CHEMBL625802,,,,,11856,0,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14380,,U,,CHEMBL625803,,,,,11857,0,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14380,,U,,CHEMBL625804,,,,,11858,0,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,Autocuration,22224,,BAO_0000019,,,,1,,A
14380,,U,,CHEMBL622530,,,,,11859,0,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,Autocuration,22224,,BAO_0000218,,,,1,,A
13701,10090.0,N,,CHEMBL622531,,,,,11860,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL622532,,,,,11861,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL623176,,,,,11862,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL623177,,,,,11863,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL623178,,,,,11864,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL623179,,,,,11865,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL623180,,,,,11866,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL623181,,,,,11867,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL624131,,,,,11868,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL624132,,,,,11869,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL624133,,,,,11870,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL624846,,,,,11871,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL624847,,,,,11872,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL624848,,,,,11873,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625012,,,,,11874,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625013,,,,,11875,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625014,,,,,11876,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625015,,,,,11877,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625016,,,,,11878,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625017,,,,,11879,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625018,,,,,11880,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625019,,,,,11881,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625020,,,,,11882,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13701,10090.0,N,,CHEMBL625021,,,,,11883,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14393,10116.0,N,,CHEMBL625022,,,,,11884,1,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14731,10090.0,N,,CHEMBL625023,,,,,11885,1,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14731,9541.0,N,,CHEMBL625024,,,,,11886,1,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
14731,9541.0,N,,CHEMBL627626,,,,,11887,1,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
13758,,U,955.0,CHEMBL627627,,,,Brain,11888,0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,Autocuration,22224,,BAO_0000218,,,,1,,A
13758,,U,1977.0,CHEMBL627628,,,,Serum,11889,0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,Autocuration,22224,,BAO_0000218,,,,1,,A
13758,,U,955.0,CHEMBL627629,,,,Brain,11890,0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,Autocuration,22224,,BAO_0000218,,,,1,,A
13758,,U,1977.0,CHEMBL627630,,,,Serum,11891,0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,Autocuration,22224,,BAO_0000218,,,,1,,A
16359,,U,,CHEMBL627631,,,,,11892,0,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,Autocuration,22224,,BAO_0000019,,,,1,,A
16359,,U,,CHEMBL629515,,,,,11893,0,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,Autocuration,22224,,BAO_0000218,,,,1,,A
15383,10090.0,N,2106.0,CHEMBL629516,,,,Spleen,11894,1,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2106.0,CHEMBL629517,,,,Spleen,11895,1,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,2106.0,CHEMBL629518,,,,Spleen,11896,1,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL877499,,,,,11897,1,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL629519,,,,,11898,1,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL629520,,,,,11899,1,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
15383,10090.0,N,,CHEMBL629521,,,,,11900,1,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629522,,,,,11901,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629523,,,,,11902,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629524,,,,,11903,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629525,,,,,11904,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629526,,,,,11905,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629527,,,,,11906,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629528,,,,,11907,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629529,,,,,11908,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629530,,,,,11909,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL629531,,,,,11910,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628656,,,,,11911,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628657,,,,,11912,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13751,10116.0,N,,CHEMBL628658,,,,,11913,1,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL628659,,,,,11914,1,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL877500,,,,,11915,1,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL628660,,,,,11916,1,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL628661,,,,,11917,1,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL628662,,,,,11918,1,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL628663,,,,,11919,1,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL628664,,,,,11920,1,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,178.0,CHEMBL628665,,,,Blood,11921,1,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,178.0,CHEMBL628666,,,,Blood,11922,1,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,178.0,CHEMBL628667,,,,Blood,11923,1,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,178.0,CHEMBL628668,,,,Blood,11924,1,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,178.0,CHEMBL628669,,,,Blood,11925,1,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,178.0,CHEMBL628670,,,,Blood,11926,1,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,178.0,CHEMBL628671,,,,Blood,11927,1,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,10000001.0,CHEMBL628672,,,,Bone,11928,1,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,10000001.0,CHEMBL630300,,,,Bone,11929,1,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,10000001.0,CHEMBL629787,,,,Bone,11930,1,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,10000001.0,CHEMBL629788,,,,Bone,11931,1,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,955.0,CHEMBL629789,,,,Brain,11932,1,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,955.0,CHEMBL629790,,,,Brain,11933,1,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,955.0,CHEMBL629791,,,,Brain,11934,1,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,955.0,CHEMBL629792,,,,Brain,11935,1,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,955.0,CHEMBL629793,,,,Brain,11936,1,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,955.0,CHEMBL629794,,,,Brain,11937,1,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10677,10116.0,N,,CHEMBL874459,,,,,11938,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10677,10116.0,N,,CHEMBL629795,,,,,11939,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10677,10116.0,N,,CHEMBL629796,,,,,11940,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10677,10116.0,N,,CHEMBL629797,,,,,11941,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10677,10116.0,N,,CHEMBL629798,,,,,11942,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10911,10116.0,N,2369.0,CHEMBL629799,,,,Adrenal gland,11943,1,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2369.0,CHEMBL629800,,,,Adrenal gland,11944,1,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2369.0,CHEMBL629801,,,,Adrenal gland,11945,1,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2369.0,CHEMBL629802,,,,Adrenal gland,11946,1,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2369.0,CHEMBL629803,,,,Adrenal gland,11947,1,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,178.0,CHEMBL629804,,,,Blood,11948,1,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,178.0,CHEMBL629805,,,,Blood,11949,1,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,178.0,CHEMBL629806,,,,Blood,11950,1,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,178.0,CHEMBL629807,,,,Blood,11951,1,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,178.0,CHEMBL629808,,,,Blood,11952,1,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,955.0,CHEMBL629809,,,,Brain,11953,1,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,955.0,CHEMBL629810,,,,Brain,11954,1,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,955.0,CHEMBL629811,,,,Brain,11955,1,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,955.0,CHEMBL629812,,,,Brain,11956,1,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,955.0,CHEMBL629813,,,,Brain,11957,1,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,955.0,CHEMBL874460,,,,Brain,11958,1,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,,CHEMBL629814,,,,,11959,1,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,,CHEMBL629815,,,,,11960,1,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,,CHEMBL629816,,,,,11961,1,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,,CHEMBL629817,,,,,11962,1,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2113.0,CHEMBL626643,,,,Kidney,11963,1,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2113.0,CHEMBL626644,,,,Kidney,11964,1,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2113.0,CHEMBL626806,,,,Kidney,11965,1,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2113.0,CHEMBL626807,,,,Kidney,11966,1,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2107.0,CHEMBL627261,,,,Liver,11967,1,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2107.0,CHEMBL627262,,,,Liver,11968,1,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2107.0,CHEMBL627263,,,,Liver,11969,1,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2107.0,CHEMBL627264,,,,Liver,11970,1,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2048.0,CHEMBL627265,,,,Lung,11971,1,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2048.0,CHEMBL627266,,,,Lung,11972,1,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2048.0,CHEMBL627267,,,,Lung,11973,1,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2048.0,CHEMBL627268,,,,Lung,11974,1,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2385.0,CHEMBL627269,,,,Muscle tissue,11975,1,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2385.0,CHEMBL627270,,,,Muscle tissue,11976,1,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627271,,,,,11977,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627946,,,,,11978,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL875472,,,,,11979,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627947,,,,,11980,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627948,,,,,11981,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628113,,,,,11982,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628114,,,,,11983,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628115,,,,,11984,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628116,,,,,11985,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628117,,,,,11986,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628118,,,,,11987,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628119,,,,,11988,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628120,,,,,11989,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628121,,,,,11990,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL628122,,,,,11991,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627297,,,,,11992,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627298,,,,,11993,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627299,,,,,11994,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627300,,,,,11995,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627301,,,,,11996,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627302,,,,,11997,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627303,,,,,11998,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627304,,,,,11999,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627305,,,,,12000,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL627306,,,,,12001,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL623982,,,,,12002,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL623983,,,,,12003,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL623984,,,,,12004,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL623985,,,,,12005,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL623986,,,,,12006,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL623987,,,,,12007,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL623988,,,,,12008,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL623989,,,,,12009,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL622215,,,,,12010,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL622216,,,,,12011,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,,CHEMBL877481,,,,,12012,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16359,,U,,CHEMBL622217,,,,,12013,0,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,Autocuration,22224,,BAO_0000218,,,,1,,A
13701,10090.0,N,,CHEMBL622218,,,,,12014,1,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14554,10116.0,N,,CHEMBL622219,,,,,12015,1,Pharmacokinetic profile AUC was evaluated in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6241,,U,,CHEMBL622220,,,,,12016,0,Pharmacokinetic property (Area under curve),,Autocuration,22224,,BAO_0000019,,,,1,,A
11537,9615.0,N,,CHEMBL622221,,,,,12017,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
11537,10090.0,N,,CHEMBL622222,,,,,12018,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
11537,9615.0,N,,CHEMBL622223,,,,,12019,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
11537,10090.0,N,,CHEMBL622224,,,,,12020,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13118,,U,,CHEMBL622225,,,,,12021,0,Plasma concentration (AUC) was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
13118,,U,,CHEMBL622226,,,,,12022,0,Plasma concentration (AUC) was determined; Not detectable,,Autocuration,22224,,BAO_0000019,,,,1,,A
9562,10141.0,N,,CHEMBL624154,,,,,12023,1,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
10363,10116.0,N,,CHEMBL624155,,,,,12024,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10363,10116.0,N,,CHEMBL624156,,,,,12025,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10363,10116.0,N,,CHEMBL624157,,,,,12026,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10363,10116.0,N,,CHEMBL624158,,,,,12027,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12504,10116.0,N,,CHEMBL624159,,,,,12028,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12504,10116.0,N,,CHEMBL624160,,,,,12029,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12504,10116.0,N,,CHEMBL624161,,,,,12030,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12504,10116.0,N,,CHEMBL624162,,,,,12031,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13317,9615.0,N,,CHEMBL624163,,,,,12032,1,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15078,10116.0,N,,CHEMBL624164,,,,,12033,1,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14941,10116.0,N,,CHEMBL624165,,,,,12034,1,The AUC(0-infinity) values in female wistar rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL624166,,,,,12035,1,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL624167,,,,,12036,1,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14941,10116.0,N,,CHEMBL624168,,,,,12037,1,The AUC(0-t)values in female wistar rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14067,10116.0,N,,CHEMBL624169,,,,,12038,1,The Area under the concentration time curve of compound was measured on rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14215,9606.0,N,,CHEMBL624170,,,,,12039,1,The area under curve (100 mg/kg) administered orally in humans,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
14215,9481.0,U,,CHEMBL624171,,,,,12040,0,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,Autocuration,22224,,BAO_0000218,,,Callithrix,1,,A
14215,314293.0,U,,CHEMBL624172,,,,,12041,0,The area under curve (12.5 mg/kg) administered intravenously in monkey,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
14215,9615.0,N,,CHEMBL624173,,,,,12042,1,The area under curve (15 mg/kg) administered intravenously in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14215,9606.0,N,,CHEMBL877488,,,,,12043,1,The area under curve (200 mg/kg) administered orally in humans,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
14215,10116.0,N,,CHEMBL624174,,,,,12044,1,The area under curve (25 mg/kg) administered intravenously in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14215,9481.0,U,,CHEMBL624175,,,,,12045,0,The area under curve (25 mg/kg) administered orally in marmoset,,Autocuration,22224,,BAO_0000218,,,Callithrix,1,,A
14215,314293.0,U,,CHEMBL624176,,,,,12046,0,The area under curve (25 mg/kg) administered orally in monkey,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
14215,9615.0,N,,CHEMBL624177,,,,,12047,1,The area under curve (30 mg/kg) administered orally in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14215,9606.0,N,,CHEMBL624178,,,,,12048,1,The area under curve (400 mg/kg) administered orally in humans,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
14215,10116.0,N,,CHEMBL624179,,,,,12049,1,The area under curve (50 mg/kg) administered orally in fasted rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14215,10116.0,N,,CHEMBL627689,,,,,12050,1,The area under curve (50 mg/kg) administered orally in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14215,9606.0,N,,CHEMBL627690,,,,,12051,1,The area under curve (800 mg/kg) administered orally in humans,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
11324,,U,,CHEMBL627691,,,,,12052,0,The compound was evaluated for area under the curve,,Autocuration,22224,,BAO_0000019,,,,1,,A
11324,9481.0,U,,CHEMBL627692,,,,,12053,0,The compound was evaluated for area under the curve in marmosets,,Autocuration,22224,,BAO_0000019,,,Callithrix,1,,A
11324,9481.0,U,,CHEMBL627693,,,,,12054,0,The compound was evaluated for area under the curve in marmosets,,Autocuration,22224,,BAO_0000019,,,Callithrix,1,,A
13875,10116.0,N,,CHEMBL627694,,,,,12055,1,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13875,10116.0,N,,CHEMBL627695,,,,,12056,1,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13875,,U,,CHEMBL627696,,,,,12057,0,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,Autocuration,22224,,BAO_0000218,,,,1,,A
13875,10116.0,N,,CHEMBL627697,,,,,12058,1,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13875,10116.0,N,,CHEMBL627698,,,,,12059,1,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13875,10116.0,N,,CHEMBL627699,,,,,12060,1,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13807,10116.0,N,,CHEMBL627700,,,,,12061,1,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14127,10116.0,N,,CHEMBL627701,,,,,12062,1,Total drug exposure is determined after oral dosing in rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15116,,U,,CHEMBL627702,,,,,12063,0,Total drug exposure (5 mg/kg) when administered intravenously,,Autocuration,22224,,BAO_0000218,,,,1,,A
15116,,U,,CHEMBL627703,,,,,12064,0,Total drug exposure (5 mg/kg) when administered orally,,Autocuration,22224,,BAO_0000218,,,,1,,A
15604,314293.0,U,,CHEMBL626873,,,,,12065,0,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
15604,10116.0,N,,CHEMBL629583,,,,,12066,1,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15604,9615.0,N,,CHEMBL629584,,,,,12067,1,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15604,9615.0,N,,CHEMBL629585,,,,,12068,1,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
13751,10116.0,N,955.0,CHEMBL629586,,,,Brain,12069,1,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,955.0,CHEMBL629587,,,,Brain,12070,1,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL629588,,,,,12071,1,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL629589,,,,,12072,1,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL629590,,,,,12073,1,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL629591,,,,,12074,1,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL629592,,,,,12075,1,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL629593,,,,,12076,1,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL629594,,,,,12077,1,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,948.0,CHEMBL629595,,,,Heart,12078,1,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,948.0,CHEMBL630290,,,,Heart,12079,1,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,948.0,CHEMBL627137,,,,Heart,12080,1,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,948.0,CHEMBL627138,,,,Heart,12081,1,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,948.0,CHEMBL627139,,,,Heart,12082,1,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,948.0,CHEMBL627140,,,,Heart,12083,1,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,948.0,CHEMBL627141,,,,Heart,12084,1,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2113.0,CHEMBL627142,,,,Kidney,12085,1,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2113.0,CHEMBL627143,,,,Kidney,12086,1,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2113.0,CHEMBL874449,,,,Kidney,12087,1,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2113.0,CHEMBL627144,,,,Kidney,12088,1,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2113.0,CHEMBL627145,,,,Kidney,12089,1,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2113.0,CHEMBL627146,,,,Kidney,12090,1,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2113.0,CHEMBL627147,,,,Kidney,12091,1,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2107.0,CHEMBL627148,,,,Liver,12092,1,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2048.0,CHEMBL627149,,,,Lung,12093,1,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2048.0,CHEMBL632160,,,,Lung,12094,1,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2048.0,CHEMBL632161,,,,Lung,12095,1,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2048.0,CHEMBL632162,,,,Lung,12096,1,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2048.0,CHEMBL632163,,,,Lung,12097,1,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2048.0,CHEMBL874469,,,,Lung,12098,1,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2048.0,CHEMBL627182,,,,Lung,12099,1,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2385.0,CHEMBL627183,,,,Muscle tissue,12100,1,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2385.0,CHEMBL627184,,,,Muscle tissue,12101,1,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2385.0,CHEMBL627185,,,,Muscle tissue,12102,1,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2385.0,CHEMBL627186,,,,Muscle tissue,12103,1,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2385.0,CHEMBL627187,,,,Muscle tissue,12104,1,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2385.0,CHEMBL627188,,,,Muscle tissue,12105,1,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2385.0,CHEMBL627189,,,,Muscle tissue,12106,1,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,,CHEMBL627190,,,,,12107,1,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2107.0,CHEMBL627191,,,,Liver,12108,1,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2107.0,CHEMBL627192,,,,Liver,12109,1,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2107.0,CHEMBL627193,,,,Liver,12110,1,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2385.0,CHEMBL874590,,,,Muscle tissue,12111,1,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2385.0,CHEMBL627194,,,,Muscle tissue,12112,1,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2385.0,CHEMBL627195,,,,Muscle tissue,12113,1,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,992.0,CHEMBL627196,,,,Female gonad,12114,1,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,992.0,CHEMBL627197,,,,Female gonad,12115,1,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,992.0,CHEMBL627198,,,,Female gonad,12116,1,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,992.0,CHEMBL627199,,,,Female gonad,12117,1,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,992.0,CHEMBL627200,,,,Female gonad,12118,1,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,1969.0,CHEMBL627201,,,,Plasma,12119,1,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,1969.0,CHEMBL627202,,,,Plasma,12120,1,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,1969.0,CHEMBL627203,,,,Plasma,12121,1,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,1969.0,CHEMBL627204,,,,Plasma,12122,1,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2106.0,CHEMBL627205,,,,Spleen,12123,1,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2106.0,CHEMBL627206,,,,Spleen,12124,1,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2106.0,CHEMBL627207,,,,Spleen,12125,1,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2106.0,CHEMBL627208,,,,Spleen,12126,1,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2046.0,CHEMBL627209,,,,Thyroid gland,12127,1,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2046.0,CHEMBL627210,,,,Thyroid gland,12128,1,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2046.0,CHEMBL627211,,,,Thyroid gland,12129,1,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,2046.0,CHEMBL627212,,,,Thyroid gland,12130,1,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,995.0,CHEMBL627213,,,,Uterus,12131,1,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,995.0,CHEMBL626599,,,,Uterus,12132,1,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,995.0,CHEMBL626600,,,,Uterus,12133,1,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10911,10116.0,N,995.0,CHEMBL626601,,,,Uterus,12134,1,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8081,,U,,CHEMBL627484,,,,,12135,0,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
17248,9541.0,N,1969.0,CHEMBL627485,,,,Plasma,12136,1,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
17248,9541.0,N,1969.0,CHEMBL628147,,,,Plasma,12137,1,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
17248,9541.0,N,1969.0,CHEMBL628148,,,,Plasma,12138,1,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
17248,9615.0,N,1969.0,CHEMBL628149,,,,Plasma,12139,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
17248,9615.0,N,1969.0,CHEMBL628150,,,,Plasma,12140,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
17248,9615.0,N,1969.0,CHEMBL628318,,,,Plasma,12141,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
17248,9615.0,N,1969.0,CHEMBL628319,,,,Plasma,12142,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15592,9615.0,N,,CHEMBL875609,,,,,12143,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
7040,,U,,CHEMBL628320,,,,,12144,0,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,Autocuration,22224,,BAO_0000019,,,,1,,A
7040,,U,,CHEMBL628321,,,,,12145,0,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,Autocuration,22224,,BAO_0000019,,,,1,,A
7040,,U,,CHEMBL628322,,,,,12146,0,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,Autocuration,22224,,BAO_0000019,,,,1,,A
7040,,U,,CHEMBL628323,,,,,12147,0,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,Autocuration,22224,,BAO_0000019,,,,1,,A
7040,,U,,CHEMBL628324,,,,,12148,0,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,Autocuration,22224,,BAO_0000019,,,,1,,A
7040,,U,,CHEMBL628325,,,,,12149,0,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,Autocuration,22224,,BAO_0000019,,,,1,,A
7040,,U,,CHEMBL628326,,,,,12150,0,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,Autocuration,22224,,BAO_0000019,,,,1,,A
9614,9615.0,N,1236.0,CHEMBL628327,,,,Adrenal medulla,12151,1,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,1236.0,CHEMBL628328,,,,Adrenal medulla,12152,1,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,178.0,CHEMBL628329,,,,Blood,12153,1,"Concentration of compound in blood of dog 1, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8608,10116.0,N,2107.0,CHEMBL628330,,,,Liver,12154,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628331,,,,Liver,12155,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628332,,,,Liver,12156,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628333,,,,Liver,12157,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628334,,,,Liver,12158,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628335,,,,Liver,12159,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628336,,,,Liver,12160,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628337,,,,Liver,12161,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628338,,,,Liver,12162,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL875610,,,,Liver,12163,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628339,,,,Liver,12164,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628340,,,,Liver,12165,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL628341,,,,Liver,12166,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL622214,,,,Liver,12167,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL623167,,,,Liver,12168,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL623168,,,,Liver,12169,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL623169,,,,Liver,12170,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2107.0,CHEMBL623170,,,,Liver,12171,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL627224,,,,Lung,12172,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL875634,,,,Lung,12173,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL627225,,,,Lung,12174,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL627226,,,,Lung,12175,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626083,,,,Lung,12176,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626084,,,,Lung,12177,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626085,,,,Lung,12178,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626086,,,,Lung,12179,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626087,,,,Lung,12180,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626088,,,,Lung,12181,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626089,,,,Lung,12182,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626090,,,,Lung,12183,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626091,,,,Lung,12184,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626092,,,,Lung,12185,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626093,,,,Lung,12186,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626094,,,,Lung,12187,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626095,,,,Lung,12188,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2048.0,CHEMBL626096,,,,Lung,12189,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15604,314293.0,U,,CHEMBL626097,,,,,12190,0,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
15604,10116.0,N,,CHEMBL626098,,,,,12191,1,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1806,,U,1969.0,CHEMBL626099,,,,Plasma,12192,0,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,Autocuration,22224,,BAO_0000218,,,,1,,A
1806,,U,1969.0,CHEMBL626100,,,,Plasma,12193,0,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,Autocuration,22224,,BAO_0000218,,,,1,,A
17237,9615.0,N,1969.0,CHEMBL626101,,,,Plasma,12194,1,AUC 0-inf in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
17237,10141.0,N,1969.0,CHEMBL626102,,,,Plasma,12195,1,AUC 0-inf in guinea pig,,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
17237,9615.0,N,1969.0,CHEMBL626103,,,,Plasma,12196,1,AUC 0-t in dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
17237,10141.0,N,1969.0,CHEMBL628391,,,,Plasma,12197,1,AUC 0-t in guinea pig,,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
15194,10116.0,N,,CHEMBL628392,,,,,12198,1,The compound was tested for brain to plasma partition in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15194,10116.0,N,,CHEMBL628393,,,,,12199,1,The compound was tested for brain to plasma partition in rat.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8787,,U,178.0,CHEMBL628394,,,,Blood,12200,0,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,Autocuration,22224,,BAO_0000019,,,,1,,A
17025,9615.0,N,,CHEMBL628395,,,,,12201,1,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
17025,314293.0,U,,CHEMBL628396,,,,,12202,0,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
17025,9986.0,N,,CHEMBL628397,,,,,12203,1,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
17025,10116.0,N,,CHEMBL628398,,,,,12204,1,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4236,9544.0,N,,CHEMBL628399,,,,,12205,1,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,Intermediate,50797,,BAO_0000218,,,Macaca mulatta,1,,A
15343,9615.0,N,,CHEMBL628400,,,,,12206,1,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15343,10116.0,N,,CHEMBL874907,,,,,12207,1,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17720,,U,,CHEMBL628401,,,,,12208,0,Area under curve of the compound was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
17788,314293.0,U,1969.0,CHEMBL628402,,,,Plasma,12209,0,AUC in monkeys at a dose of 1 mg/kg,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
17788,10116.0,N,1969.0,CHEMBL628403,,,,Plasma,12210,1,AUC in rats at a dose of 1 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8778,,U,,CHEMBL628404,,,,,12211,0,Compound was evaluated for the overall absorbance loss at pH of 2,,Autocuration,22224,,BAO_0000019,,,,1,,A
8778,,U,,CHEMBL628405,,,,,12212,0,Compound was evaluated for the overall absorbance loss at pH of 4,,Autocuration,22224,,BAO_0000019,,,,1,,A
8778,,U,,CHEMBL628406,,,,,12213,0,Compound was evaluated for the overall absorbance loss at pH of 7,,Autocuration,22224,,BAO_0000019,,,,1,,A
2249,10116.0,N,,CHEMBL628407,,,,,12214,1,Compound was evaluated for its absorption in the rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8881,10116.0,N,1088.0,CHEMBL628408,,,,Urine,12215,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8881,10116.0,N,1088.0,CHEMBL629171,,,,Urine,12216,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8881,10116.0,N,1088.0,CHEMBL629172,,,,Urine,12217,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8881,10116.0,N,1088.0,CHEMBL629173,,,,Urine,12218,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL629174,,,,,12219,1,In vitro percent permeability into rat ileum,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL629175,,,,,12220,1,In vitro percent permeability into rat ileum; Range is 10-17,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL629176,,,,,12221,1,In vitro percent permeability into rat ileum; Range is 10-18,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL629177,,,,,12222,1,In vitro percent permeability into rat ileum; Range is 10-19,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL629178,,,,,12223,1,In vitro percent permeability into rat ileum; Range is 12-15,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631869,,,,,12224,1,In vitro percent permeability into rat ileum; Range is 13-19,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631870,,,,,12225,1,In vitro percent permeability into rat ileum; Range is 14-17,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631871,,,,,12226,1,In vitro percent permeability into rat ileum; Range is 15-18,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631872,,,,,12227,1,In vitro percent permeability into rat ileum; Range is 2-5,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,,U,2116.0,CHEMBL875775,,,,Ileum,12228,0,In vitro percent permeability into rat ileum; Range is 23-42,,Autocuration,22224,,BAO_0000221,,,,1,,A
15286,10116.0,N,,CHEMBL631873,,,,,12229,1,In vitro percent permeability into rat ileum; Range is 28-36,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631874,,,,,12230,1,In vitro percent permeability into rat ileum; Range is 29-35,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631875,,,,,12231,1,In vitro percent permeability into rat ileum; Range is 46-66,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631876,,,,,12232,1,In vitro percent permeability into rat ileum; Range is 50-68,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631877,,,,,12233,1,In vitro percent permeability into rat ileum; Range is 78-81,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631878,,,,,12234,1,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631879,,,,,12235,1,In vitro percent permeability into rat ileum; nd indicates not detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631880,,,,,12236,1,In vitro percent permeability into rat ileum; nt indicates not detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15286,10116.0,N,,CHEMBL631881,,,,,12237,1,In vitro percent permeability into rat ileum; nt indicates not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13770,10116.0,N,,CHEMBL631882,,,,,12238,1,Compound was tested for oral absorption in bile-duct cannulated rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13770,10116.0,N,,CHEMBL630749,,,,,12239,1,Compound was tested for oral absorption in bile-duct cannulated rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5202,9606.0,N,,CHEMBL630750,,,,,12240,1,Oral absorption using Caco-2 cell monolayers.,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
14920,9606.0,N,,CHEMBL630253,,,,,12241,1,Percent of the drug absorbed after administration to humans was determined,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
14103,10116.0,N,1969.0,CHEMBL630254,,,,Plasma,12242,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL630255,,,,Plasma,12243,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL630256,,,,Plasma,12244,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13751,10116.0,N,2107.0,CHEMBL875781,,,,Liver,12245,1,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2107.0,CHEMBL630257,,,,Liver,12246,1,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13751,10116.0,N,2107.0,CHEMBL630258,,,,Liver,12247,1,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15807,10116.0,N,,CHEMBL630259,,,,,12248,1,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15807,10116.0,N,2435.0,CHEMBL630260,,,,Striatum,12249,1,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15807,10116.0,N,2435.0,CHEMBL630261,,,,Striatum,12250,1,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630262,,,,,12251,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630263,,,,,12252,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630264,,,,,12253,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630265,,,,,12254,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630266,,,,,12255,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2113.0,CHEMBL630267,,,,Kidney,12256,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2113.0,CHEMBL630268,,,,Kidney,12257,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630269,,,,,12258,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630270,,,,,12259,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2048.0,CHEMBL630141,,,,Lung,12260,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2048.0,CHEMBL630142,,,,Lung,12261,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2385.0,CHEMBL630143,,,,Muscle tissue,12262,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2385.0,CHEMBL630144,,,,Muscle tissue,12263,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2367.0,CHEMBL630145,,,,Prostate gland,12264,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2367.0,CHEMBL630146,,,,Prostate gland,12265,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630147,,,,,12266,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630148,,,,,12267,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL630149,,,,,12268,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2106.0,CHEMBL630150,,,,Spleen,12269,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2106.0,CHEMBL630151,,,,Spleen,12270,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2046.0,CHEMBL632031,,,,Thyroid gland,12271,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2046.0,CHEMBL632032,,,,Thyroid gland,12272,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL632033,,,,,12273,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL632034,,,,,12274,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2385.0,CHEMBL632035,,,,Muscle tissue,12275,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,,CHEMBL632036,,,,,12276,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14950,10116.0,N,2046.0,CHEMBL632037,,,,Thyroid gland,12277,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL632038,,,,Blood,12278,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL632039,,,,Blood,12279,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL632040,,,,Blood,12280,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL632041,,,,Blood,12281,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9614,9615.0,N,178.0,CHEMBL632042,,,,Blood,12282,1,"Concentration of compound in blood of dog 2, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,,CHEMBL632043,,,,,12283,1,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,,CHEMBL632044,,,,,12284,1,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,2107.0,CHEMBL632045,,,,Liver,12285,1,"Concentration of compound in liver of dog 1, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,2107.0,CHEMBL632046,,,,Liver,12286,1,"Concentration of compound in liver of dog 2, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,2048.0,CHEMBL632047,,,,Lung,12287,1,"Concentration of compound in lung of dog 1, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,2048.0,CHEMBL632048,,,,Lung,12288,1,"Concentration of compound in lung of dog 2, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,2385.0,CHEMBL632049,,,,Muscle tissue,12289,1,"Concentration of compound in muscle of dog 1, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,2385.0,CHEMBL876418,,,,Muscle tissue,12290,1,"Concentration of compound in muscle of dog 2, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,2106.0,CHEMBL632050,,,,Spleen,12291,1,"Concentration of compound in spleen of dog 1,after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9614,9615.0,N,2106.0,CHEMBL632051,,,,Spleen,12292,1,"Concentration of compound in spleen of dog 2, after administering intravenously",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
10353,,U,,CHEMBL632052,,,,,12293,0,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,Autocuration,22224,,BAO_0000218,,,,1,,F
10353,,U,,CHEMBL632053,,,,,12294,0,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,Autocuration,22224,,BAO_0000218,,,,1,,F
10353,,U,,CHEMBL632054,,,,,12295,0,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,Autocuration,22224,,BAO_0000218,,,,1,,A
10353,,U,,CHEMBL632055,,,,,12296,0,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,Autocuration,22224,,BAO_0000218,,,,1,,F
10353,,U,,CHEMBL631181,,,,,12297,0,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,Autocuration,22224,,BAO_0000218,,,,1,,F
9196,,U,,CHEMBL631182,,,,,12298,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL631183,,,,,12299,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL631184,,,,,12300,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL629774,,,,,12301,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL629775,,,,,12302,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL876549,,,,,12303,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628172,,,,,12304,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628173,,,,,12305,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628174,,,,,12306,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628175,,,,,12307,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628176,,,,,12308,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628177,,,,,12309,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628178,,,,,12310,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628179,,,,,12311,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628180,,,,,12312,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628181,,,,,12313,0,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628182,,,,,12314,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628183,,,,,12315,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628184,,,,,12316,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628185,,,,,12317,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL875617,,,,,12318,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628186,,,,,12319,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628187,,,,,12320,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628188,,,,,12321,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628189,,,,,12322,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628190,,,,,12323,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628191,,,,,12324,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626513,,,,,12325,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,Autocuration,22224,,BAO_0000218,,,,1,,A
8608,10116.0,N,2046.0,CHEMBL626514,,,,Thyroid gland,12326,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626515,,,,Thyroid gland,12327,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626516,,,,Thyroid gland,12328,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626517,,,,Thyroid gland,12329,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626518,,,,Thyroid gland,12330,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626519,,,,Thyroid gland,12331,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626520,,,,Thyroid gland,12332,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626521,,,,Thyroid gland,12333,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626522,,,,Thyroid gland,12334,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626523,,,,Thyroid gland,12335,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626524,,,,Thyroid gland,12336,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626688,,,,Thyroid gland,12337,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626689,,,,Thyroid gland,12338,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626690,,,,Thyroid gland,12339,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL626691,,,,Thyroid gland,12340,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL627319,,,,Thyroid gland,12341,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL624052,,,,Thyroid gland,12342,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8608,10116.0,N,2046.0,CHEMBL624053,,,,Thyroid gland,12343,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,,CHEMBL624054,,,,,12344,1,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,,CHEMBL624055,,,,,12345,1,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,,CHEMBL624056,,,,,12346,1,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,995.0,CHEMBL624057,,,,Uterus,12347,1,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,995.0,CHEMBL622281,,,,Uterus,12348,1,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,995.0,CHEMBL622282,,,,Uterus,12349,1,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,995.0,CHEMBL622283,,,,Uterus,12350,1,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,995.0,CHEMBL622284,,,,Uterus,12351,1,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,995.0,CHEMBL622285,,,,Uterus,12352,1,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8085,10116.0,N,995.0,CHEMBL622286,,,,Uterus,12353,1,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7657,,U,,CHEMBL622287,,,,,12354,0,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,Autocuration,22224,,BAO_0000100,,,,1,,P
8935,10090.0,N,,CHEMBL622288,,,,,12355,1,Partition coefficient (logD7.4),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,,CHEMBL622289,,,,,12356,1,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,955.0,CHEMBL622290,,,,Brain,12357,1,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,,CHEMBL622291,,,,,12358,1,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,955.0,CHEMBL622292,,,,Brain,12359,1,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,,CHEMBL622293,,,,,12360,1,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,955.0,CHEMBL622294,,,,Brain,12361,1,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,,CHEMBL622295,,,,,12362,1,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10116.0,N,955.0,CHEMBL622296,,,,Brain,12363,1,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL874409,,,,Plasma,12364,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622297,,,,Plasma,12365,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622298,,,,Plasma,12366,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622299,,,,Plasma,12367,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622300,,,,Plasma,12368,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622301,,,,Plasma,12369,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622302,,,,Plasma,12370,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622303,,,,Plasma,12371,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622304,,,,Plasma,12372,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622305,,,,Plasma,12373,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL622306,,,,Plasma,12374,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL626864,,,,Plasma,12375,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL626865,,,,Plasma,12376,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL626866,,,,Plasma,12377,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL626867,,,,Plasma,12378,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL626868,,,,Plasma,12379,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL626869,,,,Plasma,12380,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL626870,,,,Plasma,12381,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL626871,,,,Plasma,12382,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL626872,,,,Plasma,12383,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL632185,,,,Plasma,12384,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14103,10116.0,N,1969.0,CHEMBL632186,,,,Plasma,12385,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12904,,U,,CHEMBL629310,,,,,12386,0,Amount of acetic acid produced by the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
12904,,U,,CHEMBL629311,,,,,12387,0,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
9663,10116.0,N,,CHEMBL629312,,,,,12388,1,Log of (Cbrain/Cblood) in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7652,,U,,CHEMBL629313,,,,,12389,0,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000221,,,,1,,A
7652,,U,,CHEMBL629314,,,,,12390,0,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000221,,,,1,,A
7652,,U,,CHEMBL629315,,,,,12391,0,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000221,,,,1,,A
7652,,U,,CHEMBL629316,,,,,12392,0,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000219,,,,1,,B
7652,,U,,CHEMBL629317,,,,,12393,0,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000221,,,,1,,A
7652,,U,,CHEMBL629318,,,,,12394,0,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL877497,,,,,12395,0,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL629319,,,,,12396,0,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL629320,,,,,12397,0,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL629496,,,,,12398,0,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL629497,,,,,12399,0,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL629498,,,,,12400,0,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL629499,,,,,12401,0,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL629500,,,,,12402,0,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL629501,,,,,12403,0,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
7652,,U,,CHEMBL629502,,,,,12404,0,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,Autocuration,22224,,BAO_0000019,,,,1,,A
8267,,U,,CHEMBL629503,,,,,12405,0,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,F
8267,9615.0,N,,CHEMBL629504,,,,,12406,1,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14479,,U,,CHEMBL629505,,,,,12407,0,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,Autocuration,22224,,BAO_0000019,,,,1,,A
17515,,U,,CHEMBL629506,,,,,12408,0,Compound was evaluated for total body clearance,,Autocuration,22224,,BAO_0000019,,,,1,,A
17515,,U,,CHEMBL629507,,,,,12409,0,Compound was evaluated for volume of distribution at steady state,,Autocuration,22224,,BAO_0000019,,,,1,,A
8142,,U,,CHEMBL877498,,,,,12410,0,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,Autocuration,22224,,BAO_0000019,,,,1,,A
14849,,U,,CHEMBL629508,,,,,12411,0,Percentage of the diamine which is monoprotonated at pH 7.4,,Autocuration,22224,,BAO_0000019,,,,1,,A
7653,,U,,CHEMBL629509,,,,,12412,0,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,Autocuration,22224,,BAO_0000019,,,,1,,A
8631,10116.0,N,178.0,CHEMBL629510,,,,Blood,12413,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL629511,,,,Blood,12414,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL629512,,,,Blood,12415,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL629513,,,,Blood,12416,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL629514,,,,Blood,12417,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL628447,,,,Blood,12418,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL628448,,,,Blood,12419,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL628449,,,,Blood,12420,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631119,,,,Blood,12421,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631120,,,,Blood,12422,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631121,,,,Blood,12423,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL874458,,,,Blood,12424,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631122,,,,Blood,12425,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631123,,,,Blood,12426,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631124,,,,Blood,12427,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631125,,,,Blood,12428,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631290,,,,Blood,12429,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631291,,,,Blood,12430,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631292,,,,Blood,12431,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631293,,,,Blood,12432,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631294,,,,Blood,12433,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631295,,,,Blood,12434,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631296,,,,Blood,12435,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8631,10116.0,N,178.0,CHEMBL631297,,,,Blood,12436,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10263,,U,,CHEMBL631298,,,,,12437,0,Maximum biodistribution (Bmax) was determined.,,Autocuration,22224,,BAO_0000218,,,,1,,A
12364,10090.0,N,,CHEMBL631299,,,,,12438,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12364,10090.0,N,,CHEMBL631300,,,,,12439,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12364,10090.0,N,,CHEMBL631301,,,,,12440,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12364,10090.0,N,,CHEMBL630291,,,,,12441,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14793,,U,,CHEMBL630292,,,,,12442,0,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL630293,,,,,12443,0,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL630294,,,,,12444,0,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL630295,,,,,12445,0,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL630296,,,,,12446,0,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626782,,,,,12447,0,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626783,,,,,12448,0,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626784,,,,,12449,0,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626785,,,,,12450,0,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626786,,,,,12451,0,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626787,,,,,12452,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626788,,,,,12453,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL625927,,,,,12454,0,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
8374,10116.0,N,178.0,CHEMBL625928,,,,Blood,12455,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL625929,,,,Blood,12456,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL625930,,,,Blood,12457,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL625931,,,,Blood,12458,1,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627230,,,,Blood,12459,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627231,,,,Blood,12460,1,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627232,,,,Blood,12461,1,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627233,,,,Blood,12462,1,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL875470,,,,Blood,12463,1,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627234,,,,Blood,12464,1,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627235,,,,Blood,12465,1,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627236,,,,Blood,12466,1,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627237,,,,Blood,12467,1,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627238,,,,Blood,12468,1,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627239,,,,Blood,12469,1,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627240,,,,Blood,12470,1,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627241,,,,Blood,12471,1,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627242,,,,Blood,12472,1,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627243,,,,Blood,12473,1,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627244,,,,Blood,12474,1,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627245,,,,Blood,12475,1,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627246,,,,Blood,12476,1,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627247,,,,Blood,12477,1,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627248,,,,Blood,12478,1,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627249,,,,Blood,12479,1,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL625569,,,,Blood,12480,1,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL625570,,,,Blood,12481,1,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL625571,,,,Blood,12482,1,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL625572,,,,Blood,12483,1,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL625573,,,,Blood,12484,1,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL625574,,,,Blood,12485,1,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL626245,,,,Blood,12486,1,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL626246,,,,Blood,12487,1,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9196,,U,,CHEMBL626247,,,,,12488,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626248,,,,,12489,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626249,,,,,12490,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626420,,,,,12491,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626421,,,,,12492,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626422,,,,,12493,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626423,,,,,12494,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626424,,,,,12495,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
12023,9615.0,N,,CHEMBL626425,,,,,12496,1,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12023,10116.0,N,,CHEMBL875476,,,,,12497,1,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12023,9541.0,N,,CHEMBL626426,,,,,12498,1,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
10580,,U,,CHEMBL626427,,,,,12499,0,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,Autocuration,22224,,BAO_0000100,,,,1,,P
10580,,U,,CHEMBL626428,,,,,12500,0,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,Autocuration,22224,,BAO_0000100,,,,1,,P
16032,,U,,CHEMBL626429,,,,,12501,0,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
16032,,U,1088.0,CHEMBL625025,,,,Urine,12502,0,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
8594,10116.0,N,178.0,CHEMBL625026,,,,Blood,12503,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL625027,,,,Blood,12504,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL874410,,,,Blood,12505,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL625028,,,,Blood,12506,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL625029,,,,Blood,12507,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL625030,,,,Blood,12508,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL625031,,,,Blood,12509,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL625032,,,,Blood,12510,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL625033,,,,Blood,12511,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL625034,,,,Blood,12512,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624872,,,,Heart,12513,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624873,,,,Heart,12514,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624874,,,,Heart,12515,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624875,,,,Heart,12516,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624876,,,,Heart,12517,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624877,,,,Heart,12518,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624878,,,,Heart,12519,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624879,,,,Heart,12520,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624880,,,,Heart,12521,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624881,,,,Heart,12522,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL624882,,,,Heart,12523,1,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL624883,,,,Kidney,12524,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL624884,,,,Kidney,12525,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL624885,,,,Kidney,12526,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL624886,,,,Kidney,12527,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL624887,,,,Kidney,12528,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL624888,,,,Kidney,12529,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL624889,,,,Kidney,12530,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL624890,,,,Kidney,12531,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL621964,,,,Kidney,12532,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL621965,,,,Kidney,12533,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL621966,,,,Liver,12534,1,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL621967,,,,Liver,12535,1,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL622164,,,,Liver,12536,1,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7653,,U,,CHEMBL623097,,,,,12537,0,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,Autocuration,22224,,BAO_0000019,,,,1,,A
7653,,U,,CHEMBL623098,,,,,12538,0,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,Autocuration,22224,,BAO_0000019,,,,1,,A
7653,,U,,CHEMBL623099,,,,,12539,0,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,Autocuration,22224,,BAO_0000019,,,,1,,A
7653,,U,,CHEMBL623100,,,,,12540,0,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,Autocuration,22224,,BAO_0000019,,,,1,,A
9104,10116.0,N,,CHEMBL628673,,,,,12541,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9104,10116.0,N,,CHEMBL628674,,,,,12542,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9104,10116.0,N,,CHEMBL628675,,,,,12543,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9104,10116.0,N,,CHEMBL627644,,,,,12544,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9104,10116.0,N,,CHEMBL627645,,,,,12545,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9104,10116.0,N,,CHEMBL627646,,,,,12546,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9104,10116.0,N,,CHEMBL627647,,,,,12547,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9104,10116.0,N,,CHEMBL627648,,,,,12548,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12902,10116.0,N,,CHEMBL627649,,,,,12549,1,Free level in rat plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6614,,U,,CHEMBL628313,,,,,12550,0,Level reaching in blood plasma of rat or human was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
9663,10116.0,N,,CHEMBL628314,,,,,12551,1,Log (Cbrain/Cblood) in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17658,,U,,CHEMBL628315,,,,,12552,0,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,Autocuration,22224,,BAO_0000019,,,,1,,A
17658,,U,,CHEMBL628316,,,,,12553,0,Mean percentage of compound transport through membrane; expressed as membrane transport,,Autocuration,22224,,BAO_0000019,,,,1,,A
14314,,U,,CHEMBL628317,,,,,12554,0,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,Autocuration,22224,,BAO_0000218,,,,1,,A
7385,,U,,CHEMBL628473,,,,,12555,0,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,Autocuration,22224,,BAO_0000019,,,,1,,A
7385,,U,,CHEMBL628474,,,,,12556,0,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,Autocuration,22224,,BAO_0000019,,,,1,,A
7385,,U,,CHEMBL628475,,,,,12557,0,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,Autocuration,22224,,BAO_0000019,,,,1,,A
1329,,U,,CHEMBL628476,,,,,12558,0,Net water uptake by a carrier mediated transport (%cm) mechanism,,Autocuration,22224,,BAO_0000019,,,,1,,A
12187,314293.0,U,,CHEMBL628477,,,,,12559,0,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
12187,9669.0,N,,CHEMBL628478,,,,,12560,1,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
12187,9669.0,N,,CHEMBL628479,,,,,12561,1,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
12187,314293.0,U,,CHEMBL628480,,,,,12562,0,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
12187,314293.0,U,,CHEMBL628481,,,,,12563,0,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
12187,10116.0,N,,CHEMBL628482,,,,,12564,1,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12187,10116.0,N,,CHEMBL628483,,,,,12565,1,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9278,10116.0,N,1969.0,CHEMBL628484,,,,Plasma,12566,1,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9278,10116.0,N,1969.0,CHEMBL628485,,,,Plasma,12567,1,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9278,9541.0,N,1969.0,CHEMBL628486,,,,Plasma,12568,1,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
9278,9606.0,N,1969.0,CHEMBL628487,,,,Plasma,12569,1,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
9278,10116.0,N,1969.0,CHEMBL628488,,,,Plasma,12570,1,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9278,10116.0,N,1969.0,CHEMBL628489,,,,Plasma,12571,1,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9278,10116.0,N,1969.0,CHEMBL628490,,,,Plasma,12572,1,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12186,9541.0,N,,CHEMBL628491,,,,,12573,1,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
12186,9541.0,N,,CHEMBL877507,,,,,12574,1,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,Intermediate,100710,,BAO_0000218,,,Macaca fascicularis,1,,A
12186,,U,,CHEMBL628492,,,,,12575,0,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,Autocuration,22224,,BAO_0000218,,,,1,,A
12041,314293.0,U,,CHEMBL628493,,,,,12576,0,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,Autocuration,22224,,BAO_0000019,,,Simiiformes,1,,A
12041,314293.0,U,,CHEMBL628494,,,,,12577,0,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,Autocuration,22224,,BAO_0000019,,,Simiiformes,1,,A
12041,314293.0,U,,CHEMBL628495,,,,,12578,0,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,Autocuration,22224,,BAO_0000019,,,Simiiformes,1,,A
6737,9606.0,N,,CHEMBL628496,,,,,12579,1,Permeability in Caco-2 assay at 10E-6,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
13758,,U,955.0,CHEMBL628497,,,,Brain,12580,0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,Autocuration,22224,,BAO_0000218,,,,1,,A
13758,,U,955.0,CHEMBL628498,,,,Brain,12581,0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,Autocuration,22224,,BAO_0000218,,,,1,,A
5676,,U,,CHEMBL628499,,,,,12582,0,Plasma protein binding was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
14793,,U,,CHEMBL627656,,,,,12583,0,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL627657,,,,,12584,0,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626808,,,,,12585,0,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626809,,,,,12586,0,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626810,,,,,12587,0,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626811,,,,,12588,0,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL874465,,,,,12589,0,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626812,,,,,12590,0,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626813,,,,,12591,0,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14793,,U,,CHEMBL626814,,,,,12592,0,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,22224,,BAO_0000218,,,,1,,A
14000,,U,,CHEMBL626815,,,,,12593,0,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,Autocuration,22224,,BAO_0000019,,,,1,,A
5948,,U,,CHEMBL628566,,,,,12594,0,Partition coefficient (logP),,Autocuration,22224,,BAO_0000019,,,,1,,A
13824,,U,,CHEMBL628567,,,,,12595,0,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,Autocuration,22229,,BAO_0000100,,,,1,,P
10778,,U,,CHEMBL628568,,,,,12596,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
17237,9615.0,N,,CHEMBL628569,,,,,12597,1,C max in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
17237,10141.0,N,,CHEMBL628570,,,,,12598,1,C max in guinea pig,,Intermediate,50512,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
2809,,U,,CHEMBL628571,,,,,12599,0,C max value was evaluated,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL628572,,,,,12600,0,Cmax value after oral dose of 0.1 mg//kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL628573,,,,,12601,0,Cmax value after oral dose of 0.3 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL628574,,,,,12602,0,Cmax value after oral dose of 1 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL628575,,,,,12603,0,Cmax value after oral dose of 10 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL628576,,,,,12604,0,Cmax value after oral dose of 23.4 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL628577,,,,,12605,0,Cmax value after oral dose of 3 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL628578,,,,,12606,0,Cmax value after oral dose of 3.87 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12768,9615.0,N,,CHEMBL874466,,,,,12607,1,Cmax value in female Beagle dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12768,10116.0,N,,CHEMBL628579,,,,,12608,1,Cmax value in male rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12780,10116.0,N,1969.0,CHEMBL628580,,,,Plasma,12609,1,Cmax value in rat plasma when administered 20 mg/kg perorally,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15592,9615.0,N,1969.0,CHEMBL628581,,,,Plasma,12610,1,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
15592,9615.0,N,1969.0,CHEMBL628582,,,,Plasma,12611,1,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
17025,9615.0,N,,CHEMBL628583,,,,,12612,1,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
17025,314293.0,U,,CHEMBL625782,,,,,12613,0,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
17025,9986.0,N,,CHEMBL625783,,,,,12614,1,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
17025,10116.0,N,,CHEMBL625784,,,,,12615,1,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4236,9544.0,N,1969.0,CHEMBL625785,,,,Plasma,12616,1,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,Intermediate,50797,,BAO_0000218,,,Macaca mulatta,1,,A
15791,10116.0,N,,CHEMBL625786,,,,,12617,1,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11149,,U,,CHEMBL874467,,,,,12618,0,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,Autocuration,22224,,BAO_0000019,,,,1,,A
15592,9615.0,N,,CHEMBL625787,,,,,12619,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15778,12721.0,N,,CHEMBL625964,,,,,12620,1,cytotoxicity against HIV protease enzyme.,,Intermediate,50677,,BAO_0000218,,,Human immunodeficiency virus,1,,A
12745,10090.0,N,,CHEMBL625965,,,,,12621,1,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12745,10090.0,N,,CHEMBL625966,,,,,12622,1,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13941,9615.0,N,1969.0,CHEMBL625967,,,,Plasma,12623,1,The plasma clearance in dog.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13941,10116.0,N,1969.0,CHEMBL625968,,,,Plasma,12624,1,The plasma clearance in rat.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16449,10116.0,N,1969.0,CHEMBL625969,,,,Plasma,12625,1,Clearance from plasma in male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16449,9541.0,N,1969.0,CHEMBL625970,,,,Plasma,12626,1,Clearance from plasma in male cynomolgus monkeys,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14224,9615.0,N,1969.0,CHEMBL625971,,,,Plasma,12627,1,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14224,9615.0,N,1969.0,CHEMBL625972,,,,Plasma,12628,1,Clearance of compound in dog plasma,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14224,9606.0,N,1969.0,CHEMBL625973,,,,Plasma,12629,1,Clearance of compound in human plasma,,Intermediate,50587,,BAO_0000218,,In vivo,Homo sapiens,1,,A
14317,9615.0,N,,CHEMBL625974,,,,,12630,1,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14317,9615.0,N,,CHEMBL625975,,,,,12631,1,Clearance of compound when administered intravenously as an individual dose to a single dog.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14224,9615.0,N,1969.0,CHEMBL625976,,,,Plasma,12632,1,"Clearance (10 mg/kg, intravenously) in dog plasma",,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
17237,9615.0,N,,CHEMBL625977,,,,,12633,1,Clearance value in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
17237,10141.0,N,,CHEMBL625978,,,,,12634,1,Clearance value in guinea pig,,Intermediate,50512,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
14187,10116.0,N,,CHEMBL874468,,,,,12635,1,Clearance values in rats after iv administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4806,,U,1969.0,CHEMBL625421,,,,Plasma,12636,0,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15025,9986.0,N,,CHEMBL625422,,,,,12637,1,In vivo clearance (5 mg/kg) was determined in rabbits,,Intermediate,50592,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
13197,10116.0,N,,CHEMBL625423,,,,,12638,1,Plasma Clearance rate was determined for the compound in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13197,9520.0,U,,CHEMBL625424,,,,,12639,0,Plasma Clearance rate was determined for the compound in squirrel monkeys,,Autocuration,22224,,BAO_0000218,,In vivo,Saimiri,1,,A
13960,10116.0,N,,CHEMBL625425,,,,,12640,1,Plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17820,,U,,CHEMBL625426,,,,,12641,0,Plasma clearance of the compound,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14706,10141.0,N,,CHEMBL625427,,,,,12642,1,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,Intermediate,50512,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
14706,10141.0,N,,CHEMBL625428,,,,,12643,1,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,Intermediate,50512,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
6504,,U,,CHEMBL625429,,,,,12644,0,Plasma clearance was determined,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14925,9615.0,N,,CHEMBL625430,,,,,12645,1,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13197,10116.0,N,,CHEMBL625431,,,,,12646,1,Plasma clearance rate was determined for the compound in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13197,9520.0,U,,CHEMBL627307,,,,,12647,0,Plasma clearance rate was determined for the compound in squirrel monkeys,,Autocuration,22224,,BAO_0000218,,In vivo,Saimiri,1,,A
3437,,U,,CHEMBL627308,,,,,12648,0,Slow clearance (CL) was determined,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
9196,,U,,CHEMBL627309,,,,,12649,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627310,,,,,12650,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627311,,,,,12651,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627312,,,,,12652,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627313,,,,,12653,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627314,,,,,12654,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627315,,,,,12655,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627316,,,,,12656,0,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627317,,,,,12657,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627318,,,,,12658,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL627999,,,,,12659,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628000,,,,,12660,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628001,,,,,12661,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL628002,,,,,12662,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL625610,,,,,12663,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL625611,,,,,12664,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL625612,,,,,12665,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL625613,,,,,12666,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL875479,,,,,12667,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL625614,,,,,12668,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL625615,,,,,12669,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
9196,,U,,CHEMBL626302,,,,,12670,0,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,Autocuration,22224,,BAO_0000218,,,,1,,A
8374,10116.0,N,178.0,CHEMBL626303,,,,Blood,12671,1,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8374,10116.0,N,178.0,CHEMBL627420,,,,Blood,12672,1,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL627421,,,,,12673,1,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL625695,,,,,12674,1,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL625696,,,,,12675,1,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10009,10090.0,N,955.0,CHEMBL875606,,,,Brain,12676,1,Distribution of compound in mice brain was measured after 1 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,955.0,CHEMBL625697,,,,Brain,12677,1,Distribution of compound in mice brain was measured after 24 hr r,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,955.0,CHEMBL625698,,,,Brain,12678,1,Distribution of compound in mice brain was measured after 2 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,955.0,CHEMBL625699,,,,Brain,12679,1,Distribution of compound in mice brain was measured after 3 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,955.0,CHEMBL625700,,,,Brain,12680,1,Distribution of compound in mice brain was measured after 6 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,,CHEMBL625701,,,,,12681,1,Distribution of compound in mice liver was measured after 1 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,,CHEMBL625702,,,,,12682,1,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,,CHEMBL625703,,,,,12683,1,Distribution of compound in mice liver was measured after 2 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,,CHEMBL625704,,,,,12684,1,Distribution of compound in mice liver was measured after 3 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,,CHEMBL625705,,,,,12685,1,Distribution of compound in mice liver was measured after 6 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8170,9615.0,N,1236.0,CHEMBL625706,,,,Adrenal medulla,12686,1,Distribution in dog adrenal medulla 30 min after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,1236.0,CHEMBL625707,,,,Adrenal medulla,12687,1,Distribution in dog adrenal medulla 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL625708,,,,,12688,1,Distribution in female dog Ovary 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL625709,,,,,12689,1,Distribution in female dog Ovary 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624180,,,,,12690,1,Distribution in female dog adipose 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624181,,,,,12691,1,Distribution in female dog adipose 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,1235.0,CHEMBL624182,,,,Adrenal cortex,12692,1,Distribution in female dog adrenal cortex 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,1235.0,CHEMBL624183,,,,Adrenal cortex,12693,1,Distribution in female dog adrenal cortex 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8594,10116.0,N,2107.0,CHEMBL624184,,,,Liver,12694,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL877489,,,,Liver,12695,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL624185,,,,Liver,12696,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL624186,,,,Liver,12697,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL624187,,,,Liver,12698,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL624188,,,,Liver,12699,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL624189,,,,Lung,12700,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL624190,,,,Lung,12701,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL624191,,,,Lung,12702,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL624192,,,,Lung,12703,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL624193,,,,Lung,12704,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL624194,,,,Lung,12705,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL624891,,,,Lung,12706,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL624892,,,,Lung,12707,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL624893,,,,Lung,12708,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL627632,,,,Lung,12709,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL627633,,,,,12710,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL627634,,,,,12711,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL627635,,,,,12712,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL627636,,,,,12713,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL626816,,,,,12714,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL626817,,,,,12715,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL626818,,,,,12716,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL626819,,,,,12717,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL626820,,,,,12718,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL626821,,,,,12719,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL626822,,,,Thyroid gland,12720,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL626823,,,,Thyroid gland,12721,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL626824,,,,Thyroid gland,12722,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL626825,,,,Thyroid gland,12723,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL626826,,,,Thyroid gland,12724,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL626827,,,,Thyroid gland,12725,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL626828,,,,Thyroid gland,12726,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL626829,,,,Thyroid gland,12727,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL626830,,,,Thyroid gland,12728,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL627150,,,,,12729,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL627151,,,,,12730,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL627152,,,,,12731,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL627153,,,,,12732,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12904,,U,,CHEMBL627154,,,,,12733,0,Rate of acetate production by the compound was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
12904,,U,,CHEMBL627155,,,,,12734,0,Rate of acetate production by the compound was determined; Not determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
3730,,U,,CHEMBL627156,,,,,12735,0,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,Autocuration,22224,,BAO_0000019,,,,1,,A
3627,,U,,CHEMBL627157,,,,,12736,0,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,Autocuration,22224,,BAO_0000019,,,,1,,A
13799,9986.0,N,,CHEMBL627158,,,,,12737,1,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
13799,9986.0,N,1969.0,CHEMBL627159,,,,Plasma,12738,1,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
13799,10090.0,N,,CHEMBL627160,,,,,12739,1,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13799,10116.0,N,,CHEMBL628540,,,,,12740,1,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13799,10116.0,N,1969.0,CHEMBL628541,,,,Plasma,12741,1,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13799,10116.0,N,1969.0,CHEMBL628542,,,,Plasma,12742,1,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6629,,U,,CHEMBL628543,,,,,12743,0,Solubility after at a pH 1.2,,Autocuration,22229,,BAO_0000100,,,,1,,P
6629,,U,,CHEMBL628544,,,,,12744,0,Solubility after at pH 1.2,,Autocuration,22229,,BAO_0000100,,,,1,,P
6629,,U,,CHEMBL628545,,,,,12745,0,Solubility after injection of water,,Autocuration,22229,,BAO_0000100,,,,1,,P
14000,,U,,CHEMBL628546,,,,,12746,0,Statistical significance of IC 50 values; Expressed as R value,,Autocuration,22224,,BAO_0000019,,,,1,,A
8267,,U,,CHEMBL874455,,,,,12747,0,Systemic availability with respect to methyldopa was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
13799,10116.0,N,,CHEMBL628547,,,,,12748,1,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13799,10116.0,N,1969.0,CHEMBL628548,,,,Plasma,12749,1,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7132,9986.0,N,1988.0,CHEMBL628549,,,,Feces,12750,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL628550,,,,Feces,12751,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL628551,,,,Feces,12752,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL628552,,,,Urine,12753,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL628553,,,,Urine,12754,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL628554,,,,Urine,12755,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL628555,,,,Urine,12756,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL628556,,,,Urine,12757,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,2113.0,CHEMBL628557,,,,Kidney,12758,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL628558,,,,Feces,12759,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL628559,,,,Feces,12760,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL628560,,,,Feces,12761,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL874456,,,,Urine,12762,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL628561,,,,Feces,12763,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL628562,,,,Feces,12764,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL628563,,,,Urine,12765,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL628564,,,,Urine,12766,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL628565,,,,Urine,12767,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL631248,,,,Urine,12768,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL631249,,,,Urine,12769,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,2113.0,CHEMBL627214,,,,Kidney,12770,1,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL874591,,,,Feces,12771,1,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL627215,,,,Feces,12772,1,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL625471,,,,Feces,12773,1,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,,CHEMBL625472,,,,,12774,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,,CHEMBL625473,,,,,12775,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
13317,9615.0,N,,CHEMBL625474,,,,,12776,1,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
15341,9615.0,N,,CHEMBL625475,,,,,12777,1,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
15341,10116.0,N,,CHEMBL625476,,,,,12778,1,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15341,10116.0,N,,CHEMBL625477,,,,,12779,1,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15341,10116.0,N,,CHEMBL625478,,,,,12780,1,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12801,10116.0,N,,CHEMBL625479,,,,esophageal tunica muscularis mucosae,12781,1,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
12801,10116.0,N,,CHEMBL625480,,,,esophageal tunica muscularis mucosae,12782,1,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,Intermediate,50597,,BAO_0000218,,In vitro,Rattus norvegicus,1,,A
14856,10116.0,N,1969.0,CHEMBL625481,,,,Plasma,12783,1,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL625482,,,,,12784,1,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL625483,,,,,12785,1,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL625484,,,,,12786,1,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14062,10116.0,N,,CHEMBL625485,,,,,12787,1,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14346,9615.0,N,1969.0,CHEMBL625486,,,,Plasma,12788,1,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14346,10116.0,N,1969.0,CHEMBL625487,,,,Plasma,12789,1,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14346,10116.0,N,1969.0,CHEMBL625488,,,,Plasma,12790,1,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14346,10116.0,N,1969.0,CHEMBL625489,,,,Plasma,12791,1,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14346,10116.0,N,1969.0,CHEMBL625490,,,,Plasma,12792,1,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14346,9615.0,N,1969.0,CHEMBL625491,,,,Plasma,12793,1,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14346,10116.0,N,1969.0,CHEMBL625492,,,,Plasma,12794,1,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15711,9606.0,N,1969.0,CHEMBL625493,,,,Plasma,12795,1,plasma clearance in human,,Intermediate,50587,,BAO_0000218,,In vivo,Homo sapiens,1,,A
14886,10116.0,N,,CHEMBL625494,,,,,12796,1,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14886,10116.0,N,,CHEMBL625495,,,,,12797,1,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14886,10116.0,N,,CHEMBL625496,,,,,12798,1,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4115,,U,,CHEMBL625497,,,,,12799,0,1-Octanol/water partition coefficient measured at 7.4,,Autocuration,22229,,BAO_0000100,,,,1,,P
13733,,U,,CHEMBL625498,,,,,12800,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
12102,,U,,CHEMBL625499,,,,,12801,0,Partition coefficient (logP),,Autocuration,22224,,BAO_0000019,,,,1,,A
12676,,U,,CHEMBL625500,,,,,12802,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
13733,,U,,CHEMBL625501,,,,,12803,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
13740,,U,,CHEMBL625502,,,,,12804,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
12766,,U,,CHEMBL625503,,,,,12805,0,Calculated partition coefficient (clogP) (relative to BAY K 8644),,Autocuration,22229,,BAO_0000100,,,,1,,P
2764,,U,,CHEMBL625504,,,,,12806,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
12355,,U,,CHEMBL625505,,,,,12807,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
11314,,U,,CHEMBL625506,,,,,12808,0,Calculated partition coefficient of the compound,,Autocuration,22229,,BAO_0000100,,,,1,,P
12706,,U,,CHEMBL625507,,,,,12809,0,Partition coefficient (logP),,Autocuration,22224,,BAO_0000019,,,,1,,A
12645,,U,,CHEMBL625508,,,,,12810,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
13668,,U,,CHEMBL625509,,,,,12811,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
12819,,U,,CHEMBL625510,,,,,12812,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
13668,,U,,CHEMBL883125,,,,,12813,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
13017,,U,,CHEMBL625511,,,,,12814,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
2448,,U,,CHEMBL874650,,,,,12815,0,Partition coefficient of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
11526,,U,,CHEMBL625512,,,,,12816,0,Partition coefficient of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
12426,,U,,CHEMBL625513,,,,,12817,0,Partition coefficient of compound was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
2448,,U,,CHEMBL625514,,,,,12818,0,Partition coefficient was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
12001,,U,,CHEMBL625515,,,,,12819,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
12426,,U,,CHEMBL625516,,,,,12820,0,partition coefficient of compound was determined,,Autocuration,22229,,BAO_0000100,,,,1,,P
13204,9615.0,N,,CHEMBL625517,,,,,12821,1,The total body administered intravenously in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13204,10116.0,N,,CHEMBL625518,,,,,12822,1,The total body administered intravenously in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13889,10090.0,N,,CHEMBL625519,,,,,12823,1,Time taken for the administration to female NIH mice weighing 25-30 g.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13889,,U,,CHEMBL625520,,,,,12824,0,Time taken for the administration,,Autocuration,22224,,BAO_0000019,,,,1,,A
17025,9615.0,N,,CHEMBL874651,,,,,12825,1,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
17025,314293.0,U,,CHEMBL625521,,,,,12826,0,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
17025,9986.0,N,,CHEMBL623171,,,,,12827,1,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,Intermediate,50592,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
17025,10116.0,N,,CHEMBL623853,,,,,12828,1,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15067,,U,,CHEMBL623854,,,,,12829,0,Plasma clearance for the compound was determined.,,Autocuration,22224,,BAO_0000019,,,,1,,A
3091,,U,,CHEMBL874405,,,,,12830,0,CLog P value of the compound,,Autocuration,22224,,BAO_0000100,,,,1,,P
15592,,U,,CHEMBL623855,,,,,12831,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
14738,,U,,CHEMBL623856,,,,,12832,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
14738,,U,,CHEMBL623857,,,,,12833,0,ClogP value of the compound; nd ='no data',,Autocuration,22224,,BAO_0000100,,,,1,,P
14738,,U,,CHEMBL623858,,,,,12834,0,ClogP value of the compound; nd ='not determined',,Autocuration,22224,,BAO_0000100,,,,1,,P
6076,,U,,CHEMBL623859,,,,,12835,0,CLog P was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
17840,,U,,CHEMBL839829,,,,,12836,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
13589,,U,,CHEMBL623860,,,,,12837,0,CLogP was calculated,,Autocuration,22224,,BAO_0000019,,,,1,,A
17655,,U,,CHEMBL623861,,,,,12838,0,CLogP value was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
5867,,U,,CHEMBL623862,,,,,12839,0,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,Autocuration,22224,,BAO_0000019,,,,1,,A
5867,,U,,CHEMBL874406,,,,,12840,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
10783,,U,,CHEMBL623863,,,,,12841,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
14849,,U,,CHEMBL624021,,,,,12842,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
8170,9615.0,N,1236.0,CHEMBL624022,,,,Adrenal medulla,12843,1,Distribution in female dog adrenal medulla 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,1236.0,CHEMBL624023,,,,Adrenal medulla,12844,1,Distribution in female dog adrenal medulla 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624024,,,,,12845,1,Distribution in female dog bile 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624025,,,,,12846,1,Distribution in female dog bile 72 hr after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624026,,,,,12847,1,Distribution in female dog blood 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624027,,,,,12848,1,Distribution in female dog blood 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624028,,,,,12849,1,Distribution in female dog heart 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624029,,,,,12850,1,Distribution in female dog heart 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624030,,,,,12851,1,Distribution in female dog kidney 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624031,,,,,12852,1,Distribution in female dog kidney 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,160.0,CHEMBL624032,,,,Intestine,12853,1,Distribution in female dog large intestine 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,160.0,CHEMBL874407,,,,Intestine,12854,1,Distribution in female dog large intestine 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624033,,,,,12855,1,Distribution in female dog liver 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624034,,,,,12856,1,Distribution in female dog liver 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624035,,,,,12857,1,Distribution in female dog lung 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624036,,,,,12858,1,Distribution in female dog lung 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,2385.0,CHEMBL624037,,,,Muscle tissue,12859,1,Distribution in female dog muscle 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,2385.0,CHEMBL624038,,,,Muscle tissue,12860,1,Distribution in female dog muscle 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624039,,,,,12861,1,Distribution in female dog pancreas 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,,CHEMBL624040,,,,,12862,1,Distribution in female dog pancreas 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,160.0,CHEMBL624041,,,,Intestine,12863,1,Distribution in female dog small intestine 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,160.0,CHEMBL624042,,,,Intestine,12864,1,Distribution in female dog small intestine 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,2106.0,CHEMBL624043,,,,Spleen,12865,1,Distribution in female dog spleen 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,2106.0,CHEMBL624044,,,,Spleen,12866,1,Distribution in female dog spleen 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,945.0,CHEMBL624045,,,,Stomach,12867,1,Distribution in female dog stomach 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,945.0,CHEMBL624046,,,,Stomach,12868,1,Distribution in female dog stomach 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,2046.0,CHEMBL624047,,,,Thyroid gland,12869,1,Distribution in female dog thyroid 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,2046.0,CHEMBL624048,,,,Thyroid gland,12870,1,Distribution in female dog thyroid 72 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,1088.0,CHEMBL874408,,,,Urine,12871,1,Distribution in female dog urine 24 hours after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8170,9615.0,N,1088.0,CHEMBL624049,,,,Urine,12872,1,Distribution in female dog urine 72 hr after administration.,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
14283,,U,1969.0,CHEMBL624050,,,,Plasma,12873,0,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
5623,,U,,CHEMBL624051,,,,,12874,0,Plasma concentration at 7 hr after intravenous dosing,,Autocuration,22224,,BAO_0000019,,,,1,,A
13477,10116.0,N,,CHEMBL623278,,,,,12875,1,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL623279,,,,,12876,1,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL623280,,,,,12877,1,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL623963,,,,,12878,1,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL623964,,,,,12879,1,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL623965,,,,,12880,1,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL623966,,,,,12881,1,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL874415,,,,,12882,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL623967,,,,,12883,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL623968,,,,,12884,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL623969,,,,,12885,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL628409,,,,,12886,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL628410,,,,,12887,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL628411,,,,,12888,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL628412,,,,,12889,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12553,,U,,CHEMBL628413,,,,,12890,0,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,Autocuration,22224,,BAO_0000019,,,,1,,A
14548,,U,1969.0,CHEMBL628414,,,,Plasma,12891,0,The concentration in plasmat; Not determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
14393,10116.0,N,,CHEMBL628415,,,,,12892,1,Tissue level at 10 mg/kg/po in wistar rats in blood,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14393,10116.0,N,,CHEMBL628416,,,,,12893,1,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14393,10116.0,N,,CHEMBL628417,,,,,12894,1,Tissue level at 10 mg/kg/po in wistar rats in heart,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14393,10116.0,N,2107.0,CHEMBL874908,,,,Liver,12895,1,Tissue level at 10 mg/kg/po in wistar rats in liver,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14393,10116.0,N,,CHEMBL628418,,,,,12896,1,Tissue level at 10 mg/kg/po in wistar rats in plasma,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14393,10116.0,N,2385.0,CHEMBL628419,,,,Muscle tissue,12897,1,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14393,10116.0,N,,CHEMBL628420,,,,,12898,1,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
1629,,U,,CHEMBL628421,,,,,12899,0,Water solubility at 37 degree C.,,Autocuration,22224,,BAO_0000019,,,,1,,A
8194,,U,,CHEMBL626726,,,,,12900,0,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,Autocuration,22229,,BAO_0000100,,,,1,,P
8194,,U,,CHEMBL626727,,,,,12901,0,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,Autocuration,22229,,BAO_0000100,,,,1,,P
8594,10116.0,N,178.0,CHEMBL626728,,,,Blood,12902,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL626729,,,,Blood,12903,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL626730,,,,Blood,12904,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL626731,,,,Blood,12905,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,178.0,CHEMBL626732,,,,Blood,12906,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL626733,,,,Heart,12907,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL626734,,,,Heart,12908,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL626735,,,,Heart,12909,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL874909,,,,Heart,12910,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,948.0,CHEMBL626736,,,,Heart,12911,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL626737,,,,Kidney,12912,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL630999,,,,Kidney,12913,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL631000,,,,Kidney,12914,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL631001,,,,Kidney,12915,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2113.0,CHEMBL631002,,,,Kidney,12916,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL631003,,,,Liver,12917,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL631004,,,,Liver,12918,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL631005,,,,Liver,12919,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL631006,,,,Liver,12920,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2107.0,CHEMBL631007,,,,Liver,12921,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL631008,,,,Lung,12922,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL631009,,,,Lung,12923,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL631010,,,,Lung,12924,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL631011,,,,Lung,12925,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2048.0,CHEMBL631012,,,,Lung,12926,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL630271,,,,Thyroid gland,12927,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL630272,,,,Thyroid gland,12928,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL630273,,,,Thyroid gland,12929,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL630274,,,,Thyroid gland,12930,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,2046.0,CHEMBL630275,,,,Thyroid gland,12931,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL875782,,,,,12932,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL630276,,,,,12933,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL630277,,,,,12934,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL630278,,,,,12935,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8594,10116.0,N,,CHEMBL630279,,,,,12936,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8151,,U,,CHEMBL630280,,,,,12937,0,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
8151,,U,,CHEMBL630281,,,,,12938,0,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
7132,9986.0,N,,CHEMBL630282,,,,,12939,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,,CHEMBL630283,,,,,12940,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
5797,,U,,CHEMBL630284,,,,,12941,0,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,Autocuration,22224,,BAO_0000019,,,,1,,A
7849,,U,,CHEMBL630285,,,,,12942,0,Alkylating activity was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
14220,,U,,CHEMBL630286,,,,,12943,0,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,Autocuration,22224,,BAO_0000251,Microsomes,,,1,,A
8650,9986.0,N,,CHEMBL630069,,,,,12944,1,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
8650,9986.0,N,,CHEMBL630070,,,,,12945,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
8650,9986.0,N,,CHEMBL630071,,,,,12946,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
8650,9986.0,N,,CHEMBL630072,,,,,12947,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
8650,9986.0,N,,CHEMBL875110,,,,,12948,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7116,10116.0,N,,CHEMBL630073,,,,,12949,1,Compound was tested for antidiuretic activity in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14131,,U,,CHEMBL630074,,,,,12950,0,Compound was tested for inactivation kinetic values,,Autocuration,22224,,BAO_0000019,,,,1,,A
7415,,U,,CHEMBL630075,,,,,12951,0,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13178,,U,,CHEMBL630076,,,,,12952,0,Dissociation rate calculated from the first-order equation using the t1/2 value,,Autocuration,22224,,BAO_0000019,,,,1,,A
8815,,U,,CHEMBL630077,,,,,12953,0,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,Autocuration,22229,,BAO_0000100,,,,1,,P
1450,,U,,CHEMBL630078,,,,,12954,0,Aqueous solubility was measured,,Autocuration,22229,,BAO_0000100,,,,1,,P
1450,,U,,CHEMBL630079,,,,,12955,0,Aqueous solubility was measured at a pH 4,,Autocuration,22229,,BAO_0000100,,,,1,,P
1450,,U,,CHEMBL630080,,,,,12956,0,Aqueous solubility (pH 7),,Autocuration,22229,,BAO_0000100,,,,1,,P
1450,,U,,CHEMBL630081,,,,,12957,0,Aqueous solubility was measured at a pH 9,,Autocuration,22229,,BAO_0000100,,,,1,,P
12711,,U,,CHEMBL630082,,,,,12958,0,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,Autocuration,22224,,BAO_0000019,,,,1,,A
12711,,U,,CHEMBL630083,,,,,12959,0,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,Autocuration,22224,,BAO_0000019,,,,1,,A
12711,,U,,CHEMBL630084,,,,,12960,0,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,Autocuration,22224,,BAO_0000019,,,,1,,A
15032,,U,,CHEMBL629198,,,,,12961,0,Aqueous solubility of the compound,,Autocuration,22229,,BAO_0000100,,,,1,,P
9964,,U,,CHEMBL629199,,,,,12962,0,Aqueous solubility at 37 degree Celsius at pH 7.38,,Autocuration,22229,,BAO_0000100,,,,1,,P
14962,,U,,CHEMBL629200,,,,,12963,0,Aqueous solubility in pH 7.4 phosphate buffer,,Autocuration,22229,,BAO_0000100,,,,1,,P
12487,9615.0,N,,CHEMBL629201,,,,,12964,1,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12487,9615.0,N,,CHEMBL629202,,,,,12965,1,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
10026,9606.0,N,,CHEMBL875111,,,,,12966,1,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
10026,9606.0,N,,CHEMBL629203,,,,,12967,1,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
10026,9606.0,N,,CHEMBL629204,,,,,12968,1,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
10026,9606.0,N,,CHEMBL629205,,,,,12969,1,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
10026,9606.0,N,,CHEMBL629206,,,,,12970,1,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
10026,,U,,CHEMBL631185,,,,,12971,0,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,Autocuration,22224,,BAO_0000019,,,,1,,A
7415,10116.0,N,,CHEMBL631186,,,,,12972,1,Compound was evaluated for the average bile flow rat in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
17025,9986.0,N,,CHEMBL631187,,,,,12973,1,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
17025,9986.0,N,,CHEMBL631188,,,,,12974,1,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
10184,,U,,CHEMBL876419,,,,,12975,0,Average half life period was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
10184,,U,,CHEMBL631189,,,,,12976,0,Average half life period was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
8613,10298.0,N,,CHEMBL631190,,,,,12977,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL631191,,,,,12978,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL631192,,,,,12979,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL632400,,,,,12980,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL630564,,,,,12981,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL630565,,,,,12982,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL630566,,,,,12983,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL631229,,,,,12984,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL631230,,,,,12985,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
6030,,U,,CHEMBL876428,,,,,12986,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6147,,U,,CHEMBL631231,,,,,12987,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
14556,,U,,CHEMBL631232,,,,,12988,0,Calculated partition coefficient (clogP) (MacLogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
768,,U,,CHEMBL631233,,,,,12989,0,Hydrophilicity was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
14452,,U,,CHEMBL631234,,,,,12990,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
5237,,U,,CHEMBL883126,,,,,12991,0,Increased absorption was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
14378,,U,,CHEMBL631235,,,,,12992,0,Lipophilicity value was evaluated,,Autocuration,22224,,BAO_0000100,,,,1,,P
14418,,U,,CHEMBL631236,,,,,12993,0,Log P value of the compound.,,Autocuration,22224,,BAO_0000100,,,,1,,P
5249,,U,,CHEMBL631237,,,,,12994,0,Partition coefficient of compound was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
14621,,U,,CHEMBL631238,,,,,12995,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
12542,,U,,CHEMBL876429,,,,,12996,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
12542,,U,,CHEMBL631414,,,,,12997,0,Partition coefficient was measured by medchem software; Not calculated,,Autocuration,22224,,BAO_0000019,,,,1,,A
12542,,U,,CHEMBL631415,,,,,12998,0,Partition coefficient was measured by octanol-water using standard shake-flask method,,Autocuration,22224,,BAO_0000100,,,,1,,P
15462,,U,,CHEMBL631416,,,,,12999,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
14884,,U,,CHEMBL631417,,,,,13000,0,Partition coefficient (logP),,Autocuration,22224,,BAO_0000019,,,,1,,A
16526,,U,,CHEMBL631418,,,,,13001,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
13693,,U,,CHEMBL631419,,,,,13002,0,The Octanol/Water partition coefficient CLogP,,Autocuration,22229,,BAO_0000100,,,,1,,P
13693,,U,,CHEMBL631420,,,,,13003,0,The pharmacokinetic parameter C Log p was reported,,Autocuration,22224,,BAO_0000019,,,,1,,A
13779,,U,,CHEMBL631421,,,,,13004,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
14772,,U,,CHEMBL631422,,,,,13005,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
14393,,U,,CHEMBL631423,,,,,13006,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
14793,10116.0,N,1969.0,CHEMBL876430,,,,Plasma,13007,1,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL631424,,,,Plasma,13008,1,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13744,9615.0,N,1969.0,CHEMBL631425,,,,Plasma,13009,1,Compound was administered intravenously in dog to evaluate plasma clearance values,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13744,314293.0,U,1969.0,CHEMBL631426,,,,Plasma,13010,0,Compound was administered intravenously in monkey to evaluate plasma clearance values,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
13744,10090.0,N,1969.0,CHEMBL631427,,,,Plasma,13011,1,Compound was administered intravenously in mouse to evaluate plasma clearance values,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
13207,9615.0,N,1969.0,CHEMBL631428,,,,Plasma,13012,1,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
5669,9544.0,N,2107.0,CHEMBL631429,,,,Liver,13013,1,Intrinsic clearance in Rhesus liver microsome,,Intermediate,50797,,BAO_0000218,Microsomes,In vitro,Macaca mulatta,1,,A
5669,9615.0,N,2107.0,CHEMBL631430,,,,Liver,13014,1,Intrinsic clearance in dog liver microsome,,Intermediate,50588,,BAO_0000218,Microsomes,In vitro,Canis lupus familiaris,1,,A
5669,10116.0,N,2107.0,CHEMBL631431,,,,Liver,13015,1,Intrinsic clearance in rat liver microsome,,Intermediate,50597,,BAO_0000218,Microsomes,In vitro,Rattus norvegicus,1,,A
4853,9544.0,N,1969.0,CHEMBL631432,,,,Plasma,13016,1,Low plasma clearance was calculated in rhesus monkey,,Intermediate,50797,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
16452,9615.0,N,,CHEMBL631433,,,,,13017,1,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
11954,,U,,CHEMBL631434,,,,,13018,0,Plasma clearance after intravenous dose of 0.3 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL631435,,,,,13019,0,Plasma clearance after intravenous dose of 1 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL631436,,,,,13020,0,Plasma clearance after intravenous dose of 3 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11954,,U,,CHEMBL631437,,,,,13021,0,Plasma clearance after intravenous dose of 3.87 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
5669,10116.0,N,,CHEMBL631438,,,,,13022,1,Plasma clearance after peroral administration at 10 mpk in Rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5669,9544.0,N,,CHEMBL876431,,,,,13023,1,Plasma clearance after peroral administration at 10 mpk in Rhesus,,Intermediate,50797,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
5669,9615.0,N,,CHEMBL631439,,,,,13024,1,Plasma clearance after peroral administration at 10 mpk in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13662,10116.0,N,,CHEMBL631440,,,,,13025,1,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8272,,U,,CHEMBL631441,,,,,13026,0,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,Autocuration,22224,,BAO_0000019,,,,1,,A
13410,,U,,CHEMBL631442,,,,,13027,0,Critical Micellar concentration was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
13410,,U,,CHEMBL626525,,,,,13028,0,Critical Micellar concentration of the compound. was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
12628,,U,,CHEMBL627168,,,,,13029,0,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,Autocuration,22224,,BAO_0000019,,,,1,,A
9675,,U,,CHEMBL875618,,,,,13030,0,Critical micellar concentration was measured in water by the dye solubilization method,,Autocuration,22224,,BAO_0000019,,,,1,,A
12628,,U,,CHEMBL626612,,,,,13031,0,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,Autocuration,22224,,BAO_0000019,,,,1,,B
12766,,U,,CHEMBL626613,,,,,13032,0,CMR value (relative to BAY K 8644),,Autocuration,22224,,BAO_0000019,,,,1,,A
7849,,U,,CHEMBL626614,,,,,13033,0,Carbamoylating activity was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
12187,314293.0,U,,CHEMBL626615,,,,,13034,0,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
2040,,U,,CHEMBL626616,,,,,13035,0,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,Autocuration,22224,,BAO_0000019,,,,1,,A
2040,,U,,CHEMBL626617,,,,,13036,0,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,Autocuration,22224,,BAO_0000019,,,,1,,A
14180,9615.0,N,1969.0,CHEMBL626618,,,,Plasma,13037,1,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14180,10116.0,N,1969.0,CHEMBL626619,,,,Plasma,13038,1,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14474,9615.0,N,,CHEMBL626620,,,,,13039,1,"Clearance rate at 0.46 mg/kg, iv, in dogs",,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14474,10116.0,N,,CHEMBL626621,,,,,13040,1,"Clearance rate at 5.5 mg/kg, iv, in rat",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14548,9541.0,N,,CHEMBL626622,,,,,13041,1,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14548,9541.0,N,,CHEMBL626623,,,,,13042,1,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14548,9615.0,N,,CHEMBL626624,,,,,13043,1,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14548,10116.0,N,,CHEMBL626625,,,,,13044,1,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6125,10116.0,N,2107.0,CHEMBL626626,,,,Liver,13045,1,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,Intermediate,50597,,BAO_0000218,,Ex vivo,Rattus norvegicus,1,,A
6874,,U,,CHEMBL626627,,,,,13046,0,Tested for the total clearance of the compound,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15343,9615.0,N,,CHEMBL626628,,,,,13047,1,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
6236,,U,,CHEMBL626629,,,,,13048,0,Total body clearance was determined,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11510,10116.0,N,,CHEMBL626630,,,,,13049,1,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626631,,,,,13050,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8194,,U,,CHEMBL626632,,,,,13051,0,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,Autocuration,22229,,BAO_0000100,,,,1,,P
8194,,U,,CHEMBL626633,,,,,13052,0,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,Autocuration,22229,,BAO_0000100,,,,1,,P
8194,,U,,CHEMBL626634,,,,,13053,0,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,Autocuration,22229,,BAO_0000100,,,,1,,P
8194,,U,,CHEMBL626635,,,,,13054,0,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,Autocuration,22229,,BAO_0000100,,,,1,,P
8194,,U,,CHEMBL626636,,,,,13055,0,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,Autocuration,22229,,BAO_0000100,,,,1,,P
8194,,U,,CHEMBL626637,,,,,13056,0,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,Autocuration,22229,,BAO_0000100,,,,1,,P
13273,4754.0,N,,CHEMBL626638,,,,,13057,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL626639,,,,,13058,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL626640,,,,,13059,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL626641,,,,,13060,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL627272,,,,,13061,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL627273,,,,,13062,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL627441,,,,,13063,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL628355,,,,,13064,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL628356,,,,,13065,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL628357,,,,,13066,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL628358,,,,,13067,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13273,4754.0,N,,CHEMBL622307,,,,,13068,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,Intermediate,50339,,BAO_0000218,,,Pneumocystis carinii,1,,A
13118,,U,,CHEMBL622527,,,,,13069,0,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,Autocuration,22224,,BAO_0000019,,,,1,,A
13118,,U,,CHEMBL622528,,,,,13070,0,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,Autocuration,22224,,BAO_0000019,,,,1,,A
13118,,U,,CHEMBL622529,,,,,13071,0,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,Autocuration,22224,,BAO_0000019,,,,1,,A
13118,,U,,CHEMBL622992,,,,,13072,0,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,Autocuration,22224,,BAO_0000019,,,,1,,A
13118,,U,,CHEMBL622993,,,,,13073,0,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,Autocuration,22224,,BAO_0000019,,,,1,,A
13118,,U,,CHEMBL622994,,,,,13074,0,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,Autocuration,22224,,BAO_0000019,,,,1,,A
10633,10116.0,N,,CHEMBL622995,,,,,13075,1,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10633,10116.0,N,,CHEMBL622996,,,,,13076,1,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10633,10116.0,N,,CHEMBL622997,,,,,13077,1,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10633,10116.0,N,,CHEMBL622998,,,,,13078,1,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
5767,,U,,CHEMBL622999,,,,,13079,0,Cp max following ip administration at 1 mg/kg,,Autocuration,22224,,BAO_0000218,,,,1,,A
3302,,U,1969.0,CHEMBL623000,,,,Plasma,13080,0,Maximum concentration in plasma was reported at 0.5 hour,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
3302,,U,1969.0,CHEMBL623001,,,,Plasma,13081,0,Maximum concentration in plasma was reported at 2 hour,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12467,10090.0,N,,CHEMBL623002,,,,,13082,1,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
11778,,U,,CHEMBL623003,,,,,13083,0,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,Autocuration,22229,,BAO_0000100,,,,1,,P
4321,,U,,CHEMBL623004,,,,,13084,0,Steady state concentration was evaluated,,Autocuration,22224,,BAO_0000019,,,,1,,A
14884,,U,,CHEMBL623005,,,,,13085,0,Partition coefficient (logP),,Autocuration,22224,,BAO_0000019,,,,1,,A
15234,,U,,CHEMBL623006,,,,,13086,0,Partition coefficient (logD7.4),,Autocuration,22224,,BAO_0000019,,,,1,,A
14198,10116.0,N,2107.0,CHEMBL623007,,,,Liver,13087,1,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,10000001.0,CHEMBL623008,,,,Bone,13088,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2037.0,CHEMBL876654,,,,Cerebellum,13089,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL623009,,,,,13090,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL623010,,,,,13091,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,948.0,CHEMBL623011,,,,Heart,13092,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,160.0,CHEMBL623012,,,,Intestine,13093,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
8151,,U,,CHEMBL623013,,,,,13094,0,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
8151,,U,,CHEMBL623014,,,,,13095,0,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
8151,,U,1088.0,CHEMBL623015,,,,Urine,13096,0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
8151,,U,1088.0,CHEMBL623016,,,,Urine,13097,0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
8151,,U,1088.0,CHEMBL624858,,,,Urine,13098,0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,Autocuration,22224,,BAO_0000019,,,,1,,A
8151,10116.0,N,,CHEMBL624859,,,,,13099,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8151,10116.0,N,,CHEMBL624860,,,,,13100,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8151,10116.0,N,,CHEMBL624861,,,,,13101,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8151,10116.0,N,,CHEMBL624862,,,,,13102,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8151,10116.0,N,,CHEMBL624863,,,,,13103,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8151,10116.0,N,,CHEMBL876655,,,,,13104,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,9615.0,N,,CHEMBL624864,,,,,13105,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624865,,,,,13106,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624866,,,,,13107,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL624867,,,,,13108,1,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,Expert,50588,,BAO_0000218,,,Canis lupus familiaris,1,,F
6996,9615.0,N,,CHEMBL624868,,,,,13109,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628450,,,,,13110,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628451,,,,,13111,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628452,,,,,13112,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628453,,,,,13113,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628454,,,,,13114,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628455,,,,,13115,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628456,,,,,13116,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628457,,,,,13117,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL877505,,,,,13118,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628458,,,,,13119,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628459,,,,,13120,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628460,,,,,13121,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL628461,,,,,13122,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,,U,,CHEMBL628462,,,,,13123,0,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,Autocuration,22224,,BAO_0000218,,,,1,,B
6996,9615.0,N,,CHEMBL628463,,,,,13124,1,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,10116.0,N,,CHEMBL625666,,,,,13125,1,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,Expert,50597,,BAO_0000218,,,Rattus norvegicus,1,,F
6996,,U,,CHEMBL625667,,,,,13126,0,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,Autocuration,22224,,BAO_0000218,,,,1,,B
6996,10116.0,N,,CHEMBL625668,,,,,13127,1,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,Expert,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL625669,,,,,13128,1,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7114,,U,,CHEMBL625670,,,,,13129,0,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,Autocuration,22224,,BAO_0000019,,,,1,,A
7114,10116.0,N,,CHEMBL625671,,,,,13130,1,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8613,10298.0,N,,CHEMBL625672,,,,,13131,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL625673,,,,,13132,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL625674,,,,,13133,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL625675,,,,,13134,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL627637,,,,,13135,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL627638,,,,,13136,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL627639,,,,,13137,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL627640,,,,,13138,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL627641,,,,,13139,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL627642,,,,,13140,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL877506,,,,,13141,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10090.0,N,,CHEMBL627275,,,,,13142,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
11219,9669.0,N,,CHEMBL627643,,,,,13143,1,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
11219,9669.0,N,,CHEMBL631246,,,,,13144,1,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
11219,9669.0,N,,CHEMBL631247,,,,,13145,1,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
11219,9669.0,N,,CHEMBL629532,,,,,13146,1,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
11219,9669.0,N,,CHEMBL629533,,,,,13147,1,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
11219,9669.0,N,,CHEMBL629534,,,,,13148,1,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
11219,9669.0,N,,CHEMBL629535,,,,,13149,1,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,Intermediate,50506,,BAO_0000218,,,Mustela putorius furo,1,,A
14837,,U,,CHEMBL625932,,,,,13150,0,Pharmacokinetic parameter :drug bound to plasma was reported,,Autocuration,22224,,BAO_0000019,,,,1,,A
14837,,U,,CHEMBL625933,,,,,13151,0,compound was evaluated for drug bound in plasma,,Autocuration,22224,,BAO_0000019,,,,1,,A
15343,10116.0,N,,CHEMBL625934,,,,,13152,1,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13761,9347.0,U,,CHEMBL625935,,,,,13153,0,Bioavailability,,Autocuration,22224,,BAO_0000218,,,Eutheria,1,,A
14810,10116.0,N,,CHEMBL625936,,,,,13154,1,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14810,10116.0,N,,CHEMBL625937,,,,,13155,1,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13249,9615.0,N,,CHEMBL625938,,,,,13156,1,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9267,10116.0,N,1970.0,CHEMBL625939,,,,Bile,13157,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9267,10116.0,N,1970.0,CHEMBL625940,,,,Bile,13158,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9267,10116.0,N,1970.0,CHEMBL874464,,,,Bile,13159,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9267,10116.0,N,1970.0,CHEMBL625941,,,,Bile,13160,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9267,10116.0,N,1970.0,CHEMBL625942,,,,Bile,13161,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9267,10116.0,N,1970.0,CHEMBL625943,,,,Bile,13162,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15549,9606.0,N,1977.0,CHEMBL625944,,,,Serum,13163,1,In vitro protein binding in human serum at 5 ug/ml,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
10929,,U,,CHEMBL625945,,,,,13164,0,Serum protein binding ability was measured,,Autocuration,22224,,BAO_0000019,,,,1,,A
15444,,U,,CHEMBL625946,,,,,13165,0,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,Autocuration,22224,,BAO_0000019,,,,1,,A
12860,9615.0,U,,CHEMBL625947,,,,,13166,0,Oral bioavailability in dog,,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12170,10116.0,N,,CHEMBL625948,,,,,13167,1,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15173,,U,,CHEMBL625949,,,,,13168,0,Absolute oral bioavailability at an iv dose of 14 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,,U,,CHEMBL625950,,,,,13169,0,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,9347.0,U,,CHEMBL625951,,,,,13170,0,Oral bioavailability (dose 15 mg/kg i.v.),,Autocuration,22224,,BAO_0000218,,In vivo,Eutheria,1,,A
15173,,U,,CHEMBL625952,,,,,13171,0,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,,U,,CHEMBL625953,,,,,13172,0,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,,U,,CHEMBL625954,,,,,13173,0,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,,U,,CHEMBL882959,,,,,13174,0,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11767,9615.0,N,,CHEMBL625955,,,,,13175,1,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
11219,9669.0,U,,CHEMBL625956,,,,,13176,0,Bioavailability in ferret,,Autocuration,22224,,BAO_0000218,,In vivo,Mustela putorius furo,1,,A
12186,9541.0,N,,CHEMBL625957,,,,,13177,1,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
11510,10116.0,N,,CHEMBL625958,,,,,13178,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL625959,,,,,13179,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626642,,,,,13180,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL631330,,,,,13181,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL631331,,,,,13182,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL631332,,,,,13183,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL631333,,,,,13184,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632018,,,,,13185,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632019,,,,,13186,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632020,,,,,13187,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632021,,,,,13188,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632022,,,,,13189,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632023,,,,,13190,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632024,,,,,13191,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL874472,,,,,13192,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632025,,,,,13193,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632026,,,,,13194,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632027,,,,,13195,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL632028,,,,,13196,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626430,,,,,13197,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626431,,,,,13198,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626432,,,,,13199,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626433,,,,,13200,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626434,,,,,13201,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627280,,,,,13202,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627281,,,,,13203,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627282,,,,,13204,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7199,,U,,CHEMBL627283,,,,,13205,0,Total body clearance was measured at given dose,,Autocuration,22224,,BAO_0000019,,,,1,,A
7199,,U,,CHEMBL627284,,,,,13206,0,Total body clearance was measured at given dose.,,Autocuration,22224,,BAO_0000218,,,,1,,A
7095,10116.0,N,,CHEMBL627285,,,,,13207,1,Metabolic clearance from the body in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7095,,U,,CHEMBL627286,,,,,13208,0,Renal clearance from the body,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
7095,10116.0,N,,CHEMBL875477,,,,,13209,1,Renal clearance from the body in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12528,10116.0,N,,CHEMBL627287,,,,,13210,1,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12528,9615.0,N,,CHEMBL627288,,,,,13211,1,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
7095,10116.0,N,,CHEMBL627289,,,,,13212,1,Total clearance from the body in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14223,10116.0,N,1969.0,CHEMBL627290,,,,Plasma,13213,1,Clearance into cortex from rat plasma or PBS,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13569,,U,,CHEMBL627291,,,,,13214,0,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13569,,U,,CHEMBL627292,,,,,13215,0,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13569,,U,,CHEMBL627293,,,,,13216,0,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13569,,U,,CHEMBL627294,,,,,13217,0,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13569,,U,,CHEMBL875478,,,,,13218,0,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13979,,U,,CHEMBL627295,,,,,13219,0,Clearance was determined,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14315,10090.0,N,,CHEMBL627296,,,,,13220,1,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14315,9986.0,N,,CHEMBL626119,,,,,13221,1,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,Intermediate,50592,,BAO_0000218,,In vivo,Oryctolagus cuniculus,1,,A
14315,10116.0,N,,CHEMBL626120,,,,,13222,1,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12174,10116.0,N,,CHEMBL626121,,,,,13223,1,Clearance in rat after iv dose (100 ug/kg),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12797,10141.0,U,,CHEMBL626122,,,,,13224,0,Clearance in guinea pig,,Autocuration,22224,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
12797,10116.0,N,,CHEMBL626123,,,,,13225,1,Compound was evaluated for clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12797,9615.0,N,,CHEMBL623456,,,,,13226,1,Compound was evaluated for the clearance in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12797,10116.0,N,,CHEMBL623457,,,,,13227,1,Compound was evaluated for the clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11500,10116.0,N,,CHEMBL623458,,,,,13228,1,Compound was tested in vivo for clearance after iv administration in the rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15173,,U,,CHEMBL623459,,,,,13229,0,IV clearance determined at an iv dose of 14 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,,U,,CHEMBL875484,,,,,13230,0,IV clearance determined at an iv dose of 15.2 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,,U,,CHEMBL623460,,,,,13231,0,IV clearance determined at an iv dose of 15 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,,U,,CHEMBL623461,,,,,13232,0,IV clearance determined at an peroral dose of 30 mg/kg.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,,U,,CHEMBL623462,,,,,13233,0,IV clearance determined at an peroral dose of 30.2 mg/kg.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15173,,U,,CHEMBL627386,,,,,13234,0,IV clearance determined at an peroral dose of 30.3 mg/kg.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14198,10116.0,N,2113.0,CHEMBL627387,,,,Kidney,13235,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2107.0,CHEMBL627388,,,,Liver,13236,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2048.0,CHEMBL627389,,,,Lung,13237,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2385.0,CHEMBL627390,,,,Muscle tissue,13238,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,1969.0,CHEMBL627391,,,,Plasma,13239,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL627392,,,,,13240,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2106.0,CHEMBL627393,,,,Spleen,13241,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,3126.0,CHEMBL627394,,,,Trachea,13242,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,10000001.0,CHEMBL627395,,,,Bone,13243,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2037.0,CHEMBL875485,,,,Cerebellum,13244,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL627396,,,,,13245,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL627397,,,,,13246,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,948.0,CHEMBL627398,,,,Heart,13247,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,10000001.0,CHEMBL627399,,,,Bone,13248,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2113.0,CHEMBL627400,,,,Kidney,13249,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2107.0,CHEMBL627401,,,,Liver,13250,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2048.0,CHEMBL627402,,,,Lung,13251,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2385.0,CHEMBL627403,,,,Muscle tissue,13252,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,1969.0,CHEMBL627404,,,,Plasma,13253,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL623101,,,,,13254,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2106.0,CHEMBL877480,,,,Spleen,13255,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,3126.0,CHEMBL623102,,,,Trachea,13256,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,10000001.0,CHEMBL623103,,,,Bone,13257,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2037.0,CHEMBL623104,,,,Cerebellum,13258,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL623105,,,,,13259,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL623106,,,,,13260,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,948.0,CHEMBL623107,,,,Heart,13261,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,160.0,CHEMBL623108,,,,Intestine,13262,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2113.0,CHEMBL623109,,,,Kidney,13263,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2107.0,CHEMBL623110,,,,Liver,13264,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2048.0,CHEMBL623111,,,,Lung,13265,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2385.0,CHEMBL625060,,,,Muscle tissue,13266,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,1969.0,CHEMBL625061,,,,Plasma,13267,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL625062,,,,,13268,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2106.0,CHEMBL625063,,,,Spleen,13269,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,3126.0,CHEMBL625064,,,,Trachea,13270,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,10000001.0,CHEMBL625065,,,,Bone,13271,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2037.0,CHEMBL625066,,,,Cerebellum,13272,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL625067,,,,,13273,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL625068,,,,,13274,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,948.0,CHEMBL622159,,,,Heart,13275,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,160.0,CHEMBL622160,,,,Intestine,13276,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2113.0,CHEMBL622161,,,,Kidney,13277,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2048.0,CHEMBL622162,,,,Lung,13278,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2385.0,CHEMBL622163,,,,Muscle tissue,13279,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,1969.0,CHEMBL622313,,,,Plasma,13280,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,,CHEMBL622314,,,,,13281,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,2106.0,CHEMBL622315,,,,Spleen,13282,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14198,10116.0,N,3126.0,CHEMBL622316,,,,Trachea,13283,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15599,562.0,N,,CHEMBL877486,,,,,13284,1,Normal diffusion coefficient in water for Escherichia coli,,Intermediate,50212,,BAO_0000218,,,Escherichia coli,1,,A
8204,,U,,CHEMBL622317,,,,,13285,0,Average max percent decrease in RVR (renal vascular resistance) was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
8204,,U,,CHEMBL622318,,,,,13286,0,Average max percent decrease in RVR (renal vascular resistance) was determined.,,Autocuration,22224,,BAO_0000019,,,,1,,A
6154,,U,,CHEMBL622319,,,,,13287,0,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
6154,,U,,CHEMBL622320,,,,,13288,0,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
6154,,U,,CHEMBL622321,,,,,13289,0,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
6154,,U,,CHEMBL622322,,,,,13290,0,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
7114,,U,,CHEMBL622323,,,,,13291,0,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,Autocuration,22224,,BAO_0000019,,,,1,,A
7114,10116.0,N,,CHEMBL622324,,,,,13292,1,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,9615.0,N,1088.0,CHEMBL622325,,,,Urine,13293,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL622326,,,,Urine,13294,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL877487,,,,Urine,13295,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL622327,,,,Urine,13296,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL622328,,,,Urine,13297,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL622329,,,,Urine,13298,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL622330,,,,Urine,13299,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL622331,,,,Urine,13300,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL622332,,,,Urine,13301,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL622333,,,,Urine,13302,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,314293.0,U,1088.0,CHEMBL627658,,,,Urine,13303,0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL630428,,,,Urine,13304,0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL630429,,,,Urine,13305,0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL630430,,,,Urine,13306,0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL630431,,,,Urine,13307,0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,10116.0,N,1088.0,CHEMBL630432,,,,Urine,13308,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL630433,,,,Urine,13309,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL630434,,,,Urine,13310,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629372,,,,Urine,13311,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629553,,,,Urine,13312,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629554,,,,Urine,13313,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL874447,,,,Urine,13314,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629555,,,,Urine,13315,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629556,,,,Urine,13316,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629557,,,,Urine,13317,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629558,,,,Urine,13318,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629559,,,,Urine,13319,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629560,,,,Urine,13320,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,9615.0,N,1088.0,CHEMBL629561,,,,Urine,13321,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL629562,,,,Urine,13322,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL629563,,,,Urine,13323,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL629564,,,,Urine,13324,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL629565,,,,Urine,13325,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL629566,,,,Urine,13326,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL629567,,,,Urine,13327,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL629568,,,,Urine,13328,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL629569,,,,Urine,13329,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL629570,,,,Urine,13330,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,314293.0,U,1088.0,CHEMBL629571,,,,Urine,13331,0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
12170,10116.0,U,,CHEMBL629572,,,,,13332,0,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12170,10116.0,U,,CHEMBL629573,,,,,13333,0,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4985,9347.0,U,,CHEMBL629574,,,,,13334,0,Bioavailability (dose 20 mg/kg),,Autocuration,22224,,BAO_0000218,,In vivo,Eutheria,1,,A
15145,9615.0,U,,CHEMBL629575,,,,,13335,0,Bioavailability in dog,,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14080,10116.0,U,,CHEMBL874448,,,,,13336,0,Bioavailability in rat (Sprague-Dawley) (male),,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11219,9443.0,U,,CHEMBL629576,,,,,13337,0,Bioavailability in monkey (dose 10 mg/kg i.d.),,Autocuration,22224,,BAO_0000218,,In vivo,Primates,1,,A
15145,10116.0,U,,CHEMBL629577,,,,,13338,0,Bioavailability in rat,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15145,10116.0,U,,CHEMBL629578,,,,,13339,0,Bioavailability in rat,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
1202,9615.0,U,,CHEMBL629579,,,,,13340,0,Bioavailability in dog (dose 3.0 mg/kg p.o.),,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
1202,9615.0,U,,CHEMBL882958,,,,,13341,0,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
1202,9598.0,N,,CHEMBL629580,,,,,13342,1,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,Intermediate,50505,,BAO_0000218,,In vivo,Pan troglodytes,1,,A
4026,9347.0,U,,CHEMBL629581,,,,,13343,0,Bioavailability,,Autocuration,22224,,BAO_0000218,,In vivo,Eutheria,1,,A
1492,9520.0,U,,CHEMBL629582,,,,,13344,0,Bioavailability in squirrel monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Saimiri,1,,A
12793,9615.0,N,,CHEMBL628522,,,,,13345,1,Bioavailability was evaluated in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
12793,10026.0,N,,CHEMBL625432,,,,,13346,1,Bioavailability was evaluated in hamster,,Intermediate,100712,,BAO_0000218,,In vivo,Cricetinae,1,,A
12793,10116.0,U,,CHEMBL625433,,,,,13347,0,Bioavailability in rat,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL625434,,,,Plasma,13348,1,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,N,1969.0,CHEMBL625435,,,,Plasma,13349,1,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14793,10116.0,U,,CHEMBL625436,,,,,13350,0,Bioavailability in rat (dose 10 mg/kg p.o.),,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14731,9541.0,N,,CHEMBL874588,,,,,13351,1,Bioavailability was measured in cynomolgus monkeys.,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
14731,10090.0,N,,CHEMBL625437,,,,,13352,1,Bioavailability was measured in nude mice.,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
12187,9669.0,U,,CHEMBL625438,,,,,13353,0,Bioavailability in ferret (dose 10 mg/kg i.d.),,Autocuration,22224,,BAO_0000218,,In vivo,Mustela putorius furo,1,,A
12187,314293.0,U,,CHEMBL625439,,,,,13354,0,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
12187,314293.0,U,,CHEMBL625440,,,,,13355,0,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
12187,314293.0,U,,CHEMBL625441,,,,,13356,0,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
12187,10116.0,U,,CHEMBL625442,,,,,13357,0,Bioavailability in rat (dose 10 mg/kg i.d.),,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12187,10116.0,N,,CHEMBL625443,,,,,13358,1,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
17431,,U,,CHEMBL625444,,,,,13359,0,Bioavailability was determined; extremely poor,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13318,10090.0,N,,CHEMBL625445,,,,,13360,1,% bioavailability in mice after oral administration of prodrug,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9025,9615.0,N,,CHEMBL625446,,,,,13361,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL882960,,,,,13362,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625447,,,,,13363,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625448,,,,,13364,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625449,,,,,13365,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL874589,,,,,13366,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625450,,,,,13367,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625451,,,,,13368,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL626584,,,,,13369,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL626585,,,,,13370,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL626586,,,,,13371,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL626587,,,,,13372,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL626588,,,,,13373,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL626589,,,,,13374,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL626590,,,,,13375,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL626591,,,,,13376,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL627181,,,,,13377,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628083,,,,,13378,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
15173,,U,,CHEMBL628084,,,,,13379,0,IV clearance determined at an peroral dose of 15 mg/kg.,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
7732,102285.0,N,,CHEMBL628085,,,,,13380,1,Mouse oral clearance was measured against Hymenolepiasis nana.,,Expert,50064,,BAO_0000218,,In vivo,Hymenolepis nana,1,,F
7732,6339.0,N,,CHEMBL628086,,,,,13381,1,Mouse oral clearance was measured against Nematospiroides dubius,,Expert,50545,,BAO_0000218,,In vivo,Heligmosomoides polygyrus,1,,F
7732,,U,,CHEMBL628087,,,,,13382,0,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,F
7732,10090.0,N,,CHEMBL628088,,,,,13383,1,Mouse oral clearance was measured against N. nana; NT is Not Tested,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
7732,,U,,CHEMBL628089,,,,,13384,0,Mouse oral clearance was measured against N. nana; NT is Not Tested,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,B
8328,,U,,CHEMBL628090,,,,,13385,0,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
8328,,U,,CHEMBL628091,,,,,13386,0,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
8328,,U,,CHEMBL628092,,,,,13387,0,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
8328,,U,,CHEMBL628093,,,,,13388,0,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
8328,,U,,CHEMBL875607,,,,,13389,0,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
8328,,U,,CHEMBL625710,,,,,13390,0,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
8328,,U,,CHEMBL625711,,,,,13391,0,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
8328,,U,,CHEMBL625712,,,,,13392,0,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
8328,,U,,CHEMBL625713,,,,,13393,0,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13376,9615.0,N,,CHEMBL625714,,,,,13394,1,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
13477,9544.0,N,,CHEMBL625715,,,,,13395,1,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,Intermediate,50797,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
13477,10116.0,N,,CHEMBL625716,,,,,13396,1,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13477,10116.0,N,,CHEMBL625717,,,,,13397,1,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13313,10116.0,N,,CHEMBL625718,,,,,13398,1,Plasma clearance was determined for the compound in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12504,10116.0,N,,CHEMBL625719,,,,,13399,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12504,10116.0,N,,CHEMBL625720,,,,,13400,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12504,10116.0,N,,CHEMBL625721,,,,,13401,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12504,10116.0,N,,CHEMBL625722,,,,,13402,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13129,10116.0,N,,CHEMBL625723,,,,,13403,1,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
7732,6339.0,N,,CHEMBL625724,,,,,13404,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,Intermediate,50545,,BAO_0000218,,In vivo,Heligmosomoides polygyrus,1,,A
7732,6339.0,N,,CHEMBL625725,,,,,13405,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,Intermediate,50545,,BAO_0000218,,In vivo,Heligmosomoides polygyrus,1,,A
7732,6339.0,N,,CHEMBL625726,,,,,13406,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,Intermediate,50545,,BAO_0000218,,In vivo,Heligmosomoides polygyrus,1,,A
7732,6339.0,N,,CHEMBL875608,,,,,13407,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,Intermediate,50545,,BAO_0000218,,In vivo,Heligmosomoides polygyrus,1,,A
7732,6339.0,N,,CHEMBL625727,,,,,13408,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,Intermediate,50545,,BAO_0000218,,In vivo,Heligmosomoides polygyrus,1,,A
9278,10116.0,U,1088.0,CHEMBL625728,,,,Urine,13409,0,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9278,10116.0,U,,CHEMBL625729,,,,,13410,0,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9278,10116.0,U,,CHEMBL625730,,,,,13411,0,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9278,10116.0,U,1088.0,CHEMBL625731,,,,Urine,13412,0,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9278,10116.0,U,1088.0,CHEMBL626417,,,,Urine,13413,0,Urinary clearance was determined in rat at 25 mg/kg os dosage,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9278,9606.0,N,1088.0,CHEMBL626418,,,,Urine,13414,1,Urinary clearance was determined at 100 mg/kg oral dosage in human,,Intermediate,50587,,BAO_0000218,,In vivo,Homo sapiens,1,,A
9278,9615.0,N,1088.0,CHEMBL626419,,,,Urine,13415,1,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
5932,9615.0,N,1969.0,CHEMBL626592,,,,Plasma,13416,1,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
5932,10116.0,N,1969.0,CHEMBL626593,,,,Plasma,13417,1,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5182,10116.0,N,,CHEMBL626594,,,,,13418,1,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
10499,9615.0,N,,CHEMBL625035,,,,,13419,1,Clearance rate in dogs,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
6051,,U,,CHEMBL625036,,,,,13420,0,Compound was measured for intrinsic clearance,,Autocuration,22224,,BAO_0000019,,In vitro,,1,,A
17508,,U,,CHEMBL625037,,,,,13421,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6228,,U,,CHEMBL625038,,,,,13422,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6231,,U,,CHEMBL625039,,,,,13423,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
17740,,U,,CHEMBL625040,,,,,13424,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6495,,U,,CHEMBL625041,,,,,13425,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
2171,,U,,CHEMBL625042,,,,,13426,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
3255,,U,,CHEMBL874411,,,,,13427,0,Partition coefficient of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
6821,,U,,CHEMBL625043,,,,,13428,0,Permeability,,Autocuration,22224,,BAO_0000019,,,,1,,A
2685,,U,,CHEMBL625044,,,,,13429,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
17584,,U,,CHEMBL625045,,,,,13430,0,Partition coefficient (logD),,Autocuration,22224,,BAO_0000019,,,,1,,A
13824,,U,,CHEMBL625046,,,,,13431,0,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,Autocuration,22229,,BAO_0000100,,,,1,,P
13824,,U,,CHEMBL625047,,,,,13432,0,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,Autocuration,22229,,BAO_0000100,,,,1,,P
16479,,U,,CHEMBL625048,,,,,13433,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
11997,,U,,CHEMBL625049,,,,,13434,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
2988,,U,,CHEMBL625050,,,,,13435,0,Calculated logarithm of partition coefficient (P) was determined,,Autocuration,22229,,BAO_0000100,,,,1,,P
931,,U,,CHEMBL625051,,,,,13436,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
4381,,U,,CHEMBL874412,,,,,13437,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
4397,,U,,CHEMBL625052,,,,,13438,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
5889,,U,,CHEMBL625053,,,,,13439,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6154,,U,,CHEMBL623250,,,,,13440,0,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
6154,,U,,CHEMBL623251,,,,,13441,0,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
6154,,U,,CHEMBL623252,,,,,13442,0,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
6154,,U,,CHEMBL623253,,,,,13443,0,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
6154,,U,,CHEMBL623254,,,,,13444,0,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
6154,,U,,CHEMBL623255,,,,,13445,0,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,Autocuration,22224,,BAO_0000019,,,,1,,A
6887,,U,,CHEMBL626831,,,,,13446,0,Percent degradation of compound at a pH of 1 over a 18 hr period,,Autocuration,22224,,BAO_0000019,,,,1,,A
6887,,U,,CHEMBL877494,,,,,13447,0,Percent degradation of compound at pH of 1 over an 18 hr period,,Autocuration,22224,,BAO_0000019,,,,1,,A
14116,,U,,CHEMBL626832,,,,,13448,0,Delta Logarithm of Partition Coefficient value was determined.,,Autocuration,22224,,BAO_0000019,,,,1,,A
11137,,U,,CHEMBL626833,,,,,13449,0,Delta logPoct-cyc,,Autocuration,22224,,BAO_0000019,,,,1,,A
7230,,U,,CHEMBL626834,,,,,13450,0,Lipophilicity estimated on reversed phase TLC,,Autocuration,22224,,BAO_0000100,,,,1,,P
15741,,U,,CHEMBL626835,,,,,13451,0,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,Autocuration,22224,,BAO_0000019,,,,1,,A
9663,,U,,CHEMBL626836,,,,,13452,0,Delta logPoct-cyc,,Autocuration,22224,,BAO_0000019,,,,1,,A
9663,,U,,CHEMBL626837,,,,,13453,0,Change in logarithm of partition coefficient of the compound,,Autocuration,22229,,BAO_0000100,,,,1,,P
13807,,U,,CHEMBL626838,,,,,13454,0,Delta logD (pH 6.5),,Autocuration,22224,,BAO_0000019,,,,1,,A
13807,,U,,CHEMBL626839,,,,,13455,0,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,Autocuration,22224,,BAO_0000100,,,,1,,P
17425,,U,,CHEMBL626840,,,,,13456,0,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,Autocuration,22224,,BAO_0000019,,,,1,,A
12143,,U,,CHEMBL626841,,,,,13457,0,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,Autocuration,22224,,BAO_0000019,,,,1,,A
12608,,U,,CHEMBL626842,,,,,13458,0,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,Autocuration,22224,,BAO_0000219,,,,1,,A
12608,,U,,CHEMBL626843,,,,,13459,0,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,Autocuration,22224,,BAO_0000219,,,,1,,A
8649,10116.0,N,,CHEMBL626844,,,,,13460,1,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8649,10116.0,N,,CHEMBL877495,,,,,13461,1,Amount of deuterium retained was reported after normal workup in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8649,10116.0,N,,CHEMBL626845,,,,,13462,1,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8649,10116.0,N,,CHEMBL626846,,,,,13463,1,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8649,10116.0,N,,CHEMBL626847,,,,,13464,1,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8649,10116.0,N,,CHEMBL628677,,,,,13465,1,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8649,10116.0,N,,CHEMBL628678,,,,,13466,1,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9659,,U,,CHEMBL628679,,,,,13467,0,Compound was subjected to electrochemical oxidation,,Autocuration,22224,,BAO_0000019,,,,1,,A
9659,,U,,CHEMBL628680,,,,,13468,0,Compound was subjected to photochemical oxidation,,Autocuration,22224,,BAO_0000019,,,,1,,A
9659,,U,,CHEMBL628681,,,,,13469,0,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,Autocuration,22224,,BAO_0000019,,,,1,,A
9659,,U,,CHEMBL628682,,,,,13470,0,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,Autocuration,22224,,BAO_0000019,,,,1,,A
9659,,U,,CHEMBL628683,,,,,13471,0,Oxidation of compound by methemoglobin in presence of hydroperoxide,,Autocuration,22224,,BAO_0000019,,,,1,,A
9607,10116.0,N,,CHEMBL628684,,,,,13472,1,Percent diffusion through fuzzy rat skin after 48 h of incubation,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7057,,U,,CHEMBL877501,,,,,13473,0,Dissociation constant (pKa),,Autocuration,22229,,BAO_0000100,,,,1,,P
7057,,U,,CHEMBL628685,,,,,13474,0,Dissociation constant value of the compound; ND means not determined.,,Autocuration,22224,,BAO_0000100,,,,1,,P
7911,10116.0,N,178.0,CHEMBL628686,,,,Blood,13475,1,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,178.0,CHEMBL628687,,,,Blood,13476,1,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,,CHEMBL628688,,,,,13477,1,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,,CHEMBL628689,,,,,13478,1,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,2107.0,CHEMBL628690,,,,Liver,13479,1,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,2107.0,CHEMBL629363,,,,Liver,13480,1,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,2106.0,CHEMBL629364,,,,Spleen,13481,1,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,2106.0,CHEMBL629365,,,,Spleen,13482,1,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,,CHEMBL629366,,,,,13483,1,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,1088.0,CHEMBL629367,,,,Urine,13484,1,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,1988.0,CHEMBL629368,,,,Feces,13485,1,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7911,10116.0,N,1088.0,CHEMBL877502,,,,Urine,13486,1,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13792,10090.0,N,2037.0,CHEMBL629369,,,,Cerebellum,13487,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,955.0,CHEMBL629370,,,,Brain,13488,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8133,314293.0,U,1088.0,CHEMBL629371,,,,Urine,13489,0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL626276,,,,Urine,13490,0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL626277,,,,Urine,13491,0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL631250,,,,Urine,13492,0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,10116.0,N,1088.0,CHEMBL631251,,,,Urine,13493,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL631252,,,,Urine,13494,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL631253,,,,Urine,13495,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL631254,,,,Urine,13496,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL631255,,,,Urine,13497,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL631256,,,,Urine,13498,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL631257,,,,Urine,13499,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628009,,,,Urine,13500,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628010,,,,Urine,13501,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628011,,,,Urine,13502,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628012,,,,Urine,13503,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628013,,,,Urine,13504,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628014,,,,Urine,13505,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,9615.0,N,1088.0,CHEMBL628015,,,,Urine,13506,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL628016,,,,Urine,13507,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL874461,,,,Urine,13508,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL628017,,,,Urine,13509,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL628018,,,,Urine,13510,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL628019,,,,Urine,13511,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL628020,,,,Urine,13512,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL628021,,,,Urine,13513,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL628022,,,,Urine,13514,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,9615.0,N,1088.0,CHEMBL628023,,,,Urine,13515,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8133,314293.0,U,1088.0,CHEMBL628024,,,,Urine,13516,0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL628025,,,,Urine,13517,0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL628026,,,,Urine,13518,0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL628027,,,,Urine,13519,0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,314293.0,U,1088.0,CHEMBL628028,,,,Urine,13520,0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,Autocuration,22224,,BAO_0000218,,,Simiiformes,1,,A
8133,10116.0,N,1088.0,CHEMBL628029,,,,Urine,13521,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628030,,,,Urine,13522,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628031,,,,Urine,13523,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628032,,,,Urine,13524,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628033,,,,Urine,13525,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628034,,,,Urine,13526,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628035,,,,Urine,13527,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL628036,,,,Urine,13528,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL874462,,,,Urine,13529,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9025,9615.0,N,,CHEMBL628037,,,,,13530,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628123,,,,,13531,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628124,,,,,13532,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628125,,,,,13533,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628126,,,,,13534,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628127,,,,,13535,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628128,,,,,13536,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628129,,,,,13537,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628130,,,,,13538,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628131,,,,,13539,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628132,,,,,13540,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628133,,,,,13541,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628134,,,,,13542,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628135,,,,,13543,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628136,,,,,13544,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628137,,,,,13545,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628138,,,,,13546,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628139,,,,,13547,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628140,,,,,13548,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628141,,,,,13549,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628142,,,,,13550,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628143,,,,,13551,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628144,,,,,13552,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628145,,,,,13553,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL628146,,,,,13554,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625355,,,,,13555,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625356,,,,,13556,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625357,,,,,13557,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625527,,,,,13558,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL875473,,,,,13559,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,9615.0,N,,CHEMBL625528,,,,,13560,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
9025,10116.0,N,,CHEMBL626304,,,,,13561,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9025,9615.0,N,1637.0,CHEMBL624138,,,,Artery,13562,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
6448,,U,,CHEMBL624139,,,,,13563,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
17221,,U,,CHEMBL624140,,,,,13564,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6545,,U,,CHEMBL624141,,,,,13565,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
577,,U,,CHEMBL624142,,,,,13566,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6285,,U,,CHEMBL624143,,,,,13567,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6500,,U,,CHEMBL624144,,,,,13568,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6716,,U,,CHEMBL624145,,,,,13569,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
13658,,U,,CHEMBL624146,,,,,13570,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6549,,U,,CHEMBL624147,,,,,13571,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
14685,,U,,CHEMBL883123,,,,,13572,0,Calculated partition coefficient (clogP) (MacLogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6893,,U,,CHEMBL624148,,,,,13573,0,Partition coefficient (logP),,Autocuration,22224,,BAO_0000019,,,,1,,A
3687,,U,,CHEMBL874416,,,,,13574,0,Kinetic parameter was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
4207,,U,,CHEMBL624149,,,,,13575,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
4626,,U,,CHEMBL624150,,,,,13576,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
1021,,U,,CHEMBL624151,,,,,13577,0,Lipophilicity was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
3777,,U,,CHEMBL624152,,,,,13578,0,Lipophilicity was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
17533,,U,,CHEMBL622139,,,,,13579,0,Lipophilicity was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
6524,,U,,CHEMBL622140,,,,,13580,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
17533,,U,,CHEMBL622141,,,,,13581,0,Lipophilicity was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
6480,,U,,CHEMBL622142,,,,,13582,0,Lipophilicity in octanol-water,,Autocuration,22224,,BAO_0000100,,,,1,,P
17606,,U,,CHEMBL622143,,,,,13583,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
6863,,U,,CHEMBL622144,,,,,13584,0,Octanol-water partition coefficient was determined,,Autocuration,22229,,BAO_0000100,,,,1,,P
1356,,U,,CHEMBL877473,,,,,13585,0,Partition coefficient (logP),,Autocuration,22224,,BAO_0000019,,,,1,,A
3326,,U,,CHEMBL622145,,,,,13586,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
1356,,U,,CHEMBL622146,,,,,13587,0,Partition coefficient was determined; ND means not determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
12984,,U,,CHEMBL622147,,,,,13588,0,Calculated partition coefficient (clogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
17363,,U,,CHEMBL622148,,,,,13589,0,Partition coefficient of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
6827,,U,,CHEMBL883124,,,,,13590,0,Permeability was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
261,,U,,CHEMBL622149,,,,,13591,0,The compound was evaluated for the partition coefficient,,Autocuration,22229,,BAO_0000100,,,,1,,P
2685,,U,,CHEMBL622150,,,,,13592,0,Partition coefficient (logP),,Autocuration,22224,,BAO_0000019,,,,1,,A
414,,U,,CHEMBL622151,,,,,13593,0,The lipophilicity was reported,,Autocuration,22224,,BAO_0000100,,,,1,,P
15769,,U,,CHEMBL622152,,,,,13594,0,logarithm of the octanol-water partition coefficient for the compound,,Autocuration,22229,,BAO_0000100,,,,1,,P
17248,,U,,CHEMBL622153,,,,,13595,0,Clogp value was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
16935,,U,,CHEMBL877474,,,,,13596,0,Clp at a dose of 1.5 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
16935,,U,,CHEMBL622154,,,,,13597,0,Clp at a dose of 2.0 mg/kg,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14832,,U,1969.0,CHEMBL622155,,,,Plasma,13598,0,"Clp, plasma clearance at a dose of 10 mg/kg",,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
14832,,U,1969.0,CHEMBL622156,,,,Plasma,13599,0,"Clp, plasma clearance at a dose of 50 mg/kg",,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
2399,10116.0,N,1969.0,CHEMBL622157,,,,Plasma,13600,1,Compound was tested for plasma clearance in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
2399,10116.0,N,1969.0,CHEMBL622158,,,,Plasma,13601,1,Compound was tested for plasma clearance in rat; Not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6227,10116.0,N,,CHEMBL622807,,,,,13602,1,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
6227,9544.0,N,,CHEMBL622808,,,,,13603,1,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,Intermediate,50797,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
5623,,U,,CHEMBL622809,,,,,13604,0,Plasma clearance by iv administration at a dose 0.003 ug/mL,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
4854,,U,,CHEMBL622810,,,,,13605,0,Plasma clearance determined,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
4493,10026.0,N,,CHEMBL876653,,,,,13606,1,Plasma clearance after iv administration at 3 mg/kg in hamster,,Intermediate,100712,,BAO_0000218,,In vivo,Cricetinae,1,,A
4493,10026.0,N,,CHEMBL622811,,,,,13607,1,Plasma clearance after iv administration at 4 mg/kg in hamster,,Intermediate,100712,,BAO_0000218,,In vivo,Cricetinae,1,,A
14956,10116.0,N,,CHEMBL622986,,,,,13608,1,Rate of clearance in rat was determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15372,10116.0,N,1969.0,CHEMBL622987,,,,Plasma,13609,1,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15372,10116.0,N,1969.0,CHEMBL622988,,,,Plasma,13610,1,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15372,10116.0,N,1969.0,CHEMBL622989,,,,Plasma,13611,1,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15372,10116.0,N,1969.0,CHEMBL622990,,,,Plasma,13612,1,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15604,314293.0,U,1969.0,CHEMBL622991,,,,Plasma,13613,0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,Autocuration,22224,,BAO_0000218,,In vivo,Simiiformes,1,,A
15604,10116.0,N,1969.0,CHEMBL622227,,,,Plasma,13614,1,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15604,9615.0,N,1969.0,CHEMBL622228,,,,Plasma,13615,1,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
14964,10116.0,N,,CHEMBL622229,,,,,13616,1,Clpl value in rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15240,10141.0,N,,CHEMBL622230,,,,,13617,1,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,Intermediate,50512,,BAO_0000218,,In vivo,Cavia porcellus,1,,A
16449,10116.0,N,,CHEMBL622231,,,,,13618,1,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16449,9541.0,N,,CHEMBL622232,,,,,13619,1,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,Intermediate,100710,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
12902,,U,,CHEMBL622233,,,,,13620,0,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12902,,U,,CHEMBL622234,,,,,13621,0,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12902,,U,,CHEMBL622235,,,,,13622,0,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12902,,U,,CHEMBL622236,,,,,13623,0,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12902,,U,,CHEMBL622237,,,,,13624,0,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12902,,U,,CHEMBL877482,,,,,13625,0,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12902,,U,,CHEMBL622238,,,,,13626,0,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
12902,,U,,CHEMBL622239,,,,,13627,0,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11149,,U,178.0,CHEMBL622240,,,,Blood,13628,0,Cmax was calculated as maximum concentration reached in the blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
11149,,U,178.0,CHEMBL622241,,,,Blood,13629,0,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
5669,10116.0,N,,CHEMBL631013,,,,,13630,1,Cmax was determine after peroral administration at 10 mpk in Rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5669,9544.0,N,,CHEMBL631014,,,,,13631,1,Cmax was determine after peroral administration at 10 mpk in Rhesus,,Intermediate,50797,,BAO_0000218,,In vivo,Macaca mulatta,1,,A
5669,9615.0,N,,CHEMBL631015,,,,,13632,1,Cmax was determine after peroral administration at 10 mpk in dog,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
5669,10116.0,N,,CHEMBL631016,,,,,13633,1,Cmax was determine after peroral administration at 160 mpk in Rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5669,10116.0,N,,CHEMBL631017,,,,,13634,1,Cmax was determine after peroral administration at 20 mpk in Rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
5669,10116.0,N,,CHEMBL631018,,,,,13635,1,Cmax was determine after peroral administration at 50 mpk in Rat,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
4236,,U,,CHEMBL631019,,,,,13636,0,Cmax was determined,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13792,10090.0,N,955.0,CHEMBL875761,,,,Brain,13637,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,955.0,CHEMBL631020,,,,Brain,13638,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,955.0,CHEMBL631669,,,,Brain,13639,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,955.0,CHEMBL631670,,,,Brain,13640,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13792,10090.0,N,2435.0,CHEMBL631671,,,,Striatum,13641,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8418,10116.0,N,178.0,CHEMBL631672,,,,Blood,13642,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631673,,,,Blood,13643,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631856,,,,Blood,13644,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631857,,,,Blood,13645,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631858,,,,Blood,13646,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631859,,,,Blood,13647,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631860,,,,Blood,13648,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631861,,,,Blood,13649,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631862,,,,Blood,13650,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631863,,,,Blood,13651,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631864,,,,Blood,13652,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631865,,,,Blood,13653,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL631866,,,,Blood,13654,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL629360,,,,Blood,13655,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL629361,,,,Blood,13656,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL629362,,,,Blood,13657,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL630740,,,,Blood,13658,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL630741,,,,Blood,13659,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,178.0,CHEMBL630742,,,,Blood,13660,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL630743,,,,,13661,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL630744,,,,,13662,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL630745,,,,,13663,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL630746,,,,,13664,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL630747,,,,,13665,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL630748,,,,,13666,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL632056,,,,,13667,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL632057,,,,,13668,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL632058,,,,,13669,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL632059,,,,,13670,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL632060,,,,,13671,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL632061,,,,,13672,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL629207,,,,,13673,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL629208,,,,,13674,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL629209,,,,,13675,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL629210,,,,,13676,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL629211,,,,,13677,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL629212,,,,,13678,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8418,10116.0,N,,CHEMBL629213,,,,,13679,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629214,,,,Urine,13680,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL629215,,,,Urine,13681,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8133,10116.0,N,1088.0,CHEMBL635154,,,,Urine,13682,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL629216,,,,,13683,1,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL629217,,,,,13684,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL629218,,,,,13685,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL629219,,,,,13686,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL629220,,,,,13687,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL629221,,,,,13688,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631127,,,,,13689,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631128,,,,,13690,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631129,,,,,13691,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631130,,,,,13692,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631131,,,,,13693,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631132,,,,,13694,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631133,,,,,13695,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631134,,,,,13696,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL875120,,,,,13697,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631135,,,,,13698,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631136,,,,,13699,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631137,,,,,13700,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631138,,,,,13701,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631139,,,,,13702,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631140,,,,,13703,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631141,,,,,13704,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631142,,,,,13705,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631143,,,,,13706,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,10116.0,N,,CHEMBL631144,,,,,13707,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6996,9615.0,N,,CHEMBL631145,,,,,13708,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631146,,,,,13709,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631147,,,,,13710,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631148,,,,,13711,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631149,,,,,13712,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631150,,,,,13713,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631151,,,,,13714,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631152,,,,,13715,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631443,,,,,13716,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631444,,,,,13717,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631445,,,,,13718,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631446,,,,,13719,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631447,,,,,13720,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631448,,,,,13721,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631449,,,,,13722,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL631450,,,,,13723,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
6996,9615.0,N,,CHEMBL629724,,,,,13724,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
9716,10090.0,N,14.0,CHEMBL629725,,,,Zone of skin,13725,1,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,14.0,CHEMBL629726,,,,Zone of skin,13726,1,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,2106.0,CHEMBL629727,,,,Spleen,13727,1,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,2106.0,CHEMBL630404,,,,Spleen,13728,1,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,2106.0,CHEMBL630405,,,,Spleen,13729,1,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,2106.0,CHEMBL630406,,,,Spleen,13730,1,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,945.0,CHEMBL630407,,,,Stomach,13731,1,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,945.0,CHEMBL630573,,,,Stomach,13732,1,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,945.0,CHEMBL630574,,,,Stomach,13733,1,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,945.0,CHEMBL630575,,,,Stomach,13734,1,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,,CHEMBL630576,,,,,13735,1,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,,CHEMBL630577,,,,,13736,1,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,,CHEMBL630578,,,,,13737,1,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
9716,10090.0,N,,CHEMBL630579,,,,,13738,1,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
12192,10090.0,N,2113.0,CHEMBL630580,,,,Kidney,13739,1,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,2113.0,CHEMBL630581,,,,Kidney,13740,1,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,2113.0,CHEMBL630582,,,,Kidney,13741,1,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,,CHEMBL630583,,,,,13742,1,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,,CHEMBL630584,,,,,13743,1,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,,CHEMBL630585,,,,,13744,1,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,,CHEMBL630586,,,,,13745,1,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,,CHEMBL630587,,,,,13746,1,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,,CHEMBL630588,,,,,13747,1,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,,CHEMBL630589,,,,,13748,1,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,10090.0,N,,CHEMBL630590,,,,,13749,1,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12192,,U,1988.0,CHEMBL630591,,,,Feces,13750,0,Removal of 238-Plutonium(IV) in feces at 24 h,,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1988.0,CHEMBL630592,,,,Feces,13751,0,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,,CHEMBL630593,,,,,13752,0,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,,CHEMBL630594,,,,,13753,0,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630595,,,,Urine,13754,0,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630596,,,,Urine,13755,0,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630597,,,,Urine,13756,0,Removal of 238-Plutonium(IV) in urine after 0-24 h,,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630598,,,,Urine,13757,0,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630599,,,,Urine,13758,0,Removal of 238-Plutonium(IV) in urine after 0-4 h,,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630600,,,,Urine,13759,0,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630601,,,,Urine,13760,0,Removal of 238-Plutonium(IV) in urine after 4-24 h,,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630602,,,,Urine,13761,0,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630603,,,,Urine,13762,0,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,Autocuration,22224,,BAO_0000019,,,,1,,A
12192,,U,1088.0,CHEMBL630604,,,,Urine,13763,0,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,Autocuration,22224,,BAO_0000019,,,,1,,A
12017,10116.0,N,178.0,CHEMBL624869,,,,Blood,13764,1,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL624870,,,,Blood,13765,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL623189,,,,Blood,13766,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL623190,,,,Blood,13767,1,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL623191,,,,Blood,13768,1,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL623192,,,,,13769,1,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL623193,,,,,13770,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL623194,,,,,13771,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL623195,,,,,13772,1,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL623196,,,,,13773,1,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11836,10116.0,N,,CHEMBL623197,,,,,13774,1,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,,CHEMBL623198,,,,,13775,1,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,,CHEMBL623199,,,,,13776,1,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623200,,,,Muscle tissue,13777,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623201,,,,Muscle tissue,13778,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623202,,,,Muscle tissue,13779,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623203,,,,Muscle tissue,13780,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623204,,,,Muscle tissue,13781,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623205,,,,Muscle tissue,13782,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623206,,,,Muscle tissue,13783,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623207,,,,Muscle tissue,13784,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623208,,,,Muscle tissue,13785,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623209,,,,Muscle tissue,13786,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,2385.0,CHEMBL623210,,,,Muscle tissue,13787,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,,CHEMBL623211,,,,,13788,1,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11836,10116.0,N,995.0,CHEMBL623212,,,,Uterus,13789,1,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12640,,U,,CHEMBL623213,,,,,13790,0,Tested in vitro for intrinsic activity relative to quinpirole,,Autocuration,22224,,BAO_0000019,,,,1,,A
14218,,U,,CHEMBL623214,,,,,13791,0,"Relative ion enhancement, determined in pulsed ultrafiltration",,Autocuration,22224,,BAO_0000019,,,,1,,A
11296,,U,,CHEMBL623215,,,,,13792,0,% ionization at the pH 7.4 at 37 degree Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
10929,,U,,CHEMBL623216,,,,,13793,0,Percentage ionization was measured,,Autocuration,22224,,BAO_0000019,,,,1,,A
13841,9913.0,N,,CHEMBL623217,,,,,13794,1,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,Intermediate,50591,,BAO_0000218,,,Bos taurus,1,,A
10431,,U,,CHEMBL623218,,,,,13795,0,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,Autocuration,22224,,BAO_0000019,,,,1,,A
10431,,U,,CHEMBL623913,,,,,13796,0,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,Autocuration,22224,,BAO_0000019,,,,1,,A
10431,,U,,CHEMBL623914,,,,,13797,0,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,Autocuration,22224,,BAO_0000019,,,,1,,A
8826,,U,,CHEMBL623915,,,,,13798,0,Compound was evaluated for the partition coefficient in octanol/water,,Autocuration,22229,,BAO_0000100,,,,1,,P
8826,,U,,CHEMBL624080,,,,,13799,0,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,Autocuration,22229,,BAO_0000100,,,,1,,P
9884,,U,,CHEMBL624081,,,,,13800,0,Equilibrium constant measured by the pulse radiolysis at pH 7,,Autocuration,22224,,BAO_0000019,,,,1,,A
9827,9606.0,N,,CHEMBL624082,,,,,13801,1,In vitro hydrolytic rate constant determined in human blood,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
10009,9606.0,N,,CHEMBL625054,,,,,13802,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
10009,,U,,CHEMBL877485,,,,,13803,0,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,Autocuration,22224,,BAO_0000019,,,,1,,A
10009,10090.0,N,,CHEMBL625055,,,,,13804,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,,CHEMBL625056,,,,,13805,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,9606.0,N,,CHEMBL625057,,,,,13806,1,In vitro oxidation of compound in presence of human plasma,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
10009,,U,,CHEMBL625058,,,,,13807,0,In vitro oxidation of compound in presence of hydrogen peroxide,,Autocuration,22224,,BAO_0000019,,,,1,,A
10009,10090.0,N,,CHEMBL625059,,,,,13808,1,In vitro oxidation of compound in presence of mouse brain homogenate,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
10009,10090.0,N,,CHEMBL629536,,,,,13809,1,In vitro oxidation of compound in presence of mouse liver homogenate,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
11510,10116.0,N,,CHEMBL629537,,,,,13810,1,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629538,,,,,13811,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629539,,,,,13812,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL874445,,,,,13813,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629540,,,,,13814,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629541,,,,,13815,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629542,,,,,13816,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630243,,,,,13817,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630244,,,,,13818,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630245,,,,,13819,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630246,,,,,13820,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630247,,,,,13821,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630248,,,,,13822,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13100,10116.0,N,178.0,CHEMBL630249,,,,Blood,13823,1,Biodistribution in rat blood at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,178.0,CHEMBL630250,,,,Blood,13824,1,Biodistribution in rat blood at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,178.0,CHEMBL630251,,,,Blood,13825,1,Biodistribution in rat blood at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,178.0,CHEMBL630252,,,,Blood,13826,1,Biodistribution in rat blood at 3 hr after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,178.0,CHEMBL630408,,,,Blood,13827,1,Biodistribution in rat blood at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2037.0,CHEMBL630409,,,,Cerebellum,13828,1,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2037.0,CHEMBL874446,,,,Cerebellum,13829,1,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2037.0,CHEMBL630410,,,,Cerebellum,13830,1,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2037.0,CHEMBL630411,,,,Cerebellum,13831,1,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2037.0,CHEMBL630412,,,,Cerebellum,13832,1,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2037.0,CHEMBL630413,,,,Cerebellum,13833,1,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2037.0,CHEMBL630414,,,,Cerebellum,13834,1,Biodistribution in rat cerebellum at 3 hr after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2037.0,CHEMBL630415,,,,Cerebellum,13835,1,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL630416,,,,,13836,1,Biodistribution in rat cortex at 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL630417,,,,,13837,1,Biodistribution in rat cortex at 1440 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL630418,,,,,13838,1,Biodistribution in rat cortex at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL630419,,,,,13839,1,Biodistribution in rat cortex at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL630420,,,,,13840,1,Biodistribution in rat cortex at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL630421,,,,,13841,1,Biodistribution in rat cortex at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL630422,,,,,13842,1,Biodistribution in rat cortex at 3 hr after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL630423,,,,,13843,1,Biodistribution in rat cortex at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,948.0,CHEMBL630424,,,,Heart,13844,1,Biodistribution in rat heart at 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,948.0,CHEMBL630425,,,,Heart,13845,1,Biodistribution in rat heart at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,948.0,CHEMBL629462,,,,Heart,13846,1,Biodistribution in rat heart at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,948.0,CHEMBL630426,,,,Heart,13847,1,Biodistribution in rat heart at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,948.0,CHEMBL630427,,,,Heart,13848,1,Biodistribution in rat heart at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,948.0,CHEMBL625877,,,,Heart,13849,1,Biodistribution in rat heart at 3 hr after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,948.0,CHEMBL625878,,,,Heart,13850,1,Biodistribution in rat heart at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,10000000.0,CHEMBL625879,,,,Hippocampus,13851,1,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,10000000.0,CHEMBL625880,,,,Hippocampus,13852,1,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,10000000.0,CHEMBL625881,,,,Hippocampus,13853,1,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,10000000.0,CHEMBL625882,,,,Hippocampus,13854,1,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,10000000.0,CHEMBL625883,,,,Hippocampus,13855,1,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2113.0,CHEMBL625884,,,,Kidney,13856,1,Biodistribution in rat kidney at 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2113.0,CHEMBL625885,,,,Kidney,13857,1,Biodistribution in rat kidney at 1440 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2113.0,CHEMBL628649,,,,Kidney,13858,1,Biodistribution in rat kidney at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2113.0,CHEMBL628650,,,,Kidney,13859,1,Biodistribution in rat kidney at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2113.0,CHEMBL628651,,,,Kidney,13860,1,Biodistribution in rat kidney at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2113.0,CHEMBL628652,,,,Kidney,13861,1,Biodistribution in rat kidney at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2113.0,CHEMBL628653,,,,Kidney,13862,1,Biodistribution in rat kidney at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2107.0,CHEMBL628654,,,,Liver,13863,1,Biodistribution in rat liver at 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2107.0,CHEMBL628655,,,,Liver,13864,1,Biodistribution in rat liver at 1440 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2107.0,CHEMBL625238,,,,Liver,13865,1,Biodistribution in rat liver at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2107.0,CHEMBL625239,,,,Liver,13866,1,Biodistribution in rat liver at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2107.0,CHEMBL625240,,,,Liver,13867,1,Biodistribution in rat liver at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2107.0,CHEMBL625241,,,,Liver,13868,1,Biodistribution in rat liver at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2107.0,CHEMBL625242,,,,Liver,13869,1,Biodistribution in rat liver at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2048.0,CHEMBL874587,,,,Lung,13870,1,Biodistribution in rat lung at 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2048.0,CHEMBL625405,,,,Lung,13871,1,Biodistribution in rat lung at 1440 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2048.0,CHEMBL625406,,,,Lung,13872,1,Biodistribution in rat lung at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2048.0,CHEMBL625407,,,,Lung,13873,1,Biodistribution in rat lung at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2048.0,CHEMBL625408,,,,Lung,13874,1,Biodistribution in rat lung at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2048.0,CHEMBL625409,,,,Lung,13875,1,Biodistribution in rat lung at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12361,10116.0,N,1515.0,CHEMBL625410,,,,Thoracic aorta,13876,1,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12361,10116.0,N,1515.0,CHEMBL625411,,,,Thoracic aorta,13877,1,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12361,10116.0,N,1515.0,CHEMBL625412,,,,Thoracic aorta,13878,1,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12361,10116.0,N,1515.0,CHEMBL625413,,,,Thoracic aorta,13879,1,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12361,10116.0,N,1515.0,CHEMBL625414,,,,Thoracic aorta,13880,1,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12361,10116.0,N,1515.0,CHEMBL625415,,,,Thoracic aorta,13881,1,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12361,10116.0,N,1515.0,CHEMBL625416,,,,Thoracic aorta,13882,1,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12712,10116.0,N,1088.0,CHEMBL625417,,,,Urine,13883,1,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7415,10116.0,N,1988.0,CHEMBL625418,,,,Feces,13884,1,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7415,10116.0,N,1088.0,CHEMBL625419,,,,Urine,13885,1,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7415,10116.0,N,,CHEMBL625420,,,,,13886,1,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7415,10116.0,N,,CHEMBL626996,,,,,13887,1,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7415,10116.0,N,1988.0,CHEMBL626997,,,,Feces,13888,1,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7415,10116.0,N,1088.0,CHEMBL626998,,,,Urine,13889,1,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7415,10116.0,N,,CHEMBL626999,,,,,13890,1,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8050,10090.0,N,,CHEMBL627000,,,,,13891,1,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,,CHEMBL627001,,,,,13892,1,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,,CHEMBL627002,,,,,13893,1,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,,CHEMBL627003,,,,,13894,1,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627004,,,,Urine,13895,1,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627005,,,,Urine,13896,1,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL874594,,,,Urine,13897,1,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627006,,,,Urine,13898,1,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627007,,,,Urine,13899,1,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627884,,,,Urine,13900,1,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627885,,,,Urine,13901,1,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627886,,,,Urine,13902,1,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627887,,,,Urine,13903,1,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627888,,,,Urine,13904,1,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL628057,,,,Urine,13905,1,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8050,10090.0,N,1088.0,CHEMBL627405,,,,Urine,13906,1,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12582,9615.0,N,1088.0,CHEMBL627406,,,,Urine,13907,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627407,,,,Urine,13908,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627408,,,,Urine,13909,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627409,,,,Urine,13910,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL875486,,,,Urine,13911,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627410,,,,Urine,13912,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627411,,,,Urine,13913,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627412,,,,Urine,13914,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627413,,,,Urine,13915,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627414,,,,Urine,13916,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627415,,,,Urine,13917,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627416,,,,Urine,13918,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627417,,,,Urine,13919,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627418,,,,Urine,13920,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627419,,,,Urine,13921,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627320,,,,Urine,13922,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627321,,,,Urine,13923,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12017,10116.0,N,2113.0,CHEMBL627322,,,,Kidney,13924,1,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL627323,,,,Kidney,13925,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL627491,,,,Kidney,13926,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL627492,,,,Kidney,13927,1,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL627493,,,,Kidney,13928,1,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL627494,,,,Liver,13929,1,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL627495,,,,Liver,13930,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL627496,,,,Liver,13931,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL627497,,,,Liver,13932,1,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL627498,,,,Liver,13933,1,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL627499,,,,Lung,13934,1,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL627500,,,,Lung,13935,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL627501,,,,Lung,13936,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL625616,,,,Lung,13937,1,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL625617,,,,Lung,13938,1,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL625618,,,,Muscle tissue,13939,1,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL625619,,,,Muscle tissue,13940,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL625620,,,,Muscle tissue,13941,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL625621,,,,Muscle tissue,13942,1,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL625622,,,,Muscle tissue,13943,1,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL625788,,,,Spleen,13944,1,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL625789,,,,Spleen,13945,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL625790,,,,Spleen,13946,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL625791,,,,Spleen,13947,1,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL622334,,,,Spleen,13948,1,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2046.0,CHEMBL622335,,,,Thyroid gland,13949,1,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2046.0,CHEMBL622336,,,,Thyroid gland,13950,1,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2046.0,CHEMBL622337,,,,Thyroid gland,13951,1,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2046.0,CHEMBL622338,,,,Thyroid gland,13952,1,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2046.0,CHEMBL622339,,,,Thyroid gland,13953,1,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL624153,,,,,13954,1,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL628430,,,,,13955,1,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL628431,,,,,13956,1,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL628432,,,,,13957,1,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL628433,,,,,13958,1,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL628434,,,,Spleen,13959,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL626789,,,,Spleen,13960,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL626790,,,,Spleen,13961,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL626791,,,,Spleen,13962,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL626792,,,,Spleen,13963,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL626793,,,,Spleen,13964,1,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627436,,,,,13965,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627437,,,,,13966,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627438,,,,,13967,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627439,,,,,13968,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627440,,,,,13969,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627602,,,,,13970,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627603,,,,,13971,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627604,,,,,13972,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627605,,,,,13973,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627606,,,,,13974,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627607,,,,,13975,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627608,,,,,13976,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627609,,,,,13977,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627610,,,,,13978,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627611,,,,,13979,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL627612,,,,,13980,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8362,,U,,CHEMBL627613,,,,,13981,0,Octanol:water partition coefficient is evaluated,,Autocuration,22229,,BAO_0000100,,,,1,,P
8257,,U,,CHEMBL627614,,,,,13982,0,Partition coefficient in 1-octanol/water system,,Autocuration,22224,,BAO_0000100,,,,1,,P
8257,,U,,CHEMBL627615,,,,,13983,0,Partition coefficient in 1-octanol/water system measured using radio active compounds,,Autocuration,22224,,BAO_0000100,,,,1,,P
9468,,U,,CHEMBL627616,,,,,13984,0,Partition coefficient in octanol/water system was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
9468,,U,,CHEMBL627617,,,,,13985,0,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,Autocuration,22224,,BAO_0000100,,,,1,,P
10568,,U,,CHEMBL627618,,,,,13986,0,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
10568,,U,,CHEMBL627619,,,,,13987,0,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,Autocuration,22224,,BAO_0000019,,,,1,,A
15359,,U,,CHEMBL627620,,,,,13988,0,Pseudo-first-order rate constant of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
15359,,U,,CHEMBL627621,,,,,13989,0,Pseudo-first-order rate constant with 1-min time point,,Autocuration,22224,,BAO_0000019,,,,1,,A
15359,,U,,CHEMBL627622,,,,,13990,0,Pseudo-first-order rate constant without 1-min time point,,Autocuration,22224,,BAO_0000019,,,,1,,A
10431,,U,,CHEMBL627623,,,,,13991,0,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,Autocuration,22224,,BAO_0000019,,,,1,,A
10431,,U,,CHEMBL627624,,,,,13992,0,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,Autocuration,22224,,BAO_0000019,,,,1,,A
10431,,U,,CHEMBL627625,,,,,13993,0,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,Autocuration,22224,,BAO_0000019,,,,1,,A
15704,,U,,CHEMBL628523,,,,,13994,0,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
15287,,U,,CHEMBL628524,,,,,13995,0,The alkaline hydrolysis second order rate constant(K OH) of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
7516,,U,,CHEMBL628525,,,,,13996,0,The efflux rate constant of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
12973,,U,,CHEMBL625732,,,,,13997,0,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,Autocuration,22224,,BAO_0000019,,,,1,,A
12973,,U,,CHEMBL625733,,,,,13998,0,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,Autocuration,22224,,BAO_0000019,,,,1,,A
12973,,U,,CHEMBL625734,,,,,13999,0,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,Autocuration,22224,,BAO_0000019,,,,1,,F
12973,,U,,CHEMBL625913,,,,,14000,0,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
8696,,U,,CHEMBL625914,,,,,14001,0,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,Autocuration,22224,,BAO_0000019,,,,1,,A
15052,,U,,CHEMBL625915,,,,,14002,0,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,Autocuration,22224,,BAO_0000019,,,,1,,A
15052,,U,,CHEMBL625916,,,,,14003,0,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,Autocuration,22224,,BAO_0000019,,,,1,,A
10503,,U,,CHEMBL625917,,,,,14004,0,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL625918,,,,,14005,0,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL625919,,,,,14006,0,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL625920,,,,,14007,0,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL874453,,,,,14008,0,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL625921,,,,,14009,0,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
10503,,U,,CHEMBL625922,,,,,14010,0,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL625923,,,,,14011,0,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL625924,,,,,14012,0,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL625925,,,,,14013,0,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL625926,,,,,14014,0,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
13100,10116.0,N,2048.0,CHEMBL627704,,,,Lung,14015,1,Biodistribution in rat lung at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL627705,,,,,14016,1,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL627706,,,,,14017,1,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL627707,,,,,14018,1,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL627708,,,,,14019,1,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL628361,,,,,14020,1,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,,CHEMBL628362,,,,,14021,1,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2435.0,CHEMBL628363,,,,Striatum,14022,1,Biodistribution in rat striatum at 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2435.0,CHEMBL628364,,,,Striatum,14023,1,Biodistribution in rat striatum at 1440 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2435.0,CHEMBL628365,,,,Striatum,14024,1,Biodistribution in rat striatum at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2435.0,CHEMBL874454,,,,Striatum,14025,1,Biodistribution in rat striatum at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2435.0,CHEMBL628531,,,,Striatum,14026,1,Biodistribution in rat striatum at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2435.0,CHEMBL628532,,,,Striatum,14027,1,Biodistribution in rat striatum at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2435.0,CHEMBL628533,,,,Striatum,14028,1,Biodistribution in rat striatum at 3 hr after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2435.0,CHEMBL628534,,,,Striatum,14029,1,Biodistribution in rat striatum at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2046.0,CHEMBL628535,,,,Thyroid gland,14030,1,Biodistribution in rat thyroid at 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2046.0,CHEMBL628536,,,,Thyroid gland,14031,1,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2046.0,CHEMBL628537,,,,Thyroid gland,14032,1,Biodistribution in rat thyroid at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2046.0,CHEMBL628538,,,,Thyroid gland,14033,1,Biodistribution in rat thyroid at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2046.0,CHEMBL628539,,,,Thyroid gland,14034,1,Biodistribution in rat thyroid at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2046.0,CHEMBL630297,,,,Thyroid gland,14035,1,Biodistribution in rat thyroid at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,2046.0,CHEMBL630298,,,,Thyroid gland,14036,1,Biodistribution in rat thyroid at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,955.0,CHEMBL630299,,,,Brain,14037,1,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,955.0,CHEMBL628094,,,,Brain,14038,1,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,955.0,CHEMBL628095,,,,Brain,14039,1,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,955.0,CHEMBL874648,,,,Brain,14040,1,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,955.0,CHEMBL628096,,,,Brain,14041,1,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,955.0,CHEMBL628097,,,,Brain,14042,1,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13100,10116.0,N,955.0,CHEMBL628098,,,,Brain,14043,1,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13331,,U,,CHEMBL628099,,,,,14044,0,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,Autocuration,22224,,BAO_0000019,,,,1,,A
13331,,U,,CHEMBL628100,,,,,14045,0,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,Autocuration,22224,,BAO_0000019,,,,1,,A
13331,,U,,CHEMBL628101,,,,,14046,0,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,Autocuration,22224,,BAO_0000019,,,,1,,A
13331,,U,,CHEMBL628102,,,,,14047,0,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,Autocuration,22224,,BAO_0000019,,,,1,,A
13331,,U,,CHEMBL628103,,,,,14048,0,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,Autocuration,22224,,BAO_0000019,,,,1,,A
13331,,U,,CHEMBL628104,,,,,14049,0,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,Autocuration,22224,,BAO_0000019,,,,1,,A
13331,,U,,CHEMBL628105,,,,,14050,0,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,Autocuration,22224,,BAO_0000019,,,,1,,A
13331,,U,,CHEMBL628106,,,,,14051,0,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,Autocuration,22224,,BAO_0000019,,,,1,,A
10086,10116.0,N,1088.0,CHEMBL628107,,,,Urine,14052,1,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10086,,U,1088.0,CHEMBL628108,,,,Urine,14053,0,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,Autocuration,22224,,BAO_0000218,,,,1,,F
10086,10116.0,N,1088.0,CHEMBL628109,,,,Urine,14054,1,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10086,,U,1088.0,CHEMBL625299,,,,Urine,14055,0,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,Autocuration,22224,,BAO_0000218,,,,1,,F
10086,10116.0,N,1088.0,CHEMBL625300,,,,Urine,14056,1,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10086,10116.0,N,1088.0,CHEMBL625301,,,,Urine,14057,1,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10086,10116.0,N,1088.0,CHEMBL625302,,,,Urine,14058,1,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
10086,10116.0,N,1088.0,CHEMBL874649,,,,Urine,14059,1,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13248,10116.0,N,,CHEMBL625303,,,,,14060,1,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13248,10116.0,N,,CHEMBL625463,,,,,14061,1,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14527,9606.0,N,2107.0,CHEMBL625464,,,,Liver,14062,1,In vitro metabolism in human liver microsomes,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
3008,9606.0,N,,CHEMBL625465,,,,,14063,1,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
12582,9615.0,N,1088.0,CHEMBL625466,,,,Urine,14064,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625467,,,,Urine,14065,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,10116.0,N,1088.0,CHEMBL625468,,,,Urine,14066,1,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625469,,,,Urine,14067,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625470,,,,Urine,14068,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL632418,,,,Urine,14069,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627250,,,,Urine,14070,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627251,,,,Urine,14071,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627252,,,,Urine,14072,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627253,,,,Urine,14073,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627254,,,,Urine,14074,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL875471,,,,Urine,14075,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627255,,,,Urine,14076,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627256,,,,Urine,14077,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627257,,,,Urine,14078,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627258,,,,Urine,14079,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627259,,,,Urine,14080,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627260,,,,Urine,14081,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623256,,,,Urine,14082,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL874413,,,,Urine,14083,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623257,,,,Urine,14084,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623258,,,,Urine,14085,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623259,,,,Urine,14086,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623260,,,,Urine,14087,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623261,,,,Urine,14088,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623262,,,,Urine,14089,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623263,,,,Urine,14090,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623264,,,,Urine,14091,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623265,,,,Urine,14092,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623266,,,,Urine,14093,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623267,,,,Urine,14094,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623268,,,,Urine,14095,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623269,,,,Urine,14096,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623270,,,,Urine,14097,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623271,,,,Urine,14098,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623272,,,,Urine,14099,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623273,,,,Urine,14100,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623274,,,,Urine,14101,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL874414,,,,Urine,14102,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623275,,,,Urine,14103,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL629150,,,,Urine,14104,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623276,,,,Urine,14105,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623277,,,,Urine,14106,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623112,,,,Urine,14107,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623113,,,,Urine,14108,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623800,,,,Urine,14109,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623801,,,,Urine,14110,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL623802,,,,Spleen,14111,1,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,995.0,CHEMBL623803,,,,Uterus,14112,1,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,995.0,CHEMBL623970,,,,Uterus,14113,1,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,995.0,CHEMBL623971,,,,Uterus,14114,1,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,178.0,CHEMBL623972,,,,Blood,14115,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,178.0,CHEMBL623973,,,,Blood,14116,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,178.0,CHEMBL623974,,,,Blood,14117,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,178.0,CHEMBL623975,,,,Blood,14118,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,955.0,CHEMBL623976,,,,Brain,14119,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,955.0,CHEMBL623977,,,,Brain,14120,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,955.0,CHEMBL623978,,,,Brain,14121,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,955.0,CHEMBL623979,,,,Brain,14122,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,,CHEMBL623980,,,,,14123,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,,CHEMBL623981,,,,,14124,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,,CHEMBL626278,,,,,14125,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10116.0,N,,CHEMBL626279,,,,,14126,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14045,10090.0,N,,CHEMBL626280,,,,,14127,1,Biodistribution in mice bladder plus excreted urine was determined,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL626281,,,,,14128,1,"Percentage biodistribution in mouse blood, 10 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL626282,,,,,14129,1,"Percentage biodistribution in mouse blood, 30 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL626283,,,,,14130,1,"Percentage biodistribution in mouse blood, 5 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL626284,,,,,14131,1,"Percentage biodistribution in mouse blood, 60 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,955.0,CHEMBL626285,,,,Brain,14132,1,"Percentage biodistribution in mouse brain, 10 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,955.0,CHEMBL626286,,,,Brain,14133,1,"Percentage biodistribution in mouse brain, 30 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,955.0,CHEMBL626287,,,,Brain,14134,1,"Percentage biodistribution in mouse brain, 5 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,955.0,CHEMBL626288,,,,Brain,14135,1,"Percentage biodistribution in mouse brain, 60 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL626289,,,,,14136,1,"Percentage biodistribution in mouse heart, 10 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL626290,,,,,14137,1,"Percentage biodistribution in mouse heart, 30 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL626291,,,,,14138,1,"Percentage biodistribution in mouse heart, 5 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL839888,,,,,14139,1,"Percentage biodistribution in mouse heart, 60 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,160.0,CHEMBL626292,,,,Intestine,14140,1,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,160.0,CHEMBL626293,,,,Intestine,14141,1,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,160.0,CHEMBL626294,,,,Intestine,14142,1,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,160.0,CHEMBL626295,,,,Intestine,14143,1,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,2107.0,CHEMBL627659,,,,Liver,14144,1,"Percentage biodistribution in mouse liver, 10 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,2107.0,CHEMBL627660,,,,Liver,14145,1,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,2107.0,CHEMBL627661,,,,Liver,14146,1,"Percentage biodistribution in mouse liver, 5 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,2107.0,CHEMBL627662,,,,Liver,14147,1,Biodistribution in mice liver at 60 minutes of post injection,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14045,10090.0,N,2048.0,CHEMBL627663,,,,Lung,14148,1,Biodistribution in mice lungs at 10 min of post injection,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL627664,,,,,14149,1,"Percentage biodistribution in mouse lung, 30 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,,CHEMBL627665,,,,,14150,1,"Percentage biodistribution in mousee lung, 5 minutes post injection",,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,2048.0,CHEMBL627666,,,,Lung,14151,1,Biodistribution in mice lungs at 60 min of post injection,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14045,10090.0,N,2106.0,CHEMBL627667,,,,Spleen,14152,1,Percentage biodistribution in mouse spleen,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14045,10090.0,N,945.0,CHEMBL627668,,,,Stomach,14153,1,Percentage biodistribution in mouse stomach,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
11745,10090.0,N,1088.0,CHEMBL627669,,,,Urine,14154,1,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13257,,U,1255.0,CHEMBL627670,,,,Urinary bladder,14155,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,178.0,CHEMBL627671,,,,Blood,14156,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,1474.0,CHEMBL627672,,,,Bone element,14157,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL627673,,,,,14158,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2113.0,CHEMBL627674,,,,Kidney,14159,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2107.0,CHEMBL627675,,,,Liver,14160,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2048.0,CHEMBL627676,,,,Lung,14161,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL627677,,,,Muscle tissue,14162,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
8354,,U,,CHEMBL627678,,,,,14163,0,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
7095,10116.0,N,1977.0,CHEMBL627679,,,,Serum,14164,1,Affinity for protein binding expressed as association constant in fresh rat serum,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12185,,U,,CHEMBL627680,,,,,14165,0,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,Autocuration,22224,,BAO_0000019,,,,1,,A
12185,,U,,CHEMBL627681,,,,,14166,0,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,Autocuration,22224,,BAO_0000019,,,,1,,A
12185,,U,,CHEMBL627682,,,,,14167,0,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,Autocuration,22224,,BAO_0000019,,,,1,,A
12185,,U,,CHEMBL627683,,,,,14168,0,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,Autocuration,22224,,BAO_0000019,,,,1,,A
12686,,U,,CHEMBL627684,,,,,14169,0,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,Autocuration,22224,,BAO_0000019,,,,1,,A
12686,,U,,CHEMBL874441,,,,,14170,0,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,Autocuration,22224,,BAO_0000019,,,,1,,A
12686,,U,,CHEMBL627685,,,,,14171,0,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,Autocuration,22224,,BAO_0000019,,,,1,,A
12686,,U,,CHEMBL627686,,,,,14172,0,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,Autocuration,22224,,BAO_0000019,,,,1,,A
8057,,U,,CHEMBL627687,,,,,14173,0,Apparent rate constant Koff for inactivation of dTMP synthase.,,Autocuration,22224,,BAO_0000019,,,,1,,A
15778,,U,,CHEMBL627688,,,,,14174,0,The irreversible inhibitor activity by second order rate equation.,,Autocuration,22224,,BAO_0000019,,,,1,,A
12375,10116.0,N,,CHEMBL628038,,,,,14175,1,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12375,10116.0,N,,CHEMBL628039,,,,,14176,1,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12375,10116.0,N,,CHEMBL628040,,,,,14177,1,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13588,,U,,CHEMBL628041,,,,,14178,0,Dissociation rate calculated from the first-order equation using t1/2 value,,Autocuration,22224,,BAO_0000019,,,,1,,A
15039,,U,,CHEMBL630226,,,,,14179,0,The compound was tested for Binding constant against DNA,,Autocuration,22224,,BAO_0000019,,,,1,,A
9500,,U,,CHEMBL628042,,,,,14180,0,First order rate constant for cyclization of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
10014,,U,,CHEMBL625232,,,,,14181,0,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,Autocuration,22224,,BAO_0000019,,,,1,,A
10014,,U,,CHEMBL625233,,,,,14182,0,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,Autocuration,22224,,BAO_0000019,,,,1,,A
568,,U,,CHEMBL625979,,,,,14183,0,Hydrolysis rate constant was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
10026,,U,,CHEMBL625980,,,,,14184,0,Observed first order rate constant,,Autocuration,22224,,BAO_0000019,,,,1,,A
10281,,U,,CHEMBL625981,,,,,14185,0,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,Autocuration,22224,,BAO_0000019,,,,1,,A
10281,,U,,CHEMBL625982,,,,,14186,0,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,Autocuration,22224,,BAO_0000019,,,,1,,A
9680,,U,,CHEMBL625983,,,,,14187,0,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625984,,,,,14188,0,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625985,,,,,14189,0,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625986,,,,,14190,0,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625987,,,,,14191,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625988,,,,,14192,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625989,,,,,14193,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625990,,,,,14194,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625991,,,,,14195,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625992,,,,,14196,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL625993,,,,,14197,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL631973,,,,,14198,0,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL632143,,,,,14199,0,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL632144,,,,,14200,0,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL632145,,,,,14201,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL632146,,,,,14202,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL632147,,,,,14203,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL632148,,,,,14204,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL632149,,,,,14205,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL632150,,,,,14206,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL632151,,,,,14207,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
3008,9606.0,N,,CHEMBL632152,,,,,14208,1,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
4509,9606.0,N,,CHEMBL632153,,,,,14209,1,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
4509,9606.0,N,,CHEMBL632154,,,,,14210,1,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,Intermediate,50587,,BAO_0000218,,,Homo sapiens,1,,A
8613,10298.0,N,,CHEMBL632155,,,,,14211,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL632156,,,,,14212,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL632157,,,,,14213,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL632158,,,,,14214,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL632159,,,,,14215,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL626305,,,,,14216,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL626306,,,,,14217,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL626307,,,,,14218,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL626308,,,,,14219,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL626479,,,,,14220,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
8613,10298.0,N,,CHEMBL626480,,,,,14221,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,Intermediate,50602,,BAO_0000218,,,Human herpesvirus 1,1,,A
6021,,U,,CHEMBL626481,,,,,14222,0,Calculated partition coefficient (clogP) (MlogP),,Autocuration,22229,,BAO_0000100,,,,1,,P
9348,,U,,CHEMBL626482,,,,,14223,0,Equipotent potent ratio relative to carbachol (nicotinic activity),,Autocuration,22224,,BAO_0000019,,,,1,,A
15592,9615.0,N,,CHEMBL626483,,,,,14224,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15592,9615.0,N,,CHEMBL626484,,,,,14225,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
15592,,U,,CHEMBL626485,,,,,14226,0,Solubility at pH 7.4 in micro g/mL;NA denotes available,,Autocuration,22229,,BAO_0000100,,,,1,,P
15592,,U,,CHEMBL626486,,,,,14227,0,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,Autocuration,22229,,BAO_0000100,,,,1,,P
15592,,U,,CHEMBL626487,,,,,14228,0,Solubility at pH 7.4 in ug/mL;NA denotes not available,,Autocuration,22229,,BAO_0000100,,,,1,,P
15592,9615.0,N,1969.0,CHEMBL626488,,,,Plasma,14229,1,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,Intermediate,50588,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
7095,10116.0,N,1977.0,CHEMBL626489,,,,Serum,14230,1,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16618,,U,,CHEMBL626490,,,,,14231,0,Area under the MAP curve measured over 5 min; ND means Not determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
16835,,U,,CHEMBL626491,,,,,14232,0,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,Autocuration,22224,,BAO_0000100,,,,1,,P
15284,,U,,CHEMBL626492,,,,,14233,0,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,Autocuration,22229,,BAO_0000100,,,,1,,P
15750,,U,,CHEMBL626493,,,,,14234,0,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,Autocuration,22224,,BAO_0000019,,,,1,,A
16618,10116.0,N,,CHEMBL626494,,,,,14235,1,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16618,,U,,CHEMBL626495,,,,,14236,0,Half life after oral tested,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15812,10116.0,N,1969.0,CHEMBL626496,,,,Plasma,14237,1,Half life was determined in plasma of rat; NT indicates not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16618,10116.0,N,,CHEMBL626497,,,,,14238,1,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
16618,,U,,CHEMBL626498,,,,,14239,0,Oral bioavailability after oral tested,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13098,10116.0,N,,CHEMBL626499,,,,,14240,1,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13098,10116.0,N,,CHEMBL626500,,,,,14241,1,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15812,10116.0,N,1969.0,CHEMBL626501,,,,Plasma,14242,1,half life was determined in plasma of rat; NT indicates not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15812,10116.0,N,1969.0,CHEMBL626502,,,,Plasma,14243,1,half life was determined in plasma of rat; NT means not tested,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626503,,,,,14244,1,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626504,,,,,14245,1,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626505,,,,,14246,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626506,,,,,14247,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626507,,,,,14248,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626508,,,,,14249,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626509,,,,,14250,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL875480,,,,,14251,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626510,,,,,14252,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626511,,,,,14253,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL626512,,,,,14254,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL628208,,,,,14255,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL628209,,,,,14256,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL628210,,,,,14257,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL628211,,,,,14258,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL628212,,,,,14259,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL628213,,,,,14260,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628214,,,,Urine,14261,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628215,,,,Urine,14262,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628216,,,,Urine,14263,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626595,,,,Urine,14264,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626596,,,,Urine,14265,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626597,,,,Urine,14266,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626598,,,,Urine,14267,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL622242,,,,Urine,14268,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL622243,,,,Urine,14269,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL622244,,,,Urine,14270,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL622245,,,,Urine,14271,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL622246,,,,Urine,14272,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL622247,,,,Urine,14273,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL622248,,,,Urine,14274,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL877483,,,,Urine,14275,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL622249,,,,Urine,14276,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,9615.0,N,1088.0,CHEMBL622250,,,,Urine,14277,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622251,,,,Urine,14278,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622252,,,,Urine,14279,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622253,,,,Urine,14280,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622254,,,,Urine,14281,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622255,,,,Urine,14282,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622256,,,,Urine,14283,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622257,,,,Urine,14284,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622258,,,,Urine,14285,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622259,,,,Urine,14286,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622927,,,,Urine,14287,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622928,,,,Urine,14288,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL622929,,,,Urine,14289,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL623182,,,,Urine,14290,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL623183,,,,Urine,14291,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,10116.0,N,1088.0,CHEMBL623184,,,,Urine,14292,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623185,,,,Urine,14293,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL877484,,,,Urine,14294,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL627274,,,,Urine,14295,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623186,,,,Urine,14296,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623187,,,,Urine,14297,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL623188,,,,Urine,14298,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628055,,,,Urine,14299,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628056,,,,Urine,14300,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628200,,,,Urine,14301,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628201,,,,Urine,14302,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628202,,,,Urine,14303,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628203,,,,Urine,14304,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628204,,,,Urine,14305,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628205,,,,Urine,14306,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628206,,,,Urine,14307,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13257,,U,2367.0,CHEMBL628207,,,,Prostate gland,14308,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL627220,,,,Prostate gland,14309,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL627221,,,,Muscle tissue,14310,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL627222,,,,Prostate gland,14311,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL627223,,,,,14312,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL632062,,,,Muscle tissue,14313,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2106.0,CHEMBL632063,,,,Spleen,14314,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,1255.0,CHEMBL632064,,,,Urinary bladder,14315,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,178.0,CHEMBL632065,,,,Blood,14316,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,1474.0,CHEMBL632066,,,,Bone element,14317,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL632067,,,,,14318,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2113.0,CHEMBL629188,,,,Kidney,14319,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2107.0,CHEMBL629189,,,,Liver,14320,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2048.0,CHEMBL629190,,,,Lung,14321,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL629191,,,,Muscle tissue,14322,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL629192,,,,Prostate gland,14323,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL629193,,,,Muscle tissue,14324,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL629194,,,,Prostate gland,14325,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL629195,,,,,14326,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL629373,,,,Muscle tissue,14327,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2106.0,CHEMBL629374,,,,Spleen,14328,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL629375,,,,Prostate gland,14329,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,1255.0,CHEMBL629376,,,,Urinary bladder,14330,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,178.0,CHEMBL629377,,,,Blood,14331,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,1474.0,CHEMBL629378,,,,Bone element,14332,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL629379,,,,,14333,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2113.0,CHEMBL629151,,,,Kidney,14334,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2107.0,CHEMBL629152,,,,Liver,14335,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2048.0,CHEMBL629153,,,,Lung,14336,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL629154,,,,Muscle tissue,14337,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL629155,,,,Prostate gland,14338,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL629156,,,,Prostate gland,14339,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL629157,,,,Muscle tissue,14340,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL629158,,,,Prostate gland,14341,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL629159,,,,,14342,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL629160,,,,Muscle tissue,14343,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2106.0,CHEMBL629161,,,,Spleen,14344,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,1255.0,CHEMBL629162,,,,Urinary bladder,14345,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,178.0,CHEMBL629163,,,,Blood,14346,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,1474.0,CHEMBL629164,,,,Bone element,14347,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL629165,,,,,14348,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2107.0,CHEMBL629166,,,,Liver,14349,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2048.0,CHEMBL629167,,,,Lung,14350,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL629168,,,,Muscle tissue,14351,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
2193,,U,,CHEMBL629169,,,,,14352,0,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,Autocuration,22224,,BAO_0000019,,,,1,,A
2193,,U,,CHEMBL629170,,,,,14353,0,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,Autocuration,22224,,BAO_0000019,,,,1,,A
2193,,U,,CHEMBL631153,,,,,14354,0,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,Autocuration,22224,,BAO_0000019,,,,1,,A
2193,,U,,CHEMBL875121,,,,,14355,0,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,Autocuration,22224,,BAO_0000019,,,,1,,A
2193,,U,,CHEMBL631154,,,,,14356,0,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,Autocuration,22224,,BAO_0000019,,,,1,,A
2193,,U,,CHEMBL631155,,,,,14357,0,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,Autocuration,22224,,BAO_0000019,,,,1,,A
568,,U,,CHEMBL631156,,,,,14358,0,Hydrolysis rate constant was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
9680,,U,,CHEMBL631157,,,,,14359,0,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,Autocuration,22224,,BAO_0000019,,,,1,,A
9680,,U,,CHEMBL631158,,,,,14360,0,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,Autocuration,22224,,BAO_0000019,,,,1,,A
9680,,U,,CHEMBL631159,,,,,14361,0,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,Autocuration,22224,,BAO_0000019,,,,1,,A
10026,,U,,CHEMBL631160,,,,,14362,0,Observed second order rate constant,,Autocuration,22224,,BAO_0000019,,,,1,,A
10281,,U,,CHEMBL631161,,,,,14363,0,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,Autocuration,22224,,BAO_0000019,,,,1,,A
10014,,U,,CHEMBL631162,,,,,14364,0,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,Autocuration,22224,,BAO_0000019,,,,1,,A
10014,,U,,CHEMBL630313,,,,,14365,0,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,Autocuration,22224,,BAO_0000019,,,,1,,A
9680,,U,,CHEMBL630314,,,,,14366,0,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,Autocuration,22224,,BAO_0000019,,,,1,,A
9680,,U,,CHEMBL630315,,,,,14367,0,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630316,,,,,14368,0,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630986,,,,,14369,0,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630987,,,,,14370,0,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630988,,,,,14371,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630989,,,,,14372,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630990,,,,,14373,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630991,,,,,14374,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630992,,,,,14375,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630993,,,,,14376,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
13028,,U,,CHEMBL630994,,,,,14377,0,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,22224,,BAO_0000019,,,,1,,A
10014,10116.0,N,,CHEMBL630995,,,,,14378,1,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
9962,,U,,CHEMBL629252,,,,,14379,0,Association constant for compound at 31 degree C was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
12029,,U,,CHEMBL629253,,,,,14380,0,Calculated antagonist equilibrium dissociation constant of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
12029,,U,,CHEMBL629944,,,,,14381,0,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,Autocuration,22224,,BAO_0000019,,,,1,,A
10583,10141.0,N,3126.0,CHEMBL629945,,,,Trachea,14382,1,Dissociation constants vs LTE4 on guinea pig trachea,,Intermediate,50512,,BAO_0000218,,,Cavia porcellus,1,,A
568,,U,,CHEMBL629946,,,,,14383,0,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,Autocuration,22224,,BAO_0000019,,,,1,,A
568,,U,,CHEMBL629947,,,,,14384,0,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,Autocuration,22224,,BAO_0000019,,,,1,,A
568,,U,,CHEMBL629948,,,,,14385,0,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,Autocuration,22224,,BAO_0000019,,,,1,,A
568,,U,,CHEMBL856024,,,,,14386,0,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,Autocuration,22224,,BAO_0000019,,,,1,,A
7493,,U,,CHEMBL629949,,,,,14387,0,Affinity constant KD value was derived from TMP,,Autocuration,22224,,BAO_0000019,,,,1,,A
8371,,U,,CHEMBL629950,,,,,14388,0,Apparent dissociation (binding) rate constant was evaluated,,Autocuration,22224,,BAO_0000019,,,,1,,A
13114,,U,,CHEMBL630127,,,,,14389,0,Dissociation constant (KD) of the compound,,Autocuration,22224,,BAO_0000100,,,,1,,P
15515,,U,,CHEMBL630128,,,,,14390,0,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,Autocuration,22224,,BAO_0000100,,,,1,,P
522,,U,,CHEMBL630129,,,,,14391,0,Dissociation constant from ESR titration experiments,,Autocuration,22224,,BAO_0000100,,,,1,,P
13888,,U,,CHEMBL630130,,,,,14392,0,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,Autocuration,22224,,BAO_0000019,,,,1,,
2616,,U,,CHEMBL875234,,,,,14393,0,Dissociation constant was evaluated.,,Autocuration,22224,,BAO_0000100,,,,1,,P
3798,,U,,CHEMBL630131,,,,,14394,0,Dissociation constant was reported,,Autocuration,22224,,BAO_0000100,,,,1,,P
8731,10116.0,N,,CHEMBL630132,,,,,14395,1,Dissociation constant was determined in rat pituitary cells.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11892,,U,,CHEMBL630133,,,,,14396,0,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
11892,,U,,CHEMBL630134,,,,,14397,0,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
2582,,U,,CHEMBL630135,,,,,14398,0,Equilibrium dissociation constant of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
11892,,U,,CHEMBL630136,,,,,14399,0,Equilibrium dissociation constant was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
13396,,U,,CHEMBL630137,,,,,14400,0,Kinetic constant KD was evaluated,,Autocuration,22224,,BAO_0000019,,,,1,,A
603,,U,,CHEMBL630138,,,,,14401,0,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,Autocuration,22224,,BAO_0000019,,,,1,,A
15673,,U,,CHEMBL630139,,,,,14402,0,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,Autocuration,22224,,BAO_0000019,,,,1,,A
10368,,U,,CHEMBL630140,,,,,14403,0,Rate constant for hydrolysis in aqueous acetone.,,Autocuration,22224,,BAO_0000019,,,,1,,A
14228,,U,,CHEMBL875235,,,,,14404,0,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,Autocuration,22224,,BAO_0000019,,,,1,,A
11510,10116.0,N,,CHEMBL876439,,,,,14405,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630605,,,,,14406,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630606,,,,,14407,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630607,,,,,14408,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630608,,,,,14409,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630609,,,,,14410,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630610,,,,,14411,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL630611,,,,,14412,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629552,,,,,14413,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629733,,,,,14414,1,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629734,,,,,14415,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629735,,,,,14416,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629736,,,,,14417,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629737,,,,,14418,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629738,,,,,14419,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629739,,,,,14420,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629740,,,,,14421,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629741,,,,,14422,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629742,,,,,14423,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629743,,,,,14424,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629744,,,,,14425,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629745,,,,,14426,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629746,,,,,14427,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629747,,,,,14428,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629748,,,,,14429,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629749,,,,,14430,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629750,,,,,14431,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629751,,,,,14432,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629752,,,,,14433,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629753,,,,,14434,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629754,,,,,14435,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629755,,,,,14436,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629756,,,,,14437,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629757,,,,,14438,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629758,,,,,14439,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629759,,,,,14440,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL629760,,,,,14441,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11510,10116.0,N,,CHEMBL876443,,,,,14442,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
8310,9615.0,N,,CHEMBL629761,,,,,14443,1,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8310,9615.0,N,,CHEMBL629762,,,,,14444,1,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8310,10090.0,N,,CHEMBL629763,,,,,14445,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,10090.0,N,,CHEMBL629764,,,,,14446,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,10090.0,N,,CHEMBL629765,,,,,14447,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,10090.0,N,,CHEMBL629766,,,,,14448,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,10090.0,N,,CHEMBL629767,,,,,14449,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,9615.0,N,,CHEMBL629768,,,,,14450,1,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8310,10090.0,N,,CHEMBL629769,,,,,14451,1,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,9615.0,N,,CHEMBL629770,,,,,14452,1,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8310,9615.0,N,,CHEMBL629771,,,,,14453,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
8310,10090.0,N,,CHEMBL629772,,,,,14454,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,10090.0,N,,CHEMBL629773,,,,,14455,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,10090.0,N,,CHEMBL625455,,,,,14456,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,10090.0,N,,CHEMBL625456,,,,,14457,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
8310,10090.0,N,,CHEMBL625457,,,,,14458,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
12582,10116.0,N,1088.0,CHEMBL625458,,,,Urine,14459,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625459,,,,Urine,14460,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL875483,,,,Urine,14461,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL634779,,,,Urine,14462,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625460,,,,Urine,14463,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626117,,,,Urine,14464,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626118,,,,Urine,14465,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628342,,,,Urine,14466,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628343,,,,Urine,14467,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628344,,,,Urine,14468,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628345,,,,Urine,14469,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628346,,,,Urine,14470,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628347,,,,Urine,14471,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628348,,,,Urine,14472,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628349,,,,Urine,14473,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL875611,,,,Urine,14474,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628350,,,,Urine,14475,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628351,,,,Urine,14476,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628352,,,,Urine,14477,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628353,,,,Urine,14478,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628354,,,,Urine,14479,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626667,,,,Urine,14480,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626668,,,,Urine,14481,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626669,,,,Urine,14482,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626670,,,,Urine,14483,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626671,,,,Urine,14484,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626672,,,,Urine,14485,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626673,,,,Urine,14486,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626674,,,,Urine,14487,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626675,,,,Urine,14488,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626676,,,,Urine,14489,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626677,,,,Urine,14490,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626678,,,,Urine,14491,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626679,,,,Urine,14492,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL875612,,,,Urine,14493,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626680,,,,Urine,14494,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626681,,,,Urine,14495,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626682,,,,Urine,14496,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626683,,,,Urine,14497,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626684,,,,Urine,14498,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626685,,,,Urine,14499,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626686,,,,Urine,14500,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626687,,,,Urine,14501,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL624978,,,,Urine,14502,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL624979,,,,Urine,14503,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL624980,,,,Urine,14504,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL624981,,,,Urine,14505,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,9615.0,N,1088.0,CHEMBL624982,,,,Urine,14506,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
13257,,U,2367.0,CHEMBL627564,,,,Prostate gland,14507,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL627565,,,,Prostate gland,14508,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL627566,,,,,14509,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL627567,,,,Muscle tissue,14510,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2106.0,CHEMBL627568,,,,Spleen,14511,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2113.0,CHEMBL627569,,,,Kidney,14512,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,1255.0,CHEMBL627570,,,,Urinary bladder,14513,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,178.0,CHEMBL627571,,,,Blood,14514,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,1474.0,CHEMBL627572,,,,Bone element,14515,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL627573,,,,,14516,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2113.0,CHEMBL627574,,,,Kidney,14517,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2107.0,CHEMBL627575,,,,Liver,14518,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2048.0,CHEMBL627576,,,,Lung,14519,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL627577,,,,Muscle tissue,14520,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL627578,,,,Prostate gland,14521,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL627579,,,,Prostate gland,14522,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL627580,,,,Muscle tissue,14523,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL627581,,,,Prostate gland,14524,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,,CHEMBL627582,,,,,14525,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL627583,,,,Muscle tissue,14526,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2106.0,CHEMBL627584,,,,Spleen,14527,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2367.0,CHEMBL627585,,,,Prostate gland,14528,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
13257,,U,2385.0,CHEMBL627586,,,,Muscle tissue,14529,0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,Autocuration,22224,,BAO_0000218,,In vivo,,1,,A
15413,10116.0,N,,CHEMBL627587,,,,,14530,1,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL627588,,,,,14531,1,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL628250,,,,,14532,1,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL628251,,,,,14533,1,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,10000000.0,CHEMBL628252,,,,Hippocampus,14534,1,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,10000000.0,CHEMBL628253,,,,Hippocampus,14535,1,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,1898.0,CHEMBL628254,,,,Hypothalamus,14536,1,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,1898.0,CHEMBL877493,,,,Hypothalamus,14537,1,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL628255,,,,,14538,1,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL628256,,,,,14539,1,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,10000000.0,CHEMBL628257,,,,Hippocampus,14540,1,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,1898.0,CHEMBL628258,,,,Hypothalamus,14541,1,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL628259,,,,,14542,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL628429,,,,,14543,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,10000000.0,CHEMBL626862,,,,Hippocampus,14544,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,1898.0,CHEMBL626863,,,,Hypothalamus,14545,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,2037.0,CHEMBL625886,,,,Cerebellum,14546,1,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,2037.0,CHEMBL625887,,,,Cerebellum,14547,1,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL625888,,,,,14548,1,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL625889,,,,,14549,1,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,10000000.0,CHEMBL625890,,,,Hippocampus,14550,1,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,10000000.0,CHEMBL625891,,,,Hippocampus,14551,1,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,1898.0,CHEMBL625892,,,,Hypothalamus,14552,1,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,1898.0,CHEMBL625893,,,,Hypothalamus,14553,1,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,2037.0,CHEMBL625894,,,,Cerebellum,14554,1,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,,CHEMBL625895,,,,,14555,1,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12404,,U,,CHEMBL625896,,,,,14556,0,Reaction rate parameter value for phosphate with transfer with respect to ATP,,Autocuration,22224,,BAO_0000019,,,,1,,A
568,,U,,CHEMBL625897,,,,,14557,0,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,Autocuration,22224,,BAO_0000019,,,,1,,A
568,,U,,CHEMBL625898,,,,,14558,0,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,Autocuration,22224,,BAO_0000019,,,,1,,A
568,,U,,CHEMBL625899,,,,,14559,0,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,Autocuration,22224,,BAO_0000019,,,,1,,A
12404,,U,,CHEMBL626124,,,,,14560,0,Reaction rate parameter value for phosphate with transfer with respect to ATP,,Autocuration,22224,,BAO_0000019,,,,1,,A
7624,562.0,N,,CHEMBL628500,,,,,14561,1,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,Intermediate,50212,,BAO_0000218,,,Escherichia coli,1,,A
7624,10116.0,N,,CHEMBL857856,,,,,14562,1,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7624,10116.0,N,,CHEMBL628501,,,,,14563,1,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4643,,U,,CHEMBL628502,,,,,14564,0,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,Autocuration,22224,,BAO_0000019,,,,1,,A
11532,,U,,CHEMBL628503,,,,,14565,0,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,Autocuration,22224,,BAO_0000019,,,,1,,A
11018,,U,,CHEMBL628504,,,,,14566,0,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL628505,,,,,14567,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL874452,,,,,14568,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL628506,,,,,14569,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL628507,,,,,14570,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL628508,,,,,14571,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,Autocuration,22224,,BAO_0000019,,,,1,,A
8949,,U,,CHEMBL628509,,,,,14572,0,Michaelis constant (KM) was evaluated,,Autocuration,22224,,BAO_0000019,,,,1,,A
12404,,U,,CHEMBL628510,,,,,14573,0,Reaction rate parameter value for phosphate with transfer with respect to ATP,,Autocuration,22224,,BAO_0000019,,,,1,,A
7625,,U,,CHEMBL628511,,,,,14574,0,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,Autocuration,22224,,BAO_0000019,,,,1,,B
7625,,U,,CHEMBL628512,,,,,14575,0,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,Autocuration,22224,,BAO_0000019,,,,1,,B
7625,,U,,CHEMBL628513,,,,,14576,0,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,Autocuration,22224,,BAO_0000019,,,,1,,B
7625,,U,,CHEMBL628514,,,,,14577,0,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,Autocuration,22224,,BAO_0000019,,,,1,,B
12908,,U,,CHEMBL628515,,,,,14578,0,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,Autocuration,22224,,BAO_0000019,,,,1,,A
10368,,U,,CHEMBL628516,,,,,14579,0,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,Autocuration,22224,,BAO_0000019,,,,1,,A
13108,,U,,CHEMBL628517,,,,,14580,0,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,Autocuration,22224,,BAO_0000019,,,,1,,A
13108,,U,,CHEMBL628518,,,,,14581,0,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,Autocuration,22224,,BAO_0000019,,,,1,,A
15217,,U,,CHEMBL628519,,,,,14582,0,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,Autocuration,22224,,BAO_0000019,,,,1,,A
15217,,U,,CHEMBL628520,,,,,14583,0,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,Autocuration,22224,,BAO_0000019,,,,1,,A
10933,,U,,CHEMBL628521,,,,,14584,0,Binding constant was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
2363,,U,,CHEMBL630443,,,,,14585,0,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
2363,,U,,CHEMBL630444,,,,,14586,0,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL857732,,,,,14587,0,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,Autocuration,22224,,BAO_0000019,,,,1,,A
14915,,U,,CHEMBL630445,,,,,14588,0,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,Autocuration,22224,,BAO_0000100,,,,1,,P
8847,,U,,CHEMBL630446,,,,,14589,0,Catalytic rate constant of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
15357,,U,,CHEMBL630447,,,,,14590,0,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,Autocuration,22224,,BAO_0000019,,,,1,,B
2869,,U,,CHEMBL630448,,,,,14591,0,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,Autocuration,22224,,BAO_0000019,,,,1,,A
3484,,U,,CHEMBL630449,,,,,14592,0,Catalytic rate constant against phospholipase A2 was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
1373,,U,,CHEMBL630450,,,,,14593,0,"Compound was evaluated for catalytic constant, Kcat",,Autocuration,22224,,BAO_0000019,,,,1,,A
8142,,U,,CHEMBL630451,,,,,14594,0,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
14131,,U,,CHEMBL630452,,,,,14595,0,Kcat calculated from 0.693/T1/2,,Autocuration,22224,,BAO_0000019,,,,1,,A
17269,,U,,CHEMBL630453,,,,,14596,0,Kcat was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
3485,,U,,CHEMBL630454,,,,,14597,0,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,Autocuration,22224,,BAO_0000019,,,,1,,A
3485,,U,,CHEMBL630455,,,,,14598,0,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,Autocuration,22224,,BAO_0000019,,,,1,,A
3485,,U,,CHEMBL631487,,,,,14599,0,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,Autocuration,22224,,BAO_0000019,,,,1,,A
5962,,U,,CHEMBL631488,,,,,14600,0,Kcat value was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
3133,,U,,CHEMBL876440,,,,,14601,0,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,Autocuration,22224,,BAO_0000019,,,,1,,A
3133,,U,,CHEMBL631489,,,,,14602,0,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL857742,,,,,14603,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL631490,,,,,14604,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL631491,,,,,14605,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL631492,,,,,14606,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL631493,,,,,14607,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,Autocuration,22224,,BAO_0000019,,,,1,,A
4892,,U,,CHEMBL631494,,,,,14608,0,Kinetic parameter for rate of conversion to PABA was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
3133,,U,,CHEMBL631495,,,,,14609,0,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,Autocuration,22224,,BAO_0000019,,,,1,,A
11488,10116.0,N,1988.0,CHEMBL631496,,,,Feces,14610,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,1088.0,CHEMBL631497,,,,Urine,14611,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,1088.0,CHEMBL631498,,,,Urine,14612,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,1088.0,CHEMBL629776,,,,Urine,14613,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,1088.0,CHEMBL629777,,,,Urine,14614,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,1088.0,CHEMBL629778,,,,Urine,14615,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630456,,,,,14616,1,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630457,,,,,14617,1,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630458,,,,,14618,1,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630459,,,,,14619,1,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630460,,,,,14620,1,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL876550,,,,,14621,1,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630461,,,,,14622,1,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630462,,,,,14623,1,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630463,,,,,14624,1,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630464,,,,,14625,1,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630465,,,,,14626,1,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630466,,,,,14627,1,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630467,,,,,14628,1,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630633,,,,,14629,1,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630634,,,,,14630,1,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630635,,,,,14631,1,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630636,,,,,14632,1,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11488,10116.0,N,,CHEMBL630637,,,,,14633,1,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7132,9986.0,N,1988.0,CHEMBL630638,,,,Feces,14634,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL630639,,,,Feces,14635,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL630640,,,,Feces,14636,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL876551,,,,Feces,14637,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL630641,,,,Urine,14638,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL630642,,,,Urine,14639,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL630643,,,,Urine,14640,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL630644,,,,Urine,14641,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL630645,,,,Urine,14642,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL625599,,,,Feces,14643,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL625600,,,,Feces,14644,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL625601,,,,Feces,14645,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1988.0,CHEMBL625602,,,,Feces,14646,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL627470,,,,Urine,14647,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL627471,,,,Urine,14648,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL627472,,,,Urine,14649,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL627473,,,,Urine,14650,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
7132,9986.0,N,1088.0,CHEMBL627474,,,,Urine,14651,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
13925,10116.0,N,178.0,CHEMBL627475,,,,Blood,14652,1,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,178.0,CHEMBL627476,,,,Blood,14653,1,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12582,9615.0,N,1088.0,CHEMBL627477,,,,Urine,14654,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627478,,,,Urine,14655,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627479,,,,Urine,14656,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627480,,,,Urine,14657,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627481,,,,Urine,14658,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627482,,,,Urine,14659,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL627483,,,,Urine,14660,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL875636,,,,Urine,14661,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625764,,,,Urine,14662,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625765,,,,Urine,14663,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625766,,,,Urine,14664,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625767,,,,Urine,14665,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625768,,,,Urine,14666,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625769,,,,Urine,14667,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625770,,,,Urine,14668,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625771,,,,Urine,14669,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625772,,,,Urine,14670,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,9615.0,N,1088.0,CHEMBL625773,,,,Urine,14671,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,Intermediate,50588,,BAO_0000218,,,Canis lupus familiaris,1,,A
12582,10116.0,N,1088.0,CHEMBL625774,,,,Urine,14672,1,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625775,,,,Urine,14673,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625776,,,,Urine,14674,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625777,,,,Urine,14675,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625778,,,,Urine,14676,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625779,,,,Urine,14677,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625780,,,,Urine,14678,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL625781,,,,Urine,14679,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL875637,,,,Urine,14680,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626473,,,,Urine,14681,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626474,,,,Urine,14682,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626475,,,,Urine,14683,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626476,,,,Urine,14684,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL634397,,,,Urine,14685,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL626477,,,,Urine,14686,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631069,,,,Urine,14687,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631070,,,,Urine,14688,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631071,,,,Urine,14689,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631072,,,,Urine,14690,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631073,,,,Urine,14691,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631074,,,,Urine,14692,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631075,,,,Urine,14693,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631725,,,,Urine,14694,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631726,,,,Urine,14695,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631727,,,,Urine,14696,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631728,,,,Urine,14697,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631729,,,,Urine,14698,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631730,,,,Urine,14699,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631731,,,,Urine,14700,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631910,,,,Urine,14701,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15413,10116.0,N,10000000.0,CHEMBL631911,,,,Hippocampus,14702,1,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,1898.0,CHEMBL631912,,,,Hypothalamus,14703,1,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15413,10116.0,N,1898.0,CHEMBL631913,,,,Hypothalamus,14704,1,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631914,,,,Blood,14705,1,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631915,,,,Blood,14706,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL875778,,,,Blood,14707,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631916,,,,Blood,14708,1,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631917,,,,Blood,14709,1,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631918,,,,Blood,14710,1,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631919,,,,Blood,14711,1,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631920,,,,Blood,14712,1,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631921,,,,Blood,14713,1,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631922,,,,Blood,14714,1,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,178.0,CHEMBL631923,,,,Blood,14715,1,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL631924,,,,,14716,1,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL630234,,,,,14717,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL630235,,,,,14718,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL630236,,,,,14719,1,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL630237,,,,,14720,1,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL630238,,,,,14721,1,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL630239,,,,,14722,1,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL630303,,,,,14723,1,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL630304,,,,,14724,1,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,,CHEMBL630305,,,,,14725,1,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL630306,,,,Kidney,14726,1,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL630307,,,,Kidney,14727,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL630308,,,,Kidney,14728,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL630309,,,,Kidney,14729,1,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL629309,,,,Kidney,14730,1,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL629993,,,,Kidney,14731,1,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL629994,,,,Kidney,14732,1,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL629995,,,,Kidney,14733,1,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL631993,,,,Kidney,14734,1,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL631994,,,,Kidney,14735,1,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2113.0,CHEMBL631995,,,,Kidney,14736,1,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL631996,,,,Liver,14737,1,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL631997,,,,Liver,14738,1,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL631998,,,,Liver,14739,1,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL631999,,,,Liver,14740,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL632000,,,,Liver,14741,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL632001,,,,Liver,14742,1,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL874424,,,,Liver,14743,1,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL632002,,,,Liver,14744,1,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL632003,,,,Liver,14745,1,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
3133,,U,,CHEMBL632004,,,,,14746,0,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,Autocuration,22224,,BAO_0000019,,,,1,,A
2742,,U,,CHEMBL632005,,,,,14747,0,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,Autocuration,22224,,BAO_0000019,,,,1,,A
2742,,U,,CHEMBL632006,,,,,14748,0,Compound was tested for amidase rate in the presence of N62C screen enzyme,,Autocuration,22224,,BAO_0000019,,,,1,,A
2742,,U,,CHEMBL632007,,,,,14749,0,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,Autocuration,22224,,BAO_0000019,,,,1,,A
2742,,U,,CHEMBL632008,,,,,14750,0,Compound was tested for amidase rate in the presence of S166C screen enzyme,,Autocuration,22224,,BAO_0000019,,,,1,,A
2742,,U,,CHEMBL632009,,,,,14751,0,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,Autocuration,22224,,BAO_0000019,,,,1,,A
2742,,U,,CHEMBL632010,,,,,14752,0,Compound was tested for esterase rate in the presence of N62C screen enzyme,,Autocuration,22224,,BAO_0000019,,,,1,,A
2742,,U,,CHEMBL857750,,,,,14753,0,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,Autocuration,22224,,BAO_0000019,,,,1,,A
2742,,U,,CHEMBL632011,,,,,14754,0,Compound was tested for esterase rate in the presence of S166C screen enzyme,,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL632012,,,,,14755,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL632013,,,,,14756,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL632014,,,,,14757,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL629622,,,,,14758,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL629623,,,,,14759,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL629624,,,,,14760,0,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,Autocuration,22224,,BAO_0000019,,,,1,,A
17269,,U,,CHEMBL629625,,,,,14761,0,Ratio of Kcat to that of Km was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL629626,,,,,14762,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,Autocuration,22224,,BAO_0000019,,,,1,,A
2276,,U,,CHEMBL629627,,,,,14763,0,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,Autocuration,22224,,BAO_0000019,,,,1,,A
15917,,U,,CHEMBL629628,,,,,14764,0,"Compound was evaluated for constant, Kd",,Autocuration,22224,,BAO_0000019,,,,1,,A
10933,,U,,CHEMBL629629,,,,,14765,0,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,Autocuration,22224,,BAO_0000019,,,,1,,A
10933,,U,,CHEMBL629630,,,,,14766,0,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,Autocuration,22224,,BAO_0000019,,,,1,,A
14293,,U,,CHEMBL856030,,,,,14767,0,Dissociation Constant of compound determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
6698,,U,,CHEMBL629631,,,,,14768,0,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,Autocuration,22224,,BAO_0000019,,,,1,,B
6698,,U,,CHEMBL629632,,,,,14769,0,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,Autocuration,22224,,BAO_0000019,,,,1,,B
4318,,U,,CHEMBL629633,,,,,14770,0,Dissociation constant of compound with Fructose was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
4318,,U,,CHEMBL629634,,,,,14771,0,Dissociation constant of compound with Fructose was determined; Not determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
4318,,U,,CHEMBL629635,,,,,14772,0,Dissociation constant of compound with Lactulose was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
4318,,U,,CHEMBL629636,,,,,14773,0,Dissociation constant of compound with Lactulose was determined; Not determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
14959,,U,,CHEMBL629637,,,,,14774,0,Dissociation constant of the Compound,,Autocuration,22224,,BAO_0000100,,,,1,,P
5913,,U,,CHEMBL629638,,,,,14775,0,Dissociation constant by non-linear regression analysis,,Autocuration,22224,,BAO_0000100,,,,1,,P
14218,,U,,CHEMBL629639,,,,,14776,0,Dissociation constant was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
10689,,U,,CHEMBL629640,,,,,14777,0,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,Autocuration,22224,,BAO_0000100,,,,1,,P
13925,,U,,CHEMBL629641,,,,,14778,0,Dissociation constant was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
16359,,U,,CHEMBL631344,,,,,14779,0,Dissociation constant was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
10944,10116.0,N,2385.0,CHEMBL631345,,,,Muscle tissue,14780,1,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
11080,,U,,CHEMBL631346,,,,,14781,0,The dissociation constant determined by fluorescence displacement assay,,Autocuration,22224,,BAO_0000019,,,,1,,A
17805,,U,,CHEMBL631524,,,,,14782,0,kd value surface plasmon resonance (SPR) method,,Autocuration,22224,,BAO_0000019,,,,1,,A
10944,10116.0,N,2385.0,CHEMBL631525,,,,Muscle tissue,14783,1,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
16645,,U,,CHEMBL631526,,,,,14784,0,First dissociation constant of the binding of compound to V30M TTR,,Autocuration,22224,,BAO_0000019,,,,1,,F
16645,,U,,CHEMBL631527,,,,,14785,0,Second dissociation constant of the binding of compound to V30M TTR,,Autocuration,22224,,BAO_0000019,,,,1,,F
7793,,U,,CHEMBL631528,,,,,14786,0,"Compound was evaluated for equilibrium constant, Ke",,Autocuration,22224,,BAO_0000019,,,,1,,A
12199,,U,1898.0,CHEMBL631529,,,,Hypothalamus,14787,0,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,Autocuration,22224,,BAO_0000019,,,,1,,A
12199,,U,1898.0,CHEMBL631530,,,,Hypothalamus,14788,0,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,Autocuration,22224,,BAO_0000019,,,,1,,A
9680,,U,,CHEMBL631531,,,,,14789,0,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
9680,,U,,CHEMBL631532,,,,,14790,0,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
9680,,U,,CHEMBL631533,,,,,14791,0,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
13758,10090.0,N,,CHEMBL876552,,,,,14792,1,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13758,10090.0,N,,CHEMBL631534,,,,,14793,1,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13758,10090.0,N,,CHEMBL631535,,,,,14794,1,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13758,10090.0,N,,CHEMBL631536,,,,,14795,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13758,10090.0,N,,CHEMBL631537,,,,,14796,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13758,10090.0,N,,CHEMBL631538,,,,,14797,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13758,10090.0,N,,CHEMBL631539,,,,,14798,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
13758,10090.0,N,,CHEMBL631540,,,,,14799,1,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,Intermediate,50594,,BAO_0000218,,,Mus musculus,1,,A
14393,10116.0,N,,CHEMBL625637,,,,,14800,1,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14393,10116.0,N,,CHEMBL625638,,,,,14801,1,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
15078,10116.0,N,,CHEMBL625639,,,,,14802,1,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13925,10116.0,N,955.0,CHEMBL625640,,,,Brain,14803,1,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,955.0,CHEMBL625641,,,,Brain,14804,1,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,948.0,CHEMBL625642,,,,Heart,14805,1,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,948.0,CHEMBL625643,,,,Heart,14806,1,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2113.0,CHEMBL625644,,,,Kidney,14807,1,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2113.0,CHEMBL625645,,,,Kidney,14808,1,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2107.0,CHEMBL625646,,,,Liver,14809,1,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2107.0,CHEMBL625647,,,,Liver,14810,1,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2048.0,CHEMBL625648,,,,Lung,14811,1,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2048.0,CHEMBL625649,,,,Lung,14812,1,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2385.0,CHEMBL625650,,,,Muscle tissue,14813,1,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2385.0,CHEMBL625651,,,,Muscle tissue,14814,1,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,14.0,CHEMBL625652,,,,Zone of skin,14815,1,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,14.0,CHEMBL625653,,,,Zone of skin,14816,1,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2106.0,CHEMBL625654,,,,Spleen,14817,1,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,2106.0,CHEMBL625655,,,,Spleen,14818,1,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,178.0,CHEMBL625656,,,,Blood,14819,1,Biodistribution of Compound in rat blood after 15 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,178.0,CHEMBL625657,,,,Blood,14820,1,Biodistribution of Compound in rat blood after 2 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,955.0,CHEMBL625658,,,,Brain,14821,1,Biodistribution of Compound in rat brain after 15 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,955.0,CHEMBL625659,,,,Brain,14822,1,Biodistribution of Compound in rat brain after 2 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,948.0,CHEMBL625660,,,,Heart,14823,1,Biodistribution of Compound in rat heart after 15 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,948.0,CHEMBL625661,,,,Heart,14824,1,Biodistribution of Compound in rat heart after 2 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,2107.0,CHEMBL625662,,,,Liver,14825,1,Biodistribution of Compound in rat liver after 15 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,2107.0,CHEMBL625663,,,,Liver,14826,1,Biodistribution of Compound in rat liver after 2 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,2048.0,CHEMBL875621,,,,Lung,14827,1,Biodistribution of Compound in rat lung after 15 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,2048.0,CHEMBL628382,,,,Lung,14828,1,Biodistribution of Compound in rat lung after 2 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,2385.0,CHEMBL628383,,,,Muscle tissue,14829,1,Biodistribution of Compound in rat muscle after 15 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
9712,10116.0,N,2385.0,CHEMBL628384,,,,Muscle tissue,14830,1,Biodistribution of Compound in rat muscle after 2 minutes of administration,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
13925,10116.0,N,,CHEMBL628385,,,,,14831,1,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13925,10116.0,N,,CHEMBL875753,,,,,14832,1,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
13925,10116.0,N,,CHEMBL628386,,,,,14833,1,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL628387,,,,,14834,1,Organ distribution in rat blood 2 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL628388,,,,,14835,1,Organ distribution in rat blood 2 hr after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL628389,,,,,14836,1,Organ distribution in rat blood 30 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL632756,,,,,14837,1,Organ distribution in rat blood 30 min after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL628390,,,,,14838,1,Organ distribution in rat brain 2 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631811,,,,,14839,1,Organ distribution in rat brain 2 hr after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631812,,,,,14840,1,Organ distribution in rat brain 30 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631813,,,,,14841,1,Organ distribution in rat heart 2 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631814,,,,,14842,1,Organ distribution in rat heart 2 hr after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631815,,,,,14843,1,Organ distribution in rat heart 30 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631816,,,,,14844,1,Organ distribution in rat kidney 2 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL875758,,,,,14845,1,Organ distribution in rat kidney 2 hr after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631817,,,,,14846,1,Organ distribution in rat kidney 30 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,2107.0,CHEMBL631818,,,,Liver,14847,1,Organ distribution in rat liver 2 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,2107.0,CHEMBL631819,,,,Liver,14848,1,Organ distribution in rat liver 2 hr after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,2107.0,CHEMBL631820,,,,Liver,14849,1,Organ distribution in rat liver 30 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631821,,,,,14850,1,Organ distribution in rat lung 2 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631822,,,,,14851,1,Organ distribution in rat lung 2 hr after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,,CHEMBL631823,,,,,14852,1,Organ distribution in rat lung 30 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,2385.0,CHEMBL631824,,,,Muscle tissue,14853,1,Organ distribution in rat muscle 2 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,2385.0,CHEMBL631825,,,,Muscle tissue,14854,1,Organ distribution in rat muscle 2 hr after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
6941,10116.0,N,2385.0,CHEMBL631826,,,,Muscle tissue,14855,1,Organ distribution in rat muscle 30 minutes after intravenous injection,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
14439,10090.0,N,,CHEMBL631827,,,,,14856,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL631828,,,,,14857,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL631829,,,,,14858,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
12582,10116.0,N,1088.0,CHEMBL875759,,,,Urine,14859,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631830,,,,Urine,14860,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631831,,,,Urine,14861,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631832,,,,Urine,14862,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631833,,,,Urine,14863,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631834,,,,Urine,14864,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631835,,,,Urine,14865,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631836,,,,Urine,14866,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631837,,,,Urine,14867,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631838,,,,Urine,14868,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631839,,,,Urine,14869,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631840,,,,Urine,14870,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631841,,,,Urine,14871,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631842,,,,Urine,14872,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631843,,,,Urine,14873,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631844,,,,Urine,14874,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631845,,,,Urine,14875,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631846,,,,Urine,14876,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL875760,,,,Urine,14877,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL632199,,,,Urine,14878,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631847,,,,Urine,14879,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL631848,,,,Urine,14880,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628707,,,,Urine,14881,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628708,,,,Urine,14882,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628709,,,,Urine,14883,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628710,,,,Urine,14884,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628711,,,,Urine,14885,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628712,,,,Urine,14886,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628713,,,,Urine,14887,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
12582,10116.0,N,1088.0,CHEMBL628714,,,,Urine,14888,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7415,10116.0,N,,CHEMBL628715,,,,,14889,1,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
7313,,U,,CHEMBL629179,,,,,14890,0,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,Autocuration,22224,,BAO_0000019,,,,1,,A
7313,,U,,CHEMBL629180,,,,,14891,0,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,Autocuration,22224,,BAO_0000019,,,,1,,A
7313,,U,,CHEMBL875108,,,,,14892,0,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,1235.0,CHEMBL629181,,,,Adrenal cortex,14893,0,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,1235.0,CHEMBL629182,,,,Adrenal cortex,14894,0,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629183,,,,,14895,0,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629184,,,,,14896,0,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,1235.0,CHEMBL629185,,,,Adrenal cortex,14897,0,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,1235.0,CHEMBL629186,,,,Adrenal cortex,14898,0,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629187,,,,,14899,0,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629887,,,,,14900,0,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629888,,,,,14901,0,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629889,,,,,14902,0,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,1235.0,CHEMBL629890,,,,Adrenal cortex,14903,0,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629891,,,,,14904,0,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629892,,,,,14905,0,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,1235.0,CHEMBL629893,,,,Adrenal cortex,14906,0,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629894,,,,,14907,0,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
7570,,U,,CHEMBL629895,,,,,14908,0,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,Autocuration,22224,,BAO_0000019,,,,1,,A
14122,9615.0,U,,CHEMBL875109,,,,,14909,0,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,Autocuration,22224,,BAO_0000218,,In vivo,Canis lupus familiaris,1,,A
16449,9541.0,U,,CHEMBL629896,,,,,14910,0,Absolute bioavailability in male cynomolgus monkeys,,Autocuration,22224,,BAO_0000218,,In vivo,Macaca fascicularis,1,,A
16449,10116.0,U,,CHEMBL629897,,,,,14911,0,Absolute bioavailability in maleSprague-Dawley rats,,Autocuration,22224,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL629898,,,,Liver,14912,1,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL630057,,,,Liver,14913,1,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2107.0,CHEMBL630058,,,,Liver,14914,1,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630059,,,,Lung,14915,1,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630060,,,,Lung,14916,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630061,,,,Lung,14917,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630062,,,,Lung,14918,1,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630063,,,,Lung,14919,1,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630064,,,,Lung,14920,1,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630065,,,,Lung,14921,1,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630066,,,,Lung,14922,1,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630067,,,,Lung,14923,1,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2048.0,CHEMBL630068,,,,Lung,14924,1,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL631113,,,,Muscle tissue,14925,1,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL631114,,,,Muscle tissue,14926,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL631115,,,,Muscle tissue,14927,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL631116,,,,Muscle tissue,14928,1,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL630528,,,,Muscle tissue,14929,1,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL630529,,,,Muscle tissue,14930,1,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL630530,,,,Muscle tissue,14931,1,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL630531,,,,Muscle tissue,14932,1,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL630532,,,,Muscle tissue,14933,1,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2385.0,CHEMBL630533,,,,Muscle tissue,14934,1,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
15045,10090.0,N,178.0,CHEMBL630534,,,,Blood,14935,1,Biodistribution in normal mice blood after 120 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,178.0,CHEMBL630535,,,,Blood,14936,1,Biodistribution in normal mice blood after 24 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,178.0,CHEMBL630536,,,,Blood,14937,1,Biodistribution in normal mice blood after 4 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,10000001.0,CHEMBL630537,,,,Bone,14938,1,Biodistribution in normal mice bone after 120 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,10000001.0,CHEMBL630538,,,,Bone,14939,1,Biodistribution in normal mice bone after 24 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,10000001.0,CHEMBL630539,,,,Bone,14940,1,Biodistribution in normal mice bone after 4 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,948.0,CHEMBL630540,,,,Heart,14941,1,Biodistribution in normal mice heart after 120 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,948.0,CHEMBL630541,,,,Heart,14942,1,Biodistribution in normal mice heart after 24 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,948.0,CHEMBL630542,,,,Heart,14943,1,Biodistribution in normal mice heart after 4 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,2113.0,CHEMBL630543,,,,Kidney,14944,1,Biodistribution in normal mice kidney after 120 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,2113.0,CHEMBL630544,,,,Kidney,14945,1,Biodistribution in normal mice kidney after 24 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,2113.0,CHEMBL630545,,,,Kidney,14946,1,Biodistribution in normal mice kidney after 4 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,2107.0,CHEMBL630546,,,,Liver,14947,1,Biodistribution in normal mice liver after 120 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,2107.0,CHEMBL630547,,,,Liver,14948,1,Biodistribution in normal mice liver after 24 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,2107.0,CHEMBL630548,,,,Liver,14949,1,Biodistribution in normal mice liver after 4 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,2106.0,CHEMBL630549,,,,Spleen,14950,1,Biodistribution in normal mice spleen after 120 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,2106.0,CHEMBL630550,,,,Spleen,14951,1,Biodistribution in normal mice spleen after 24 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
15045,10090.0,N,2106.0,CHEMBL876426,,,,Spleen,14952,1,Biodistribution in normal mice spleen after 4 hr,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
12017,10116.0,N,2106.0,CHEMBL630551,,,,Spleen,14953,1,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL630552,,,,Spleen,14954,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL630553,,,,Spleen,14955,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL630554,,,,Spleen,14956,1,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL630555,,,,Spleen,14957,1,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL630556,,,,Spleen,14958,1,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL630557,,,,Spleen,14959,1,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL630558,,,,Spleen,14960,1,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL630559,,,,Spleen,14961,1,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2106.0,CHEMBL630560,,,,Spleen,14962,1,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
12017,10116.0,N,2046.0,CHEMBL876427,,,,Thyroid gland,14963,1,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,Intermediate,50597,,BAO_0000218,,In vivo,Rattus norvegicus,1,,A
14941,10116.0,N,,CHEMBL630561,,,,,14964,1,The Kel values in female wistar rats.,,Intermediate,50597,,BAO_0000218,,,Rattus norvegicus,1,,A
4646,,U,,CHEMBL630562,,,,,14965,0,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
8847,,U,,CHEMBL630563,,,,,14966,0,Hydrolysis rate constant of the compound,,Autocuration,22224,,BAO_0000019,,,,1,,A
11778,,U,,CHEMBL629673,,,,,14967,0,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,Autocuration,22229,,BAO_0000100,,,,1,,P
2363,,U,,CHEMBL629674,,,,,14968,0,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,Autocuration,22224,,BAO_0000019,,,,1,,A
2363,,U,,CHEMBL629675,,,,,14969,0,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,Autocuration,22224,,BAO_0000019,,,,1,,A
2363,,U,,CHEMBL629676,,,,,14970,0,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,Autocuration,22224,,BAO_0000019,,,,1,,A
2363,,U,,CHEMBL629677,,,,,14971,0,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,Autocuration,22224,,BAO_0000019,,,,1,,A
8371,,U,,CHEMBL629678,,,,,14972,0,Apparent inactivation rate constant was evaluated,,Autocuration,22224,,BAO_0000019,,,,1,,A
14883,,U,,CHEMBL629679,,,,,14973,0,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,Autocuration,22224,,BAO_0000019,,,,1,,A
14883,,U,,CHEMBL629680,,,,,14974,0,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,Autocuration,22224,,BAO_0000019,,,,1,,A
4643,,U,,CHEMBL629681,,,,,14975,0,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,Autocuration,22224,,BAO_0000019,,,,1,,A
3519,,U,,CHEMBL629682,,,,,14976,0,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,Autocuration,22224,,BAO_0000019,,,,1,,A
10600,,U,,CHEMBL629683,,,,,14977,0,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,Autocuration,22224,,BAO_0000019,,,,1,,A
8501,,U,,CHEMBL629684,,,,,14978,0,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,Autocuration,22224,,BAO_0000019,,,,1,,F
8505,,U,,CHEMBL629685,,,,,14979,0,Dissociation constant was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
9778,,U,,CHEMBL629686,,,,,14980,0,Dissociation constant was determined,,Autocuration,22224,,BAO_0000100,,,,1,,P
9778,,U,,CHEMBL872932,,,,,14981,0,Dissociation constant at pH 7.4,,Autocuration,22224,,BAO_0000100,,,,1,,P
9778,,U,,CHEMBL629687,,,,,14982,0,Dissociation constant in presence of 1 mM dithiothreitol,,Autocuration,22224,,BAO_0000100,,,,1,,P
13007,,U,,CHEMBL872931,,,,,14983,0,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,Autocuration,22224,,BAO_0000019,,,,1,,A
13007,,U,,CHEMBL628151,,,,,14984,0,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,Autocuration,22224,,BAO_0000019,,,,1,,A
13007,,U,,CHEMBL628152,,,,,14985,0,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,Autocuration,22224,,BAO_0000019,,,,1,,A
13007,,U,,CHEMBL628153,,,,,14986,0,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,Autocuration,22224,,BAO_0000019,,,,1,,A
11482,,U,,CHEMBL628154,,,,,14987,0,Kinetic constant for aromatization of androstenedione,,Autocuration,22224,,BAO_0000019,,,,1,,A
11482,,U,,CHEMBL628155,,,,,14988,0,Kinetic constant for aromatization of testosterone,,Autocuration,22224,,BAO_0000019,,,,1,,A
2303,,U,,CHEMBL628156,,,,,14989,0,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,Autocuration,22224,,BAO_0000019,,,,1,,A
11964,,U,,CHEMBL628157,,,,,14990,0,Local inhibition constant was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
3140,4932.0,N,,CHEMBL857533,,,,,14991,1,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,Intermediate,50347,,BAO_0000218,,,Saccharomyces cerevisiae,1,,A
10650,,U,,CHEMBL628158,,,,,14992,0,Dissociation constant value of the compound,,Autocuration,22224,,BAO_0000100,,,,1,,P
4667,,U,964.0,CHEMBL628159,,,,Cornea,14993,0,In vitro permeability through cornea without epithelium,,Autocuration,22224,,BAO_0000019,,,,1,,A
4667,,U,964.0,CHEMBL875616,,,,Cornea,14994,0,In vitro permeability through intact cornea,,Autocuration,22224,,BAO_0000019,,,,1,,A
9199,9986.0,N,964.0,CHEMBL628160,,,,Cornea,14995,1,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,Intermediate,50592,,BAO_0000218,,,Oryctolagus cuniculus,1,,A
11966,,U,,CHEMBL628161,,,,,14996,0,Rate of enzyme inactivation for the compound was determined,,Autocuration,22224,,BAO_0000019,,,,1,,A
4667,,U,964.0,CHEMBL628162,,,,Cornea,14997,0,In vitro permeability through cornea without epithelium,,Autocuration,22224,,BAO_0000019,,,,1,,A
4667,,U,964.0,CHEMBL628163,,,,Cornea,14998,0,In vitro permeability through intact cornea,,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628164,,,,,14999,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628165,,,,,15000,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628166,,,,,15001,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628167,,,,,15002,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628168,,,,,15003,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628169,,,,,15004,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628170,,,,,15005,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628171,,,,,15006,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL627434,,,,,15007,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL627435,,,,,15008,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628110,,,,,15009,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628111,,,,,15010,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628112,,,,,15011,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628260,,,,,15012,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
8354,,U,,CHEMBL628261,,,,,15013,0,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,22224,,BAO_0000019,,,,1,,A
14439,10090.0,N,,CHEMBL628262,,,,,15014,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,9606.0,N,,CHEMBL628263,,,,,15015,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,Intermediate,50587,,BAO_0000218,,In vivo,Homo sapiens,1,,A
14439,10090.0,N,,CHEMBL628264,,,,,15016,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628265,,,,,15017,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628266,,,,,15018,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628267,,,,,15019,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628268,,,,,15020,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628269,,,,,15021,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628270,,,,,15022,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628271,,,,,15023,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
14439,10090.0,N,,CHEMBL628272,,,,,15024,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,Intermediate,50594,,BAO_0000218,,In vivo,Mus musculus,1,,A
